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It s all very blurry.' Exploring the messy realities of living w ith hepatitis C.
A thesis subm itted fo r the degree o f Doctor o f Philosophy 
January 2014 
Heather Louise Mack BA(hons)
Abstract
Across the UK, 200,000 -  500,000 people live w ith  chronic hepatitis C. Spread through blood 
to  blood contact, the main route o f transmission in the UK is via sharing injecting drug use 
equipm ent. The negative perceptions which accompany this, coupled w ith  the hidden nature 
o f the  illness and the slow course o f the infection, have enacted and materialised hepatitis C 
as a low  prio rity  fo r services and policy. There are treatm ents which can eradicate the virus, 
though trea tm ent can exacerbate and produce severe im pairm ent effects and disablism.
Given the lack o f a ttention  afforded to  hepatitis C experience in the UK, at the heart o f this 
PhD study are 21 people w ith  the virus, who participated in qualitative interviews. Findings 
are structured around topics currently under addressed in UK literature; including the period 
fo llow ing diagnosis, the post trea tm ent experience, the impact on em ploym ent and the 
experience o f claiming social security benefits.
The accounts generated in these interviews were much messier than anticipated. The 
concept o f 'mess' has emerged as central to  the constitution o f this thesis and, as I show, 
central to  responding to  the needs o f those living w ith  hepatitis C. The practical implications 
and manifestations o f this messiness are theorised using the concepts o f metaphor, 
lim ina lity, pharmakon and pharmakos. The thesis also applies insights from  the fie ld o f 
d isability studies, a discipline which has not been used extensively to  theorise the 
experiences o f living w ith  hepatitis C.
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The thesis engages in an important and timely discussion of the everyday realities of living 
w ith  hepatitis C and the role o f professional health and social care support. Particularly given 
the contingent nature o f living w ith  the virus and the state o f flux participants found (and 
find) themselves in, due to  public service reforms and new trea tm ent development. It shows 
th a t despite the current (and increasing) dominance o f medical responses to  hepatitis C, 
there  is an urgent need fo r o ther professionals, including social work and those working in 
disability studies, to  address hepatitis C.
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Glossary of terms
It has been necessary to  provide a glossary o f terms at the beginning to  this thesis, as some 
o f the term s are used before they are fu lly  explained. This has proven to  be unavoidable in 
the dra fting  and redrafting o f the thesis and fu rthe r challenges the linear presentation o f 
research accounts.
Acute infection. Infection lasting less than 6 months.
Antibody test. The firs t test undertaken to  determ ine w hether someone has hepatitis C. This 
test detects hepatitis C antibodies. The presence o f hepatitis C antibodies in the blood does 
not necessarily mean someone is currently  living w ith  hepatitis C, just tha t they may have 
been exposed to  the virus. Current hepatitis C infection is determ ined w ith  a PCR test (see 
below).
Asymptomatic. Displaying no signs or symptoms o f infection.
Chronic infection. Infection lasting longer than six months.
Co-constitute. To engage in an active process o f bringing realities and things in to  being in a 
way which acknowledges tha t phenomena shape and are shaped by processes and things 
w ith  which they intra-act.
Combination treatment. The standard trea tm ent fo r hepatitis C at the tim e o f interview. 
Two medications taken in combination, Pegylated Interferon and Ribavirin.
Cirrhosis. Permanent scarring or damage to  the liver which impairs its ability to  function.
Direct Acting Anti Virals (DAA). Medications which act directly on the virus.
14
Disability. Distinct from impairment, disability is the disadvantage or restriction of activity 
caused by contem porary social organisation which takes little  or no account o f people who 
have im pairm ents, thereby excluding them  from  fu ll partic ipation in mainstream life (UPIAS, 
1974: 14).
Enact. To bring specific objects or realities into being. In my view, the term  enactment 
recognises th a t w hat is brought in to being is contingent - continually engaged in a process o f 
com ing in to  being, w ithou t one fixed final product at the end of, or separable from , those 
processes.
Fibrosis. The development o f scar tissue on the liver as a result o f in flam m ation or damage.
Genotype. The strain o f hepatitis C virus. There are six types -  known by numbers i.e. 
genotype 1, 2, 3,4,5,6 and these can be divided into subtypes i.e. genotype lb .  Knowledge of 
genotype is im portant fo r determ ining the type and duration o f treatm ent.
Hinterland. A term  used by Law (2004) to  refer to  the work and relations which accumulate 
and bundle together over tim e and through specific research practices. The work tha t comes 
before to  shore up understandings and realities in particular ways.
Illness. Illness is used throughout the thesis in conjunction w ith  (and in tertw ined w ith) 
im pairm ent. Commensurate w ith  Thomas (2007), illness is understood as a category o f 
im pairm ent. Illness in this context is used to  describe the state o f being unwell due to  
hepatitis C. Illness can be long term  (chronic) or short term  so is particularly suited to  
describing the unpredictable nature o f living w ith  the virus. W ith in  the thesis, participants 
described themselves as 'ill' but not necessarily as 'im paired'.
Impairment. Im pairm ent is used in the thesis in a functional (but not necessarily medical) 
sense. Im pairm ent is a variation or difference in a person's body which may restrict 
m ovem ent or activ ity in some way (Thomas, 2004). It is deliberately not used in this thesis to
15
describe a lack or a 'loss' and is clearly d ifferentia ted from  'd isability.' W ith in  the thesis, 
im pairm ent was not a term  used participants, but is retained in the thesis when discussing 
the w ork o f o ther academics or referring to  functional aspects o f living w ith  the v iru s ..
Impairment effects. A term  taken from  the work o f Carol Thomas (2007; 136) which refers 
to  restrictions o f bodily activity and behaviour tha t are directly a ttribu tab le  to  'im pairm ents' 
ra ther than those imposed upon people because they have designated impairments 
(disablism)' (emphasis in original text).
Intra-act. Differentiated from  the term  'in te raction ' which implies a separation between 
relations, in intra-action there is no such separation.
Liminal. Taken from  Turner (1966) and later used by M urphy (1981, 1988) among others. 
Lim inality refers to  being in between, neither one th ing nor another.
Materiality. That which is material and physical; m atter, blood, bodies, structures.
Metaphor. Frequently used to  mean giving something a name which belongs to  something 
else. I fo llow  Ricoeur (2003) in understanding tha t metaphor and reality cannot be prised 
apart from  each o ther and tha t m etaphor should be considered, not as a creative addition to  
language but fundam ental to  making it.
Method Assemblage. An active gathering o f relations and objects which carry w ith  them 
assumptions about reality and at the same tim e, contribute to  enactments o f tha t reality. 
M ethod assemblage includes research questions, in terview  schedules, researchers, 
participants, tape recorders, transcription pedals as well as assumptions about reality 
research methods and political understandings.
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M u ltip le . Not singular and fixed but numerous and overlapping. Expressed by Mol (2002) as 
more than one less than many' -  meaning tha t there may be more than one enactm ent or 
reality, which are not separate and bounded but mingle together.
Ontological politics. Connected to  the notion o f m ultip le defined above. If m ultip le 
enactments o f objects and realities are possible, then the notion o f a single answer or 
in te rp re ta tion  ceases to  exist. So decisions have to  be made about which in terpre ta tion  to  
accept and which reality to  bring into being, which in the case o f this thesis, is highly 
political. These debates about what to  bring into being are ontological politics.
PCR (Polymerase Chain Reaction) test. The PCR test is the second test in the process o f 
diagnosing w hether someone has hepatitis C. It determ ines whether the virus is currently 
replicating w ith in  the blood. If the test is positive this means someone is currently living w ith  
hepatitis C.
Phenomena. Taken from  Barad (1998). Phenomena do not pre-exist but are remade and co­
constituted in intra-action w ith  o ther phenomena. Thus the term  phenomena is used to  
describe 'objects' such as hepatitis C, ' trea tm ent' 'stigma' relations and emotions, 
recognising the continually intra-active nature o f the constitution o f reality (see Fraser and 
valentine, 2006).
Pharmakon. Used by Plato and later by Derrida (1981). Pharmakon is the th ing which is both 
poison and remedy, simultaneously. It is undecidable and contingent.
Pharmakos. Related to  the term  pharmakon, pharmakos means scapegoat.
Pharmakoi. Plural o f Pharmakos.
SVR (Sustained Virological Response). When the hepatitis C virus remains undetectable in 
the blood six months fo llow ing treatm ent.
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Trip le therapy. The use o f three d ifferent medications to  trea t hepatitis C. In April 2012 the 
com bination o f in terferon, ribavirin and direct acting antivirals were approved fo r the 
trea tm en t o f hepatitis C genotype one.
Viral Load. The am ount o f hepatitis C virus in the blood.
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C h a p t e r  One: In t r o d u c in g  the  r e s e a r c h
In troduct ion
In this firs t chapter, I pave the way fo r the rest o f the thesis. I explain why investigating the 
lived experiences o f people w ith  hepatitis C in the UK, is particularly im portant at this point 
in tim e. I outline how the research has been shaped by participant priorities and the current 
political and economic climate, as well as existing academic work. I introduce the rationale 
fo r the research, together w ith  the aim and research questions, before exploring how during 
the study, practical experiences o f fie ldw ork and my theoretical influences co-constituted 
each other. I briefly explore my personal and professional m otivations fo r the research, 
before summarising the content o f forthcom ing chapters to  guide the reader through the 
thesis. At the close o f the chapter, each o f the participants is briefly described.
Kcsedrc li ing (h r  c xpi i it iu e of living with  hepatit is C
At the heart o f this thesis are in-depth interviews w ith  21 people who lived w ith , or had lived 
w ith , hepatitis C in the UK. The thesis explores the ir experiences prior to  diagnosis and 
through testing, treatm ent and beyond, w ith  the intention o f exploring the impact o f 
hepatitis C on the ir everyday lives. Their support and inform ation requirements remain an 
explicit focus throughout.
Given the dearth o f qualitative studies which exist in relation to  the experience o f hepatitis 
C, particularly in the UK, the thesis explores a broad range o f themes and issues which were 
highlighted as im portant by participants. The thesis makes both the messy nature o f living 
w ith  the virus and the messy experience o f researching it, visible. In doing so, what is 
included here is necessarily both partial and situated - a 'cu t' (Barad, 1998) in participant 
lives at a specific point in tim e. The findings are thus not intended to  be representative o f
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any part o f the experience o f hepatitis C, given its contingent and shifting nature, but are 
intended to  docum ent and validate the experiences o f participants in this study and to  
stim ulate and invigorate discussion around responses to  hepatitis C. The thesis provides 
im portan t insights across a number o f areas, including participants social support 
requirem ents, welfare benefit, employm ent and post trea tm ent experiences. It contributes 
to  alternative enactments o f hepatitis C and people w ith  it, in addition to  and beyond, the 
current medical focus.
Rationale  tor tlu* research
At present a significant proportion o f existing qualitative research focuses on hepatitis C 
from  nursing and healthcare perspectives, especially research in the UK and Northern Ireland 
(Glacken et al., 2001; Grogan and Timmins, 2010; Frazer et al., 2011a, 2011b; Tait et al., 
2010). A key focus o f research in relation to  hepatitis C is harm reduction (Taylor et al., 2004) 
among people who use drugs, including how to  reduce the spread o f the virus and how to  
encourage access to  testing and trea tm ent (Harris et al., 2012a). W hilst this is undoubtedly 
im portant, this means tha t the needs and experiences o f those who are diagnosed w ith  
hepatitis C, or who access treatm ent, appear to  be o f lim ited concern. Indeed, this lack o f 
research interest beyond access to  treatm ent treats the ir needs as having been adequately 
addressed. This thesis shows tha t the opposite is true, tha t a new set o f needs and 
challenges arise post diagnosis which are inadequately supported at present.
The voices o f those w ith  hepatitis C, especially in a UK setting, are scarce in research, in 
comparison to  the am ount o f quantita tive research available. In addition, some have noted 
th a t people w ith  hepatitis C are often represented only as participants in clinical trials 
(Korner and Treloar, 2006; Korner, 2010). Thus, it was im portant fo r me to  include some of 
the  voices o f people living w ith  hepatitis C at present, both to  develop recommendations fo r 
services and to  encourage the inclusion and representation o f people w ith  hepatitis C in
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w ider society, particularly in debates about services and welfare reforms, given the rapid 
changes taking place.
1 ho t w i s t s  .Hid ( u r n s  ol  the  r e s e a r c h  p ro c e s s
I in itia lly  planned to  explore the experience o f living w ith  hepatitis C from  the perspective o f 
those living w ith  the virus and the professionals supporting them , by interview ing people 
w ith  hepatitis C and then using these interviews to  develop and inform  the sample and 
in terv iew  schedules fo r professionals; my intention was to  explore how the perspectives of 
both groups could contribute to  improved services. During the course o f generating the data,
I found tha t the experience o f living w ith  (and working w ith) hepatitis C was far more 
complex and, indeed messy, than I had in itia lly anticipated: The tools used to  generate 
accounts and the data m utually informed and constituted each other, and the support and 
in form ation needs o f participants w ith  hepatitis C went far beyond what was provided by 
services. These needs (and participant accounts o f these needs) were shaped by cultural, 
societal and political forces and expectations, w ith  serious and far reaching implications fo r 
partic ipant wellbeing. Participant accounts also highlighted a need fo r the involvement o f a 
much w ider range o f professionals. As a result, the concept o f mess (see Law, 2004) has 
emerged as vita l in this thesis and both necessitated and explained the focus on the accounts 
o f people w ith  hepatitis C, rather than in conjunction w ith  professional accounts as in itia lly 
planned.
Personal and professional motivations
Initial in terest in the experiences o f those w ith  hepatitis C arose in the context o f my 
undergraduate degree in social work, where hepatitis C was covered under the module 
'Social W ork and Drug Use' and was introduced as an issue o f increasing concern fo r social 
work. This was augmented during my final placement w ith  a statutory Social Services team,
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working w ith  physically disabled adults. W hilst on placement, I worked w ith  Sandra1 who 
was preparing fo r discharge from  hospital a fte r an am putation, but whose referral also 
indicated a positive hepatitis C status. Sandra expressed extrem ely negative views around 
hepatitis C (and around the professionals who had disclosed her status to  me) and resisted 
my attem pts to  discuss it again fo r the duration o f our work. When I talked it over w ith  my 
Practice Assessor at supervision, she explained she was unfam iliar w ith  hepatitis C and did 
not often come across it in the course o f her work.
As a result o f this less than ideal encounter, I reflected on how I m ight have facilitated more 
positive discussion, but also on the potentia l w ider role and implications fo r social work w ith 
people who have hepatitis C. This led to  an undergraduate dissertation on the interaction 
between hepatitis C, social work and harm reduction (Mack, 2007) which fu rthe r ignited an 
interest in doing empirical work in this area. The PhD has thus enabled me to  engage and 
combine a passionate interest in hepatitis C and the role o f social work in drug use and 
health more w idely. In addition, as the PhD progressed, I came to  understand tha t my status 
as a disabled woman also influenced the research and I became interested in what disability 
studies could o ffe r in understanding the experience of living w ith  hepatitis C.
Orig inal i ty  ai 1 im portance  of the research
The thesis makes im portant contributions, firs t and forem ost in exploring the experience of 
hepatitis C in the UK, from  w ith in  the social sciences and especially social work. It challenges 
the sole focus o f medicine in responding to  hepatitis C.
W here much o f the existing qualitative literature focuses on reducing hepatitis C related 
harm fo r those who use drugs and encouraging them  into testing and treatm ent, the 
partic ipant sample was made up o f those not currently injecting drugs and who were able to
1A pseudonym.
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access trea tm ent and who would thus appear to be well served by existing services, (for 
example: GPs, hepatitis C clinics). Further, including the experiences o f co-infected gay men 
in the research highlights the importance o f responding to  those w ith  co-infection and 
makes suggestions fo r how services m ight respond in the future.
This thesis adds to  and intersects w ith  a number o f bodies o f work, most obviously to  the 
hepatitis C social research literature. It also contributes to  literature which explores 
participants' use o f metaphor to  describe experiences o f illness and to  an emerging body o f 
w ork which investigates how hepatitis C is materialised through social and political forces 
(Fraser and valentine 2008; Fraser and Seear, 2011). It applies research and theory which 
had only previously been applied to  hepatitis C in an Australian context, to  a UK setting. It 
illum inates in new and im portant ways the experience o f living w ith  hepatitis C (and its 
trea tm ent) in the UK; including how people w ith hepatitis C see themselves, how culturally 
pro lific diseases (Weiss, 1997) are made and remade depending on context, the people they 
affect and material conditions. It applies insights emerging from  the field o f disability studies 
-  a discipline which to  date, has not been applied to  the experience o f hepatitis C and 
explores the application o f the concept o f psycho-em otional disablism, (Thomas, 2007; 
Reeve, 2008) both in direct and indirect forms.
Furthermore, it addresses a number o f areas which are currently under explored in existing 
literature, notably the experience o f post treatm ent, welfare benefits and employment, the 
experience o f HIV and hepatitis C co-infection, and participant feelings around identifying as 
disabled. It makes practical contributions concerning inform ation and support requirements. 
Vitally, it recognises and argues fo r increased recognition and involvement from  social work 
in providing this in form ation and support, maintaining they are uniquely placed to  address 
many o f the issues participants raised in the thesis.
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The diverse nature of the chapters, the broad range of experiences and the inclusion of 
d iffe ren t bodies o f work enact the contingent, m ultip le and complex nature o f living w ith  
hepatitis C. This explains, in part, the d ifficu lty  in responding adequately to  hepatitis C, but 
also the highly political and ideological way in which services are constituted. The thesis has 
a d istinctly political aim: to  call fo r greater response to  hepatitis C in the UK (including co- 
in fection) and to emphasise the com m onality o f experience and needs among others w ith  
chronic illness.
Research aim and questions
As was explained above, the current research focus in the UK is on hepatitis C and drug use, 
specifically harm reduction, or on encouraging people into testing and treatm ent. I wanted 
to  investigate w hat happened a fte r  diagnosis in order to  improve professional responses to  
hepatitis C. Thus the aim o f the thesis is to  explore understandings, experiences and social 
im plications o f living w ith  hepatitis C in the UK, focusing on the fo llow ing specific questions:
1. W hat are the support and inform ation needs o f people living w ith  and being treated 
fo r hepatitis C in the UK?
W hilst talking about the ir support needs, it became clear tha t participants' needs (and 
perceptions o f them ) were shaped by understandings and expectations related to  the 
cultura l position o f hepatitis C. Therefore, research question tw o  was form ulated:
2. W hat do participant accounts reveal about the cultural and social position of 
hepatitis C in the UK at present and how can this improve our understanding and 
response?
In itia lly  I understood this cultural position to  relate to  the stigma around injecting drug use. 
Hence research question three:
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3. Do people w ith  hepatitis C experience stigma and discrim ination?
W hilst the experiences o f stigma and discrim ination were enacted and are addressed in the 
thesis, the concept o f psycho-emotional disablism is also applied to  the experience o f 
hepatitis C. Thus whilst the original research question still stands, the thesis moves beyond it 
by exploring structural barriers and oppression on an inherently political level.
An introduct ion to tlio concepts used in the thesis
W ith in the thesis, a number o f theoretical concepts are used to  unfold and explain 
particu larly messy aspects o f living w ith  hepatitis C. They are introduced briefly below.
Metaphor
Explored in chapter six, metaphors have been recognised as fundamental to  how we see the 
w orld  and function w ith in  it (Lakoff and Johnson, 1990), in particular in illum inating (Lupton, 
2003) and shaping (Sontag, 1991) experiences and aspects o f illness. Despite this, there has 
been little  explicit discussion about the role o f m etaphor in participant accounts o f hepatitis 
C. A particu larly im portant and fresh contribution that this thesis makes, is an exploration o f 
how participants used a comparison w ith  cancer, and the way this was both used as a 
m etaphor and became a m etaphor fo r being 'undeserving' o f support.
I.iminnlity
The te rm  lim inality was used by Turner (1966) and later by Murphy et a l,  (1988), to  describe 
being 'in between', neither one thing nor another; fo r example, neither well nor ill. 
Lim inality is a highly relevant concept given tha t it makes the contingent and constructed 
nature o f the world  visible. The thesis shows tha t participants experienced lim inality because 
society continues to  disable them  both structurally (W ille t and Deegan, 2001) and psycho- 
em otionally. Lim inality is also relevant given the association between people experiencing
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lim ina lity  and the concepts o f pollution or contagion (W illet and Deegan, 2001). Participants 
described finding themselves in lim inal spaces, where there was little  in the way o f support 
o r recognition, at numerous junctures in the ir lives, though this was sometimes a powerful 
position. The specific implications o f this w ill be returned to  and explored throughout.
P l i i i r m a k o n / T h m  makus
Pharmakon and pharmakos are tw o separate but interrelated concepts, explored in greater 
depth in chapter seven. Pharmakon tha t which is simultaneously poison and remedy, and 
undecidable (Derrida, 1981). Pharmakon is used to  explore how particular enactments (i.e. 
remedy) are privileged in talking about and providing support fo r hepatitis C, but tha t a clear 
division between poison and remedy is impossible to  maintain, which has particular 
im plications fo r people w ith hepatitis C. The related concept pharmakos, meaning 
scapegoat, is used to  draw together sim ilarities between people w ith  hepatitis C and (other) 
disabled people. The ways in which participants, hepatitis C and trea tm ent are enacted as 
pharmakos  are explored through chapters seven and eight. The use o f this concept, in 
particular, marks a unique contribution o f the thesis given tha t it has not been used to  
explore hepatitis C to  date.
T he s tructure  ol  the thesis
Chapter Two 'Crafting hepatitis C realities in social research' reviews existing literature. It 
traces the development and enactm ent o f hepatitis C related knowledge, via prevalence 
rates, policy responses and testing and trea tm ent options. It draws on research from  
countries outside o f the UK owing to  the small body o f research tha t currently exists there. 
There is exploration o f the cultural position o f hepatitis C, and how hepatitis C has been 
materialised as an illness associated w ith  injecting drug use. It explores aspects o f the 
lite ra ture  which have relevance to  the forthcom ing chapters including: disclosure, diagnosis,
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professional and peer support, HIV co-infection, awareness, the dominance of medicine, 
welfare benefits, em ploym ent, and the role o f social work. The last part o f the chapter 
introduces selected disability studies literature, fo r the purposes o f this thesis, and explains 
the shift from  exploring stigma to  paying attention  to  psycho-emotional disablism (Reeve, 
2012a).
Chapter Three 'Getting messy; theoretical underpinnings' explores in depth the way the 
practical realities o f fie ldw ork shaped my theoretical understanding o f hepatitis C - and the 
w orld  - as messy, contingent and intra-active. It is closely in tertw ined w ith  chapter four 
(hence the sim ilar title ) and deciding on the orders o f these tw o  chapters was particularly 
d ifficu lt given the changes in epistemological and ontological understanding which took 
place during fie ldw ork. The decision was taken to  explore the 'concept' o f mess first, but 
then to  move back and forth .
Chapter Four 'Getting messy; the practical realities o f fie ldw o rk ' describes the research 
m ethods I used to  generate participant accounts o f the experience o f living w ith  hepatitis C 
and the decision to  focus solely on participants w ith  hepatitis C. I explore ethical approval 
processes, research design, recruitm ent methods, interview ing modes and ethical issues that 
arose in the course o f the fie ldwork, as well as the analysis and early dissemination practices. 
This chapter and chapter three make original contributions in tha t they apply Law's (2004) 
arguments, specifically around mess, in applied and practical ways in relation to  hepatitis C.
Following on from  this, the data chapters weave findings and relevant literature together - 
each one intra-acting w ith  the last, developing a cumulative (if still partial) reality and 
contribu ting  to  a new hepatitis C hinterland (Law, 2004). The findings chapters are 
in tentiona lly  chronological to  guide the reader through the thesis, but chiefly to  show how 
partic ipant experiences diverge from  this chronology and linearity. They simultaneously
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make visible the dominance o f medicine and the inadequacy o f current responses to 
hepatitis C.
Chapter Five, 'She said you're positive - I thought 'positive fo r  w hat? ' f irs t encounters w ith  
hepatitis C  explores participants' in itia l experiences as a means o f giving context to  the 
o the r findings chapters which fo llow . It addresses participants' experiences of undiagnosed 
illness and invalidation (Wendell, 1996, 2006), problematising hepatitis C's 'asymptomatic' 
nature, before moving on to  explore experiences o f diagnosis and how these contribute to  
the enactm ent o f hepatitis C as a low priority. The chapter makes an im portant contribution 
in providing a recent addition to  the diagnosis literature, and in documenting participants' 
need fo r post diagnosis support. It also explores how representations o f the virus in current 
awareness raising campaigns, both draw from , and reinforce, current service responses. 
Participant experiences of structural disablism are explored, as well as the impact on 
partic ipants' psycho-emotional wellbeing.
Chapter Six is entitled  "People w ith HIV and cancer get a ll the publicity'. Talking about 
hepatitis C: metaphors, comparisons and im plications.' This chapter investigates the cultural 
position o f hepatitis C. It foregrounds specific metaphors used by participants to  ta lk about 
the virus and treatm ent, explores strategies used to  manage the interaction w ith  others and 
how inform ation provision shapes hepatitis C and participants' sense o f self. Participants' 
use o f the m etaphor 'silent killer' is considered, specifically the way this is used to  reinforce 
the personal im portance o f treatm ent. Comparisons w ith  tw o high profile illnesses, cancer 
and HIV are discussed in depth. Here the concept o f a hierarchy o f im pairm ent and the 
implications fo r participants' wellbeing and identification w ith  o ther groups are explored.
Chapter Seven "Left in lim bo ' Hepatitis C treatm ent; pharmakon and pharm akos' explores 
participants' trea tm ent experiences and support requirements, which were crucial in the ir 
accounts. It explores how medicine enacts and materialises people w ith  hepatitis C in
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specific ways, which both reinforce the need fo r trea tm ent and potentia lly marginalise 
additional needs. The concepts o f pharmakon  and pharmakos are used to  unfold and 
explore the ambiguous experience of trea tm ent and the position of people w ith  hepatitis C, 
and to  draw out sim ilarities and intra-actions between the oppression and exclusion faced by 
people who use drugs, people w ith  hepatitis C and (other) disabled people.
Chapter Eight 'It was an aw fu l shock to s till fee l like I d id ' explores partic ipant experiences o f 
post trea tm ent effects and support needs, including how post trea tm ent support m ight look, 
the role o f self-management programmes and the concept o f recovery.
Chapter Nine; "And you're thinking, am I ill enough?' welfare benefits and employment w ith  
hepatitis C' explores participants' experiences and sense o f entitlem ent to  claim welfare 
benefits. It weaves current debates about welfare reform w ith  participant accounts o f try ing 
to  claim benefits, and cultural understandings o f hepatitis C w ith  understandings o f the 
benefits system as psycho-emotionally disabling (as explored by Reeve, 2008, 2012a). Later, 
participants' experiences o f employment, specifically in obtaining reasonable adjustments 
under the Disability Discrim ination Act (1995, 2005) (now part o f The Equality Act, 2010) and 
the degree to  which they fe lt they were covered by existing legislation are also addressed.
Chapter Ten 'Concluding thoughts' brings together the main research findings and discusses 
how the thesis has addressed and shaped the research questions. It describes the unique 
and original contributions tha t this thesis has made to  a number o f existing bodies of 
knowledge. The thesis ends by suggesting areas fo r fu rthe r research.
Appendix one details a range o f 'Recommendations fo r  policy and practice ' given tha t the 
length o f the thesis prohibited the ir inclusion in the final document.
A b r ie f  in tro duction  to partic ipants
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Below I provide a short in troduction to each participant in order to  provide context to  the 
chapters tha t fo llow  and to  maintain a focus on the ir personhood, consistent w ith  viewing 
hepatitis C in the context o f participants' everyday lives. M ost o f the participants chose 
pseudonyms. Others chose to  keep the ir own names.
Morgan was 56. She found out she had hepatitis C in 2008, although she had been tested six 
years previously. At the tim e o f interview, she had finished 24 weeks o f combination 
trea tm en t and was waiting to  see if she had attained SVR. She has since cleared the virus. 
Morgan was unsure where she had contracted the virus but recalled incidences o f medical 
trea tm en t abroad a number o f years ago. Morgan lived alone but received support from  her 
children and her friends whilst on treatm ent. She emphasised tha t it was im portant to  her 
to  live close to  nature. She was self-employed as an alternative health practitioner and 
described knowing something was wrong when she began to  feel dizzy and unwell at work. 
She had stopped w ork at the tim e of in terview  due to  the side effects o f trea tm ent and post 
treatm ent.
Laurie was 44. He lived w ith  his w ife and tw o  children and described his fam ily as extremely 
supportive. Laurie was made redundant part way through treatm ent, though he was back to  
w ork at the tim e o f interview. He is a keen musician. He is unsure where he contracted 
hepatitis C, although he believes he may have caught it accidentally from  a sibling. He was 
diagnosed in 2006 by the National Blood Service. He undertook a course o f combination 
trea tm en t fo r 24 weeks in 2007 and attained SVR. He explained he did not return to  work fo r 
five months post trea tm ent due to  on-going effects.
Freda was 53. She was diagnosed w ith  hepatitis C in 1990 by the National Blood Service. She 
believes tha t she contracted hepatitis C during a blood transfusion given during the b irth o f 
one o f her children in the 1970s. Freda did not discuss her hepatitis C w ith  anyone until she 
was referred to  a gastroenterologist. Freda was on treatm ent at interview  but stopped at 28
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weeks due to  trea tm ent failure and the severe treatm ent effects she experienced. Freda 
works in physical rehabilita tion and continued to  work throughout treatm ent, although she 
found this very d ifficu lt.
Kerry was 30 at the tim e of in terview  and was a single mum. She lived alone and described 
relying on support from  her fam ily in order to  get through treatm ent. She was coming to  the 
end o f 24 weeks o f trea tm ent fo r hepatitis C at the tim e o f in terview  and has since attained 
SVR. She has been actively involved in campaigning fo r greater awareness around hepatitis 
C. Kerry thinks tha t she contracted hepatitis C through sharing equipm ent fo r injecting drug 
use, although she stopped using drugs in 2005 when pregnant. Kerry lives w ith  an existing 
mental health condition. Kerry is interested in music and has a degree in Politics.
Ken was 59. He was retired due to  a range o f health issues which he fe lt arose from  35 years 
o f drug use. He had cleared hepatitis C five years prior to  the interview  (2005). He was 
diagnosed in 2003 at his local drug service. He had undertaken combination treatm ent 
successfully. He was a member o f a local support group and described providing on-going 
support to  people w ith  hepatitis C. He lives w ith  his partner. Ken fe lt it was very im portant 
to  pass on his life experience to  others. He volunteers fo r a local drug service and in a local 
prison.
JB was 55. He participated in the interview  w ith  his w ife Pixie w ith  whom he set up an 
online support group fo r people w ith  hepatitis C. JB described contracting hepatitis C from  
experim enting w ith  injecting drugs fo r a short period in the 1970s. JB was diagnosed by his 
GP in 2004/5. JB had been treated tw ice in tw o  d iffe rent geographical areas which 
highlighted differences in support. At the tim e o f the interview  JB had finished trea tm ent fo r 
the second tim e and was waiting to  see if he had attained SVR. He has since cleared the 
virus.
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Pixie was in her 50s at the tim e o f interview. She was married to JB and set up an online 
support group due to  a lack of social support. She is active both in running this and raising 
w ider awareness around hepatitis C. She contracted the virus in 1980 from  a blood 
transfusion and was diagnosed in 2000. At the tim e there was no funding available in her 
area so she did not begin trea tm ent until 2005. Pixie underwent trea tm ent fo r 48 weeks and 
described experiencing no side effects. She attained SVR in 2007.
Carl participated in a group interview  w ith  Andrew and Brad. Carl was diagnosed 15 years 
p rio r to  in terview  (late 1990s) a fte r his liver function was tested before he w ent onto a 
m edication. At the tim e o f diagnosis, no treatm ent, in form ation or support was available. 
Carl described experiencing no illness prior to  beginning trea tm ent and began trea tm ent 
a fte r entering recovery. He attained SVR and experienced post trea tm ent effects fo r about 
14 weeks.
Andrew also participated in the group interview  w ith  Brad and Carl. He was diagnosed w ith  
hepatitis C approximately 12-15 years ago. He was given the diagnosis w hilst attending a 
substance misuse service w ith  very little  accompanying inform ation, which he a ttribu ted  to  
the tim e period. Andrew reported feeling no effects from  the hepatitis C until he started 
trea tm ent. He had completed trea tm en t and attained SVR tw o  years prior to  interview, but 
described ongoing post-treatm ent effects.
Brad participated in the group interview  w ith  Carl and Andrew. He contracted both hepatitis 
C and HIV a fte r being raped. He was diagnosed w ith  hepatitis C much iater than Andrew and 
Carl (m id-late 2000s). He finished trea tm ent tw o  years ago, at the tim e o f the interview  
(2010), but explained tha t the experience fe lt very raw. He completed 48 weeks of 
trea tm en t and experienced serious post trea tm ent effects.
Richard was 60. He found out he had hepatitis C in 2000 a fte r undergoing numerous
investigations. He was diagnosed by a local drug service because he did not want colleagues
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or his GP to  know he was being tested. He thinks he contracted hepatitis C though injecting 
drug use in the 1970s/1980s. He underwent six months o f mono interferon trea tm ent but 
did not atta in SVR. At this point he had cirrhosis o f the liver and was put on the list fo r a liver 
transplant, which he had in 2004. He has since undergone a course o f combination therapy, 
though this was also unsuccessful. Richard was also involved w ith  his local support group and 
at the tim e o f in terview  was researching the possibility o f setting up a telephone support 
service fo r people w ith  hepatitis C.
A t the tim e o f in terview  Grace was in her 40s and lived w ith  her partner and teenage child. 
She thinks she caught hepatitis C around 20 years ago. Grace was not sure where she 
contracted it, but believes it may have been from  a blood transfusion fo llow ing childbirth or 
from  a dentist. Grace was diagnosed in 2007 by a locum GP after seeking advice fo r a range 
o f im pairm ent effects fo r about tw o years. Grace gave up work and sold her own business, 
before she started treatm ent. Grace did trea tm ent tw ice and at the tim e of interview  had 
been on trea tm ent fo r a year and a half. She has since attained SVR.
Daniel was diagnosed w ith  hepatitis C in June 2009. At the tim e o f interview he was waiting 
to  see if he had cleared the virus after discontinuing the trea tm ent due to  an allergic 
reaction. He has a partner and a daughter. He is currently studying to  become a therapist. He 
discovered he had hepatitis C after going 'fo r an MOT after getting clean and sober'. He has 
since attained SVR.
Holi was 46. She lives w ith  her husband and has tw o adult daughters who she described as 
being very supportive during treatm ent. She discovered she had hepatitis C in 2008 but had 
been feeling unwell fo r about 20 years. Holi explained tha t she has never been in one o f the 
'risk groups' fo r hepatitis C, so can only speculate as to  how she m ight have contracted it. 
She underwent 24 weeks o f trea tm ent and has attained SVR. Holi described severe
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im pairm ent effects during trea tm ent including losing all o f her hair. Holi worked as a 
therap ist but reduced her hours on treatm ent.
Shaun lived w ith  HIV and hepatitis C. At the tim e o f in terview  he was coming to  the end o f a 
24 week trea tm ent having previously been treated fo r hepatitis C and cleared it. He was o ff 
w ork due to  the effects o f treatm ent.
Charlie lives w ith  HIV and at the tim e o f interview  was clear o f hepatitis C having completed 
48 weeks o f trea tm ent. He has been HIV positive since 2000. Charlie cleared hepatitis C in 
2009 fo llow ing combination treatm ent. He works fo r a regional blood borne virus 
organisation which he fe lt was helpful in understanding how d ifficu lt the trea tm ent was.
Ben also lived w ith  hepatitis C and HIV. He had been through treatm ent tw ice fo r hepatitis C. 
Ben was diagnosed w ith  hepatitis C during a routine appointm ent fo r HIV in 2003 and thinks 
it was transm itted sexually. He began the firs t course o f trea tm ent in 2004. He underwent 
trea tm ent fo r 48 weeks and attained SVR at six months but found the virus was detectable 
again at eight months. He took a break and undertook trea tm ent fo r a fu rthe r 48 weeks in 
2007 and sustained SVR in 2008. He described very d iffe rent employer responses to  his 
request fo r reasonable adjustments.
At the tim e o f interview, David was living in a residential rehabilitation centre and in the 
early stages o f 48 weeks o f treatm ent. He has now attained SVR. He was diagnosed in prison 
in 2000, but was unable to  access treatm ent until 2010 when he entered rehabilitation. He 
believes he contracted hepatitis C during a short period o f injecting drug use. He described 
participating in the interview  as an im portant part o f his recovery. David described his fam ily 
and friends as very im portant to  him and worked hard to  support those who were also 
undergoing treatm ent. He was training to  become a counsellor and worked as a volunteer in 
a drug service.
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Keith was 48 and had undertaken treatm ent tw ice (one 48 weeks one 72 weeks). He lived 
w ith  his youngest daughter. He had experienced both im pairm ent effects prior to  diagnosis 
and experienced a range of debilita ting trea tm ent effects. He had attained SVR at the tim e 
o f in terview  but still experienced post trea tm ent effects and was unable to  work - though 
prio r to  being made redundant his employer had made adjustments to  enable him to  work 
from  home. Keith was diagnosed w ith  hepatitis C after he was diagnosed w ith  Diabetes.
Boab was 51. He lives in a small rural com m unity w ith  his w ife and son. Boab contracted 
hepatitis C fo llow ing a blood transfusion in the 1970s. He described repeatedly visiting his GP 
fo r a period o f eight to  ten years prior to  diagnosis, eventually being diagnosed during a 
consultation fo r an additional im pairm ent. Boab ceased trea tm ent due to  trea tm ent failure, 
but reported severe im pairm ent effects. W hilst he described in itia l re lie f at not having to  
continue w ith  the treatm ent, he was concerned about his fu ture  health. Boab worked in a 
local factory and was the union representative.
Steve was 51 and to  his knowledge had hepatitis C fo r 31 years. He was not sure how he 
contracted it but had experimented w ith  injecting drugs in the 1970s. He was diagnosed in 
late 2000s after visiting his GP w ith  a number of health issues. He had finished 24 weeks o f 
trea tm en t and at the tim e o f in terview  was waiting to  see if he had attained SVR. Steve 
described severe treatm ent and post trea tm ent effects. He described stopping work prior to  
beginning trea tm ent due to  im pairm ent effects. He was supported by his w ife and children 
during trea tm ent and had recently become a grandfather. Steve has since cleared the virus.
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C h a p te r  1 wo: Ci a i l in g  h e p a t i t is  C re a l i t ie s  in  p o lic y  a n d  socia l  
re s e a r c h
In tro d u ctio n
This chapter introduces the hepatitis C social research literature. It begins by outlin ing 
prevalence rates, transmission routes and current understandings o f disease progression and 
im pairm ent effects.2 The purpose o f the literature review is to  outline how hepatitis C and 
the realities o f living w ith  it, have been constituted and enacted in the literature to  date, and 
to  briefly explore some o f the material consequences o f this. Although academic research 
lite ra tu re  comprises the m ajority o f the material reviewed, government policy and 
organisational reports are included where appropriate, fo r the insights they can provide 
regarding the UK context.
The main body o f the literature review addresses participants' experiences o f living w ith  
hepatitis C. These sections explore the themes o f diagnosis, disclosure, support and 
in form ation needs, knowledge and awareness, treatm ent experiences and developments, 
the role o f professionals and the financial and em ploym ent implications.
The last section o f the literature review, introduces the disability studies literature relevant 
to  the thesis, highlighting the interconnection between cultural beliefs around disease and 
disability, stigma and disablism.
The structure o f the thesis and the weaving o f academic literature throughout the data 
chapters make the intra- active nature o f the findings and the far reaching impact o f living
2 As will be explored below, I use the term 'impairment effects' from the work of Carol Thomas (2007; 
136) which refers to 'restrictions of bodily activity and behaviour that are directly attributable to 
bodily variations designated 'impairments' rather than those imposed upon people because they have 
designated impairments (disablism)' (emphasis in original text).
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w ith  hepatitis C, visible. Thus some sections of the literature review are shorter than others 
and links to  o ther chapters are appropriately signposted throughout.
The review mainly draws upon literature from  Anglophone countries, including the UK, 
Republic o f Ireland, Canada and the United States. Much o f the social research literature is 
drawn from  an Australian and New Zealand context, particularly from  the National Centre of 
HIV and Social Research at the University o f New South Wales, where social research interest 
in hepatitis C has been nurtured and expanded over the past decade. This significant body o f 
social research has inspired and influenced my own work; contributing to  a hepatitis C 
hin terland  (Law, 2004) which opens up space fo r a discussion o f issues beyond those 
currently focused on in academic literature and policy the UK, enacting hepatitis C as 
phenomena w ith  far-reaching social and material consequences.
The dearth  o f  m h 'm 'I r r s e a r r h
Research around hepatitis C has historically focused on clinical and medical aspects, 
including epidem iology (Shepard et a!., 2005; Aceijas and Rhodes, 2007; Nelson et a i,  2011) 
characteristics o f the virus and its progression, (Freeman et a!., 2001; Forton e t a i,  2001; 
Seeff, 2002) transmission routes (Macdonald et al., 1996; McMenamin et a i,  2008; Aaron et 
a i,  2008; Doerrbacker et a i,  2011; Jafari et al., 2012) trea tm ent options and contra­
indications (Heathcote and Main, 2005; McHutchinson et a i,  2009), including - as this thesis 
has been w ritten  - the increasing momentum  o f clinical tria ls3 and the development o f new 
treatm ents (Pockros, 2010; Kowdley et a i,  2013; Stedman, 2013). This clinical focus and the 
accompanying lack o f research into the social aspects o f living w ith  hepatitis C (Hopwood
3 Although it is important to note that some recent studies have combined both social and clinical 
aspects. For example, Maher et a i (2010a) who in seeking to understand motivations and barriers to 
participating in vaccine trials for people who inject drugs, point to the need for an understanding of 
social research in clinical trials from the start. Maher et a i, (2010b) also use the current emphasis on 
and privilege of biomedicine in order to reassert the importance of developing a safe and effective 
vaccine -  emphasising the limited effectiveness of harm reduction initiatives in reducing hepatitis C 
infection rates.
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and Southgate, 2003) from  the perspective o f those living w ith  the illness, has been noted in 
the lite ra ture  (see fo r example, Copeland, 2004; Crockett and G ifford, 2004; Conrad e t al., 
2006; Butt et al., 2008a; 2008b; W in te r et al., 2008; Harris, 2009a). There is a startling lack of 
a tten tion  to  the experience o f living w ith  hepatitis C w ith in  the UK and the nuances and 
differences in policy response and services tha t this entails.
The thesis is inform ed by ideas arising from  an emergent body o f work (Fraser and valentine, 
2008; Fraser, 2011; Fraser and Moore, 2011; Fraser and Seear, 2011; Fraser, 2012) which 
explores hepatitis C by drawing on insights from  science and technology studies - explored in 
greater detail in chapter three and in the findings chapters. The thesis utilises this work to  
explore how hepatitis C is enacted and materialised when it is no longer assumed to  be a 
fixed pre-existing entity, but is constituted as it comes into contact w ith  o ther phenomena, 
shaped by social political and cultural forces (Fraser, 2011) and is understood as a socio­
political en tity  as well as a medico-scientific one (Korner and Treloar, 2006: 16). The thesis 
also draws on insights from  disability studies, (a brief in troduction to  which is provided 
below and elaborated on throughout the thesis) and explores aspects o f recent 
developments in social policy in Britain and the impact this has on the lives o f people w ith 
hepatitis C.
Although this may seem haphazard, it should be viewed as a materialisation o f the wide 
ranging and varied impact o f hepatitis C on the lives o f participants in this study. In reviewing 
the literature, the crafting o f hepatitis C realities (i.e. the current dominance o f medical focus 
and medical treatm ent) is made visible and space is opened up fo r the new contributions to  
knowledge made by the findings chapters.
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The basics o f hepatitis  C
Hepatitis C is a virus which, when enacted in medical terms, predom inantly affects the liver 
(Foster, 2008). It is spread through blood to  blood contact, was 'iden tified ' in 1989 and has 
been shown to  account fo r most cases previously referred to  as 'non A non B hepatitis' 
(NANBH) (Departm ent o f Health (DH), 2002a). Infection can be roughly divided into six major 
strains (genotypes). In the UK the most common genotypes are one and three (Health 
Protection Agency, 2012). Genotype is im portant in determ ining length4 o f trea tm ent (Thein 
and Dore, 2009).
The m ajority o f studies (including social research) begin by describing the prevalence and 
incidence o f hepatitis C locally and globally, [see Crofts et al., (1997); Glacken et al., (2001); 
Crockett and G ifford, (2004); G ifford et al., (2003; 2005); Ehsani et al., (2006); Brener and 
Treloar, (2009); Swan et al., (2010) fo r examples] indicating how many members o f the 
population are affected. The W orld Health Organisation estimates tha t 150 m illion people 
live w ith  chronic hepatitis C w orldw ide5, w ith three to  four m illion infections occurring each 
year (WHO, 2012). W ith in  the UK, estimates of infection range between 250,000 (DH, 2009) 
and 500,000 (RCGP, 2007) people. The most recent Health Protection Agency (HPA) (2012) 
figures suggest that, at present, there are 216,000 people living w ith  hepatitis C in the UK. 
Fraser and Seear (2011) indicate that the use o f statistics in this way 'scales up' the interest 
in hepatitis C and highlights it as a problem which needs to  be addressed. While this is vital, 
they maintain tha t this prim arily enacts it as a 'public health' issue rather than one which 
affects people. The implications of this are discussed further below and in chapter seven.
4 Since April 2013 genotype has also been used to determine treatment type (i.e triple therapy for 
those with genotype one)
5 Though global estimates also vary from 180 million to 123 million (Treloar et al., 2010a).
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As the dom inant mode of infection w ith  hepatitis C in the UK is the sharing o f equipment 
used to  inject drugs, there has been an understandable academic focus on injecting drug use 
and the people who practice it, w ith a view to  prevention o f infection or facilita tion into 
trea tm ent and support. Studies have explored sharing behaviours among drug users (Craine 
et al., 2004; Taylor et al., 2004; Treloar et al., 2008), effective harm reduction interventions, 
knowledge and perceptions o f hepatitis C (Doab et aL, 2005; Roy et al., 2007; O'Brien e t al., 
2008; Jost et al., 2010) and its treatm ent among people who use drugs (Munoz-Plaza et al., 
2008; Treloar and Holt, 2008;Hellard et al., 2009; Wilson and Bryant, 2010). There has also 
been a focus on the knowledge and attitudes of health professionals and those who work 
w ith  injecting drug users around hepatitis C (Brener et al., 2007; Richmond et al., 2007; 
Resnick et al., 2012). More recently qualitative social research has focused on barriers to  
trea tm ent fo r people who use drugs (Swan et al., 2010; Harris et al., 2012a) and developing 
models to  encourage access to  treatm ent (Harris et al., 2012a; Islam et al., 2012,). The 
feasibility o f and views around the integration o f hepatitis C treatm ent into methadone 
maintenance therapy services (Novick and Kreek, 2008; Treloar and Fraser, 2009; Wilson et 
al., 2010) have also been an area o f interest.
The research emphasis on people who use drugs is undoubtedly vital in helping to  bring 
the ir needs and experiences into focus, and in harnessing the ir expertise in prevention 
(Taylor et al., 2004; Harris et al., 2012b; Harris and Rhodes, 2012a; Harris and Rhodes, 
2012b; Harris et al., 2013), support (Sylvestre and Zweben, 2007; Brener e t al., 2013a; Brener 
e t al., 2013b) and treatm ent (Swan et a l,  2010; Harris et ah, 2012a). However, it also 
potentia lly marginalises the support needs of those who are not currently using drugs, who 
may have been living w ith  it fo r a long tim e and who may currently be perceived to  be well 
supported by current models (ACMD, 2009).
The course of hepatitis  C infection
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As m entioned above, hepatitis C is a virus spread through blood to  blood contact w ith  a 
person living w ith  the virus. Globally, the main route o f infection is iatrogenic, through 
unscreened blood, blood products and reuse of medical equipm ent which has been 
inadequately sterilised (Alter, 2006). Prior to  1992, before blood products were effectively 
screened, some UK recipients acquired hepatitis C in this way (DH, 2002a), including those 
who underwent surgery, caesarean births, received blood transfusions and blood products 
used in the trea tm en t o f haemophilia (Archer et al., 2009). In response, some services have 
been developed to  provide support to  people, who contracted hepatitis C iatrogenically, 
notably compensation from  the Skipton Fund and the development o f the Caxton 
Foundation. There are campaign groups who maintain these responses are inadequate (see 
Taintedblood, 2013).
A t present in western countries, transmission most commonly occurs through the sharing o f 
equipm ent during past o r present injecting drug use, including needles used fo r injecting 
and associated paraphernalia - spoons, filters, tourniquets, water, w ater filte rs and 
containers, surfaces and cookers (Hagan et al., 2001; Doerrbecker e t al., 2011; Doerrbecker 
e ta l., 2013). People injecting performance enhancing drugs may also be exposed to  hepatitis 
C (McVeigh et al., 2003; Day et al., 2008; Larance et al, 2008). Evans-Brown e t al. (2009) also 
note sharing o f equipm ent fo r the injection o f Melanotan I and II (used mainly to  tan the 
skin.) Injecting is not the only way hepatitis C can be transm itted, as there is a theoretical risk 
o f transmission via sharing equipm ent used to  inhale drugs (Aaron e t al., 2008). There is also 
potentia l fo r the  transmission o f HIV and hepatitis C through sharing o f crack smoking tools, 
particu larly homemade ones as the raw materials o f these often cause sores or blisters 
around o r inside the m outh, increasing the possibility o f exposure to  blood (Leonard e t al., 
2008). As th is thesis was being w ritten  up, a ttention  has also turned to  the  increasing 
v is ib ility  o f gay men who inject crystal meth, mephedrone and '6 ' in a sexual context (NAT, 
2013).
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Increasingly men and women o f south Asian origin are enacted as a group o f people who 
may be an elevated possibility o f contracting hepatitis C and o f it having a greater impact on 
the ir health. In particular, those originating from  Pakistan, Bangladesh and India (Uddin et 
al., 2010). Mann et al. (2008:425) found tha t 'ethnic m inority populations6 living in England 
were more likely than w hite  populations' to  be adm itted to  hospital w ith  severe liver disease 
or to  die from  it. The authors conclude tha t there are m ultip le reasons fo r this, including 
higher prevalence in countries o f origin, not identifying as needing a test, living w ith  hepatitis 
C fo r a longer period, and d ifficu lty  accessing healthcare and support. Of concern are the 
substantial proportion o f those testing positive fo r hepatitis C via an oral swab who refused 
to  re-attend fo r confirm atory testing or engage in services, despite e fforts to  make this as 
accessible as possible (i.e. by funding taxis or providing home visits) (Mann et al., 2008). The 
needs o f the South Asian population are an area requiring fu rthe r research.
Other possible routes o f transmission include unsterile ta ttoo ing and piercing (Jafari e t al.,
2010) and perinatal transmission (McMenamin et al., 2008). This is increased if the m other 
also lives w ith  HIV (DH, 2004). Sexual transmission among heterosexual couples is possible, 
but a recent study by Terrault et al. (2013) found tha t it was so infrequent tha t it was not 
necessary to  change advice to  people w ith  hepatitis C, regarding sexual transmission.
Here, identify ing routes o f transmission is done fo r the sake o f clarity. It is not my intention 
to  create divisions between groups, or to  suggest tha t the communities described above are 
singular and discrete. Indeed, this type o f division or one dimensional representation is 
untenable (see Ellard, 2007). Yee et al. (2001) also found tha t many who were diagnosed 
w ith  hepatitis C had experienced m ultip le opportunities fo r infection and concluded tha t it 
would be d ifficu lt to  isolate how someone has contracted hepatitis C - in particular to  
separate ou t those who had defin ite ly  contracted it via injecting drug use. Despite this,
6 People who identified as Pakistani, Bangladeshi, Indian Chinese, Other or Mixed heritage.
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Grogan and Timmins (2010) note tha t injecting drug use has been used to  inform  (an 
adm itted ly lim ited) response in policy and service development. The focus on drug users has 
led to  hepatitis C being confounded w ith  drug use (Hopwood and Treloar, 2003) particularly 
injecting drug use (Harris, 2005). This association has serious social and material 
consequences fo r those living w ith  hepatitis C.
The p ro file  o f hepatitis  C
Despite the numbers o f people living w ith  hepatitis C in the UK, only 5% o f between 200,000 
and 500,000 people are believed to  have been diagnosed (Frazer e t al., 2011b). Public and 
professional awareness and knowledge related to  the virus has historically been low - both in 
the UK (Copeland, 2004; Rhodes Davis and M artin, 2004; APPGH, 2006) and across the globe 
(Treloar e t al., 2002; Van De M orte l, 2002; Van De M orte l 2003; Zickmund et al., 2004; Gupta 
et al., 2006). Hepatitis C is thus term ed the 'silent epidemic' (Grow and Christopher, 2008).
Public awareness
Hepatitis C has been characterised by uncertainty and confusion since it was firs t 'identified ', 
particularly around methods o f transmission and the long term  implications fo r health and 
wellbeing (Hopwood and Treloar, 2003). Existing literature shows confusion regarding the 
d iffe ren t types o f hepatitis, transmission routes and treatm ent options, among those who 
used drugs. Ellard's participants (2007) described poor or partial understanding o f hepatitis 
C. Davis and Rhodes (2004) found that people who used drugs made sense o f hepatitis C in 
relation to  HIV (returned to  below) and a recent study by Treloar et al. (2011) found that 
misconceptions prevailed concerning the availability and e lig ib ility fo r treatm ent.
Levels o f knowledge among the general public have also been found to  be poor. In 2002, a 
French street survey found tha t participants confused hepatitis C w ith  HIV/AIDS and had 
poor levels o f knowledge concerning the availability o f vaccination and transmission via
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casual contact (Munoz-Sastre et al., 2002). A more recent survey commissioned by the 
Departm ent o f Health (Drugscope, 2009) found tha t a th ird  o f the people questioned in the 
UK were not aware o f the major transmission routes fo r hepatitis C. The survey o f 1500 
people, found tha t one in four were unaware tha t it could be transm itted by sharing a 
needle, w ith  fou r in ten unaware o f its blood borne nature and one in eight believing it could 
be passed on through kissing. Crutzen and Goritz (2012) explored levels o f knowledge 
around hepatitis A, B and C in The Netherlands and Germany, and found there was a dearth 
o f practical knowledge in terms o f prevention o f transmission and vaccination. There is also 
evidence to  suggest tha t despite concerted efforts in Australia, there is still work to  do; 
Hopwood et al., (2012) surveyed University students in Australia and found tha t although 
knowledge around transmission o f viral hepatitis C was relatively high; students had poor 
knowledge regarding trea tm ent options or vaccination.
Professional awareness
In the literature, professionals also show differing levels o f awareness and expertise. Van de 
M orte l (2002; 2003), in her survey o f Australian nurses, found tha t questions around 
transmission were incorrectly answered by most participants and the risk o f infection was 
overestimated, leading to  possible negative treatm ent o f patients w ith  hepatitis C. Dentists 
in Temple-Smith's (2006) study described feeling concerned about transmission, even if they 
were well inform ed and sometimes taking unnecessary precautions such as avoiding treating 
people w ith  the virus or double gloving (see also Richmond et al., 2007). Clearly there is 
some overlap here between knowledge and beliefs and discrim inatory treatm ent.
Frazer e t al. (2011b) in the ir survey o f Irish nurses' knowledge, found it was much higher 
among nurses working in drug services, compared w ith those working in general nursing or 
practice nursing. Nurses working in substance use services were more likely to  have 
attended an educational course on hepatitis C and exhibited higher levels o f awareness
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concerning vaccination availability and trea tm ent options. W hilst this is perhaps not 
surprising, Frazer et al. (2011b) discuss the importance o f extending education and support 
beyond substance use services and into more general settings, stating tha t professionals do, 
and w ill increasingly, come into contact w ith  patients w ith  hepatitis C .
Awa reness ca in p;i ig11 s
In England, the lack o f awareness and knowledge has been connected to  inadequate funding, 
provision and development o f hepatitis C services (Copeland, 2004; APPGH, 2006; Agarwal et 
al., 2007; Frazer et al, 2011b). The lethargic response to  raising awareness has been 
a ttribu ted  to  the link between injecting drug use and hepatitis C, (Crofts et al., 1997; Treloar 
et al., 2002) as well as its historical position in relation to  HIV and the long term  ('less visible') 
nature o f the effects o f living w ith  the virus. Ehsahni et al. (2006) have pointed to  the lim ited 
political interest around people w ith  hepatitis C. It may also be tha t awareness remains low 
fo r more insidious reasons, given tha t there is evidence to  suggest tha t in the event o f a 
concerted national e ffo rt, the am ount o f people coming forward may be too  great fo r 
services to  manage (Orgel et al., 2005). There are already reports o f services being 
overstretched w ith  delays to  beginning trea tm ent (Agarwal, et al., 2007; The Hepatitis C 
Trust, 2013c). Successive governments have failed to  respond adequately to  hepatitis C, 
including addressing serious structural problems, such as resource allocation and lack of 
awareness and policy direction (McKeown and Gibson, 2007). This is on-going, w ith  the 
recent abandonment o f the national liver disease strategy (DWG, 2013) and increasing 
concerns around the costs o f new drugs (Knox, 2013; Tucker, 2013).
Scotland is the only UK country to  have begun to  adequately address hepatitis C, allocating 
funding fo r capacity building o f s ta ff and education o f professionals, as well as investment in 
developing services and strategies covering specific tim e periods in which to  make progress 
(Scottish Government, 2008; Scottish Executive, 2006; Scottish Government, 2011).
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However, the d ifficulties in raising awareness must be acknowledged. Hepatitis C affects a 
w ide variety o f people both w ith in  and outside o f mainstream services (for example: drug 
services and GPs). El la rd (2007) points to  the need fo r education to  be delivered broadly and 
in a m ultitude  o f ways, particularly among those who may not perceive themselves to  be at 
risk. In 2007, the All Party Parliamentary Group on Hepatology explored ways o f raising 
awareness based on existing national public health campaigns. They concluded that 
campaigns need to  be long term , maintain m omentum and use a variety o f media outlets. 
Indeed, the  report concluded tha t the most effective campaigns were those developed by 
Cancer Research UK.
Smith e t al. (2006), in the ir evaluation o f an Australian mass media campaign, indicated that 
the use o f television advertisements was particularly useful in facilita ting calls to  the local 
hepatitis C inform ation centres7. The authors indicate tha t the campaign was particularly 
valuable in showing tha t hepatitis C is not just confined to  one small segment o f the 
population, and emphasised tha t increased funding from  public health is required. Study 
participants reported increased knowledge w ith  regard to  transmission routes and a key 
finding was tha t the involvem ent o f people w ith  hepatitis C was necessary fo r changing 
attitudes and beliefs (also reported by Hopwood and Treloar, 2004). In an American study 
where participants o f local support groups evaluated public service announcements about 
hepatitis C, Grow and Christopher (2008) found tha t stigma and structural barriers inhibited 
health prom otion and awareness messages. Participants stated tha t to  be effective, 
messages must be liked; they must feel new, relevant, encouraging and positive. Fear based 
campaigns have the potentia l to  stigmatise and discourage people from  being tested (see 
Slavin, 2006). Grow and Christopher (2008) indicate tha t structural barriers must be 
addressed, such as lack o f inform ation, or difficulties in accessing services.
7 Though a key problem is that local information centres do not exist in the same way in the UK.
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Increased education and awareness has continued to  comprise a key recommendation 
across studies (Swan et al., 2010). Treloar et al., (2011) have emphasised tha t hepatitis C 
prevention lacks urgency, meaning tha t prevention and support services are politically 
vulnerable to  funding cuts.
Living w ith  hepatitis  C
Ten years ago Hopwood and Southgate (2003; 251) called fo r an 'expanded sociocultural 
understanding o f hepatitis C to  account fo r the material effects o f medicalisation, 
stigmatisation and discrim ination and the sociocultural impact o f trea tm ent on the lives of 
people w ith  hepatitis C.' W hilst progress has been made in Australia, qualitative exploration 
o f people living w ith  hepatitis C is lacking in the UK and is where this thesis provides 
im portan t insights. The next section o f the literature review explores the everyday 
experience o f living w ith  hepatitis C.
Diagnosis
Guidance from  the National Institute fo r Clinical Excellence8 (NICE) (2012c) estimates tha t 
95,000 people had been diagnosed w ith  hepatitis C in England by the end o f 2011, which 
means a significant number remain undiagnosed. Increasing the number o f people 
diagnosed w ith  hepatitis C and raising awareness in order to  promote testing and support 
has comprised a key element o f UK policy (DH, 2002a, 2004; Scottish Executive, 2006; 
Department o f Health, Social Services and Public Safety, 2007; The Scottish Government, 
2008; Welsh Assembly Government, 2010; Scottish Government, 2011 HPA, 2012, NICE, 
2012c).
8 From 1st April 2013 NICE was renamed the National Institute for Health and Care Excellence, 
following the introduction of the Health and Social Care Act 2013.
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Hepatitis C status is determ ined by an in itia l test to  detect the presence o f exposure 
antibodies in the blood. A confirm ation blood test then determ ines w hether the virus is 
currently present and replicating - and in what quantity (Klapper, 2009). Testing rates may be 
increased through the use o f dried blood spot testing or oral swab testing, due to  the speed 
and lack o f need fo r venepuncture (W hite et al., 2008). Efforts to  increase testing both 
among people who use drugs and the general population, include dedicated drives in local 
comm unities (Uddin et al., 2010; Readhead et al., 2012) and the successful p iloting o f oral 
testing (w ith results available in 30 minutes). This is done in non-clinical settings by key 
workers in regular contact w ith  people who attend substance use services (Evans et al., 
2012). Testing facilitated by peers is also described in the literature (Aitken e t al., 2002). As 
this thesis was being w ritten  up, calls have been made fo r rapid testing, particularly dried 
blood spot and point o f care testing (Shivkumar et al., 2012) to  be made available in as many 
venues as possible, including prim ary care and drug services (UWG, 2011) sexual health 
services, prisons and young offenders institutions (NICE, 2012c), and com m unity pharmacies 
(Watson et al., 2003; The Hepatitis C Trust, 2010a).
The experience o f diagnosis is one o f the more developed areas o f social research in relation 
to  hepatitis C, though the empirical literature exploring the experience o f diagnosis centres 
around the early 2000s (Glacken et al., 2001; Dunne and Quayle, 2001; Dunne and Quayle 
2002; Hopwood and Treloar 2003; Davis and Rhodes, 2004; Hopwood and Treloar 2004). This 
opens up a space to  explore more recent experiences o f diagnosis, particularly in England.
The experience of diagnosis
The lack o f awareness and the confusion attached to  hepatitis C, has meant tha t diagnosis is 
frequently  described as d ifficu lt or unexpected (Harris, 2009b). Participants reported feeling 
shock, disbelief, fear and anxiety about the fu ture (Glacken et al., 2001; Tompkins et al., 
2005; Sgorbini et al., 2009; Stewart et al., 2012). In Pakistan, Gill et al. (2005) found
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participants described the diagnosis as more stressful than divorce, moving house or a loss of 
income. 16% (15 participants) o f the sample reported anxiety severe enough to  w arrant a 
referral to  psychological support. Faye and Irurita (2003) described this is terms o f being 
'contam inated or condemned' and sim ilar feelings were reported by participants in Fraser 
and Treloar's (2006) study (six o f 38 participants) who used the words 'd irty ' and 'to ta lly  
contam inated' to  describe the ir feelings.
Others have emphasised the contextual nature o f diagnosis. Sutton and Treloar (2007) found 
tha t reactions to  diagnosis among 36 people living w ith  hepatitis C in Australia ranged from  
having no real impact to  being a life changing event. Some fe lt tha t it was an inevitable part 
o f being an injecting drug user (consistent w ith  Rhodes Davis and M artin 's (2004) study in 
the UK), o r o f little  consequence, e ither because they had grown up w ith  it or it had no 
visible effects.
In Harris's (2009b) qualitative exploration o f diagnosis, her sample was almost evenly split 
between those who described it as 'devastating' and those who fe lt it was 'no big deal'. 
Harris (2009b) states diagnosis is understood and in tertw ined w ith  bodily, structural and 
cultural responses9.
Preparation for diagnosis
Fry and Bates (2012), in the ir exploration o f the experience o f diagnosis in Australia, found 
tha t it was experienced as more d ifficu lt if preparation fo r the diagnosis or the delivery o f 
the results were insensitive or inappropriate to  participant needs. The need fo r clear pre 
and post-test in form ation during a hepatitis C test has been repeatedly emphasised, and 
guidance has been enhanced over the years to  incorporate tailored inform ation appropriate 
to  literacy levels, culture and need (Department o f Health, 2004; Royal College o f GPs 2007;
9 This reminds me of Oliver's (1990) observations that impairment does not carry intrinsic meaning or 
negativity, but depends on social contexts or community responses.
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NICE, 2012c). NICE (2012c) emphasises the need fo r clear explanation o f infection 
implications and transmission routes, trea tm ent options and exploration o f support 
networks, as well as adequate explanation of the testing process and gathering informed 
consent. Results should be provided by the same person who delivered the test in a face to  
face consultation. W ritten  inform ation should be provided, along w ith  referral to  fu rthe r 
support. The guidance produced by the RCGP (2007) elaborates on the types o f inform ation 
which should be provided both pre and post-test, extending to  the provision o f emotional 
support, on-going counselling and/or mental health support.
However, the experience o f diagnosis has frequently been described in the literature as poor 
and in need o f urgent improvement. Hopwood and Treloar (2003, 2004) in the ir exploration 
o f diagnosis using both surveys (504 responses) and in depth interviews (19), found tha t the 
m ajority o f participants were given the ir diagnosis o f hepatitis C by a doctor, but tha t one 
th ird  (123) o f the sample fe lt tha t they had had no explanation o f what the diagnosis meant 
and only 27.8% (116/417) fe lt tha t they had been provided w ith  all the inform ation they 
needed. 137 (32.8%) participants diagnosed between 1989 and 2001 had received no 
in form ation  regarding conventional or alternative treatm ents, counselling or referral to  
fu rthe r in form ation or support services; the year o f diagnosis did not affect the am ount o f 
support provided.
This has been echoed in the work o f Gifford et al. (2005) who found tha t few  o f the men who 
completed the ir questionnaire (308) reported receiving e ither pre or post-test discussion 
(although th is data was collected in 2000). G ifford et al. (2005) also found tha t few  members 
o f the sample were provided w ith  referral to  a specialist or liver clinic (30%), and only 26% 
were referred to  a support group. Pre and post-test counselling was also rare fo r women in 
the female arm o f the study (Gifford et al., 2003). Only 17% o f the sample received pre-test
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counselling and 4% post-test. The likelihood o f receiving post-test counselling was associated 
w ith  a later diagnosis.
In the UK, Davis and Rhodes (2004) described participants being diagnosed in a way which 
devalued and trivialised hepatitis C, and experienced 'blase' responses from  workers who did 
not acknowledge the seriousness and the impact on the person's life. A sim ilar finding was 
also reported by Tompkins et al. (2005) in the ir study o f the experience among homeless 
people in the UK. Harris (2009b) describes how this kind o f response from  professionals, can 
reinforce the belief tha t hepatitis C diagnosis is unim portant and nothing to  be concerned 
about - affecting engagement w ith  services and support as well as personal beliefs about 
self-worth - see below.
As outlined above, the lack o f in form ation and referral to  support o r specialists, raised 
specific issues around te lling others about the infection, which the next section focuses on.
Disclosure to others
There is no legal requirem ent to  disclose hepatitis C positive status in the UK, o ther than if 
em ploym ent involves a blood to  blood contact e lem ent10. Despite this, disclosure constitutes 
a serious issue fo r people living w ith  hepatitis C and is often a precursor to  poor treatm ent 
and discrim ination (Hopwood and Treloar, 2003; Conrad et al., 2006). The decision to  
disclose often involves the weighing up o f costs and benefits, opening up the possibility o f 
accessing support but also risking negative reactions from  others. In this thesis the process o f 
disclosure is examined using both hepatitis C literature and literature from  disability studies.
10 The complexities around the issues of transmission and 'infectiousness' are enacted in the recent 
modernisation of the rules allowing HIV positive healthcare workers to carry out dental and surgical 
procedures which they had previously been barred from (DH, 2013) -  despite no evidence of anyone 
ever contracting HIV from a healthcare worker in the UK. Less than a month later, in September 2013, 
the Aneurin Bevan Health Board in Wales announced that a 'look back' exercise has been launched 
after a retired healthcare worker who treated patients in Wales between 1984-2003, was diagnosed 
with hepatitis C. Two patients have subsequently been diagnosed with hepatitis C.
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The vague and 'asym ptom atic' nature o f hepatitis C related illness, and the accompanying 
lack o f visib ility, has been recognised as providing people living w ith  hepatitis C w ith  a choice 
about w hether or not to  disclose the ir status (Fry and Bates, 2012).
Participants in Hopwood and Treloar's (2004) research maintained tha t they disclosed 
because they fe lt it was the 'righ t th ing ', part o f being in a mutually respectful relationship 
w ith  a health care professional. Conrad et al. (2006) found participants disclosed to  promote 
trus t or because they fe lt obligated to, though they often received poor trea tm ent as a 
result. Hopwood et al. (2010) described participants feeling judged or pressured to  disclose 
in healthcare settings, particularly when infection control precautions were not universally 
applied by health care staff. O ther participants in the same study described having the ir 
hepatitis C status disclosed to  someone else w ithou t the ir consent. This negative treatm ent 
proved to  be counterproductive. Both Hopwood and Treloar (2004) and Hopwood et al.
(2010) found a num ber o f participants reported tha t they were less likely to  disclose in the 
fu ture , due to  fear o f negative reactions, which in tu rn  acted as a barrier to  receiving care 
and treatm ent.
Similarly, Blasiole et al. (2006) found tha t one fifth  o f the people interviewed did not 
disclose to  anyone in order to  avoid negative reactions and Schaefer et al. (2005) found that 
25% o f 103 people w ith  hepatitis C surveyed, preferred not to  disclose due to  fear o f being 
rejected or treated negatively. Participants in Sgorbini et al's., (2009) study stated tha t they 
preferred to  keep the ir status to  themselves, as they were concerned they would be 
questioned about how it was acquired.
To avoid being viewed negatively, Conrad et o/.'s (2006) participants developed strategies fo r 
disclosing the ir status. Those who had contracted hepatitis C iatrogenically, accompanied the 
disclosure o f status w ith  an explanation. These participants reportedly found it easier to 
disclose. However, the association o f hepatitis C w ith  injecting drug use, and the tendency to
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overestim ate the risk o f potentia l infection, meant tha t negative reactions and experiences 
were not necessarily avoided.
In the ir exploration o f how people w ith  hepatitis C te ll others about the ir status, Hopwood et 
a/.,(2006) described fou r main strategies: non-disclosure (not te lling anyone), strategic 
disclosure (disclosing only to  those who are trusted), substitute disclosure (disclosing 'liver 
disease' o r something similar) and open disclosure. Substitute disclosure in particular was 
helpful in explaining the visible impact on participant health in interactions w ith  others, 
w ith o u t the possibility o f experiencing negative reactions.
T re a tm e n t  for Hepatitis C
The previous sections provided an introduction to  hepatitis C and engaged w ith  diagnosis 
and disclosure literature. The next part o f the review addresses the main response to  
hepatitis C; medical treatm ent. There is currently no vaccine fo r hepatitis C, though these 
are currently being developed and tria lled (Halliday et al., 2011). At the tim e data was 
generated, the recommended trea tm ent fo r all genotypes o f hepatitis C was a combination 
o f In terfe ron11 (injected once per week) w ith  tw ice daily oral Ribavirin12 (NICE, 2006). 
Combination therapy has a sustained virological response (SVR) rates o f 50% and 80% 
depending on genotype and medical literature has pointed to  the value o f treatm ent even 
w ithou t SVR, as trea tm ent can inh ib it the progress of the virus (Gow and M utim er, 2001). 
For those w ith  genotype 2 or 3, hepatitis C treatm ent lasts fo r 24 weeks. For people living 
w ith  genotype one, 48 weeks o f treatm ent are recommended. Patients can be said to  have
11 Interferons are viral proteins which occur in the body and work to stop viruses from replicating and 
stimulate immune response. Pegylated interferon are chemically modified versions of interferon 
which increase the amount of time the interferon is effective within the body, requiring only one 
injection per week (Sgorbini et al., 2009).
12 Ribavirin is not fully understood, but when used in combination with interferon as oral anti-viral 
medication, it increases treatment effectiveness (Sgorbini et al., 2009).
53
cleared the virus if they achieve a sustained viral response rate 24 weeks fo llow ing the end 
o f trea tm ent (NICE, 2006).
In the existing literature, the effectiveness o f treatm ent responses shift in line w ith  the 
specific realities being enacted. For example, Grogan and Timmins (2010: 2869) indicate that 
hepatitis C 'trea tm ent success rates are high', where M urphy (2011) and Fraser and Seear
(2011) po int to  the 'lim ited ' effectiveness o f treatm ent. Here hepatitis C trea tm ent becomes 
d iffe ren t things depending on the reality being enacted; in Grogan and Timmins' (2010) 
study to  shore up the role o f the hepatitis C specialist nurse and the need fo r increased 
services, and in Fraser and Seear's case (2011), to  point to  the dom inant response o f 
medicine.
Here hepatitis C trea tm ent as 'm u ltip le ' (Mol, 2002, Law, 2004) is made visible. Clearly I too 
have participated in enacting a specific reality fo r the purposes o f this literature review and 
this thesis, and in doing so, have paid attention to  the realities enacted and the political and 
material consequences - discussed fu rthe r in chapter three and throughout.
At present, both in the UK and globally, trea tm ent uptake is low (Fry and Bates, 2012; Harris 
et al., 2013). Recent reports from  the Health Protection Agency (2012) state tha t only 3% o f 
those w ith  hepatitis C in the UK are currently accessing treatm ent, in spite o f the 
recommendations from  NICE (2006) tha t drug use should not act as a barrier to  treatm ent. 
Thus fo r many, hepatitis C is experienced as a long term  condition.
This makes the sample o f participants in this research (all o f whom underwent treatm ent) 
well placed to  understand the impact o f treatm ent, as well as the everyday experience of 
living w ith  the virus. Participants reported no (longer participating in) injecting drug use, 
were housed, maintained regular contact w ith  health professionals and adhered to  
treatm ent. They would thus appear to  be well served by the current system. The findings 
contained w ith in  this thesis suggest tha t this is not the case.
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As is explored in greater depth in chapter seven, hepatitis C treatm ent has been documented 
as extrem ely d ifficu lt to  to lerate and described as being worse than living w ith  hepatitis C 
(Jenner and Scott, 2008). Emphasis is made w ith in  the literature o f the variable and 
unpredictable nature o f im pairm ent effects and side effects (Fraenkel et al., 2006; Hopwood 
e t al., 2006; Treloar and Sutton, 2007; Harris et al., 2012a).
Existing qualitative literature describes a significant and diverse range o f experiences o f 
treatm ent, and indicates tha t trea tm ent effects have a significant impact on everyday life -  
physically, psychologically and socially (Hopwood et al., 2006; Sgorbini e t al., 2009). 
Participants in Fraenkel et al.'s study (2006) indicated tha t the difficulties they experienced 
on trea tm ent, both in severity and unpredictability o f effects (severe cognitive impairm ent, 
d ifficu lties in eating and insomnia), meant they fe lt underprepared to  manage it. Further to  
this, the lack o f in form ation concerning side effects made it d ifficu lt fo r them  to  seek 
support. Some were able to  develop a routine on treatm ent, others referred to  the 
unpredictability o f the side effects which made it d ifficu lt to  manage work and social 
com m itm ents (Sgorbini e ta !., 2009).
Professionals interviewed as part o f an Australian study into participant support needs, 
indicated tha t needs on trea tm ent varied from  week to  week, w ith  some participants 
requiring intensive support and a weekly check in w ith  the specialist nurse, whilst others 
required far less (Hopwood et al., 2006). The support and inform ation needs o f participants 
in this study and the implications are addressed in chapter seven.
In addressing the effects o f the treatm ent, participants reported relying on a combination of 
medical support, such as ancillary medicines (Hopwood and Treloar, 2005; Hopwood et al., 
2006) or self-management. Hopwood and Treloar (2005) found participants developed 
coping strategies which were outside the realm o f medicine, such as organising childcare or 
giving up work, though clearly this depends on having the financial resources to  be able to
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do so. Swan et al. (2010), in a Northern Irish study, indicated that participants required 
practical form s o f support, such as childcare provision and help to  facilita te work and study. 
Close relationships w ith  fam ily and friends were acknowledged both as a vital source of 
support (Hopwood e t al., 2006) and a key factor in pursuing trea tm ent (McNally e t al., 2004, 
W ilson et a l.,2010), but were often placed under extreme pressure whilst participants lived 
w ith  the virus o r undertook treatm ent. Participants described feeling tha t they had to  shield 
fam ily members from  w orry or fe lt guilty tha t they could not participate in fam ily life to  the 
same degree (Dunne and Quayle, 2001; Sgorbini et al., 2009).
New treatments; new enactments of hepatitis C
The tim e period during which this thesis was w ritten  proved to  be one o f particularly fe rtile  
development o f hepatitis C treatm ents. In April 2012, tw o  direct acting antivirals, Bocepravir 
and Telapravir (hereafter referred to  as DAAs), were approved by NICE (2012a; 2012b), a fter 
a decade o f only one form  o f treatm ent. These direct acting antiviral agents are taken in 
com bination w ith  Ribavirin and Interferon (referred to  as trip le  therapy) fo r those w ith 
genotype one. Bocepravir and Telapravir whilst providing increased cure rates fo r people 
w ith  genotype one, do have side effects which compound those occurring in combination 
therapy. O ther direct acting antivirals are currently in late stage trials, including interferon- 
free combinations, which may reduce both side effects and treatm ent duration. Some 
treatm ents are fo r specific genotypes whilst others are intended fo r people w ith  all 
genotypes o f hepatitis C (Stedman, 2013). Studies have an increasingly optim istic tone (for 
example, Kowdley et al., 2013), although given tha t some studies w ith  interferon showed 
tha t com bination trea tm ent was approximately 20% less effective in real life settings than in 
clinical tria ls (Kramer et al., 2012), and phase three trials can involve highly selected subsets 
o f patients, some caution is necessary. A fu lle r explanation o f the d ifferent combinations and
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the ir effectiveness and impact is beyond the scope o f this thesis, particularly given the rapid 
changes -  but is clearly an area fo r fu rthe r research.
At present this m ajor focus on new drugs and the focus on increasing effectiveness enact 
hepatitis C and its treatm ents in specific ways. For example, Chung (2011) describes the 
present as a 'watershed m om ent' and 'trea tm ent revolution '. Others refer to  a 'new  era' o f 
trea tm ent (Jensen et al., 2011) and the 'final nail in the coffin ' fo r hepatitis C (Manns and 
Cornberg, 2013). This is part o f the rhetoric around scientific progress explored by Fraser and 
Seear (2011) and the heroics o f medicine, which overlook the d ifficulties in terms o f access 
to  treatm ent.
In addition, newer treatm ents are likely to  be more expensive (Rice, 2011), raising issues fo r 
already stretched hospital budgets (Swan, 2013). This issue takes on additional importance 
given a recent report which found tha t usage o f even NICE approved medication w ith in  the 
NHS was one o f the lowest in Europe13 (Stephens, 2012); raising questions about the 
consequences tha t re-organisation o f and cuts to, the NHS w ill have fo r new treatm ent. 
Further, Rice (2011) estimates tha t it w ill be five years before in terferon and ribavirin free 
treatm ents reach the hospitals as they still need to  be tested among diverse groups. Here, 
new hepatitis C treatm ents w ill intra-act w ith  political and social conditions to  enact and 
materialise the experience o f living w ith  hepatitis C in new ways.
It is also im portant to  note tha t w ith  the focus on increasing effectiveness, the approval o f
new treatm ents w ith  potentia lly reduced side effects (interferon free treatm ents) and
shorter trea tm ent duration, there is a danger tha t hepatitis C w ill be seen as increasingly
transient or (even more) unim portant. Living w ith  hepatitis C may be increasingly enacted as
temporary, overlooking issues such as access to  treatm ent, the needs o f those fo r whom
trea tm ent does not work, and o f those fo r whom hepatitis C exacerbates other
13 For impairments including hepatitis C, intractable Asthma and Eczema, as well as therapy for 
specific forms of cancer - a significant finding in the context of the discussion in chapter six.
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im pairm ents/disablism. In addition, it marginalises the need fo r help fo r those on trea tm ent 
a t the m oment, and potentia lly negates against taking action to  provide support.
D om inance of a medical response
It has been recognised tha t living w ith  hepatitis C poses a range o f issues across social, 
reproductive, physical, psychological and em otional areas, requiring international and 
interdisciplinary research (Banwell et al., 2005; Stewart et al., 2012). Despite this, medicine 
has provided the overwhelm ing response to  hepatitis C.
In qualitative interviews w ith  Australian Hospital consultants, Teague e t al. (1999) found tha t 
views on the support needs o f people w ith  hepatitis C were varied. Although some 
consultants were open to  working w ith  support groups and hepatitis C councils, they were 
unclear about the aim and function o f these groups. Others described a reluctance to  refer 
to  support services, not understanding why anything o ther than medical support would be 
required. W hilst these findings could be a ttribu ted to  the tim ing o f this study (it being one of 
the earliest qualitative investigations), there is evidence tha t this focus on medicine at the 
expense o f o ther aspects persists.
Critiques come from  both w ith in  and outside medicine. Nursing scholars Paterson et al. 
(2006) note tha t support offered to  those living w ith  hepatitis C centres on inhibiting the 
progression o f virus and liver disease alone, rather than exploring other dimensions of 
experience (see also Sgorbini et al., 2009). Participants reported being given advice which 
fitte d  poorly w ith  the context o f the ir own lives (for example, being advised to  take bed rest 
when they were the sole wage earner in the ir household) - w ith  one participant stating that 
the consultant 'only cares about my liver' (p.217). Here I am reminded o f an observation 
made in Oliver (1990), who indicates tha t medicine is indeed im portant and helpful, but tha t 
'the problem...is tha t medical people tend to  see all difficulties from  the perspective of
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proposed treatm ents fo r a patient w ithou t recognising tha t the individual has to  weigh up 
w hether trea tm en t fits the overall economy o f the ir life ' (Brisenden 1986, cited in Oliver, 
1990: 5).
In a rare UK based study, nurse researchers Grundy and Beeching (2004) lend support to  the 
observation tha t the UK medical system concentrates on medical aspects o f experiences 
during appointm ents at the expense o f w ider issues, constituting and re-constituting the 
power o f medicine.
Similar findings have been reported by New Zealand Sociologist Harris (2005), who herself 
lived w ith  hepatitis C, indicated tha t if participants could not to lerate treatm ent, or did not 
wish to  undertake it, there was very little  tha t could be offered. Others have since described 
only a partial f i t  between what medical markers ( i.e. liver function tests, viral loads) indicate 
about partic ipant illness and the forms o f support they need (Sutton and Treloar, 2007), and 
this is particularly the case w ith  regard to  post trea tm ent (Paterson et al., 2006) - discussed 
in chapter eight. M ost recently, Harris et al. (2012a) has highlighted the medical focus, 
noting tha t o f 44 o f 53 EU countries who responded to  a survey fo r W orld Hepatitis Day, 68% 
reported a care pathway -  though fo r many, this only consisted o f referral to  a specialist or 
hospital.
Hepworth and Krug (1999) indicate that in times o f uncertainty, medicalisation can be 
im portant in helping people make sense o f the ir lives and the ir illness (cf. Jenner and Scott, 
2008). W endell (1996:123, 2006) notes tha t medicine has a cognitive authority to  define 
'valid ' impairments. This means tha t they come to  understand it in particular ways and which 
potentia lly marginalises the ir experiences (what Wendell refers to  as 'epistemic 
invalidation'), as well as cultural and social implications (and the accompanying support) 
(Hopwood and Southgate, 2003). Jenner and Scott (2008) note the certainty offered by 
medicine in existing literature (which the ir findings refute). As discussed in chapters seven
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and eight, fo r participants in this study, trea tm ent offered more uncertainty even when SVR 
was obtained.
W hilst medical knowledge is im portant, it is not the only basis on which individuals act. 
Aspects o f life affected by hepatitis C include work, fam ily, relationships, friends and 
participants' understanding o f themselves, and there are increasing calls fo r models o f 
support to  account fo r this (Harris, 2005; Sutton and Treloar, 2007; M urphy and Fitzpatrick,
2011). This thesis makes an im portant contribution in exploring the experiences o f living w ith  
hepatitis C and trea tm ent in the UK, and looking both at and beyond medicine to  see which 
o ther form s o f support are necessary.
Professional Support
In the UK, the key role o f professionals in supporting and treating those who have, or may 
contract, hepatitis C has been acknowledged in all action plans (DH, 2004; Scottish Executive, 
2006; Department o f Health, Social Services and Public Safety, 2007; The Scottish 
Government, 2008; Welsh Assembly Government, 2010; Scottish Government, 2011). In the 
UK, trea tm ent is commonly delivered by a specialist hepatologist or gastroenterologist 
alongside a specialist nurse in a large hospital (Tait et al., 2010). Patients attend weekly and 
then m onth ly appointments w ith  the specialist nurse, and maintain contact until six months 
post treatm ent.
Ehsani e t al. (2006) in the ir interviews w ith  14 key stakeholders o f liver clinics in Victoria 
indicated tha t specialist hepatology nurses are crucial in improving trea tm ent uptake and 
maintaining people on treatm ent. In the firs t study which explored patient perceptions o f 
specialist nurses, Grogan and Timmins (2010) surveyed 106 patients in the Republic o f 
Ireland, six months after treatm ent, concerning the care and support they had received. 
W hilst overall the cohort surveyed were very satisfied w ith  the ir care, the authors
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maintained tha t those w ith  genotype one required greater support, including referral to  
support groups, help to  manage side effects and provision o f individually ta ilored support - 
though they do not make clear how this m ight look.
Interestingly, the authors link the need fo r increased support among those w ith  genotype 
one, to  m ethod o f transmission (from blood products) rather than the increased duration o f 
trea tm ent (48 weeks). This enacts those w ith  hepatitis C contracted through blood products 
as requiring greater support and marginalises the impact o f treatm ent fo r everyone. No 
referral is made in the study to  m ulti-disciplinary support, and though Grogan and Timmins 
(2010) make reference to  the need fo r psychological care, no specific forms are described.
The need fo r m ulti-disciplinary support in addressing the needs fo r those living w ith  hepatitis 
C is acknowledged in UK policy. Welsh and Scottish Action Plans (Scottish Executive, 2006; 
Scottish Government 2008; Welsh Assembly Government, 2010; Scottish Government, 2011) 
outline how effective trea tm ent provision requires collaboration between d iffe rent agencies 
including prim ary care, social services, mental health, alcohol and o ther drug services, 
support groups and crim inal justice agencies. They refer to  clearly defined pathways o f care 
decided at the local level, in order to  make treatm ent accessible, minimise nonattendance 
and encourage adherence and completion.
The need fo r a multi-disciplinary response has also been described elsewhere, w ith  Janke et 
al. (2008) indicating tha t 'wherever possible clinicians should seek to  work w ith 
m ultid isciplinary teams or mental health care providers' (p. 499). In the ir study exploring 
pre-treatm ent preparation, Hopwood and Treloar (2007) describe treatm ent being managed 
w ith in  a multid isciplinary network, including specialists, nurses, psychiatrists and social 
workers. Sternhell et al. (2012) describe the successes o f a multidisciplinary integrated 
support service fo r people living w ith  hepatitis C and HIV who require mental health support 
in Australia. The service comprises o f a clinical psychologist, psychiatrist and a clinical nurse
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consultant, as w ell as an adm inistrator, and the service liaises w ith  the person's GP which 
reduces adverse events fo r patients. The need fo r professional support from  counselling 
services has also been noted, as has the inconsistency in availability o f services depending on 
where a person lives (Hopwood and Treloar, 2005).
Nursing scholar Jacqui Richmond (2008), w riting in an Australian context, indicates that 
optim al care fo r people w ith  hepatitis C involves a range o f professionals, including: 
hepatologist, specialist nurses, GPs, counsellors, complementary and alternative therapists 
and pharmacists. O ther professionals referred to  by Ehsani e t al. (2006) include drug and 
alcohol services, psychiatrists, social work staff and interpreters. Yet they also indicate tha t 
funding and resources are an issue fo r services - which at the tim e were delivered on an ad 
hoc basis. Stewart et al. (2012) also recognise funding constraints in provision o f support and 
indicate tha t this m ight be remedied by provision of in ternet support services and by the 
expansion o f existing hepatitis C services in Australia. The problem w ith in  the UK 
(particularly England) is tha t the same infrastructure o f support does not exist. Sgorbini et 
al.'s (2009) participants suggested tha t due to  the connection between hepatitis C and 
injecting drug use, there was far less support than if a person had a d iffe rent chronic illness. 
The connection between negative beliefs and support provision is explored in greater depth 
in chapters six, seven and nine.
The emphasis on multi-disciplinary support here is not intended to  'scale up' (Fraser and 
Seear, 2011) responses to  hepatitis C in a way which pathologises those living w ith  the virus - 
not all people w ith  hepatitis C w ill need access to  a wide range o f services, or indeed will 
require form al support. As Treloar et al. (2011: 400) state, 'assuming people o f a 
disadvantaged group are deprived and debilitated, can do more harm than good. When 
working w ith  people who inject drugs, it is im portant to  recognise the impact tha t housing 
em ploym ent and social networks have on access to  healthcare services. It is equally
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im portant to  recognise tha t fo r some, access to  healthcare services is all they need and 
a ttem pts to  connect them  to  welfare services are misguided'.
Social W o rk  support
The previous sections have explored the documented social issues and implications o f living 
w ith  hepatitis C (Crockett and G ifford, 2004), and the accompanying need fo r support. One 
particularly underexplored form  o f support fo r people w ith  hepatitis C is tha t o f social work, 
making it an im portant element o f the thesis, revisited in chapter seven.
The absence o f literature which explores in depth the role o f social work in supporting 
people w ith  hepatitis C has been noted (Paylor and Orgel, 2004; Paylor and Mack, 2010; 
M oulton, 2011). This is surprising given tha t explicit recognition o f social work and social care 
in addressing hepatitis C is also present in policy and guidance. Both the Department of 
Health's (2002a;2004) Hepatitis C Strategy and Action Plan fo r England made reference to 
the provision o f support and inform ation, facilitating testing and support to  children and 
families, and even the provision o f Direct Payments to  enable the provision o f care, including 
a case study o f a specialist hepatitis C social work role. In recent years, the Archer Inquiry 
(2009) into the needs o f those who acquired hepatitis C from  blood and blood products 
indicated tha t there may be a need fo r substantial input from  social work including support 
fo r carers, access to  financial support and homecare.
In spite o f the clear recognition o f the role o f social workers, there is scant evidence that, this 
discussion and recommendations have been meaningfully engaged w ith  in England (as the 
thesis explores). In 2004, Paylor and Orgel pointed to  the need fo r social work to  'wake up' 
to  hepatitis C and more recently, Mack (2007) and Paylor and Mack (2010) outlined the 
junctures at which social workers could raise the issue of, or become involved in, supporting 
people w ith  hepatitis C.
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The potentia l reasons fo r social work's lim ited engagement are numerous. It may be 
explained in significant part by the increasingly constrained resource and policy 
environments in which social workers are expected to  function (Galvani, 2007) and even 
purposeful marginalisation o f the issue, given the anticipated costs, both economically and in 
term s o f social workers' tim e (Orgel et al., 2005). It may also be explained by social work's 
lim ited engagement w ith  substance use in the UK, given tha t sharing injecting drug use 
equipm ent is a main route o f transmission. People who use drugs require support from  a 
range o f services, including social work (Neale, 2008). Their needs cut across the range of 
social work teams and may be one o f a number o f interlinked issues (Keene, 2001). Despite 
this, there  is a severe lack of specialised education on undergraduate, postgraduate and post 
qualifying education in social work (Galvani and Hughes, 2010, see also Natale et al., 2010). 
This means social workers lack knowledge and understanding about the effects o f hepatitis C 
and the client groups it affects. This lack o f a ttention to  substance use (and hepatitis C) on 
the social work curriculum reinforces the perception o f substance use (and blood borne 
viruses) as health issues, and sends a message about how concerned and involved social 
workers are expected to  be (Galvani and Hughes, 2010).
In a recent mixed methods study involving surveys and focus groups w ith  social workers 
from  both children's and adult services, a key finding was that those working w ith  adults 
(older people and disabled people in particular) fe lt uncomfortable or found it d ifficu lt to  ask 
about substance use, and as a result rarely or never asked about it. This is im portant as it 
simultaneously reduces the opportun ity  to  have a discussion about hepatitis C and other 
BBVs. Though social workers in children's services did feel tha t asking about substance use 
was in the ir rem it, this often only occurred when the social worker perceived it was 
impacting on the parent's ability to  fu lfil social roles or caring responsibilities, when harm 
may have already occurred. Thus hepatitis C may go unnoticed and unsupported. Galvani et 
al. (2013) point out tha t talking about substance use maximises the opportun ity to  address it
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and provide support. This is equally applicable to  talking about hepatitis C. The lack o f 
guidance exploring the role o f social workers in relation to  hepatitis C (a notable exception 
being Paylor, 2010) may mean tha t social workers are unsure when to  raise the possibility o f 
a test, the kinds o f support and inform ation they can provide or how to  support people 
through treatm ent.
A lthough the tw o  viruses have d iffe rent social and material implications, given the dearth o f 
available literature, it has been useful to  extrapolate some findings from  the HIV social work 
lite ra ture  here. Social work has played a key role in prevention support and care o f people 
w ith  HIV over the last three decades globally (Natale et al., 2010), and is involved in 
addressing a range o f issues pertaining to  diagnosis, trea tm ent and everyday life w ith  HIV. 
However, UK based social work academic Clarke (2012) also notes tha t disease progression 
and successes related to  HIV are measured in medical terms, which may lead to  the social 
circumstances being overlooked. Clarke (2012) emphasises the vital place o f HIV on the 
social w ork curriculum, given tha t people affected by HIV may also be affected by a wide 
range o f issues including drug use, loss and bereavement, m igration and crim inal justice - 
although she does not m ention disability issues, an im portant omission in the context o f this 
thesis. Clarke (2012) maintains tha t social workers should be equipped w ith  knowledge 
around transmission and disease progression, treatm ent, loss, and pre and post-test 
counselling fo r HIV. She concludes by emphasising the need fo r expansion o f this basic 
in form ation onto social work degrees across the country. These findings could equally be 
applied to  hepatitis C.
To date, only one in-depth empirical study explicitly exploring the role of social work fo r 
those w ith  hepatitis C has been undertaken. M oulton (2011) interviewed 10 o f the 15 
specialist social workers attached to  hepatitis C trea tm ent centres in New South Wales, 
Australia, regarding the ir perspectives on the support needs o f people on treatm ent, as well
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as the skills, values and experiences required o f the workers. M oulton (2011) found tha t 
client needs centred on inform ation and support fo llow ing diagnosis, identifying personal 
strengths and resources, support to  access drug and alcohol services and to  access and 
complete trea tm ent. This study was from  the perspectives o f specialist social workers and 
this thesis makes an original and im portant contribution in exploring the extent o f social 
w ork support available to  the participants, as well as identifying the kinds o f support 
required and the potentia l barriers to  social work involvement (see chapter seven).
As was noted above, living w ith  hepatitis C can have a serious impact on everyday life. 
Groessl e t al. (2008) found tha t participants in the ir study had specific concerns about 
disclosing to  fam ily members and preserving relationships. This is paradoxically a tim e when 
people are most likely to  require support, but may feel most isolated having absorbed w ider 
negative assumptions around hepatitis C. This isolation is likely to  be exacerbated (Janke et 
al., 2008) by o ther life circumstances, including financial strain (as explored in chapter nine, 
changes to  ESA and DLA may increase isolation) previous drug use, involvement in the prison 
system and recent in troduction o f the under occupancy penalty may mean moving to  
d iffe ren t areas resulting in uprooted social networks, making social work involvement 
particularly tim ely.
Hepatitis  C and peer expertise
Given th a t hepatitis C can impact negatively on social networks (Sgorbini et al., 2009) and 
given the lack o f form al services, there is a need fo r forms o f support which utilise 
inform ation and expertise from  sources o ther than professionals, notably, support groups 
and peer support services. The role o f peer support fo r people living w ith  hepatitis C is 
increasingly recognised (Harris, 2005; Treloar and Abelson, 2005; Grogan and Timmins 2010; 
Stewart e t al., 2012). Peer support can represent an im portant addition and challenge to  the 
dominance o f the medical discourse. The particular knowledge and expertise o f peers in
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relation to  hepatitis C is noted by Treloar et a l's. (2010a) study o f participation in prospective 
vaccine trials fo r hepatitis C. Participants indicated tha t where health professionals knew 
about hepatitis C from  books and academic inform ation, peers had an embodied form  of 
knowledge tha t came from  living w ith  the virus (see also Treloar et al., 2011). Although it is 
im portant to  note tha t the experiences o f peers and people w ith  hepatitis C are not 
homogenous (Treloar et al., 2010b), and peer education methods and modes need to  
accommodate d iffe rent learning styles and experiences.
The privileging o f peer perspective functions as a message to  others tha t they are w orthy of 
good trea tm ent rather than being seen as a 'th rea t' to  public health (Hopwood and Treloar,
2003). Hopwood and Treloar (2003) found tha t peer support groups served a number of 
purposes, from  providing up to  date inform ation, to  sharing strategies fo r dealing w ith  the 
effects o f hepatitis C in everyday life. Participants indicated that the emotional support they 
attained from  meeting others w ith  hepatitis C, and being listened to, was also vital (see 
Galindo e ta l., 2007, and Harris, 2005).
The specific knowledge and experience of peers who do not have hepatitis C has also been 
recognised as im portant in light o f still developing hepatitis C knowledge, specifically among 
injecting drug users, who after a long injecting career are still free from  hepatitis C. Mateu- 
Gelabert et al. (2007) refer to  an international study ('The Staying Safe Project'), concerning 
the risk protection strategies employed by people who inject drugs. In the Australian arm of 
the study, Harris et al. (2012b) found the strategies tha t protected injectors were not directly 
related to  hepatitis C or harm reduction messages, but rather were concerned w ith 
maintaining social (friendships, fam ily relationships) and structural (housing) resources, 
managing w ithdrawal and maintaining appearance. For example, using new needles to  avoid 
scarring which simultaneously avoided sharing, and living in a stable home which meant tha t
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participants were able to  endure w ithdrawal to  wait to  inject in a safer environm ent (see 
also Rhodes and Harris 2012b).
Peer support has been used successfully to  encourage engagement w ith  services among 
people who use drugs. Aitken et al. (2002) described the successes o f a trained peer in 
delivering hepatitis C testing and counselling to  clients visiting a needle exchange in 
Australia. Sylvestre and Zweben (2007) describe an integrated peer based service in the US 
to  encourage people using drugs to  engage w ith  hepatitis C support. Here, support groups 
are led by those who have recently completed treatm ent, in collaboration w ith  a member o f 
the medical staff. The group supports peers w ith  a wide range o f issues, from  treatm ent 
effects to  housing and transport and has resulted in increased engagement testing and 
treatm ent. Galindo et at., (2007) w riting  in the ir capacity as peer educators fo r the above 
project, indicate tha t peers are vital fo r bridging the gap between people w ith  hepatitis C 
and the medical system, given tha t people w ith hepatitis C may have had negative 
experiences w ith  the health care system in the past.
Norman et al. (2008) describes the integration o f support into a 'one stop shop' fo r people 
attending a drug service who undertake treatm ent fo r hepatitis C. A peer worker employed 
by the organisation acts as an empathetic and experienced listener, as well as being able to  
provide support such as arranging alternative therapies, providing transport and support at 
hospital appointments. However, lack o f funding is identified as a major concern, as well as 
the need fo r a professional fram ework (see also Treloar et al., 2012) fo r peers, given that 
they fe lt they were not trusted by the medical professionals. A fram ework would also 
provide clear boundaries to  the role, given its labour intensive nature and the complex needs 
o f those supported.
More recently, the role o f peers has been incorporated into self-management programmes. 
Groessl (2008; 2011) in the ir development o f such a programme fo r people w ith hepatitis C
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have included specific sessions where peers who have done trea tm ent participate in 
discussions and answer questions. There is evidence to  suggest tha t peers are also influentia l 
in trea tm ent decisions: Munoz-Plaza (2008) found tha t peers were often the main source of 
in form ation when deciding w hether to  in itia te treatm ent. Although peers can be 
instrum ental in encouraging individuals to  access trea tm ent (Galindo, 2007) they can also 
represent a source o f anxiety or negative inform ation (Munoz-Plaza et al., 2008). Swan et 
al.'s (2010) participants described hearing horror stories from  peers regarding treatm ent 
which acted as a deterrent to  trea tm ent in itia tion. Even when respondents were being 
supported by a doctor, input from  the ir peers meant they still expressed reticence about 
receiving trea tm ent. The role o f peers is returned to  in chapter seven.
The im pact on finances and em ploym ent
Qualitative research relating to  the impact o f living w ith  hepatitis C on employm ent and 
finances is scarce and, as such, constitutes a key gap in the literature. The focus on 
em ploym ent and finances (specifically welfare benefits) is particularly tim ely, given tha t the 
thesis has taken shape in a global economic recession, and as major reforms o f the welfare 
benefits system and the NHS, and deep cuts to  services have been announced. This thesis is, 
therefore, situated at an im portant point in tim e; generating data in the early days o f reform 
has meant it is possible to  provide a point o f comparison and to  engage in discussion o f how 
some aspects o f reform  m ight affect those living w ith  hepatitis C.
Hepatitis C and employment
Both qualitative and quantita tive studies have stated tha t the emotional and physical 
dimensions o f illness, trea tm ent side effects and the ir wide ranging and unpredictable nature 
(Conrad et al., 2006) can affect participation in the workplace (Coughlan et al., 2002; Crockett 
and G ifford, 2004; Blasiole et al., 2006). A recent Australian study described participants'
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difficulties in sustaining the ir careers and ambitions. They a ttribu te  this to  hepatitis C related 
fatigue which they state both exacerbated o ther symptoms and altered the ir daily routines 
and tasks (Fry and Bates, 2012). The study found tha t participants reduced the ir hours from  
fu ll to  part tim e, or stopped altogether, as part o f what they termed 'self-care' (p.470). It 
highlights tha t people w ith  hepatitis C face the dilemma between needing to  work fo r financial 
and personal reasons but not always being able to  do so (Swan et al., 2010). As a result this 
may mean tha t people w ith  hepatitis C seek financial support elsewhere (discussed fu rthe r 
below). Platt and G ifford (2003), in the only qualitative study to  focus solely on em ploym ent 
experiences, found tha t in addition to  the financial benefits, work was an im portant marker o f 
self-worth, enabled participants to  feel part o f the ir community, and provided structure to  
manage the effects o f living w ith  hepatitis C (findings m irrored by Hopwood et al., 2006). The 
authors found tha t the loss o f employm ent had a serious impact on participant self-confidence 
and wellbeing (see also Glacken et al., 2001). Additionally, a US study found tha t em ployment 
(even part tim e) was associated w ith  greater access to  inform ation and support in relation to  
hepatitis C (Zucker, 2006).
However, in a comprehensive inquiry in to the discrim ination faced by people w ith  hepatitis C 
in New South Wales Australia in 2001 submissions to  the inquiry indicated that employment 
was the most common site o f discrim ination, a fter healthcare settings, and that discrim ination 
often fo llowed disclosure in the workplace (ADBNSW, 2001). For participants in Crockett and 
G ifford's (2004) study, a fear o f negative consequences meant they hid the ir status from  
employers, thus creating difficulties in explaining the need fo r tim e o ff fo r regular hospital 
attendance (see also Hopwood et al., 2006), potentia lly impacting on the ir ability to  maintain 
appointments and therefore affecting the ir health (Swan et al., 2010). Hopwood et al., (2010) 
found tha t very few  people had disclosed the ir hepatitis C status to  the ir boss or work 
colleagues, 16.5% (83/504) and 17.3% (87/504) o f participants respectively, due to  concerns 
about the ir reactions. Although some did describe feeling obligated to  te ll the ir colleagues
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(see also Platt and G ifford, 2003). Other studies described how participants w ithheld the ir 
status in the workplace as they were concerned they would lose the ir jobs or would not be 
considered fo r the position at all (Butt et al., 2008b; Moore, 2009).
Discrim inatory workplace procedures have also been described in the literature, including 
being subjected to  invasive questions concerning the method o f transmission (Conrad et al.,
2006) or assumptions related to  participants' (perceived) status as someone who used drugs 
(ADBNSW, 2001). In a US context, Moore (2009) found tha t occupational health 
examinations were also used as a site o f discrim ination, enacting hepatitis C as highly 
contagious. M oore's (2009) study is one of the few  which makes explicit reference to  the 
possibility o f protection afforded to  people w ith  hepatitis C at work through legislation (in 
this case the Americans w ith  Disabilities Act) and the ADBNSW (2001) in an Australian 
context refers to  coverage o f people w ith hepatitis C under the Anti-D iscrim ination Act 1991 
and the Disability Discrim ination Act 1992.
In the UK, the recent Scottish BBV and sexual health fram ework (Scottish Executive, 2011:24) 
acknowledges tha t people living w ith  HIV may face financial hardship and tha t these financial 
d ifficulties can impact on the ir ability to  live well. It refers to  the need to  support both those 
who were diagnosed before effective therapy became available and those who are living 
w ith  more recent HIV, including support to  work fo r as 'long as they can and wish to '. The 
fram ew ork points to  the importance o f providing inform ation to  both em ployer and 
employee on the effects o f HIV on working life, including confidentiality, avoiding stigma and 
discrim ination and obligations under equalities legislation - although sim ilar guidance is not 
provided in relation to  hepatitis C. This apparent lack o f acknowledgement tha t hepatitis C 
can affect em ploym ent fu rthe r emphasises the importance o f the contributions o f the thesis 
in this area.
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A ttention  to  the qualitative experiences o f employm ent fo r people w ith  hepatitis C is 
particularly im portant given tha t the findings in some quantita tive literature could have 
highly disabling consequences. Two studies14 concluded tha t side effects o f combination 
trea tm en t led to  decreased productiv ity in the workplace and the need to  w ork shorter 
hours (McHutchinson, et al., 2001; Perillo et al., 2004). In 2010, Su et a l.'s analysis o f 
em ploym ent records maintained on a human resources database found tha t those w ith 
hepatitis C (who were not on treatm ent) were less productive at work - though it is not clear 
w hat this means - and had more tim e o ff sick, both short and long term . Although the 
authors acknowledge tha t this could act as a source o f stress and anxiety fo r the workers, no 
reference is made to  the obligations o f employers under legislation or to  the possibility o f 
adjustments tha t could be made to  facilitate and maintain employm ent. Given the authors' 
affiliations w ith  pharmaceutical and health assessment human resources organisations, 
these studies contribute to  a disabling hinterland, where hepatitis C is constituted as an 
individual problem to  be managed, and where people w ith  hepatitis C are seen as a burden 
to  employers. This has potentia lly very serious material consequences in terms o f the 
em ploym ent o f people w ith  hepatitis C.
Hepatitis C and social security benefits
The financial implications o f living w ith  hepatitis C and the experiences o f claiming social 
security benefits are underexplored in existing literature. Studies which do refer to  
participants receiving welfare benefits do so mainly as part o f the demographic inform ation 
(Balfour et al., 2004; Crockett and Gifford, 2004; McNally, 2004; Banwell et al., 2005; 
Sternhell e t al., 2012), but do not explore the process or the implications o f this in great 
depth. W elfare benefits are an im portant and tim ely topic fo r people w ith  hepatitis C, and 
were raised spontaneously by participants. This thesis makes an im portant contribution in
14 The research teams included medical staff, pharmaceutical researchers, as well as those from 
companies who measure health outcomes.
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exploring participants' experience o f welfare benefits in the UK, notably Employment and 
Support Allowance and Disability Living Allowance, and the interconnection between 
(form er) drug use, hidden im pairm ent, discourses and attitudes related to  welfare benefits, 
chronic illness and disabling barriers.
Due to  lim ited engagement w ith  hepatitis C to  date, useful insights can be gained from  HIV 
literature. In a recent Australian study, McAlister et al. (2012) surveyed 335 people living 
w ith  HIV and found tha t financial stress affected treatm ent adherence fo r a small, but 
significant, number. 65 (19.6%) found it very d ifficu lt to  adhere to  trea tm ent due to  the 
financial impact. 49 (14.6%) stated tha t they had delayed buying medication due to  
pharmacy costs and 30 (9%) had ceased trea tm ent due to  cost. A fu rthe r 19 (5.7%) fe lt tha t it 
was d ifficu lt to  attend appointments due to  travel costs. In spite o f this, only a small 
p roportion has been asked by the ir care teams about the difficulties they faced in meeting 
financial needs. McAlister et al. (2012) emphasise tha t people should be asked about this 
routine ly as part o f appointments.
Owen and Catalan (2012), in the ir interviews w ith  British men about the process o f ageing 
w ith  HIV, found tha t moral as well as financial concerns existed, specifically anxiety and 
shame regarding 'benefit' and 'state dependency'. Those diagnosed prior to  the 
development o f HAART15 were more likely to  receive disability benefits, but expressed 
concerns tha t they were caught in a 'benefits trap '. They described feeling stigmatised and 
marginalised fo r claiming financial support. This moral dimension o f claiming benefits is 
tim ely given the current 'scrounger' rhetoric (Garthwaite, 2011) in the media, and the 
perceived im m orality associated w ith  drug use (Harris, 2009a). Receipt o f government 
support (or not) and the intrinsic links between hepatitis C, drug use and its' 'self-in flicted' 
nature, are explored in greater depth in chapter nine.
15 Highly Active Anti Retroviral Therapy
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Cultural representations of disease
W ith in  existing literature, hepatitis C is frequently compared w ith  HIV (Treloar, 2002; 
Copeland, 2004; Davis and Rhodes, 2004; Davis et aL, 2004; Korner and Treloar, 2006; 
Treloar and Rhodes, 2009; Harris, 2009b; Swan et aL, 2010; Farrell and Comisky, 2012). This 
is often suggested as a reason fo r the lack o f political engagement w ith  hepatitis C (Treloar 
and Rhodes, 2009), or used to  contextualise the provision o f funding and support. For 
example, Copeland (2004) indicates tha t despite hepatitis C affecting greater numbers o f 
people than HIV, the profile o f HIV remains much higher than hepatitis C. W hile Korner and 
Treloar (2006) maintain tha t people w ith  HIV and hepatitis C face sim ilar social issues - both 
illnesses are uncertain, both treatm ents require com m itm ent and can have d ifficu lt side 
effects. Hepatitis C is perceived as the 'poor re lation' o f HIV, existing in its shadow. Hepatitis 
C was enacted as a 'prob lem ' only after a high level o f media coverage and public health 
awareness raising in the 1980s around HIV -accompanied by 'in form ation fatigue'(Slavin, 
2006, Treloar et aL, 2011). A sim ilar level o f media interest has never existed fo r hepatitis C, 
in part because hepatitis C has not had the same impact, w ith  men and women dying 
suddenly and visibly. Nor is there the same level o f concern about hepatitis C spreading to  
the general population (Pisani, 2009). In addition, hepatitis C and injecting drug use are 
frequently conflated (Harris, 2005) which positions hepatitis C as something that happens to  
'o the r' people.
Further, hepatitis C was historically referred to  as 'non A non B hepatitis' before it was 
named hepatitis C in 1989, which Harris (2009b) indicates contributed to  its constitution as 
triv ia l. It is made sense o f in relation to  other more established forms o f hepatitis, 
understood as w hat it is not, rather than what it is. Harris' (2009b) participants indicate tha t 
this meant they found it d ifficu lt to  take seriously. This is augmented w ith  the common
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practice o f provision o f hepatitis C test results alongside results fo r HIV, which im plic itly 
creates a hierarchy where hepatitis C is marginalised.
Treloar et al. (2002) maintain tha t hepatitis C has not received the same level o f concern 
regarding policy input as HIV due to  the association w ith  injecting drug use, and the 
perception by health bureaucracy o f people who inject drugs as disorganised and not 
constitutive o f a com m unity in the way the gay com m unity was perceived during the HIV 
epidemic. Treloar et al. (2002) (see also Butt et al., 2008a) maintain tha t this slow 
Government response amounts to  systemic discrim ination against people w ith hepatitis C 
and tha t negative perceptions o f hepatitis C as a 'drug users disease' have impeded 
adequate funding.
More recently, hepatitis C has been discussed alongside o ther forms o f hepatitis fo r 
example, W orld Hepatitis Day (WHO, 2012), or other blood borne viruses as in Scotland's 
Sexual Health and BBV Framework (Scottish Government, 2011). This works to  focus 
a ttention on the range and intra-action o f BBVs and the need fo r a response. It lends fu rthe r 
support to  the position tha t hepatitis C and HIV do not exist as fixed entities but are enacted 
d iffe rently  (w ith material implications) depending on how and who constitutes them.
Stigma, d iscrim ination  and using disability  studies to explore  
hepatitis  C
The connection between hepatitis C and stigma is well documented in the literature (Crofts 
et al., 1997; ADBNSW, 2001; Van De M orte l, 2002; 2003; Hopwood and Southgate, 2003; 
Zickmund et al., 2003; Grundy and Beeching, 2004; Golden et al., 2006; Treloar et al., 2006; 
Zacks et al., 2006; Moore, 2009). Indeed, it is described as a central element o f the 
experience o f living w ith  hepatitis C (Hopwood and Southgate, 2003; Zacks et al., 2006), 
leading Richmond et al. (2004) to  refer to  hepatitis C as tw o  illnesses - living w ith  the virus 
and its effects, and living w ith the stigma.
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Existing literature has explored stigmatising responses and experiences in a number o f 
settings, notably responses o f fam ily and friends (Zickmund et al., 2003; Fraser and Treloar, 
2006; M oore, 2009). The literature in this field reports overestimation o f transmission risk 
(Zickmund e t al., 2003) which impacted negatively on personal interactions and relationships 
(Groessl, 2008). People reported being deterred from  playing w ith  child relatives, being to ld  
they could not use the bathroom and being deprived o f physical contact (Zickmund et al., 
2003, Crofts et al., 1997), thus fu rthe r isolating people w ith  hepatitis C and leading to  
reduced support networks (Blasiole et al., 2006; Moore, 2008; McCreaddie et al., 2011).
Stigmatising responses are also documented w ith in  institu tional settings, particularly 
healthcare, given tha t status is most frequently disclosed here (see ADBNSW, 2001; Habib 
and Adorjany, 2003; Hopwood and Treloar, 2003). Participants reported healthcare staff 
judging them  negatively, using universal precautions to  stigmatise and shame them, refusing 
to  trea t them, or treating them  only at particular times, such as the end o f the day 
(ADBNSW, 2001; Temple Smith et al., 2006; Moore, 2008). Negative treatm ent by healthcare 
workers potentia lly becomes a cyclical process where people w ith  hepatitis C who have been 
treated negatively, anticipate poor treatm ent and respond defensively - thus inhibiting a 
respectful and helpful relationship (Paterson et al., 2007). Other incidences o f discrim inatory 
trea tm ent documented by the ADBNSW (2001) (see also Crofts et al., 1997) explored stigma 
in the context o f funeral services (refusal to  allow viewings or embalm, storage or burial of 
bodies in unnecessary ways), employment (involuntary disclosure and subsequent poor 
treatm ent), or welfare organisations (segregation from  others).
Stigma is most frequently a ttribu ted to  perceptions o f injecting drug use. As a result those 
w ith  hepatitis C are enacted as irresponsible, morally deficient and to  blame fo r the ir 
infection (Richmond et al., 2004; Paterson e t al., 2007; Moore, 2008). Other studies have 
suggested tha t people who use drugs are understood as dangerous, deceitful (concerned
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only w ith  obtaining drugs), u ltim ately to  be avoided (Hunt and Derricott, 2001; Paterson et 
al., 2007; Peckover and Chidlaw, 2007; Lloyd, 2010) and thus, those w ith  hepatitis C are 
constituted as less 'deserving' o f support (revisited in chapter nine).
Those who continue to  inject drugs report more incidences o f discrim ination and are more 
likely to  experience negative assumptions (Paterson et al., 2007; Day et al., 2008; Foster, 
2008), w ith  Hopwood and Treloar (2004) noting tha t they received less support fo llow ing 
diagnosis, were less likely to  be referred to, or in itia te treatm ent, or were treated 
reluctantly. For those who did not contract hepatitis C via drug use, there is evidence tha t fo r 
some, the assumption o f drug use persisted (Gifford et al., 2005; Conrad et al., 2006), forcing 
them  to  make the transmission route clear, or even to  lie about it. O ther studies have 
suggested tha t negative treatm ent is not only related to  drug use. Women in particular 
described poor trea tm ent (Crofts et al., 1997), including being advised to  term inate 
pregnancies (Gifford et al., 2003) or made to  feel tha t they were unfit parents. This feeds 
existing perceptions o f women who use drugs and/or have hepatitis C as deviant and as unfit 
mothers (Zickmund et al., 2003; Ettore, 2007) and enacts them, and the lives o f the ir 
(potentia l) children, as having little  value. Lesbian and bisexual women also reported 
receiving less support from  services (Banwell et al., 2005).
O ther literature has referred to  'self-stigma' where people w ith  hepatitis C have absorbed 
negative views, shame or incorrect beliefs about themselves and about hepatitis C (Waller, 
2004; Zacks et al., 2006), accepting or expecting poor treatm ent (Crockett and Gifford, 
2004). O ther studies reported participants being afraid to  disclose because o f fear of 
negative reactions or the potentia l to  damage social relationships. Zacks et al. (2006) 
indicated tha t 'self-stigma' was not necessarily related to  mode o f transmission, whilst 
M oore (2009) found tha t those who had contracted hepatitis C via needle stick or 
transfusion reported more positive interactions.
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Elsewhere, participants described 'feeling contagious' or being labelled as contagious 
(Moore, 2009) and, as such, being subjected to  hum iliating treatm ent. Others reported not 
necessarily experiencing stigma but fearing it in interactions which both lead to, and was 
augmented by, concealment o f the ir hepatitis C status. These actual o r anticipated 
experiences o f stigma and discrim ination had a direct impact on participants' experiences of 
seeking help and support on treatm ent, as well as on the ir feelings o f self-worth, confidence 
and self-esteem (Habib and Adorjany, 2003; Temple smith et al., 2004; Jenkinson e t al., 
2008). The issue o f self-stigma is returned to  under internalised oppression below.
Shortcomings o( stigma literature
However, there has been an acknowledgement tha t much o f the existing stigma literature 
focuses on interactions between individuals, thus enacting stigma as an individual tra it, or 
indeed blaming individuals (i.e. healthcare practitioners) fo r the ir behaviour (Paterson et al., 
2007), w ith  insufficient a ttention to  the structural aspects which contribute to  the 
maintenance o f stigma and discrim ination (Rhodes et al., 2004; Paterson e t al., 2013; 
Hopwood e t al., 2006). Paterson e t al. (2013) point to  the need to  look to  the w ider social 
and structural context which co-constitutes these negative views and works to  maintain 
them  (see Parker and Aggleton, 2003). For example, policies determ ining who is eligible fo r 
treatm ent, money spent on treatm ents (Stephens, 2012), service responses (or lack thereof). 
Harris et al. (2013) highlight how the hospital environment facilitates or impedes access to  
trea tm ent fo r people who inject drugs, via inflexible appointment systems, conflicting 
schedules and the layout and distance to  the hospital. Paterson et al. (2013) explore how 
policies, practices and rules w ith in  the hospital restrict access and support fo r people who 
use drugs. The authors found tha t patients were introduced as 'drug users', before detailing 
why they had been adm itted, were flagged as 'infectious', or noted as drug seeking in a log 
book and made to  answer questions in public spaces, which was perceived as threatening
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and invasive. The highlighting o f structural barriers faced by people who use drugs (and have 
hepatitis C) in accessing treatm ent and support is vital, and this opens up a niche to  explore 
the experience o f structural disablism faced by people w ith  hepatitis C which is discussed in 
greater depth below and in chapter five.
W ithin the existing literature, the forces contributing to  the development and maintenance 
o f the negative status of those w ith hepatitis C include: the illegal nature o f injecting drug 
use (Harris 2009a), the controversies and potential lack o f support fo r harm reduction 
methods, such as needle exchanges (Crofts et al., 1997), and, more recently, safer injecting 
facilities (Strathdee and Pollini, 2007; Hathaway and Tousaw, 2008). In addition, the 
transmissible nature o f hepatitis C fu rthe r marginalises the virus via fear o f contagion, illness 
and death (Richmond et al., 2004).
In an im portant recent piece o f work, Harris (2009a) shifted from  descriptions o f instances of 
stigma, to  focusing on the processes and beliefs which constitute and contribute to  stigma in 
the context o f hepatitis C, specifically the association w ith injecting, perceptions o f contagion 
and beliefs about chronic illness. She indicates that the act o f injecting disturbs the strongly 
held perception o f the body as a clean closed vessel. In injecting, the person breaches the 
boundaries o f the body at points o f the ir own making, drawing out and reintroducing bodily 
fluids which may be perceived as polluting. This, together w ith the (often incorrect or 
exaggerated) perceptions of the infectiousness o f the virus and the unwillingness to  engage 
w ith  chronic illness (which may not be immediately visible, may fluctuate and ultim ately 
challenge linear notions of 'getting well') constitutes hepatitis C related stigma. Similar 
sentiments are echoed by Barnes (1997) when he states tha t fears related to  disability are 
connected to  tha t which is considered abnormal or abject (revisited below).
Theories of stigma
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Parker and Aggleton (2003) note tha t the concept o f stigma is frequently used but often 
poorly defined. They draw attention  to  widespread use o f the notion of stigma as a 'mark o f 
disgrace' w ith  lim ited fu rthe r explanation. Perhaps the most famous o f stigma theories is 
Goffman's (1963) 'Stigma; notes on the management o f a spoiled identity '. Goffman (1963) 
describes how stigma originated in Ancient Greece as bodily sign to denote tha t a person had 
done something morally wrong. Over tim e, stigma has come to  be understood as being 
produced in interactions where individuals w ith  specific (negatively perceived) attributes are 
marked out as d iffe rent in comparison w ith  what Goffman (1963) terms 'normals.' Goffman 
(1963) is concerned w ith  the interaction between stigmatised and 'norm al' people, and the 
'm anagement' o f this interaction undertaken by the stigmatised person. Goffman's (1963) 
theory has been shown to  be helpful in exploring interactions between disabled and non­
disabled people (Keith, 1996) and his work on creditable and discreditable attributes, and 
'passing', is particularly im portant and is examined in chapter six.
However, Goffman (1963) has been subject to  criticism concerning his focus on individual 
interactions at the expense o f structural conditions and processes tha t facilitate stigma, and 
fo r treating stigma as a single event or a ttribu te  rather than a contingent shifting process 
which is not inevitable (see Parker and Aggleton, 2003; Reeve, 2004; Harris, 2009a). Further 
to  this, others maintain Goffman's (1963) use o f 'stigma' serves to  shift the attention from 
those who create the problem on to  those who appear to  signify it, and maintains the 
underlying perception tha t those considered stigmatised are 'no t quite human' (see Bogdan 
and Taylor, 1989).
Oliver (1990) maintains that stigma as a concept is inherently individualist and points to  the 
need to  pay attention to  discrim ination and oppression instead. Similar views are echoed by 
Sayce (1998), w riting  in the mental health field. W hilst I agree w ith  the need to  explore the 
experiences o f people w ith  hepatitis C using a fram ework o f discrim ination and oppression,
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in paying a tten tion  to  the w ider social context, stigma remains im portant and useful to  this 
discussion, not least because it was so frequently referred to  by participants and forms an 
im portant component o f existing hepatitis C literature.
Here it is im portant to  re iterate the words o f Finkelstein (1980:29) 'no t everyone, o f course, 
uses the term  "stigm a" in the same way or consistently. In very many cases "stigm a" is used 
in the same sense as "prejudice".
A note on the usage of terms
W ithin this thesis, the concepts o f stigma, prejudice and disablism are entangled and messy 
and subsequently, the ir usage is slippery. It is im portant to  emphasise tha t this is not due to  
poor understanding o f the terms, but fo r a num ber o f reasons. Participants favoured the 
term  stigma w ith in  the ir accounts, rather than prejudice or discrim ination. This may be 
because it is more frequently used, both w ith in  society and w ith in  hepatitis C literature, 
where o ther terms (in particular disablism) are used in more academic arenas. It may also be 
because participants had potentia lly absorbed the negative views around hepatitis C as an 
'individual' issue.
However, there are significant commonalities between stigma and prejudice which 
contributes to  the ir entanglement. Phelan et al. (2008) in the ir analysis o f the sim ilarities 
and differences between stigma and prejudice, point out tha t bodies o f literature on these 
concepts mingle together and indeed 'bo rrow ' from  each other. Such 'borrow ing' took place 
during the course o f this research as I came to  realize what participants (and indeed the 
literature) term ed stigma might more accurately and usefully be term ed disablism or 
prejudice.
As explored above, stigma is most frequently understood as an individual mark or 
characteristic which is perceived to  be socially or morally unacceptable. Goffman (1963)
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maintains tha t the stigmatized person becomes reduced in the eyes o f others; not quite a full 
person. Thus the focus o f stigma is the individual themselves. They are the one w ith  the 
'p rob lem ' tha t needs to  be solved, much like the individual model o f disability.
Prejudices refer to  negative ideas and judgments held about individuals or groups o f people. 
Prejudice is most commonly applied to  groups (i.e. race and ethnicity) (Phelan et al., 2008). 
Prejudice is d iffe rent from  stigma in tha t it shifts the focus from  the individual to  the person 
holding the views. They are the ones who hold prejudices. Disabled activist Jenny Morris 
(1991) makes explicit reference to  prejudice in her exploration o f the negative views o f non­
disabled people about w hat life as a disabled person is like. Examples o f prejudice include 
the perception tha t being disabled is tragic or tha t disabled people strive fo r norm ality or 
cure above all else.
Pyscho-emotional disablism (Reeve, 2008) flows from  M orris ' (1991) w ork by recognising 
tha t the negative messages and values (prejudices) held in society about what it means to  be 
a disabled person (or indeed a person w ith  hepatitis C) circulate and are absorbed and 
reabsorbed by both w ider society and disabled people. These prejudices can become 
internalized w ith  negative consequences fo r the person's wellbeing (explored in greater 
depth below).
It is here tha t links w ith  disablism are made. The absorption o f prejudice are term ed by 
Reeve (2008) as pyscho-emotional disablism. In using the term  disablism, rather than stigma 
which has a focus on the individual or prejudice (which focuses on the person holding the 
views), this oppression becomes a distinctly political concept which shares commonalities 
w ith  oppressions, such as (hetero) sexism and racism, which are recognised w ith in  w ider 
society and can be challenged w ith  collective action. The focus is shifted to  the w ider 
structures in society which contribute to  the creation and maintenance o f oppression. 
Harris (2010) maintains tha t stigma and discrim ination, though inter-related, are not the
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same th ing and tha t the concept o f stigma captures assumptions, and values in a way tha t 
discrim ination does not. Reeve (2008) maintains that Goffman (1963) insightfully describes 
the intricacies o f interaction between stigmatised and non-stigmatised people, including the 
negative feelings associated w ith  the stigma and the way tha t these are absorbed by the 
person. Scambler and Hopkins (1986) d ifferentia te between concepts o f 'fe lt ' and 'enacted' 
stigma which translate to  the expectation o f stigma and the actual experience o f it. They 
maintain tha t it is often the 'fe lt ' stigma which is more damaging and indeed, w ith in  the 
research, participants described being concerned tha t they would experience negative 
trea tm ent much more than incidences where it actually occurred. So, this d iffe rentia tion  is 
im portant. However, the tone o f Scambler and Hopkins' (1986) work still enacts those 
interviewed as deviant, w ithou t paying attention to  w ider structural and contextual forces, 
though Scambler later acknowledges this (see Scambler, 2004). Barnes (2012) critiques 
Scambler's work as 'inward looking', taking insufficient account o f the work already done in 
this area by disability studies scholars. Thus, stigma as a concept continues to  be used 
throughout the thesis. I have made particular efforts to  define my use o f the word stigma 
where necessary, and to  maintain its usage both by participants and in existing literature. 
However, I have chosen to  use the term  'oppression' as a distinctly political decision, focused 
on the impact o f w ider structures rather than individuals. The remaining section o f the 
literature review introduces the im portant insights drawn from  disability studies fo r the 
purpose o f this thesis.
A b r ie f  in troduction  to d isability  studies
In line w ith  the theoretical perspective outlined in chapter three, the intertw ined and in tra­
active nature o f hepatitis C, disablement, illness/im pairm ent, drug use, medicine, and 
cultural and political forces should be kept in mind. The exploration o f the literature begins
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w ith a brie f outline o f the constitution and trea tm ent o f disabled people in western history. 
This is explicitly linked to  chapters seven, eight and nine, and the discussions o f pharmakos 
and access to  financial support. Next, the decision to  use the 'extended social relational 
model o f disability and im pairm ent' is clarified, and the concept o f psycho-emotional 
disablism, as introduced by Thomas (1999; 2007) and expanded on by Reeve (2002; 2004; 
2008; 2012a) (addressed fu rthe r in chapters five, six, and nine), is explained. Some key 
form s o f psycho-emotional disablism are introduced. Finally the place o f disability studies in 
adding to  discussions around hepatitis C is briefly explored.
Historical enactm ents and m ateria lisations of im p a irm e n t and  
disablism
W ith in  UK disability studies, disability is understood as the oppression o f those who live w ith  
impairments tha t are visible or indicate tha t the individual is in some way 'd iffe ren t'. In 
exploring the roots o f disabled people's oppression, Barnes (1997) outlines the historical 
trea tm ent o f those w ith  impairments. He maintains tha t contem porary attitudes have the ir 
roots in Greek and Roman times (see also Stiker, 1999), where great emphasis was placed on 
physical strength and achieving bodily ideals. Greek Gods exiled those w ith  impairments, so 
on earth, many o f those16 w ith  visible impairments were murdered at birth, le ft to  die or 
became objects o f ridicule. They were used as pharmakos (scapegoats) providing 
'communities o f Antiqu ity w ith  the opportun ity to  project the ir transgressions onto those 
who - by v irtue o f the ir physical or intellectual difference - existed on the margins' (Hughes, 
2012:19). The discussion o f pharmakos and the intertw ined nature o f disability, medicine, 
hepatitis C and drug use is taken up again in chapter seven. W ithin Judeo-Christian beliefs, 
impairments were also seen as divine punishment fo r past wrongdoing (Shakespeare, 1996; 
Barnes, 2012). Given tha t Barnes (1997) indicates tha t Judaeo-Christian beliefs are the
16 Barnes (1997) indicates that there was clearly some resistance to this given that disabled people 
have been present throughout history.
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foundation fo r current moral values, this may contribute to  perceptions o f 'deserving' and 
'undeserving' in relation to  drug use and people w ith  hepatitis C.
Disability studies scholars (Finkelstein, 1980; Oliver, 1990; Gleeson, 1999 in Thomas, 2007) 
later trace the advent o f industrialisation in the cementing o f exclusion o f disabled people17. 
Where those w ith  im pairm ents had previously made contributions via agriculture or small 
scale industry, the shifting o f modes o f production to  factories meant they were excluded, 
owing to  patterns of work and inaccessible locations (Oliver, 1990). This led to  the 
determ ination o f those who could not work as problematic and they were subsequently 
segregated in institutions, such as asylums and workhouses.
At this tim e, it quickly became apparent tha t workhouses required a system o f determ ining 
who could be defined as 'unable to  w ork ' and under the Poor Law Am endment Act (1834), 
the workhouse test and the principle o f less e lig ibility were introduced. Oliver (1990) does 
make it clear tha t not all disabled people went to  the workhouse, many remained w ith  the ir 
families. However, disabled people who lived in families tha t no longer fe lt they could 
support them  tended to  be moved into institutions. Oliver (1990) indicates tha t this was 
im portant in enacting im pairm ent as shameful and in drawing divisions between those 
perceived as 'deserving' or 'undeserving' o f support from  the state. This is explored in 
greater depth in chapter nine.
Key to  determ ining who was found f it  fo r work were doctors. Stone's (1986) exploration of 
social policy in three countries (America, Britain and Germany) traced the development o f 
systems fo r those unable to  work and how the decisions around who is (not) f it  fo r work are 
determ ined through systems o f power -  notably medicine (Marks, 1999; Lupton, 2003; 
Borsay, 2005; Beauchamp-Pryor, 2011). Finkelstein (1980) also discusses how this led to  the
17 Though Borsay (2012) does caution against oversimplifying the factors enacting disabled people's 
exclusion here.
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development o f a w ide range o f health and social care professionals, cementing the medical 
response.
During the 20th century and arguably persisting to  date, the dom inant understanding o f 
disability in the west is one o f personal tragedy and disaster, reflecting w ider societal beliefs 
tha t it is something to  be managed or addressed by the individual (Oliver, 1990; Beauchamp- 
Pryor, 2011; Oliver, Sapey and Thomas, 2012), and treated and cured wherever possible 
(Crow, 1996). Challenges or barriers faced by the person are perceived as a direct result o f 
the ir im pairm ent (Thomas, 1999).
These ideas about disabled people and the 'cause' o f disability began to  be challenged in the 
1960s and 1970s by the collective action o f grass roots movements o f disabled people, who 
shared experiences w ith  o ther oppressed groups, and united against the paternalistic 
medical and charitable organisations tha t claimed to  speak fo r them (Roulstone et al., 2012; 
Campbell 1997). In 1968, Vic Finkelstein, a disabled psychologist, met Paul Hunt, a disabled 
man who had rejected life in an institu tion. Discussion between the tw o led to  a 
fundamental change in the interpretation o f 'd isability ' which was understood as 'a social 
relationship between a person w ith  an im pairm ent, and the social environment in which 
they live, rather than a personal (medical) possession' (Finkelstein, 2005: 2). Together w ith  a 
group o f o ther disabled people, Hunt and Finkelstein formed the Union o f the Physically 
Impaired Against Segregation (UPIAS), and the Fundamental Principles o f Disability were 
developed in 1976. The principles clearly separated im pairm ent and disability: Impairment 
was understood as biological, a functional difference, and recognised as 'lacking all or part o f 
a limb or having a defective limb or mechanism o f the body'. Disability was understood as a 
social phenomenon and defined as: 'Something imposed on top o f our impairments by the 
way we are unnecessarily isolated and excluded from  society. Disabled people are therefore 
an oppressed group' (UPIAS, 1976:4).
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Mike Oliver then form ulated the social model o f disability as a means o f aiding 
understanding among social workers and o ther professionals (Oliver, 1990; Finkelstein, 
1996). Oliver (1990) suggested tha t the individual model (of which medicine was a key 
component) situated disability as a personal problem to  be individually managed or treated; 
w ith in  this model, the couse o f disability was a functional problem or 'abnorm ality ' o f 
impairm ent. The social model o f disability rejects these principles, situating disability firm ly 
w ith in  society; the 'prob lem ' o f disability lies in the barriers and oppression tha t disabled 
people face in daily life, including access to  education, employment and services, physical 
barriers in the structural environm ent and oppressive professional practices.
Since then, although the social model has been critiqued, it has remained the vital starting 
point, w ithou t which disability studies would not exist (Barnes, 2012). Indeed, Thomas (1999: 
26) maintains tha t w ith in  disability studies, the 'social model has created the space which 
makes everything else possible'.
The lim itations o f the social model have been recognised, notably fo r the purpose o f this 
thesis, by disabled fem inist writers, including Morris (1991), French (2003) Crow (1996) and 
Thomas (2004), who critique the model's focus on structural barriers, indicating that it has 
prioritised structural exclusion and disablement w ithou t taking adequate account o f 
im pairm ent, relegating it to  the realm o f 'personal trouble '. Thus, many o f the difficulties 
which can be a ttribu ted to  im pairm ent and impairment effects are effectively silenced and 
marginalised. However, it is im portant to  note that the social model has never ruled out the 
importance o f the experience o f im pairm ent: Oliver (1990,1996) indicated it was not 
something he was concerned w ith  and tha t it is more pragmatic and potentia lly 'easier' to  
address structural barriers, where clear solutions and areas o f work exist (Reeve, 2004).
Thomas (2004:40) maintains tha t 'the exclusions that constitute disability should include 
those which work along psychological and emotional pathways' and tha t 'oppression
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operates on the inside as well as on the outside'. Furthermore, Thomas (1999; 2007) and 
Reeve (2012) have emphasised that im pairm ent is inextricably bound up w ith  the kinds of 
disablism people experience. Up to  this point, im pairm ent has remained in the realm o f the 
private in order to  clearly sever the link between im pairm ent and disability, fo r fear this 
would represent a step back to  the belief tha t im pairm ent causes disability. However, Reeve 
(2012) staunchly maintains tha t im pairm ent is not the cause o f disability, but tha t there are 
dimensions o f disability and disablism which remain under addressed because o f a 
reluctance to  engage w ith  emotional and personal dimensions.
Psycho-emotional disablism
The recent w ork o f tw o  female disability studies scholars in particular, Carol Thomas and 
Donna Reeve, w ill be drawn upon. Thomas (1999; 2007) developed the extended social 
relational defin ition o f disability, in itia lly form ulated in her work, Female fo rm s  (Thomas, 
1999). This defin ition was later refined to  include the term  disablism (Reeve, 2012a) in order 
to  explicitly imbue the oppression faced by disabled people w ith  the same weight as those 
who experience racism (hetero)sexism and ageism (see also Abberley, 1987; Taylor, 2004):
'Disablism is a form  o f social oppression involving the social imposition o f restriction of 
activ ity on people w ith  impairments and the socially engendered undermining o f the ir 
psycho-emotional wellbeing' (Thomas. 2007: 73).
This is the defin ition tha t I work from  and that Reeve (2008; 2012a) has developed and 
explored in her w ork on the experience o f psycho-emotional disablism. Both Thomas (1999;
2007) and Reeve (2008; 2012a) have highlighted the d iffe rent forms o f disablism. Structural 
disablism relates to  the barriers such as inaccessible environments or processes, physical and 
social exclusion and discrim ination 'which is implied by the social model' (Reeve, 2012a:79).
88
The o ther form  o f disablism covered by the defin ition, provided by Thomas, are those 
barriers which impact on wellbeing:
'Social barriers place restrictions on w hat disabled people can do, but psycho- 
em otional barriers place restrictions on who they can be, shaping inner worlds sense 
o f self and social behaviours' (Thomas, 2007:72).
This recognises tha t oppression can operate at both public and private levels (though these 
are not easily separated). Reeve (2002) gives examples o f being stared at, or made to  feel 
ashamed. These emotional aspects can make disabled people feel invaluable, invalid, 
stressed and ashamed, excluding them  as effectively as any structural barrier might (Reeve,
2004).
In exploring the experience o f disablism both psycho-emotionally and structurally, Reeve 
(2008; 2012a) has responded to  calls to  include the body in theorising about im pairm ent and 
disability, and to  retrieve the experience o f im pairm ent from  the margins (Hughes and 
Paterson, 1997; Paterson and Hughes 1999). Harris (2009a; 2009b; 2010) has sim ilarly called 
fo r the recognition o f the body in experiences o f hepatitis C and it is at this point o f overlap 
tha t this thesis is positioned.
This approach to  im pairm ent and disablism is commensurate w ith  the theoretical position 
outlined in chapter three and the accompanying discussion about the messiness o f hepatitis 
C. Disability studies scholars have indicated tha t impairm ent and disability are socially 
constructed, not existing as prior or fixed, but brought into being via particular social 
cultural, political and historical forces, practices and understandings.
Abberley (1987) has noted how some impairments are more prevalent in specific parts o f the 
world, due to  the d istribution o f resources. In the same way, hepatitis C infection (often 
a ttribu ted solely to  individual behaviour) results from  social and structural forces, including
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access to  in form ation, clean equipment, and governm ent funding fo r blood products (see 
Archer e t al., 2009) and services.
Further to  this, im pairm ent and disability are contingent, varying depending on tim e, place 
and understanding; a person m ight be disabled in one workplace, or may be impaired on 
some days and not others, and cultural understandings o f illness/im pairm ent may d iffe r over 
tim e (i.e. understandings of HIV, ME). Mol (2002) has shown how the common im pairm ent 
Atherosclerosis becomes d iffe rent things, fo r example in an X-ray or an MRI or in a 
conversation w ith  a friend (this is explored in chapter three). Recognising the contingency of 
realities and impairments in this way challenges the dominance o f medicine.
Reeve (2012a) indicates tha t im pairm ent and disability are not easily separated (not to  be 
confused w ith  the argument tha t im pairm ent causes disability), but tha t impairment, 
im pairm ent effects and disablism are intertw ined. The kind o f im pairm ent someone has 
influences the kinds o f disablism they experience. This is especially the case fo r hepatitis C.
For the purpose o f this thesis, hepatitis C is treated as a chronic illness18 (Paterson et al., 
2006) and thus as a category o f im pairm ent (Thomas, 2007). Wendell (2001) has emphasised 
the need to  pay greater a ttention to  the experience o f chronic illness, (see also Gibson and 
Lindberg, 2007) and this thesis adds to  a body o f work w ith in  disability studies which has 
begun to  address chronic illness (see fo r example, Wendell, 1996; Wendell 2001; Carrie and 
Chan, 2008; de W olfe 2012). Closely intertw ined w ith this are de W olfe's (2002) comments 
on the division between illness and disability. De W olfe (2002) indicates tha t she had 
previously thought o f herself not as 'disabled' but as 'ill' and she did not feel tha t she could 
define herself as disabled. W hilst the disability movement has worked to  emphasise tha t it is 
possible to  be healthy and disabled, elim inating illness from  discussions o f disability shifts
18 Defined as being long term, fluctuating, difficult to treat, not following a conventional illness 
trajectory (symptoms -diagnosis -  treatment - recovery) and not necessarily visible (see Lightman et 
al., 2009).
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the boundaries o f exclusion, meaning people who are chronically sick remain the sole 
responsibility o f medicine. De W olfe (2002) maintains tha t a firm  division between the tw o 
cannot be maintained and sim ilar sentiments are expressed by Harris (2010) who describes 
health and illness as a continuum.
Direct psycho-emotional disablism
Donna Reeve (2002; 2006; 2008; 2012a) differentiates and names specific forms o f psycho- 
em otional disablism. She distinguishes between direct and indirect psycho-emotional 
disablism. Indirect psycho-emotional disablism arises from  intra-action w ith  experiences o f 
structural disablism, whereas direct psycho-emotional disablism arises from  being made to 
feel bad about oneself via the actions o f others, fo r example, thoughtless comments or 
actions.
Internalised oppression
Internalised oppression is one specific form  o f direct psycho-emotional disablism, as Morris 
(1991:19) states:
'One o f the biggest problems are the underlying messages which we receive every day of 
our lives from  the non-disabled world tha t surrounds us and become our way o f thinking 
about ourselves.'
Internalised oppression occurs as a result o f poor treatm ent w ith in  society (Mason, 
1990). Negative views (prejudices) in relation to  impairment and disability are absorbed, 
u ltim ately affecting w hat the person feels and thinks about themselves (Reeve, 2012a), 
and these can be d ifficu lt to  challenge given the lim ited positive cultural representation 
or understanding o f disability. W hilst Reeve (2004) has emphasised tha t internalised 
oppression is not inevitable and can be resisted, this clearly depends both on personal
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biography and support, as well as professional input, which works to  challenge and break 
down these internalised views.
As w ill be explored throughout the thesis, the experience o f internalised oppression is 
highly relevant to  the experience o f hepatitis C. Negative assumptions related to  drug 
use and people who use drugs, along w ith  perceptions o f contagion and infectiv ity, and 
self-infliction, intra-act w ith  w ider perceptions concerning chronic illness and e lig ib ility  fo r 
support and can have a direct impact on both w hat people w ith  hepatitis C can be and 
also the services they are able to  access. This is explored throughout the findings 
chapters.
Indirect psycho-emotional disablism
Indirect psycho-emotional disablism arises from  experiences o f structural disablism - i.e. not 
being able to  access buildings. Imrie (2002) maintains these spaces separate out disabled 
and non-disabled people and as a result, send messages that disabled people are not 
welcome (Morris, 1991) or are indeed, out o f place (Kitchin, 1998). Buildings and structures 
carry w ith  them  about the people who (are expected to) use them, fo r example, tha t people 
w ith  hepatitis C have no access needs or need to  be hidden away (explored fu rthe r in 
chapter five), potentia lly inhibiting engagement w ith  services (cf. Harris et al, 2012a).
Reeve (2008; 2012a) maintains tha t psycho-emotional disablism is more d ifficu lt to  address 
than structural disablism because it operates informally, though fo r people w ith  hepatitis C, 
recognising this experience as disablism may be an im portant firs t step. Reeve (2004) also 
acknowledges tha t the extension o f the social model to  incorporate psycho-emotional 
aspects potentia lly weakens its campaigning power, given that it is d ifficu lt to  incorporate 
something tha t is complex, intangible and d ifficu lt to  quantify (cf. de Wolfe, 2012). However, 
as this thesis shows, psycho-emotional disablism is a widespread phenomenon that exists for
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hepatitis C and naming it as a form  o f disablism potentia lly increases campaigning power in 
o ther ways, fo r example: encouraging reflection on media and public health messages and 
flagging up disablist beliefs manifested in service responses.
This chapter has reviewed existing social research literature in relation to  hepatitis C, 
exploring in-depth aspects o f the experience o f living w ith  the virus to  which this thesis 
contributes. Specific gaps in the literature have been identified. The la tte r part o f the 
chapter introduced disability studies fo r the purpose o f the thesis, explaining the decision to  
draw on the extended social relational model o f disability and the concept o f psycho- 
em otional disablism. The next chapter explores the theoretical position taken throughout 
the PhD process.
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Chapter Three: 'Getting messy', theoretical underpinnings
In troduction
This chapter explains and explores the ontological and epistemological shift which occurred 
during fie ldw ork and the implications this has fo r the thesis (in both form  and content), and 
fo r understanding and responding to  hepatitis C. This shift can be briefly described as one 
which acknowledges the messy and contingent nature o f the research process and the world 
(Law, 2004). The chapter and thesis draw on the work o f John Law (2004; 2006; 2009; Law et 
al., 2011), specifically his work on mess and the active role o f methods in co-constituting 
reality. In addition, this thesis draws on Karen Barad's (1998; 2003) concept o f agential 
realism, which recognises the inseparable, intra-active and co-constitutive nature o f the 
agencies o f observation and the thing tha t is being observed, and Anne Marie Mol's (2002) 
work on m ultip lic ity  and ontological politics, which suggests that realities are m ultiple and, 
thus, bringing realities into being is a political act. These works w ill be discussed in greater 
depth later in the chapter. They have recently been used to  explore the politics and 
constitution o f hepatitis C by Australian Sociologist Suzanne Fraser (Fraser, 2009; 2010; 2011; 
2012; Fraser and Seear, 2011). This developing body o f work, emerging in published form at 
as I w rote and thought about this thesis, both informed and inspired my own th inking19.
My work differs from  tha t which has gone before, given that a central tenet o f the approach 
outlined by Law (2004; see also Mol, 2002 and Barad, 2003) is tha t knowledge is always 
partial and contingent - and the politics and enactments o f hepatitis C shift and materialise, 
based on local intra-actions w ith  phenomena such as bodies, policies and systems o f 
support. Interviews have been conducted w ith  UK residents at a tim e o f political and 
economic upheaval which has had, and w ill continue to  have, significant consequences fo r
19 It is part of the 'hinterland' (Law, 2004) on which this study draws: the work and relations which 
accumulate and bundle together to shore up understandings and realities in particular ways.
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people w ith  hepatitis C, enacting the virus and materialising participant experiences in 
specific ways. A tten tion  is paid throughout the thesis to  enactments o f hepatitis C and 
implications currently under addressed in the hepatitis C social research literature, fo r 
example, the experience o f trea tm ent and post treatm ent, seeking welfare benefits, support 
and experiences o f disablism.
This chapter proved to  be extremely challenging to  w rite  given (as w ill be discussed) the 
inseparable nature o f methods, data and w riting  (Richardson, 1994; Smart, 2009), the ever 
expanding reach o f the discussion, the d ifficu lty  o f drawing a boundary around this chapter 
and chapter fou r20, and the contingent nature o f the w riting and re-writing process. In order 
to  make this chapter accessible and enjoyable fo r the reader, it stays close to  my experience 
o f doing the research and uses examples from  the data.
W hat is presented in the thesis is necessarily partial. It is not my intention to  provide an 
overview  o f the research experience, instead, it is intended as a walk  (Mol and Law, 2002; 
see also Fraser and Seear, 2011) through some o f the messiness o f the experience and the 
issues raised throughout the research process. The walk, introduced by DeCertau (1983) and 
utilised by Mol and Law (2002), differs from  the overview in tha t instead o f attem pting to  
take a broad and sweeping view overall, it is a way of covering a small amount o f ground 
whilst immersed in what is happening locally and specifically. Through walks it is possible to  
encounter things tha t are interesting, intricate, and unexpected. In walks, these things can 
exist alongside each o ther w ithou t try ing to  capture a whole picture (Mol and Law, 2002). 
'W alking' is a pertinent m etaphor given tha t I frequently travelled on foo t during fie ldwork 
(see chapter four), and walks - both during fie ldwork and in w riting the chapters - also 
involve stumbles, detours, getting lost and forging new paths.
20 To a certain degree this is a false divide; in order to enhance readability, chapter four concentrates 
on the practicalities of the method, whereas chapter three explores in greater depth the philosophical 
underpinnings and understandings. I have tried as much as possible to avoid repetition between these 
chapters whilst simultaneously attempting to make clear the intertwining and co-constitutive nature 
of the content.
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In the spirit o f the advice given by Crim inologist Martina Feilzer (2009), the chapter (and 
indeed thesis) aims to  'te ll a good story' (p.480); to  articulate in an engaging, accessible and 
honest way, the d ifficulties and challenges I faced in the course o f this work. Feilzer (2009) 
maintains tha t discussions such as these are im portant in stim ulating debate and in 
contributing to  policy responses (see the recommendations in appendix one).
Thus, the chapter walks the tw isting and messy nature o f the fie ldw ork addressing how this 
complex, frequently d ifficu lt and uncomfortable process, co-produced the reality and the 
phenomena being studied, paving the way fo r new understandings. It introduces the 
changes which occurred throughout the research process and outlines how and why the 
eventual decision was made to  focus the thesis on the accounts o f people w ith  hepatitis C. It 
firs t addresses how research accounts are commonly presented as linear and ordered, w ith  
clear outcomes, which during the fie ldwork, generated a sense that I was 'doing it wrong'. 
The chapter then moves on to  a theoretical discussion o f the concept o f mess, the change in 
ontological and epistemological understanding and how the world itself is complex, diffuse 
and vague (Law, 2004). Furthermore, I w ill explain why mess is a useful concept in discussing 
the experiences o f hepatitis C. Here space is made fo r talking about the theoretical and 
political aspects involved in discussing mess -  including the implications and consequences 
o f understanding the world and hepatitis C as messy and flu id, and the responsibility this 
entails fo r the researcher21.
The messy realities of f ie ld w o rk
The shift to  exploring mess in itia lly emerged from  a sense o f anxiety around my research 
practices. The research began w ith  the intention o f generating accounts from  tw o participant
21 Although to some degree I am providing an overview in this paragraph and clearly some overviews 
are necessary for the sake of clarity and engagement. Law's (2004) observation that complexity has to 
involve some simplification, in order to hold something still long enough to explain it, is pertinent 
here.
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groups - people who (had) lived w ith  hepatitis C and professionals working in the fie ld22. I 
planned to  interview  people w ith  hepatitis C about the ir experiences and use these as a basis 
to  guide both the interview schedule and the professional sample. I set out w ith  the 
intention to  interview  15 people w ith hepatitis C and 15 related professionals. During the 
interviews w ith  people who had hepatitis C, it became clear tha t support had been required 
(though as this thesis explores, not necessarily provided) from  a much w ider sample o f 
professionals than in itia lly anticipated. As well as liver specialists, hepatitis C specialist 
nurses, harm reduction and other drugs services staff (reported in the literature: Teague et 
al., 1999; Ehsahni et al., 2006; Brener et al., 2007; Janke et al., 2008; Grogan and Timmins, 
2010; Stewart et al., 2012), participants also described contact w ith, or requiring support and 
inform ation from , social work teams (working w ith disabled people, in mental health, w ith 
older adults and children and families), the Department fo r Work and Pensions (DWP) and 
welfare benefits advisory staff, GPs, housing services and professionals from  the funeral 
service industry. The role o f these professionals in supporting those w ith  hepatitis C is rarely 
reported, especially in the UK, although the responses o f governmental organisations and 
the funeral industry have been reported in an Australian context, (Crofts et al., 1997; 
ADBNSW, 2001; Hopwood and Treloar, (2003).
Thus, I, rather ambitiously fo r a single researcher w ith  lim ited tim e, established contact w ith 
a wide range o f professionals (w ith ethical approval from  research sites and local 
organisations), intending to  interview  a range o f them and aiming to  embrace the experience 
and docum ent the complexity o f what occurred in the field (Becker 1966; Holloway and 
Biley, 2010). This activity can be seen as an attem pt to  gain an overview o f the experience of 
living and working w ith  hepatitis C, indicative o f my understanding, at tha t tim e, tha t it was
22 It is important to note that the experiences of living and working with hepatitis C are not necessarily 
separable -  another complexity which will be revisited throughout the thesis.
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possible to  'capture' the experiences to  develop a fu lle r picture. As w ill be explored, my 
views on this have altered in the course o f this work.
I found tha t generating data from  professionals was complex: those who were involved w ith  
hepatitis C (i.e. liver specialists, hepatitis C specialist nurses) were happy to  ta lk form ally 
about the ir experiences in a recorded interview, but speaking to  o ther professionals who did 
not perceive themselves to  be directly connected to  hepatitis C (social workers, alcohol 
support services, Job Centre staff, welfare benefits advisors) was more d ifficu lt and required 
flexib ility. Data generation (where it occurred) was often informal and sw ift - 10 m inute 
discussions in staff meetings, 'straw polls' in open plan offices, inform al discussions and 
snatched telephone conversations23.
In these situations I fo llowed the advice o f Buchanan et al. (1988) who suggest tha t when 
doing research in organisations, a researcher must do what they can, when they can. When a 
social work manager invited me to  conduct a 'straw poll' o f his sta ff in an open plan office 
concerning the ir work (or apparent lack thereof) w ith  people w ith  hepatitis C, although I had 
in itia lly anticipated returning at a later date (i.e. a staff meeting) to  speak w ith  the staff more 
form ally (and w ith  a digital recorder!) I took this as the only opportun ity I would get owing to  
pressures o f work on the team and the distance travelled on my part24. Another team o f 
social workers allowed me a short tim e period in a staff meeting (even though I offered to  
provide some tra ining and inform ation on hepatitis C in return fo r a larger amount o f time)
23 Others, such as housing services, gave greater time and requested information and training around 
hepatitis C. This raised specific methodological issues. Data was generated alongside information 
provision. Here there was a conflict between wanting to promote greater awareness of hepatitis C 
and wanting to generate data for the thesis. This is just one of many messy strands it has been 
impossible to explore more fully.
24 Following cuts and reorganisation of services, some of these teams have been reformed. This has 
implications for dissemination of the findings in that they will be both disseminated more widely 
among the participants across teams, but that the findings potentially have a lesser impact another 
materialisation of the messy context of the thesis.
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which necessarily lim ited the data generated25. However, the sense o f messiness was more 
than negotiating methodological issues and research practicalities, the phenomena o f 
hepatitis C fe lt d ifficu lt to  grasp.
An example o f this can be seen in the way professional narratives shifted from  talking about 
hepatitis C to  discussions of HIV, hepatitis A and B, and even alcohol related hepatitis [sim ilar 
to  Law and Singleton (2005) - see below]. In these interactions, hepatitis C shifted in and out 
o f focus, connected to , but not the same as o ther diseases. In short, hepatitis C could no 
longer be understood in isolation or as a clearly bounded object (see Barad, 2003 and 
below).
For example, on a team o f social workers who worked w ith  learning disabled adults, when 
asked about hepatitis C, one participant shifted the focus o f the conversation to  describe 
being vaccinated fo r hepatitis B in a previous occupation and the experience o f one service 
user in relation to  treatm ent fo r hepatitis B. Another participant described the negative 
trea tm ent o f one service user in institu tional care related to  her HIV positive status. This 
particular interaction was interjected by one o ther worker who commented 'w ou ldn 't the 
nurses down the hall know more about this26?'
To a degree, this echoes Davis and Rhodes' (2004) findings, tha t given the partial nature o f 
the ir knowledge, participants made sense o f hepatitis C in the context o f diseases they fe lt 
they knew more about but it was more than this. A sim ilar phenomenon was visible in 
participant accounts, suggesting that the shifting was not solely a m atter o f degree of 
knowledge about hepatitis C on the part o f the professionals, as some literature has
25 Clearly this raises some methodological issues, notably around the collection of consent in ad-hoc 
situations (this was collected verbally and no identifying information from the participants was 
obtained, only their position in the team). A full and robust discussion of the methodological issues 
raised in these situations are beyond the scope of this thesis.
26 This shows that hepatitis C is marginalised in favour of diseases that the professionals perceived 
were better understood enacting it as something beyond their remit, as a health issue as discussed in 
chapter 2 and chapter 7.
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suggested (van de M orte l, 2002, 2003; Paylor and Orgel, 2004). Interviews generated much 
messier accounts than I was prepared for. Participants living w ith  hepatitis C also talked 
about HIV, cancer, housing and o ther existing impairments, as well as recovery and financial 
issues which were related to, but not the same as (Law and Singleton, 2005) hepatitis C, as 
this extended extract from  David shows:
'Hep C has been one my biggest consequences o f my active addiction in tha t physically 
i t  has taken this year o f treatm ent out o f me. Emotionally and physically, i t  has given 
me all this pain fo r  a ll these years o f living in denial and hiding it  fro m  people and it  
has given me a lo t o f pain, but i t  is only a consequence.... There are other consequences 
o f mine, the other is tha t I do only get to see my son every couple o f weeks watching 
foo tba ll, another consequence is tha t I d idn 't get to watch him grow  up... Hep C w ill 
always be, like I am hoping now it  w ill be an experience, the treatment, tha t I w ill be 
able to pass on my experience to others ju s t to te ll them 'look don 't leave it  as long as I 
did, you don 't have to'. In 5 years' time w ill i t  [having hepatitis C] be more socially 
acceptable? I don 't know. I do believe the only chance it's got tha t the people who do 
go through treatm ent and get successful outcomes, tha t they don 't ju s t piss o ff  to the ir 
norm al everyday lives and fo rg e t where it  was they come from  because by doing that, 
they are fo rge tting  w hat they was like when they needed someone to ta lk to... 
someone who had gone through it  and got [understood] it. I am gratefu l tha t I am in 
recovery w ith other recovering addicts who have completed this treatm ent eight years 
ago and s till w ant to help people...because they s till remember what i t  was like fo r  
them and they w ant to give something back and I believe tha t is p a rt o f my pa rt o f my 
purpose in the fellowships and bejing] in my workplace, to le t people know and 
hopefully there w ill be more kind o f support and there w ill be more agencies and there 
most definitely, hopefully be more education'.
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Here in a recorded interview, the shifting, complex and m ultip le phenomena o f hepatitis C is 
made visible. As David describes the implications o f living w ith  hepatitis C, each thought 
builds on the next w ith  no clear separation between concepts, the experience o f hepatitis C 
is inextricably bound up w ith  other aspects o f his life. Here, it is possible to  see how hepatitis 
C is enacted (comes into being) d iffe rently  in d iffe rent places what Mol (2002) refers to  as 
'm u ltip lic ity '. Hepatitis C is variously enacted as a serious physical im pairm ent requiring 
d ifficu lt medical treatm ent, and as an experience which has had impact on his emotional 
wellbeing, relationships and sense o f self. Then it shifts. It is peripheral in his narrative as 
'only a consequence' -  one o f many he negotiates daily -  and then enacted as an im portant 
rem inder o f his recovery, and as a point o f identification and support w ith  others who have 
done treatm ent, as well as a fu ture  opportun ity  fo r him to  support others.
Im portantly, it shows that the experience o f hepatitis C is not fixed and therefore not 
totalising or inherently oppressive, but depends on the practices and relationships which 
bring it in to being -  explored under ontological politics (Mol, 1999) below. David explicitly 
links his own experiences and treatm ent as an individual to  w ider social structures (support 
education, service availability and treatm ent policy), resisting individualising oppression.
David's interview  and the way hepatitis C moved about in it and seeped into o ther areas, 
facilitated an ethically (and politically) im portant moment in the research what Guillemin 
and Gillam (2004: 262) describe as 'the d ifficu lt, often subtle and usually unpredictable 
things tha t arise in the practice o f doing research' this required reflexivity and prompted me 
to  discuss this issue in greater depth w ith  my supervisors.
Getting messy and m aking sense
In 2010, ten months into collecting data around personal and professional perspectives on 
hepatitis C, I had fo llowed up m ultip le threads and been drawn down m ultiple avenues of
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research, where hepatitis C appeared to  shift and change (rather than become better 
understood or more clear) and was d ifficu lt to  grasp or link together between one interview 
and the next. Some o f the issues explored in interviews w ith  people w ith  hepatitis C, 
overlapped and connected w ith  professional accounts (for example, the importance o f 
access to  treatm ent), whereas others were marginalised or not discussed at all (Law and 
Singleton, 2005) (for example, the need fo r social work support or post treatm ent 
experience) the implications and consequences o f which are discussed throughout the 
thesis.
I no longer had a clear idea w hat I was exploring, what I had found or how it could be 
w ritten , resulting in a deep sense o f failure (M ellor, 2001). I was signposted to  Law's (2004; 
2006) w ork after discussing the anxiety and mess o f the research process w ith  my 
supervisors. We discussed how to  some degree research fie ldw ork is messy and contingent 
(see also Duff, 2012 and chapter four), but this fe lt like more than the pitfalls o f doing 
research in organisations, rather, the reality o f living or working w ith  hepatitis C was d ifficu lt 
to  understand, accounts did not always neatly f it  together, were d ifficu lt and inconsistent. 
Reading Law's (2004) A fte r M ethod; mess in social science research provided the recognition 
(and re lie f!27) tha t the research process and findings were messy, because most o f the tim e 
the world is messy and accounts o f it often 'd is to rt it into clarity ' (Law, 2004:2).
Producing m isleading hygienic accounts
The sense o f messiness and the thesis being d ifficu lt to  hold still, was reinforced in 
interactions w ith  o ther postgraduates and academics who appeared to  explain the ir research 
topic w ith  relative ease. I, generating and analysing data and drafting chapters, had real
27 Like Guttorm (2012) I experienced an emotional, as well as an intellectual, connection with texts 
which is not something frequently included in research accounts, but is part of the complexity of the 
research process.
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difficu lty  explaining w hat my thesis was about. It is possible tha t this can be attributed, in 
part, to  the shifting and learning involved in the PhD process (Ferguson and Thom as- 
MacLean, 2012), but it was also heavily influenced by research accounts which appeared to  
set out w ith  a research question in mind, conduct interviews or carry ou t methods and then 
come back and w rite  it all up (cf. Smart, 2010).
A number o f scholars in varying disciplines [see fo r example, Cameron (2007) in 
physiotherapy, M ellor (1998; 2001) and Cook (1998; 2009) in educational research and 
Thomas-MacLean (2012) in drama], have drawn attention to  the dissonance between the 
realities o f fie ldw ork and the accounts o f it what Silverman (1985:4 in Buchanan et a!., 1988) 
refers to  as a 'reconstructed logic'. They posit tha t the omission or removal o f difficulties in 
accounts,28 equates to  a loss fo r academic scholarship including the contribution to  
knowledge tha t accounts o f failed research can make concerning the avoidance o f future 
potentia l harm (Cameron, 2007), or the role o f these accounts in providing support to  those 
experiencing something sim ilar in the future, together w ith  the creative opportunities that 
messy experiences provide (M ellor, 2001). Others have problematised the expectation that 
research should be a linear, clean and tidy process w ith  clear outcomes, stipulating that 
detours and changes o f direction in research can result in valuable outcomes fo r those the 
research is fo r (Ferguson and Thomas-MacLean, 2012).
Thus, it is not tha t the research process is not messy or d ifficu lt - but tha t this may be 
concealed in accounts. That is, the work that produces these accounts and the consequences 
this has fo r enactment and materialisation o f hepatitis C experiences is removed what Law 
(2004:41) refers to  as the 'flu id ities, leakages and entanglements o f the hinterland of 
research....the, missing seven eighths o f the iceberg involved in method', (see also Fraser and 
valentine, 2008) explored fu rthe r below.
28 Another kind of silence - this is discussed in chapter six.
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Accounts (both w ritten  and verbal) o f intense, messy, d ifficu lt fie ldw ork and the resulting (or 
co-existing) struggle to  understand, or painful changes in consciousness (see Stanley and 
Wise, 1979; Reeve, 2012a) are relatively scarce. In particular, I identified w ith  Cook (1998) 
who referred to  the sense o f shame and guilt her untidy work generated. Both Cook (1998) 
and Law (2004; 2006; Law et a i,  2011) indicate tha t this is actually part o f the process of 
generating new knowledge and forging new understandings.
There is some overlap here between the concerns raised above and Law's (2004) call to  
move away from  accounts o f method that are concerned w ith  'hygienic' research, fo llow ing 
instructions (constraints) around how methods are supposed to  be done, to  produce clean, 
tidy  and justifiable findings. Though Law's (2004) understanding o f mess diverges from  some 
o f the above accounts, in tha t messiness is not treated as part o f a stage in the process to 
eventual clarity and resolution. Rather, Law (2004) indicates tha t we need to  recognise and 
accommodate messiness, because the world is multiple, d ifficu lt and active, and to  ignore 
this would am ount to  asking reality to  adjust itself to  f it  w ith  our accounts (Law and 
Singleton, 2005).
A note of caution and explanation
It is im portant to  note tha t I am not using the concept o f mess as a means o f sidestepping 
d ifficu lt questions about my work (Singleton, 1996), or suggesting tha t we abandon existing 
methodological texts. This is not what Law (2004) suggests and as can be seen in chapter 
four this is not at all what I did. Instead, Law (2004; 2006) suggests that we need 
understandings o f mess and method which are broader, more generous, which recognise the 
role methods play in creating realities and the lim it o f conventional methods. Thus, I have 
explored the role tha t methods played in enacting specific realities and used the notion of 
mess to  explore how hepatitis C is enacted in and through the experiences o f people w ith it.
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This, in turn, is in tertw ined w ith  and helped produce my thesis, pushing me to th ink about 
hepatitis C in new ways (Fraser and Seear, 2011).
At this point, I need to  be clear about what I mean by mess, not as a means o f creating a 
fixed defin ition, but in order to  make what follows accessible and understandable. Thus 
avoiding falling in to a trap identified by Fraser and M oore (2008) (who use the example of 
the 'chaotic' in literature concerning people who use drugs) whereby the lack o f defin ition 
around a term , means that it becomes totalising, potentia lly oppressive and fu rthe r 
contributes to  embedded assumptions around the term . This is especially the case in 
discussing mess, which is often perceived as something negative which should be avoided, 
contained or at least hidden from  direct view (LaCom, 2007).
There are also some im portant connections here between the notion o f messiness in 
research as something negative29 which needs to  cleaned up, w ith  enactments and 
representations o f hepatitis C (and bodies w ith  it30) as infectious, abject (Harris, 2009a) and 
potentia lly dangerous and leaky (LaCom, 2007; Shildrick and Price, 1999; Lenton et al., 
2011).
Harris (2009a) uses the concept o f the abject in exploring the constitution o f hepatitis C 
stigma, related to  fears about contagion and the breach o f bodily boundaries. Kristeva's 
(1982) words on the abject are particularly pertinent to  the concept o f mess discussed here 
the abject is 'tha t which disturbs identity, system, order and which does not respect 
boundaries, positions, rules -  the in-between, the ambiguous' (Kristeva, 1982: 4). The abject 
is described as tha t we wish to  th rust aside, but never fu lly can, given tha t borders are 
illusory. In the same way, it is impossible to  thrust away messiness in research, like the intra­
29 Used as a put down for those obsessed with making things tidy, an observation of Lucy Suchman in 
Law (2006).
30 See also Imogen Tyler's (2008; 2010) discussion of the bodies of 'chavs' as excessive and beyond 
control.
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action o f hepatitis C and injecting drug use (Harris, 2009a), even as this concept disturbs our 
perceptions o f the world as defin ite and pre-existing and o f objects as defin ite and clearly 
bounded.
Both messiness in research and bodies w ith  hepatitis C are subject to  moralising discourses 
(see Fraser, 2004; Harris, 2010) concerning the need fo r containm ent or concealment. This is 
reinforced when we consider tha t blood is often enacted as a pollutant (Douglas, 1966) 
which represents contagion or negativity (Sanabria, 2009), and tha t blood flows, leaks and 
seeps (Shildrick and Price, 1999; Fraser and valentine, 2006)31 beyond constructed 
boundaries. Fraser and Treloar (2006) found tha t this was enacted in the im plic it structuring 
o f some health prom otion inform ation based on binary understandings o f the body w ith 
hepatitis C (i.e. open/closed, clean/contam inated, hea lthy/ill32) w ith  the body represented as 
a clean, closed fortress). Participants in the ir study frequently internalised these binaries and 
representations resulting in a sense o f 'to ta l contam ination' (their bodily boundaries had 
been breached). Fraser and Treloar (2006) suggest these binaries need to  be disrupted in 
order to  address (and avoid perpetuating) oppression, and alternative models should be 
proposed which recognise bodies as simultaneously open and closed (things enter and leave 
the body daily) and unstable and fixed (as w ith  chronic illness). In the same way, I too  wish 
to  disrupt the tidy/m essy dualism (along w ith  other binaries33).
W ith in this thesis, the term  mess is used to  describe tha t which does not f it  into existing 
frameworks, which disturbs boundaries and neatness and is frequently marginalised. It is
31 However, the multiple nature of blood as creative and active is discussed below (Fraser and 
valentine, 2006).
32 Fraser and Treloar (2006) maintain that another binary, that of 'having/not having hepatitis C  is 
also present. As will be discussed in chapters seven and eight, this is not clearly delineated. Although 
use of these binaries is perhaps medical, they do not provide sufficient insight into what it means to 
live with hepatitis C every day.
33 In chapter seven the concept of pharmakon is used to describe the experience of treatment - 
disturbing binaries.
106
also tha t which is vague, fluid, and ephemeral, and d ifficu lt to  make sense o f (see Law, 2004). 
'Messy' issues are those which are not easily addressed or 'fixed.'
Law's (2004) approach was chosen because it treats messiness as an end it itself rather than 
a state which is passed through to  achieve clarity, given tha t clarity may be the result o f 
d istortion and oversim plification. The concept o f mess as Law (2004) uses it was also highly 
relevant given tha t bodies w ith  hepatitis C have the potential to  be 'messy'. First, because as 
people who are chronically ill they do not f it  into clearly defined categories (healthy or ill) or 
processes. Their everyday lives and experiences are nonlinear and characterised by shift and 
change34. Second, bodies w ith  hepatitis C are messy given that im pairm ent effects (and 
trea tm ent and post treatm ent effects) fluctuate. Further, as explored above, the blood 
borne nature o f hepatitis C and the perception o f hepatitis C as contagious (Harris, 2009) add 
a potentia lly physically 'messy' element. Third, hepatitis C is (and has the potentia l to  
become) 'messy' given that, as the thesis shows, it is currently under addressed. There are 
no 'quick fixes' and it crosses professional boundaries (medicine, social work, community 
services e.g. departm ent fo r work and pensions, housing). Criticisms levelled by Stanley and 
Wise (1993) (see also Law, 2004) concerning clean, ideal accounts o f research, are paralleled
34 The focus on non linearity and continuous and abrupt change might also be seen to have much in 
common with complexity theory; a meta theory which draws from a number of disciplines, including 
physics, computer science, maths and biology. This has increasingly been used within social work 
(Stevens and Cox, 2008; Stevens and Hassett, 2012), particularly in child protection and mental health 
contexts. Complexity theory offers a means of understanding complex and adaptive systems which 
constantly shift and change and which self-organise to produce effects which cannot be predicted 
(Stevens and Cox, 2008). A key feature of complexity is non linearity (Stevens and Hassett, 2012), 
which maintains that intended interventions are not always effective because the components of the 
system are not systematic or consecutive (A + B=C). In a linear model, hepatitis C testing and diagnosis 
should result in support and help for the person being diagnosed, but as is explored in chapter five 
this is not necessarily the case. In my view, complexity theory has much to offer those working in the 
hepatitis C field, for example, in aiding understanding of working effectively with people who use 
drugs or who are homeless , as complexity theory focuses on the whole system (the individual, their 
family and friends, the environment, the organisation context, the practitioners working with them) 
and explicitly rejects narrow thinking or oversimplification. As such, this is an area for further 
research. The work of Law (2004) was favoured in this thesis because of the explicit attention and 
recognition given to research methods in his work (which is where I began to realise the applicability 
of the concept of mess) and because I wished to focus on individual accounts rather than the systems 
in which hepatitis C care and support are delivered..
107
in Kuppers' (2006) and Turner's (2007) criticisms o f the sterile idealised bodies exhibited in 
Von Hagen's 'Korperwelten' (Body Worlds) exhibition. Both criticise the concealment o f the 
process o f crafting and maintaining the bodies in the exhib ition35 and the sense o f removal 
from  the messiness o f living tissue. Kuppers (2006) in particular critiques the exhibition's 
prom otion and re-enactment o f the ideal, closed, dry, non-disabled and (mainly) male body. 
Kuppers (2006) and Turner (2007) also note tha t the cleanliness and closure is not 
maintainable; the bodies 'leak36'to  make visible the processes which brought them  into 
being. Kuppers (2006) points to  the need fo r messier, more fluid, changing and affecting 
engagement w ith  bodies (and diseases), such as Shimon Attie 's exhibition about living w ith 
diabetes, 'W hite Nights Sugar Dreams', which combines personal stories o f the experience of 
diabetes w ith  video installations o f changing landscapes. It does not present idealised 
bodies or conceal the process o f production. Similar to  my research, it 'started out as a 
project about Diabetes [hepatitis C] and goes somewhere else w ith  it.' Thus the account o f 
my own research (and the 'ob ject' o f study) is not provided in a clean and sanitised way. The 
process o f production is acknowledged as an active constituent in the fie ldw ork and the 
thesis; the messiness o f the accounts 'leak' and seep through these and m ultip lic ity is 
enacted.
Law's argum ent
Law (2004; 2006) critiques methodological norm ativity: the understanding tha t research 
carried out according to  specific rules w ill necessarily lead to  solid, clear findings and that 
research which does not conform to these rules (or produces results tha t do not fit) are 
marginalised or denounced as failure. This has been recognised by a number o f scholars, fo r 
example, Gould (2006), w riting  in the field o f mental health social work, levels similar
35 Kuppers (2006) also notes that the metal scaffold used to augment the positioning of one exhibit is 
airbrushed in promotional material, giving the impression that exhibits maintains their positions 
unaided
36 Mould is present on one exhibit and scalpel marks are visible on others.
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criticisms at the dominance o f randomised control trials (RCTs) in determ ining the evidence 
base fo r mental health37. Similarly, crim inologist Alex Stevens (2011) describes how powerful 
groups (including governments and policy makers) decide w hat counts as 'w orthy evidence', 
and use it to  shore up ideological assumptions surrounding illegal drug use (e.g. tha t it is 
inherently damaging and users must be punished or treated). Evidence which does not 
support these assumptions is ignored. This means that dom inant groups and forms of 
knowledge maintain power and control, and thus have material consequences fo r those 
affected by decisions (i.e. impacts on policy).
These observations challenge conventional understandings o f method as a technical 
endeavour, the em ployment o f a set o f tools designed to  capture a social world (Law et a i,  
2011) and a social reality which is assumed to  be fa irly defin ite and amenable to  being 
understood through a set o f specific processes (Law, 2004). Law (2004) asks what method 
would look like if we no longer understood the world and reality to  be definite, tha t instead 
o f passive tools we understood tha t methods actually actively work to  bring specific realities 
into being.
In making his argument, Law (2004) states tha t much research is based on a set o f what he 
terms 'Euro-American assumptions', tha t the world is assumed to  be independent (of our 
attem pts to  know it), anterior (exists before our attempts to  know it), definite (bounded, 
clear, graspable) and singular (that is the world that exists is a singular material one). Law 
(2004) works to  challenge these assumptions, positing tha t the world can actually be 
understood as vague, m ultiple, flu id and indefin ite (Duff, 2012). Further to  this, these 
processes have the ir own agency, active and evolving methods participate in producing 
active and evolving realties. Because the world is shifting and multiple, it is not possible to  
capture anything entirely; objects and experiences are brought into being in ways which are
37 For a fuller exploration of the alternative non-hierarchical knowledge framework he proposes, see 
Gould (2006).
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necessarily contingent, partial, and dependent on the methods being used and on the 
assumptions underpinning them.
Law (2004) uses the concept o f 'm ethod assemblage' in exploring the vague, flu id and 
m ultip le nature o f the world. Encompassing the broader, shifting concept o f method, he 
argues: 'Assemblage is a process o f bundling, and recursive self-assembling where elements 
are not fixed in shape' (Law, 2004: 24.) Thus, these methods and the realities expand 
outwards, shifting and changing w ith  tha t which they come into contact. They necessarily 
exclude some things as they bring others into being, some which we are aware o f (manifest 
absence) and others which we are not (otherness). The forms tha t this method assemblage 
took is explored in chapter four.
This has much in common w ith  (and indeed draws on) Barad's (1998:3) concept o f agential 
realism which she defines as an: 'epistemological and ontological fram ework which 
understands science [and o ther phenomena] as material-discursive practices which are 
productive rather than descriptive'. Barad (2003) draws on Neils Bohr's rejection of 
Newton's assumption, positing tha t objects cannot be understood as independent, clearly 
bounded and possessing independent properties, rather Barad (2003; 1998) argues fo r 
ontologically prim itive relations (which she terms phenomena) which do not pre-exist but 
are co-constituted in intra-action w ith  other phenomena. Thus, the term  phenomena is used 
to  describe 'objects' such as hepatitis C, 'trea tm ent', 'stigma' relations and emotions, 
recognising the continually intra-active nature o f the constitution o f reality (see Fraser and 
valentine, 2006). Barad (2003) also challenges the separation between tha t which is being 
observed and the process and means o f observation. Barad has been explicit in terms o f the 
implications and applicability her work has fo r tha t outside science. In recognising that 
apparatus are active in bringing some realities into being and thereby marginalising others 
this has im portant political implications and consequences.
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A key aspect o f Barad's (1998; 2003) work is tha t we need to  be concerned w ith  matter. She 
maintains this has been marginalised by an appeal to  language w ith in  the social sciences, but 
m atter contributes to  the creation o f realities. Moser (2008:99) using Law (2004b) describes 
how the term  m atte r can be understood to  mean 'o f importance', as m atter-ing (i.e. in 
constant motion, enacted and re-enacted in various practices) and tha t they are 'm atter-real 
not reduced to  discourse or culture'. Similar critiques o f post structuralism concerning the 
emphasis on language and the absence o f the body, have been addressed by Hughes and 
Paterson (1997; Paterson and Hughes, 1999), Reeve (2004; 2012a) and Harris (2010) who call 
fo r the body to  be brought back in to  discussions and use phenomenology (the study o f the 
body being in the world) to  facilitate this. Though I have not explicitly drawn on 
phenomenology [for an example o f this in relation to  hepatitis C see Harris, (2009b)], I have 
paid specific a ttention  to  the m ateria lity o f the body, how it is brought into being in and 
through practices and relations, and the importance o f embodied experiences in the data.
Focusing on people w ith  hepatitis  C
The experience o f shifting ontological and epistemological perspective, recognising the world 
as vague and messy, has been uncomfortable and very d ifficu lt at times. As the 
understandings and writings o f mess expanded, this enacted new issues and problems tha t I 
was required to  th ink through. Previous frameworks fo r understanding the world were no 
longer sufficient (Cook, 2009). This thinking through required attention to  detail and rigorous 
exploration, which could only be explored on a smaller scale. Mol and Law (2002:3) point to  
the smoothing process tha t occurs in the making o f an academic piece, tha t even though 
these texts discuss objects and events tha t may be unusual, unexpected or d ifficu lt, the tone 
is 'alm ost always calm' and gentle. In this final edited draft, I too  have participated in a
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smoothing process38, necessarily excluding some realities in including others. A degree of 
sim plification has occurred. Mol and Law (2002) indicate tha t this is unavoidable and is 
actually necessary to  explore the richness o f the mess (see also Fraser, 2010: 232). One such 
sim plification was the decision to  focus only on the data generated from  those living w ith 
hepatitis C, rather than also trying to  focus on the professional accounts.
During fie ldw ork and w riting  to  make sense (the second and th ird  year o f the PhD), there 
was a noticeable concentration in my w riting on the data generated w ith  those living w ith 
hepatitis C. Early chapters which took shape focused on the comparison participants made 
between cancer and hepatitis C, the experience o f social security benefits and the 
experience o f trea tm ent and post treatm ent. W hilst the insights professionals offered were 
valuable, I fe lt tha t there was far more to  be said at the tim e o f w riting by those living w ith 
hepatitis C. These experiences were complex and deserved in depth and focused attention.
Law (2004) is clear tha t it is not simply a m atter o f choice over which reality to  bring into 
being, but tha t realties are enacted and depend on a hinterland. The hinterland is a 
constantly expanding bundle o f relations, knowledge and practices which are usually made 
invisible during the research process, but which carry w ith  them a weight and authority in 
dictating what is im portant in research.39 In this case the hinterland included previous social 
research which explored the experience o f living w ith  hepatitis C, the dearth o f such 
research w ith in  the UK (indeed the exclusion o f specific enactments o f reality), the 
enactm ent and materialisation o f hepatitis C as a low prio rity  fo r funding and support, and 
the increasing push towards medical treatm ents. Thus, in the th ird  year o f my PhD, as draft
38 Although it has not been my intention to smooth out all the edges or to hide the mess, I have also 
attempted to relate the anxiety and slow progress generated.
39 This makes me think of a quote from Plumb (2001:873), reproduced in Banwell et a!., (2005:341), 
concerning the dearth of research around women who have sex with women: 'without funding we 
cannot do research, without research we cannot be published in medical journals, without being 
published in medical journals we cannot convince medical professionals that a health need exists and 
without convincing them that a health need exists we cannot get finding for research prevention or 
programmes'.
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chapters were w ritten  and the thesis began to  be formed and shaped, I made the decision to  
focus only on the accounts o f people w ith  hepatitis C.
The move to  focus the thesis on the accounts o f those living w ith  hepatitis C should not be 
taken as one which attem pts to  avoid exploring messy issues in professional accounts, or 
indeed draw a boundary around the accounts to  contain them, rather, it was im portant to  
recognise tha t it would be impossible to  address in depth (and satisfactorily) the nuances o f 
both personal and professional accounts. The decision to  focus solely on participant accounts 
was also a political one. In privileging the realities o f those living w ith  hepatitis C and 
focusing on issues which they had raised as im portant, this afforded specific a ttention to  
realities often marginalised or othered in the literature. This in turn contributes to  making 
these realities more real (Law, 2004) and to  a hinterland which recognises tha t living w ith 
hepatitis C requires social and emotional support, and tha t people w ith  hepatitis C 
experience disablism. This is not to  say tha t I w ill not be returning to  interviews w ith  
professionals in the future, but this task requires care, tim e and adequate space, and as such 
is beyond the scope o f this research.
The app licab ility  of the concept of mess in exploring hepatitis C.
As described above, Law (2004; 2006; 2009) argues against the notion o f pre-existing, fixed 
notions o f realties and of objects (Barad, 1998; 2003). These positions have been used to 
explore hepatitis C by Fraser (2011). Fraser draws on Duffin's (2004a) assertions that 
hepatitis C, rather than being unearthed fu lly formed (frequently referred to  as being 
'discovered' o r 'identified ' in 1989), has been actively constructed over the last 20 years and 
is still very much under construction, socially, politically, culturally and medically. Fraser 
(2011) is explicit in her assertions tha t hepatitis C does not pre-exist the populations it
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affects, but is enacted and materialised in specific practices40. I have fo llowed Fraser (2010) 
in 'denaturalising' hepatitis C,41 exploring how it is enacted by people w ith  it (and myself) in 
interviews, in intra-action w ith  the responses o f services, welfare benefits application 
processes and trea tm ent experiences. These enactments and intra-actions depend on, a 
hinterland, which the thesis and interviews draw upon and feeds back into, contributing to  
new enactments and re-enactments o f hepatitis C and o f treatm ent and the material, social 
and political consequences.
Law (2004) states tha t the world is in flux and tha t stability may only be possible fo r very 
short periods (see also Barad, 2003) indeed, this is visible w ith  the use o f the word 'enact' in 
the thesis. Enactment is a contingent, continual process, always already happening. The tim e 
period during which I participated in fie ldwork and w rote the thesis, means it is particularly 
pertinent to  talk about messiness and flux. At the tim e o f writing, major reforms o f social 
security benefits and the NHS are taking place (DH, 2010; Royston, 2012) and public services 
are being cut or reformed. This is part o f a hinterland o f political and economic action which 
w ill enact and materialise hepatitis C in m ultip le ways. For example, historical (and recent) 
enactments o f welfare benefit claimants as undeserving (see Borsay, 2005; Garthwaite, 
2011; Garthwaite et al., 2013) intra-act w ith the conflation o f injecting drug use and hepatitis 
C (Harris, 2005). This, together w ith  an increasingly restrictive benefits application system 
and public in form ation provided by some hepatitis C organisations; enacts hepatitis C as an 
illness experience which does not warrant financial support. This, in turn has serious 
consequences fo r people w ith  hepatitis C. The experience of applying fo r welfare benefits
40 A strikingly similar point has also been made by Disability Studies scholar Oliver (1990:58) in relation 
to normative speech, who indicates that pathologising individuals is part of an ideological 
commitment to shifting responsibility onto the individual and creating a role for Speech and Language 
professionals.
41 This is not to say that hepatitis C does not have very real consequences. Law (2004) himself 
describes a commitment to 'primitive out thereness' - that we participate in a real reality. Similarly 
Treichler (1999) and Fraser and Seear (2011) emphasise the role of theory in contributing to urgent 
and positive change for people with blood borne viruses. This also involves employing 'mindfulness 
and reflexivity (Warin, 2011), as explored below.
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and the way tha t this process produces people w ith  hepatitis C and hepatitis C is explored in 
chapter nine. In addition newer treatm ents have developed during the w riting  of this thesis 
(NICE, 2012a; 2012b), which w ill enact hepatitis C and the bodies o f people w ith  hepatitis C 
in new ways.
The concept o f m ultip lic ity  is also useful here, developed by Dutch philosopher Annemarie 
M ol (2002) and later used by Law (2004) in outlin ing his messy ontology. Mol (2002) 
explores how the disease atherosclerosis 42 is brought into being in various hospital 
departments; fo r example, under a microscope, in an operating theatre and in a consultation 
w ith  a patient. In each o f these environments, atherosclerosis is enacted differently, 
becoming d iffe rent things fo r d iffe rent people (Duffin, 2004b). This is not the same as saying 
tha t the disease is a fixed object upon which there are many d ifferent perspectives, but 
rather tha t the object itself is brought into being through specific practices in the hospital 
which produces d ifferent objects. Mol explores how some o f these objects overlap, or are 
brought together (for example, in negotiations between doctors or in administrative 
processes), whilst others which do not, are rationalised away. In the thesis, I too explore 
how hepatitis C can be enacted d iffe rently in d ifferent places, i.e. in accounts made by 
people w ith  hepatitis C, in work capability assessments, in blood tests, in appointments w ith 
consultants. Some o f these enactments hang together or overlap w ith other enactments [for 
example, the hepatitis C (treatm ent) enacted by Keith in his conversation w ith  the housing 
departm ent overlaps w ith  the hepatitis C (treatm ent) enacted by his consultant -  see 
chapter seven], but not w ith  others (for example, the post treatm ent effects reported by 
participants diverge from  the post trea tm ent protocol in the hepatitis C clinics). Here it is 
possible to  see tha t d ifferent hepatitis Cs exist.
42 Conventionally understood as a build-up of plaques in arteries which occur mainly in the legs. 
Impairment effects include pain and difficulty walking.
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Mol (2002) uses an unwieldy concept to  describe how these objects are not the same thing, 
but not entire ly separable e ither - 'more than one less than many'. This involves a decision 
about what to  bring into being. As Fraser (2010:233) observes, if realities are being made 
and remade in the process o f intra-action, the unsettled nature o f knowledge about hepatitis 
C infection and treatm ent, means decisions about what to  bring into being are highly 
im portant.
Revisiting tlie messy f ie ld w o rk  process
Now tha t I have outlined and explored the shift in understanding, I return to  the examples 
from  the data to  explore how messy methods can be re-understood in light o f Law's 
argument, and how this contributed to  the co-constitution o f the thesis. Or, as W atts 
(2012:36) states: 'the method was as much an effect o f my fie ldwork as my evidence'. As 
was described above, the fie ldw ork process was more complex, the sample much broader, 
the methods were shaped by organisational priorities (but also understandings of hepatitis C 
-  see below) and interviews covered topics tha t I had not readily anticipated. In addition, 
participant illness, geographical location and my own views about hepatitis C shaped the 
method.
Both Charmaz (2004) and Law (2004) discuss how methods shape, and are shaped by, the 
circumstances and the phenomenon being explored. Harraway (1988) states there is a need 
to  make room fo r the unexpected and also u ltim ately recognise tha t we are not 'in charge' o f 
what happens in the world. As I engaged more w ith Law (2004), I recognised tha t I could not 
simply capture what was 'ou t there ' and tha t hepatitis C was a phenomenon enacted in ways 
which overlapped, diverged and connected.
Charmaz (2004) discusses embracing the ambiguity and bewilderment in the research 
project, and the opportun ity this presents, to  gain an understanding o f the phenomenon as a
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result. For example, although the decision was made to  discuss the personal perspectives of 
hepatitis C throughout the rest o f the thesis, it was not a simple m atter o f separating 
professional and personal perspectives. Apart from  the overlap tha t occurred fo r some 
participants, in tha t they worked in a substance use or blood borne virus service, the realities 
enacted in personal interviews made present the extensive reach o f hepatitis C in terms o f 
professions tha t are well placed to  take a more active role. These professional interviews, in 
turn, also shaped personal interviews.
Charlie's interview (and subsequent publicising o f my research w ith in  his network) led to  the 
recruitm ent o f tw o additional participants who were co-infected w ith  HIV and hepatitis C, an 
im portant aspect o f the research which may not have been made present if I had not been 
open to  travelling w ith  the flow  o f the project. This is an example o f how methods 
necessarily make some things present, others knowingly absent [for example, the experience 
o f hepatitis C among transgendered people also discussed by Charlie (Deacon et al., 2013)] 
and others unknowingly absent (othered) (Law, 2004).
The data generated during a sw ift participation in a staff meeting, or the unanticipated 
generation o f accounts w ith  embalmers or men w ith HIV, might be seen by conventional 
understandings as a poor or failed method. However, the shift to  understanding the multiple 
and shifting nature o f hepatitis C, and the role o f methods in enacting it, meant tha t I began 
to  see the method as flu id and hepatitis C as a flu id object. In describing the maintenance of 
a clean water pump in Zimbabwe, Mol and deLaet (2000) found that although the pump was 
delivered to  d ifferent communities in a standardised form , over tim e it was adapted by 
particular communities, using unconventional parts (i.e. not from  the manufacturer) which 
the residents had adjusted to  f it  the purpose. Similarly, over time, my method and the 
realities I explored were adjusted, extending to  explore a w ider range o f professionals and to 
explore enactments o f hepatitis C beyond those made in medicine. If I had only maintained
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the focus on the professional sample as anticipated (and which is predom inantly reported in 
the literature), and not made adjustments to  accommodate the messiness o f hepatitis C in 
participant interviews, this would have smoothed out (and thus reproduced) the experience 
o f hepatitis C as solely a medical issue and repressed those aspects which were vague and 
d ifficu lt to  address. Here, Mol and deLaet's (2000) observations tha t it is the flu id and 
responsive nature o f the object which makes it strong are particularly pertinent. The fluid 
and shifting nature o f the method meant tha t I came to  see how hepatitis was enacted and 
re-enacted by participants in d iffe rent ways, making the research robust and opening up 
possibilities and opportun ity fo r change. I acknowledged that I could not maintain control 
over the project if it was to  be o f most use to  readers/participants. This approach also 
highlighted tha t hepatitis C has a much w ider impact on a person's life than is currently 
enacted and materialised in policy responses.
In making efforts to  explore tha t which is often made absent or 'othered', I have explored 
how hepatitis C is enacted by and materialised in the bodies o f participants who reported 
not using illic it drugs, a group whose hepatitis C realities, and the significance o f hepatitis C 
in the ir lives, are frequently 'o thered ' through policy and media responses which promote 
access to  treatm ent and little  else. I have also explored the social and emotional experience 
o f treatm ent, given tha t current policy responses enact barriers to  treatm ent as the biggest 
issue, whilst the need for support on treatm ent (or after) is marginalised. Moore and 
Measham (2012) in the ir work around the production o f the 'drug' and 'drug problem ' 
GHB/GBL (or 'G'), discuss how researchers contribute to  the production o f meaning of 
phenomena based on the participants who are interviewed (i.e. 'recreational' G users, or 
here, people who were no longer injecting drugs), the questions asked and the places in 
which interviews are conducted. This works to  make specific enactments o f hepatitis C - and 
the way in which treatm ent materialises in the bodies o f those w ith  hepatitis C - more 
visible. In seeking to  combat the silence around hepatitis C w ith in England, I have enacted
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and performed specific hepatitis Cs, shaping w hat it is and how it is understood, especially 
regarding aspects which are more frequently marginalised.
As outlined above, hepatitis C was d ifficu lt to  make sense of, between one interview and the 
next. These experiences were vindicated (and indeed stabilised and made more real) when 
reading Law and Singleton's (2005) experiences o f exploring 'alcoholic liver disease'. Like Law 
and Singleton (2005), I found tha t pathways to  and through diagnosis were flu id and m ultiple 
and which contributed to  the making o f hepatitis C in specific and particular ways. In 
addition, it was d ifficu lt to  map one tra jectory onto another. Some trajectories were not co­
ordinated. For example, the tra jectory o f treatm ent did not (and does not) co-ordinate w ith 
trajectories fo r welfare benefits such as Disability Living Allowance (or Personal 
Independence Payment).
As w ith  Law and Singleton (2005), it is possible tha t services for people w ith hepatitis C 
would be improved w ith  better organisation and co-ordination between services43. However, 
poor organisation o f services is only part o f the issue, hepatitis C and the structures 
surrounding it are flu id and non-coherent and so, imposing order necessarily oversimplifies 
the experience. Hepatitis C must be understood in a context o f m ultip lic ity and non­
coherence.
The w r it in g  process; m aking and cleaning up mess
This section addresses the process, practice and role o f w riting in co-constituting the thesis 
and enacting specific realities. It first addresses the im portant role tha t w riting  occupied fo r 
the duration o f the PhD, and the forms and functions o f this writing. The chapter moves on 
to  discussing w riting as a political activity (Mol, 2002; Law, 2004) bringing into being some
43 Though some of the lack of co-ordination for people with hepatitis C may serve a political purpose, 
increasingly, restrictive PIP mean that the social and support needs of people with hepatitis C are even 
further marginalised -  see chapter nine.
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realities, excluding and 'othering ' others. To bring the section to  a close, I raise some 
questions which I have been forced to  th ink through around the lim itations o f the w ritten  
word in enacting and materialising mess and accounts o f hepatitis C.
W riting has been key in constituting the thesis at every stage. The w riting  process was 
messy, m ultip le and not adequately captured by the term  'w riting  up' which, as Smart (2010) 
indicates, suggests a kind o f hygiene and an approach devoid o f creativity. For me, w riting 
was a form  o f research (Mellor, 1998; M inkin, 1997) intertw ined w ith  fie ldwork and reading 
a means o f inquiry, used in a very sim ilar way to  Richardson (1994:517) who states tha t she 
writes 'in order to  think, to  find out more about a topic or myself and to  travel in the thinking 
tha t w riting produces'.
This w riting  took a number o f forms, I wrote around topics I wanted to  try  out or make sense 
of, not all o f which made it into the final thesis other times I w rote through difficulties, to 
make sense, to  construct a chapter or to  take a point as far as I could. I w rote down in order 
start somewhere, to  have something on the page, or to  get it out o f my head. W riting up44 
came much later when final chapters and edits were being ground out and refined.
Forms o f w riting included: notes in my research diary, transcription, annotations on 
transcripts and articles, scrawled post-it's on trains and buses, keywords or observations on 
a bedside notepad, as well as working drafts, conference papers, presentations to 
professionals and documents fo r PhD requirements, plans and ideas45. In addition, I made 
room fo r m ultip le interpretations (and multiple realities) using the comments function in 
M icrosoft Word to  record my thoughts or reflections, links I made w ith other chapters, or to 
question my own observations during the w riting and re-writing process. M inkin (1997:172-
44 In Lakoff and Johnson's (1988) discussion of the orientational metaphors 'up' and 'down', 'up' is 
frequently used with the implication of positivity, success and progress, whereas 'down' is frequently 
used to denote negativity, states of unhappiness, subordination and loss. Thus, 'writing up' implies a 
progress, a sense of control over the PhD, which I would argue against.
45Part of the method assemblage (Law, 2004).
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175) makes a sim ilar point in talking about w riting, he says: 'movements back and fo rth  will 
o ften depend on the way the mind engages and connects w ith  the data as well as how the 
data the data is accumulated...chance can produce new associations and new productive 
connections'. In the interests o f presenting an account which includes m ultip lic ity, I have 
included these, where possible, in the final product. I have not pursued a singular account 
but made room fo r m ultip le enactments. The 'cut and paste functions' in M icrosoft Word 
enabled saving, moving to  o ther documents (and chapters), drafting and redrafting. This also 
meant tha t m ultip le enactments o f the thesis reality could exist alongside each o ther at the 
same tim e, facilitating the thinking through o f the consequences (e.g. the comparisons 
participants made w ith  cancer and the challenges to  it). Here, w riting  allowed and 
maintained my focus on m ultip lic ity o f thought and interpretation (Law, 2004), and 
highlights how the process o f w riting  was just as im portant as the final product in enacting 
messy realities.
Conventional accounts o f w riting emphasise the gradual move towards clarity, sense making 
and singularity (M inkin, 1997). In earlier drafts I found myself using phrases like 'as the 
research moved forw ard ' or 'as the research progressed', which imposed a fram ework of 
progress and obscured the back, fo rth  and circular movement o f chapters46. This was 
particularly evident in earlier versions o f this chapter where new mess was made w ith  each 
draft. As mentioned above, not all o f the w riting was enjoyable, this process has been 
anxiety producing, tedious and d ifficu lt to  keep going. W riting as a process o f discovery 
(M inkin, 1997) meant I was forced to  th ink through new and d ifficu lt concepts (like mess!) 
which were sometimes uncomfortable as the ground shifted (and indeed continues to  shift) 
beneath my feet. I had to  consistently remind myself o f Cook's (1998) observations about 
the skill, tim e (and I would add, patience) in enacting mess. This echoes and intra-acts w ith
46 Cf. Mol and Law (2002) suggest that research and writing might be viewed as tidal, rather than 
linear. Tidal movement makes space for ebb and flow, swirling and being caught in currents.
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the comm ent from  one participant, Pixie (revisited in chapter seven), about the impossibility 
o f a 'quick fix ' in developing support fo r people w ith  hepatitis C. Obscuring or removing the 
messiness and difficulties o f w riting  in order to  make w riting  (and th inking!) sw ifte r and 
easier47, would create and re-enact silence around the difficulties fo r people w ith  hepatitis C 
and contribute to  enactments o f hepatitis C which were lim ited and fu rthe r removed from 
participant experience.
Continuing to  w rite  also enabled me to remain engaged w ith  the PhD. When the messy 
nature o f the fie ldw ork meant tha t it was d ifficu lt to  see a way through, or when previous 
understandings were shifting, w riting was a way o f establishing and maintaining a 
connection w ith  the data and the thesis (Mellor, 2001; W oodby et al., 2012), and it is 
possible to  see the development o f the thought process on earlier drafts. W riting was also an 
embodied process48 which I used to  establish whether a point or draft fe lt 'righ t' or not - this 
is not easily translated onto the page but feels both ephemeral and at the same tim e searing 
(Mason, 2011). Key findings and working drafts were developed, understood and refined 
through reflexive engagement w ith  feelings o f discomfort, pain and positivity (the 'yes!' 
moments), as well as flashes o f inspiration and identification (Law, 2004). These 
engagements helped me to  make sense of 'ethically im portant moments in research' 
(Guillemin and Gillam, 2008) and to  negotiate the contingency o f the research and writing 
process (Whiteman, 2010) which fu rthe r shaped the thesis.
Reflexivity in w riting  was im portant in understanding and reflecting on what kinds o f realities 
I was crafting (Law, 2004): what was being made present, what was being made absent and
47 Although this would have involved 'considerable violence to the data' (Smart, 2010:4) in making it 
fit.
48 In addition as explored by Crooks et al., (2012), my own impaired body and the need to make 
adjustment to my workspace shaped the production of my work in terms of what and how I wrote. On 
days when impairment related pain was well managed, writing on my laptop was much more focused. 
Days when pain was not as well managed (or indeed where impairment effects were exacerbated by 
sitting at the laptop) often forced me to return to handwritten notes and drafts. Here, the space 
afforded by being away from the laptop meant that writing-related stumbling blocks were often 
overcome.
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what was being othered or repressed (Law, 2004). W riting is an inherently political activity 
(see Mol, 2002; Law, 2004; M oore and Measham 2012), as explored above. In recognising 
this, I have paid attention  to  the m ultip le natures o f interpretations, making space fo r tha t 
which does not f it  or is usually excluded. For example, the tim e period between diagnosis 
and receipt o f form al support (chapter five), discussions o f cancer and HIV (chapter six), 
trea tm ent and post trea tm ent experiences (chapters seven and eight), and the difficulties 
and non-coherences around accessing social support and applying fo r welfare benefits 
(chapter nine).
The intra-active nature o f w riting  means that it is not just a uni-directional process o f putting 
words on a page, but the act o f doing this sparks thought and discussion and alters ideas and 
realities. As Barad (2003) indicates, realities cannot be brought into being through processes 
which are solely social -  in this way the electronic document, being cut and pasted and 
commented on, 'kicked back' (Barad, 1998:116) and became an active participant in the 
constitution o f the thesis. The comments function meant I was able to  make links and 
connections between chapters, which augmented and supported my use o f Reeve's (2002; 
2004; 2008; 2012a) concept o f psycho-emotional disablism. A draft chapter on the symbolic 
nature o f blood (space constraints and the specific direction o f the thesis means tha t this has 
been necessarily made absent) augmented the fie ldwork and the object o f study as messy. 
The firs t draft o f what eventually became chapter six also incorporated discussion around 
post trea tm ent effects which, over tim e, in struggling to  draft and redraft, I realised was a far 
bigger issue tha t needed to  be explored in a standalone chapter.
One o f the most im portant points tha t Law (2004) (and others, see Barad 1998; Mol, 2002) 
make concerning the role o f methods is the possibility tha t reality can be remade - realities 
can always be another way. Law (2004) maintains tha t this crafting o f specific realities 
requires a researcher to  take responsibility. If realities can be another way, then there is a
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need to  pay attention to  what a 'good' reality m ight be, and what the implications and 
consequences m ight be (see also Fraser, 2010). In keeping w ith  Law's (2004) philosophy, no 
general answers can be provided, and can only be decided specifically and locally, clearly this 
depends on the hinterland o f my own disciplinary commitments. For example, my 
com m itm ent to  challenging the oppression of disabled people and to  developing an 
improved response to  hepatitis C in the UK. Law (2004) suggests that politics is one form  of 
good which we can pay attention to  in enacting realities. Realities and method assemblages 
tha t are crafted, can contribute to  better social (and non-social) arrangements, amplifying 
particular patterns and thus, enacting some realities as more real than others. W ithin the 
thesis I have tried to  work in ways which contribute to  improved social arrangements for 
people w ith  hepatitis C, making realities which materialise the social and emotional realities 
o f living w ith  hepatitis C, as well as the medical ones.
However, M oore and Measham (2012) highlight the lim its o f the researcher's ability to  enact 
particular realities. They discuss the generative potential fo r research maintaining tha t its 
agentic qualities mean tha t the researcher is not always in control o f the realities tha t are 
enacted, in the reading and use o f published data. This, therefore, has the potential to 
compound, as well as challenge, inequalities and the making o f disease experience in 
particular ways.
This final section explores the lim itations o f w riting in making the vague, fuzzy and 
ephemeral (Law, 2004) known. Just as Moore (2008) indicates that it is d ifficu lt to  translate 
the embodied experience o f pleasure onto the page, Law (2004) also questions whether that 
which is vague and messy can be translated onto the page, given tha t w riting  about non­
coherence necessarily produces some kind o f order. Law (2004) does make some 
suggestions about the forms this m ight take, fo r example, the presentation o f objects or 
poetry which do not depend on a reality which is independent, pre-existing, definite or
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s ingu la r49. The use o f poetry and other forms o f w riting is explored, and used, by Guttorm 
(2012) in her discussion o f the development o f a conference paper. Guttorm  (2012) states 
tha t once she acknowledged mess, she found it impossible to  return to  the definiteness o f a 
conventional research account.
Paradoxically fo r me, although the process of w riting has made room fo r mess, my own 
political com m itm ent tha t the thesis be o f use, necessarily requires a coherent, accessible 
and engaging final product, which m ight appear to  be at odds w ith mess. In addressing and 
justify ing this, I focused on Law's (2004) observation described above, tha t enacting good 
realities depend on reflexivity and political decisions. In crafting a w ritten  account, I have a 
final thesis which conforms to  w hat Law terms 'common sense realism', partly out o f 
necessity to  receive the PhD (because o f the hinterland tha t academic scholarship is built on 
- indeed Law (2004) himself indicates that this is d ifficu lt to  avoid), but also in order to  be of 
use to  practitioners who may read the thesis (or parts o f it), and to  give credence and make 
visible in an academic arena those areas o f participants' lives which may not have been 
made visible before. However, I have also paid attention to  what is not being said and what 
emerged in the spaces between participant accounts. For example, in asking participants 
about the ir experiences o f services and the ir treatm ent by professionals, they spoke about 
feeling undeserving o f welfare benefits (chapter nine) and also o f the meaning o f the dingy 
nature o f services they attended (see chapter five).
One o f the messiest examples o f living w ith  hepatitis C was from  the participant who later 
w ithdrew  from  my study. This w ithdrawal has meant tha t it is not possible to  include data 
from  this particular participant and points to  a larger issue concerning the difficulties and 
constraints involved in making mess visible and reporting on it. For this participant, the 
experience was (literally) messy in tha t it was very difficu lt to  make sense o f and had intra­
49 American writer and academic Michelle Leavitt has used poetry to explore aspects of her own 
experience of living with hepatitis C - see Leavitt (2011).
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acted w ith  many o ther life experiences to  the point where it became clear it was unethical to  
include them . The exclusion o f her d ifficu lt, but im portant, story has actively shaped the 
thesis, w ith  consequences fo r the discussion around the impact o f treatm ent and the need 
fo r support from  mental health services. This highlights the way tha t mess is often 
concealed or unreported. Indeed, it is potentia lly too messy fo r ethical review processes, 
requiring negotiation of, and a ttention to, contingency throughout (see Whiteman, 2010) 
and the development o f 'ethics in practice' (Guillemin and Gilliam, 2004), as is explored in 
chapter four. I have tried to  ensure tha t the participant's e ffo rt in recounting these d ifficu lt 
experiences was not in vain, by exploring some o f the messiness involved in the interview 
process (rather than content) in chapter four.
M aking recom m endations
The move to  understanding the shifting and continually intra-acting nature o f hepatitis C has 
raised specific questions and ethical dilemmas about how to  bring the thesis (indeed the 
chapters!) to  a close, and how to  balance the need to  make recommendations fo r practice, 
policy and fu rthe r research w ithou t also falling back into viewing hepatitis C as singular and 
fixed. It has been necessary to  acknowledge that providing a neat, clean end to  the thesis has 
involved a degree o f obfuscation, silencing some o f the complex realities o f living w ith 
hepatitis C. Acknowledging the shifting and vague nature of reality and the need to  provide 
some starting points fo r improvements to  practice and policy, has involved a 'delicate 
balancing act' (Warin, 2011: 807) between the theoretical and philosophical commitments 
which make such recommendations possible in the first place, and the need to  honour the 
contributions o f participants (Etherington, 2007) who wish to  see change in the way people 
w ith  hepatitis C are supported. It is not my intention to  draw a division between these tw o 
things, in addressing this issue, I argue (follow ing Warin, 2011) that it was necessary to
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reflect on the reasons fo r engaging in the research and in doing so, I realised tha t 
recommendations, whilst involving a degree of fixity, can also acknowledge the ambiguous 
and shifting phenomena o f hepatitis C and indeed, this should form  part o f the 
recommendations. Therefore the recommendations in appendix one are included w ith  a 
recognition tha t they are intended to  be taken forward and built on to  create new 
enactments and materialisations o f hepatitis C.
This chapter has explored and outlined the shift in ontological and epistemological 
understanding tha t occurred through and w ith in  the process o f fieldwork. Given tha t a key 
point w ith in  the chapter concerned the active role o f methods in bringing realities into 
being, chapter fou r now explores these methods in more detail.
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Chapter Four: 'Getting messy', the realities of fieldwork
In troduction
This chapter describes the tw ists and turns o f the research process, exploring in depth the 
messy and complex practicalities I faced during fie ldwork. It should be read alongside 
chapter three, w ith  which it is closely intertw ined. As explained in chapter one, the decision 
concerning the ordering o f (what became) chapters three and four was not an easy one, 
given tha t I wished to  remain fa ith fu l to  the co-constitutive nature o f the phenomena o f 
hepatitis C, the methods used and the accounts generated. It was through the research 
process tha t the 'messiness' became apparent and shaped the epistemological and 
ontological position (Braun and Clarke, 2006), and the reader should remain m indful o f this.
The firs t section o f this chapter outlines aspects o f methodology which underpinned the 
study from  the outset. It details personal and professional experiences and attributes which 
shaped the research process, design and goals. The rationale fo r using qualitative methods is 
provided. The second section addresses the practicalities o f the research process, detailing 
the development o f the research design, application for NHS and Lancaster University ethical 
approval, sampling and recruitm ent strategies, including how the cultural position o f 
hepatitis C and the current responses to  it in the UK were enacted in these strategies. I then 
move on to  discuss the research interviews, the need fo r flexib ility  in interview mode and 
the generation o f participant accounts.
Later, I explore some pertinent issues which arose during the fie ldwork process, including 
the realities o f 'in form ed consent', the challenges in recruiting from  a connected community 
(i.e. support groups and online forums), and the role and responsibilities o f the researcher 
during fie ldwork. The chapter ends w ith an exploration o f the analysis process and how early
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dissemination shaped the findings, before closing w ith  a discussion o f the lim itations o f this 
study.
This chapter makes new and im portant contributions in a number o f areas. It adds to  the 
emerging body o f work around hepatitis C which recognises the co-constitutive role o f the 
method in enacting specific realities o f living w ith  hepatitis C. It explores some o f the 
methodological issues which arose from  working w ith  people who have hepatitis C, which 
have not been documented to  date (for example, recruiting from  a pool o f people who know 
each other and the effects o f treatm ent on the consent process). Further to  this, existing 
qualitative research w ith  people who have hepatitis C has favoured face to  face interviews. I 
show tha t interviews can also be conducted using other mediums (MSN and telephone) and 
tha t these modes enact d ifferent realities o f living w ith the virus. The chapter (and indeed 
the thesis) has the explicit aim o f talking honestly and transparently about the difficulties 
faced, and how rather than being seen as moments of failure or poor practice, these 
difficulties were indicative o f the complex and flu id nature o f hepatitis C.
The use of qualita tive  in terviews with people w ith  hepatitis C
Qualitative methods aimed at generating accounts o f participants' meanings, interpretations 
and experiences (Mason, 2002) were chosen from  the outset. Hepatitis C has historically 
been marginalised, both globally and w ith in  the UK (especially in England where most o f the 
participants lived), and Korner and Treloar (2006) highlight how people w ith  hepatitis C have 
frequently been included as subjects in clinical trials, rather than as people w ith  support 
needs. Harris (2009a; 2010) sim ilarly describes how those who use drugs are frequently
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referred to  as 'IDU', obscuring the ir personhood. Thus it fe lt im portant to  utilise methods 
where greater emphasis was given to  the perspective o f participants50.
Further to  this, Conrad et ol. (2006) maintain tha t the complexity o f living w ith  hepatitis C is 
lost (or rather, enacted in an even more partial way) through quality o f life measurements 
reinforcing the need fo r a flexible and accommodating method. The com m itm ent to  
including the perspectives o f people w ith  hepatitis C has become increasingly important, 
given the rapid developments in treatm ent (see chapter tw o and chapter seven). Here 
hepatitis C becomes something to  be cured rather than an experience which impacts on a 
person's life. It is im portant to  emphasise here than I am not aiming to  naively 'give voice' to  
participants (explored in greater depth below), but to  provide and open up fu rthe r space fo r 
accounts which make visible the complexity o f living w ith hepatitis C.
Rationale for qualita tive  research
Mason (2002:1) maintains tha t qualitative inquiry requires researchers to  be engaged on 
emotional, physical, practical and intellectual levels, and tha t the biography o f the 
researcher plays an im portant part in shaping the research design. Here my background in 
social work was im portant in developing the position I took towards the research 
participants, notably tha t expertise arises from  living in and through particular experiences 
(Beresford and Croft, 2001). Thus the experience o f hepatitis C was given a place of 
'epistemic privilege' in the research (see Shah 2006; Stanley and Wise, 1993).
As described above, the perspectives o f people w ith hepatitis C have historically been 
marginalised, so it was particularly im portant fo r me to  pay attention to  power relations in 
the interview process and create an environment where the interview became an exchange 
o f views, rather than one person questioning another (Burgess, 1984). Though I indicated
50 Though this is not to imply that the researcher does not play a central role in shaping these 
accounts -  discussed below.
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from  the outset that, like Harris (2010), I aimed to  combat the silences and silencing tha t 
operates around hepatitis C, this does not mean tha t I uncritically subscribe to  the claim to  
'give voice' to  the participants in this study (see James, 2007; Ashby, 2011) indeed, 
participants described numerous ways in which they were using the ir own voice to  raise the 
profile o f hepatitis C, including responding to  consultations on the national liver strategy, 
w riting  to  the ir MPs about the difficulties faced on treatm ent, talking about hepatitis C 
w ith in  services, working w ith  services to  develop improved responses and setting up support 
themselves. Thus, the research is just one area where the ir views were being given. 
Furthermore, the 'one o ff' nature o f the interviews meant tha t very partial realities were 
enacted, when the ir bodies, feelings and experiences shift, o ther partial realities may come 
into being; as Richard stated 'there m ight be other things tha t m ight occur to me another 
day.'
W hilst the sample did also include those who were less vocal about the ir hepatitis C 
experiences (indeed I was only one o f a handful o f people some participants had told), it is 
im portant to  note tha t participant voices are necessarily qualified by the researcher. The 
choices in selecting quotations (choosing and editing which voice to  present), in interpreting 
and developing themes, and the w riting, did not involve the participants directly (Braun and 
Clarke, 2006), recognising that the interpretations are my own, and that my voice is 
im portant too  (Ashby, 2011). However, in working from  the positions I did (see below), I was 
carrying out the research w ith  the key aim o f combatting oppression (Vernon, 1997) faced by 
people w ith  hepatitis C.
During the research process, I made specific efforts to  address power relations including 
letting participants choose the location and mode o f the interview, travelling to  them, giving 
them  control over switching the recorder on and off, and making it clear tha t I was aware of 
the ir expertise in relation to  hepatitis C. I was mindful o f Oakley's (1981) observations that
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interviews are best based on non-hierarchical relationships, when the interviewer is 
prepared to  share the ir own experiences and respond honestly and meaningfully to  
questions. During the interviews I shared details o f my interest in hepatitis C, my 
professional background, my home life and my im pairment when appropriate. This was 
im portant in establishing rapport and reciprocity (Elmir et al., 2011), showing an 
appreciation fo r the stories they had shared w ith me and (hopefully) negating any sense that 
I was 'm ining' (Kitchin, 2000) the ir experiences. I also did my best to  answer questions. These 
included [as Oakley (1981) defines] questions about the research, the outputs and requests 
fo r in form ation (though there were lim its here - see below). I also answered personal 
questions, including one which stayed w ith  me fo r a long time:
Grace: 'Do you fee l I am contagious? When you mix w ith us?
Heather: No! I really don 't -and I mean tha t honestly.
Grace: Is tha t because o f what you've read or because o f what you haven't read? 
(Chuckling)
Heather: Probably because I have spent a lo t o f time - as a student you're taught to 
f in d  s tu ff that's... rigorous and solid in form ation - I've go t a fa ir ly  good idea o f how  
(hepatitis C) is spread and there isn 't really tha t opportun ity there. And I don 't think 
it's  helpful, certainly not fo r  me to think o f i t  in tha t way. I don 't th ink o f people w ith  
hep C as contagious.
Grace: Are you okay mixing w ith people w ith AIDS?
Heather: Yeah
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Grace: Do you know something I don 't have a problem mixing w ith people w ith AIDS, I 
never have and I don 't know anyone who has i t  bu t I've always thought I wouldn 't 
have a problem w ith it'.
By asking w hether I thought she was contagious, Grace requests personal reassurance and 
explores my values and motivations. This strengthened my assertion tha t multiple 
interpretations are possible. However, Grace quickly moved to  talking about people w ith 
hepatitis C in general. I remember feeling unsure about how to  answer this question at the 
tim e, it fe lt im portant to  try  and address some o f the negative feelings around hepatitis C 
tha t Grace had, particularly around how 'contagious' hepatitis C is and, indeed, tha t having 
hepatitis C at all, should be inherently bad. At the same tim e, I was reluctant to  be so 
vociferous tha t Grace fe lt her views were dismissed, potentia lly contributing to  fu rther 
oppression, or guilt, and damaging rapport. On reflection, I am uncomfortable w ith  the links 
I firs t made around transmission, which enacted hepatitis C, predominantly as 'possibly 
infectious'. However, this observation and the reflection on it, intra-acted w ith  and has 
informed the findings chapters. This also motivated me to  reflect on the pervasiveness of 
internalised oppression (Mason, 2001; Reeve, 2008) and negative views experienced by 
people w ith  hepatitis C . When Grace moves on to  discussing people w ith AIDS, she appears 
to  be both seeking my approval in developing rapport and is simultaneously enacting a 
hierarchy o f disease -  see chapter six.
Influences and identities I brought to the research
M ilner (2007) states tha t all researchers should reflect on the ir position in relation to  
participants. There has been vast literature around the issue o f the researcher sharing the 
experiences o f the people they are interviewing or working w ith  (see fo r example: 
Fatimilhein and Coleman,1999; Allman et al., 2007). W ithin disability studies there has been 
much discussion about the role o f non-disabled researchers in disability research (see fo r
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example: Drake, 1997; Branfield, 1998; Duckett, 1998). My negative hepatitis C status proved 
to  be a source o f significant anxiety fo r me in the planning stages o f the research, in tha t I 
would be considered an 'outsider' and therefore less suited to  researching such a sensitive 
issue. W hilst there were some incidences where participants indicated that my hepatitis C 
negative status negated understanding on an experiential and embodied level, others 
referred to  the importance (and unusualness) o f someone who does not have the virus being 
interested in it, o r the value o f having a d iffe rent perspective (Holloway and Biley, 2010). 
Furthermore, the complexity o f hepatitis C experience and the m ultitude o f contextual 
factors which impact on participant understandings (i.e. age, gender, life experience, and 
trea tm ent experience) would not have been minimised in the event tha t I too, had hepatitis 
C.
I worked from  the position tha t identities and traits are fluid and unstable rather than 
essential categories, and I occupied a range of d ifferent positions which were understood 
d ifferently by participants (Halse and Honey, 2007). The privileging o f hepatitis C status 
potentia lly overlooks the m ultiple and cross cutting characteristics shared (or not) between 
researcher and participant. Brown and Boardman (2011) indicate that d ifferent facets o f 
the ir identities came to the fore during the research process. Similarly, my identity as a 
woman, disabled person, research student, social worker, advocate, and partner all made 
appearances during the research process and helped me to  support participants, whilst my 
experiences o f living in a d ifferent geographical area, my age, gender and my sexual 
orientation may have inhibited some areas o f discussion (Takeda, 2012). As Measham and 
Moore (2006:19) note, 'insider and outsider status is partial, flexible negotiated w ith a range 
o f positive and negative implications fo r the research process.'
As both Shah (2006) and Brown and Boardman (2011) have recently indicated, research is 
always shaped by the researchers experience, my own experience of impairment and
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disablism also brought a shared experience o f oppression, which then connected the 
experiences o f people w ith  hepatitis C w ith  o ther disabled people.
Shah (2006) maintains tha t a researcher can bring ontological privilege (see also Goodley and 
Tregaskis, 2005) including the use o f empathy which helps to  understand and identify both 
sim ilarities and differences. Warin (2011) emphasises the importance o f interrogating the 
feelings o f sim ilarity (the 'me too ' moments), so tha t blind spots are not created or 
overlooked. Thus, I became wary tha t I could over identify  commonalities between myself 
(and o ther disabled people) and those w ith hepatitis C. I made reflexive efforts to  explore 
the differences between people w ith  hepatitis C and (other) disabled people. Some 
participants' rejection o f a disabled identity and the ways in which people w ith  hepatitis C 
may not f i t  easily, are reflected on in chapter nine.
My previous experience as a social worker (and my on-going com m itm ent to  social work) 
meant tha t I maintained sensitivity to  the role social workers can play in supporting those 
w ith  hepatitis C. However, it also engendered strong feelings during and especially post, 
interview. Reading through notes and transcribing interviews, I was repeatedly struck by 
feelings o f frustra tion concerning the lack o f support offered to  people w ith  hepatitis C, 
which increased throughout analysis, where a role fo r social work support was clear.
My age and my female gender may have also impacted on the research particularly in 
establishing open and supportive relationships. My age (m id-twenties at the tim e of 
interview) coupled w ith  my status as a student may potentia lly have deterred some 
participants from  taking part, in terms o f feeling I was 'just a student' (see Sampson and 
Thomas, 2003). I took steps to  guard against this, fo r example, by introducing myself as a 
'postgraduate researcher' (see also Garthwaite, 2009). My status as a student may have 
helped me to  gain access to  some participants, fo r example, Daniel was currently engaged in 
fu rthe r education and Kerry and Laurie indicated a willingness to  take part because they too
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had also completed research based dissertations. Some of the participants indicated tha t I 
was about the same age as the ir children and this may have helped them  to feel more 
com fortable and balanced out some o f the power differences.
My female gender may have been helpful in some ways, participants may have fe lt it was 
easier to  share details w ith  a woman [given the stereotypical positioning o f women as caring 
and good listeners (Padfield and Procter, 1996)] but it may also have meant tha t participants 
shared more than they meant to  (Finch, 1993) indeed, some asked fo r aspects to  be 
removed from  the ir transcripts. My gender may also have inhibited some areas o f discussion, 
fo r example, in relation to  sexual relationships. W hilst some o f the female participants 
discussed this w ith  me, it was less common among men. In addition, w ith  the participants 
who lived w ith  both HIV and hepatitis C, there may have been some areas o f discussion tha t I 
may not have had easy access to, given the one-off nature o f the interview.
My own 'personal qualities' played a significant part in the progress and route o f the 
research and eventual form ulation o f this thesis (Punch, 1994). There is little  existing 
literature about the way tha t the research is shaped by the researcher's own (shifting) traits, 
but my passionate interest in the experience o f living w ith  hepatitis C, flexib ility  and 
openness to  fo llow ing the flow  o f research in unexpected directions were integral in 
exploring and enacting the complex and m ultiple experience. It was im portant fo r me to  be 
receptive to  the phenomena of hepatitis C, to  engage w ith as many accounts as possible and 
w ith  as many facets as possible. This curiosity and passion sustained me through d ifficu lt 
periods and the untidiness and openness meant that I followed up on things tha t a more 
structured PhD may not have allowed.
In doing so, reflexivity was key, defined here as the continual exercise o f 'stepping back' 
from  the research to  critically examine the researcher's position, in relation to  the research 
and participants. It is described by Hertz (1997: viii) as an intense examination o f 'what I
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know and how I know i t /  an on-going conversation, w hilst existing in the present moment. 
The feelings and observations which arose from  this process were noted in my research 
diary, post interview notes and using the comments function when drafting in M icrosoft 
Word. These observations shaped and, in turn, were shaped by, engagement w ith  the 
research process and thus became a form  o f data (Crooks et al., 2012; Takeda, 2012). As will 
be discussed below, openly exploring and explaining my position and the ways in which the 
findings and the thesis came into being are used to  exhibit rigour w ith in  the research (see 
Koch and Harrington, 1998; Jootun et al., 2009).
Gaining ethical approval
I in itia lly intended to  advertise the research in local hepatitis C clinics, and drug and blood 
borne virus services, in order to  make contact w ith  people w ith  hepatitis C and professionals 
involved in the ir care, although I was not asking services to  play any part in the recruitm ent 
o f participants because o f the potentia l th reat to  anonymity. As I anticipated tha t staff 
interviews would take place on work premises, I was required to  obtain ethical approval 
from  the local NHS Research Ethics Committee (REC) and individual sites via local Research 
and Development offices.
This involved completing a lengthy online application process known as the 'Integrated 
Research Application System' (IRAS). IRAS is intended to  be a comprehensive system for 
applying fo r the permissions and approvals fo r health and social care research in the UK, in 
one single electronic application (IRAS, 2010). Completing the application and awaiting 
approval proved to  be a long and labour intensive process, taking 12 months from  beginning 
the application to  gaining REC approval, which brought w ith it both benefits and 
challenges51. The ethical approval process started only 8 weeks after beginning my PhD,
51 Here NHS Ethical Approval is pharmakon (Derrida, 1981). A concept explored in greater depth in 
chapter seven.
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which was helpful in encouraging me to systematically th ink through the research project 
from  beginning to  end, including ethical issues I thought I m ight face. This process required 
fix ity  and clarity, potentia lly inhibiting creativity in research design. Ethical approval 
processes such as this have been criticised by social researchers who maintain tha t the 
process does not lend itself to  the flexible and shifting nature o f qualitative fie ldwork, and 
tha t risks posed to  participants in biomedical research (for whom the process was in itia lly 
designed) are very d iffe rent (see Dyer and Demerit, 2009). This process also obscures the 
complexities inherent in fie ldwork which cannot be systematically addressed in applications, 
explored below.
Others maintain these lengthy ethical approval processes, far from  encouraging researchers 
to  reflect on the ir project, become a 'hurdle ' to  clear or are intended fo r institutions to  
protect themselves rather than providing protection to  participants (Hammersley, 2006; 
McDonagh et al., 2007; Alderson and M orrow, 2011). Further, as W inlow and Hall (2012: 
412) suggest, there is the potentia l fo r ethical commitments to  be replaced 'by a world 
weary cynical process deprived o f the real substance which would make the process real and 
valuable'.
As I outline below, the ethical issues I faced in the field were on-going and contingent 
(W hiteman, 2010) and could not be addressed through a one o ff process (Halse and Honey, 
2007). Indeed there is a difference between what Guillemin and Gillam (2004) term  
'procedural ethics' (discussed by ethics boards) and 'ethics in practice' (the unpredictable 
issues which arise in everyday fie ldwork). I thus employed the advice o f Halse and Honey 
(2007) and Guillemin and Gillam (2004) to  engage reflexively w ith the research process, 
place respect fo r persons at the centre and to  pay attention to  ethically im portant moments 
arising in the course o f research.
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I applied at the same tim e to  Lancaster University Research Ethics Committee (UREC), 
receiving approval in 2009. Thus I was able to  make contact w ith local support groups not 
attached to  NHS services and also w ith  online forums. The lengthy nature o f the NHS 
approval meant tha t I actually recruited 13 participants w ith  UREC approval and a fu rthe r 8 
a fte r obtaining NHS clearance. This shaped my research in tha t I moved away from  recruiting 
in form al services, the implications o f which are explored below.
Sampling and recru itm en t
Due to  the 'silent' nature o f hepatitis C (explored in greater depth in the data chapters) 
people living w ith  it are neither physically nor culturally visible (see Suarez and Shindo, 2008) 
and can be marginalised, meaning recruitm ent strategies needed to  be sensitive and careful. 
The recruitm ent strategies themselves were also bound up w ith  and constrained by, the lack 
o f dedicated form al support services, and the post code lottery which exists in the UK. This 
meant some participants were more easily accessed than others and thus, the experiences o f 
hepatitis C included in this study were enacted in particular ways.
I was keen to  access a range o f people living w ith hepatitis C, both those who were and were 
not in touch w ith  formal services (including drug services). I printed a list o f support groups 
from  The Hepatitis C Trust website and contacted support groups in turn. I contacted every 
support group tha t provided email addresses in England (approximately 1252), and local53 
ones (5) by phone, as well as visiting local services both to  publicise the research and make 
myself known to  professionals. I made the decision not to  recruit from  the support groups 
run by The Hepatitis C Trust, given tha t they provide a wide range o f support services54 from
52 The numbers of support groups was correct at the time of research.
53 Defined as being within one hours' journey from Lancaster
54 Including support groups, awareness raising, welfare benefits advice, telephone support and 
information.
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the ir base in London and I wished to  obtain the views o f participants who may not have had 
access to  such services.
I quickly learned tha t making initial contact w ith  support groups via email was more fru itfu l 
than making contact via telephone, often calls were not returned or voice mail messages 
were not responded to. This may be because this was effectively a 'cold call' (Genovese, 
2004) from  someone unknown to  the support group facilitator, or mobile telephone 
numbers may have changed, or I may have been calling at inconvenient times. The improved 
response when recruiting via email may have been because support group leaders were able 
to  absorb the inform ation I provided in w ritten  form  more easily, before responding to  my 
request to  visit.
Due to  the uneven distribution o f support groups in England and the concern tha t my 
em ail/phone contact would have to  pass through a support group leader who may or may 
not pass on the research details to  those in the support group, I was advised by a support 
group co-ordinator to  contact an online forum  w ith whom they had close contact. Online 
recru itm ent proved to  be the most rewarding way o f contacting participants (see below) and 
there was some crossover between forum  participation and support group attendance, 
which helped w ith  snowballing. I anticipated tha t recruiting via online forums may also mean 
I accessed those who were not currently accessing services in relation to  the ir hepatitis C, 
though this was not borne out in the sample.
It became clear when I visited support groups to  advertise the research and hand out flyers, 
tha t those who wanted to  participate were more interested in doing a one to  one interview 
than participating as part o f a group (also reported by Carrick et al.,2001), so the method 
was altered to  accommodate the ir preferences (Kerruish, 1995). In retrospect, this allowed 
me to  gather more in-depth data and to  side-step issues, such as preventing those who did 
not wish to  participate from  attending the ir support group, maintaining confidentiality, and
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logistical issues such as access to  rooms, which support groups often paid fo r and I would 
have had to  fund.
As I was aware tha t those most at risk o f contracting hepatitis C were those who used drugs, 
I also made a concerted e ffo rt to  advertise and make contact w ith in  drug services. I sent 
in form ation and flyers to  local services, including hepatitis C specialist clinics (three), 
homelessness services (one), housing support services (one), drug services (five), a local drug 
user forum  (one), sexual health services (three) and residential rehabilitation services 
(three). I also tried, as far as possible, to  visit and spend tim e in these services (though this 
may not have been enough), and I know o f professionals who approached those they knew 
had hepatitis C and invited them fo r interview. During this time, I obtained only one 
interview  w ith  a participant who reported using illic it drugs, though he was unsure o f his 
hepatitis C status (waiting fo r a test result), so his data has not been included in this study. 
Thus, although some participants were in recovery or had used illic it drugs in the past, no- 
one in the study reported actively using illic it drugs at the time. This may also be a 
performance o f candidacy fo r treatm ent (Coupland and Maher, 2010) (i.e. those who are 
actively using drugs are not routinely offered treatm ent despite guidance to  the contrary) 
and thus, may not have wanted to  come forward to  talk about the ir experiences. 
Notw ithstanding this obvious lim itation, this focus on those who were not using drugs could 
be considered a virtue o f the study. The research has provided insights into areas which at 
present remain under explored, namely what happens after diagnosis, what it is like to  live 
w ith the virus, and support and inform ation needs on treatm ent.
Eight participants were recruited from  online forums, seven were recruited from  support 
groups, four were snowballed from  existing contacts, one saw an advert on an email list, and 
one was recruited through advertising in a service.
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Recruiting from  an online forum
The potentia l afforded by the in ternet (in my case, online support forums) in making contact 
w ith  those who are isolated, hidden, or d ifficu lt to  engage, has been widely recognised and 
utilised (Davies, et al., 2004; Sanders, 2005). Two separate support group leaders 
recommended tw o  d ifferent support forums to  advertise my research and make contact 
w ith  participants. I contacted a named m oderator on each o f the forums55 to  explain who I 
was, what I was doing and asked to  post inform ation about my project in order to  encourage 
people to  come forward fo r interview. Brownlow and O'Dell (2002) question the ethics o f 
recruiting from  online forums when these may be the only groups people have to  talk about 
d ifficu lt issues. M indfu l o f this, I maintained throughout tha t I would not be using the 
comments on the forum  in the research. The forum  would only act as a means o f recruiting.
However, this in itse lf may require additional assurances and the researcher may be 
explicitly required to  establish credibility (see Sanders, 2005 fo r a robust discussion o f 
these issues), as I learned from  one forum  moderator. A fter posting inform ation about 
the study and my contact details on the forum , this message was posted:
'Heather, There's no problem w ith a researcher jo in ing  the Forum and asking 
questions, BUT as a fo rm e r research student 1/ we would
a) - ask you to post to the moderators f irs t (just to ensure the questions/survey is 
appropriate).
b) - provide ethical assurances about your research from  a supervising lecturer.
C) - research is done in an open post - no t a private post where appropriate.
55 For both forums there were a number of moderators unbeknown to me at the time.
142
I know how hard research is and we'd like to help in any way as long as you're happy to 
comply'.
This gave me the opportun ity  to  clarify the role o f the forum  in the research and provide 
ethical and confidentia lity assurances, which one participant in particular indicated was key 
in his decision to  participate in the research. Interestingly, this only happened on one forum. 
Those on the second forum  appeared to  be happy to  participate w ithou t these explicit 
assurances (though these were given on the inform ation sheet), where forum  moderators 
acted as gatekeepers. Indeed these moderators suggested that advertising the research gave 
the ir forum  credib ility (see Brownlow and O'Dell, 2004).
One participant did wish to  check my credentials prior to  going any fu rther and contacted my 
research supervisor. The name o f my second supervisor was given as a contact point on the 
inform ation sheet fo r anyone who wanted fu rthe r inform ation or who had any concerns (see 
appendix three).
It is im portant to  note here tha t although the online forum  provided a valuable opportun ity 
to  make and maintain contact w ith  participants, including those who may not be in touch 
w ith  support groups, or who were too impaired to  attend in person (Hopwood et al., 2006) - 
there were clear influences and lim itations on the sample. Most obviously, tha t participation 
on an online forum  depends on access to  the internet, so those who do not have it, cannot 
afford it, or fo r whom it is inaccessible (Watling, 2011) are excluded. In addition, those who 
participated on the online forum  and were available fo r interview may have had some 
particularly extreme experiences as Keith indicated: 'the people tha t do go on tend to be the 
kinds tha t are having a hard time'.
However, the sample did include those who experienced no treatm ent effects and who
worked fu ll time, indicating a range o f experiences are included. Participants were also
recruited offline through advertising in services, adverts on mailing lists and snowballing. The
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sample did include people who were active in moderating forums and developing support 
fo r people w ith  hepatitis C, and who may have spoken about aspects o f the ir experiences 
before which 'crystallise into a certain form  over tim e ' (Stacey, 1997:39). Many who 
participated in the interviews made it clear tha t they fe lt it was im portant to  raise awareness 
o f the issues around living w ith  hepatitis C (and being on treatm ent) and thereby contribute 
to  change (Clark, 2010). However, the ir involvement in the field meant tha t they frequently 
moved from  talking about the ir personal experiences to  talking more w idely about the 
experiences o f others. Thus the account is a co-construction between me, the participant 
and others w ith  hepatitis C, the accounts cannot be considered in isolation, but are 
connected to  (and a m aterialisation of) w ider connections to  the community.
Sem i-structured in terv iew s
This section explores the use o f semi structured interviews which were undertaken on a one 
to  one basis w ith  16 o f the participants. Three others participated in a group interview and 
tw o  were interviewed as a couple.
I was m indful tha t in asking people w ith  hepatitis C to  talk to  me about the ir experiences, 
tha t this should be treated as a sensitive topic (Lee and Renzetti 1993) and that it may have 
taken considerable e ffo rt fo r them to  come forward56. W ith this (and possible impairment 
and treatm ent effects) in mind, participants chose the mode o f interview (face to  face, 
telephone, MSN or email) to  make it as easy as possible fo r them to participate (Sturges and 
Hanrahan, 2004; Hanna, 2012). 11 participated in face to  face interviews; five at the ir home, 
one in the workplace, one at a residential rehabilitation centre and four at a local support 
meeting (three in a group interview). Eight participated in telephone interviews and tw o 
interviews were conducted via MSN messenger. Face to  face and telephone interviews were
56 This may explain why no one came forward to be interviewed in drug services being seen with me, 
as someone who interested in researching hepatitis C, might imply a positive status for those who are 
concerned about it.
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recorded w ith  the consent o f participants, using a digital voice recorder. One telephone 
interview  recording failed, so notes were made and then sent to  the participant fo r checking.
Semi structured interviews were chosen fo r the ir informal nature, described as 
'conversations w ith  a purpose' (Burgess, 1984; 102) providing direction fo r those who may 
be unused to  talking about the ir experiences, but also allowing room fo r flex ib ility  to 
elaborate on the ir specific experience57. Interviews ranged in duration from  55 minutes to  
three and a half hours, and were typically tw o hours long. I have chosen to  use the term  
'generating accounts' rather than 'collecting data' to  acknowledge that the interview is not a 
process o f excavating fu lly form ed experiences from  a participant, in which the researcher 
plays no part, but tha t interviews are dialogic, multiple processes whereby utterances and 
questions shape the interaction (Mason, 2002).
The interview  guide
The interview  schedule (see appendix four) explored the experience o f hepatitis C broadly, 
including the firs t tim e participants heard of it, the experience o f diagnosis, access to  
treatm ent, types o f support received, areas where support was required or missing, together 
w ith  positive and negative aspects o f living w ith  the virus. A fter each interview, I listened to, 
reflected on and made notes on each account. This meant tha t I refined the interview 
schedule to  include specific areas o f questioning that participants had raised (i.e. post 
treatm ent support), thus enacting these as im portant and worthy o f discussion.
571 have tried, as Law (2004) and Mellor (1998) advocate, to acknowledge the fuzziness of the world 
and to explore it. The open-ended nature of the interviews, and the flexible way in which I 
approached data collection, has allowed for some of this mess to remain unrepressed, whilst 
acknowledging that this mess has itself been refined and tidied in specific ways (i.e. in deciding what 
to ask of interviewees, in making decisions about which participant groups to include).
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During analysis and w riting  up, the linearity and unidirectional nature o f the schedule 
became apparent, re-enacting hepatitis C care pathways and existing policy responses (see 
fo r example: DH 2004; HCV Action, 2012; NHS Medway, 2010).
Here it became clear tha t I had attem pted to  enforce a kind o f order and tha t accounts had 
wriggled out o f this (Smart, 2009; 2010). The flexib ility  o f the interview schedule, together 
w ith  my decreasing reliance on it as I participated in more interviews (Stephens, 2007), and 
my willingness to  go w ith  the flow  o f research, meant tha t the messy, nonlinear, non- 
chronological nature o f the experience was enacted. The multiple nature was also made 
clear when participants frequently asked fo r the tape recorder to  be turned back on to  
record the ir thoughts as the interview drew to  a close. This is not to  say, however, tha t the 
interviews generated a 'fu ll' account experience, as they are always partial.
Face to face interviews
Face to  face interviews are commonly considered superior to  other modes o f interviewing 
(Sturges and Hanrahan, 2004)58 as they enable both parties to  participate in embodied 
communication, as well as verbal. Many o f the face to  face interviews took place in 
participants' homes. These interviews enacted a reality which was not present in the other, 
non-face to  face interviews. Treatment and post treatm ent effects and the impacts o f these 
were much more visible. For example, some of the issues Morgan later discussed in her 
interview  became clear before I had even arrived at her house. The nearest large town was 
half an hour from  where Morgan lived, requiring a bus journey and then a taxi journey. This 
travelling provided me w ith an additional understanding o f the disabling structural barriers 
she faced when travelling to  appointments (discussed in chapter five). Furthermore, before 
the interview  began, Morgan showed me the rash which covered parts o f her upper body
58 Though as discussed below, I would argue that the experiences enacted in telephone and MSN 
interviews were just as strong they merely bring different realities into being,
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and the hair loss she had experienced as an effect o f treatm ent. Here, hepatitis C was 
enacted as something which needed to  be justified, as well as something which had serious 
effects. The intra-action and inclusion of details concerning participants' bodies is also part 
o f engaging w ith  the messy and embodied reality o f hepatitis C. The rashes and itching in 
particular, were characterised by Morgan as the toxins o f the treatm ent seeping through her 
skin. Charlie, who was interviewed in his workplace, enacted a reality whereby his employer 
was supportive o f his experience of hepatitis C (explored fu rthe r in chapter nine). Other, 
documentary evidence o f participant experiences were provided in the face to  face 
interviews, such as letters from  doctors in support o f applications for benefits59, manuscripts 
they were working on to  te ll the ir story, government consultation responses, completed 
questionnaires and poems they had w ritten  as part o f the ir recovery. This makes the 
m ultip le nature (Mol, 2002) o f hepatitis C visible and gives strength to  the use o f flexible 
qualitative methods used in this study.
Between a focus group and a group interview
Two participants chose to  be interviewed as a couple and three participants were 
interviewed in a group at the ir local support service (in line w ith  what I had originally 
planned at the outset). The interview  w ith  the support group highlighted issues that I did not 
encounter so visibly in the one to  one interviews, notably working w ith  gatekeepers. Access 
to  these participants was facilitated by a professional w ith whom I had contact and who 
provided advice and support to  the group. I had no idea how many participants would be in 
attendance before I arrived fo r the interview tha t day, and had not corresponded w ith 
individuals in advance to  explain the study and provide the questions and information sheet
59 This could also be seen as an effort by the participant to be seen as 'credible' and' genuine' (see 
Werner and Malterud, 2003; Werner et a l., 2004) - explored in chapters five, eight and nine.
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in the same way I had fo r previous interviews60 - which had been valuable in establishing 
rapport. The support group fac ilita tor was present throughout the discussion w ith  these 
participants. W hilst I in itia lly  had some concerns tha t participants m ight be less inclined to  
talk openly, the worker's input, prom pting and existing relationship and knowledge o f the 
participants, meant tha t she prompted fu rthe r dialogue or elaboration.
I have used the term  'group interview ' to  describe this method o f data generation, rather 
than focus group. Gibbs (1997) indicates tha t it is im portant to  note the difference between 
focus groups and group interviews. Where focus groups explore the dynamics and 
interactions between participants and use this as a source of data (see Kitzinger, 1995; 
Krueger and Casey, 2000), group interviews are questions and answers asked o f each 
participant (Thompson and Demerath, 1952) although in indexing of studies, these terms are 
often used interchangeably. In practice, the data generation fell somewhere between a 
focus group and an interview, w ith participants building on and disputing each other's points 
o f view, as well as responding individually to  questions. The intra-active nature o f the group 
interview meant tha t topics were covered more broadly and this led to  frustration tha t I had 
not been able to  hear more about one participant's views. Brad had spoken openly prior to 
the arrival o f o ther participants, but had been less vocal in the group setting. Here, more 
confident and vocal participants enacted the ir particular hepatitis C, whereas less common 
hepatitis Cs (Brad's was contracted through rape) were marginalised, or less easily shared in 
a group setting. Clearly this also depended on my ability to  facilitate and shape the 
interaction, which I could have taken greater control over, to  give Brad more space to  speak. 
That being said, the participants did enact hepatitis C in shared ways, particularly in relation 
to  how they fe lt about treatm ent and the ir own blood.
60 Although I sent these to the (professional) support group facilitator.
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Two o ther participants were interviewed about the ir experiences together; they were not 
only able to  build on each other's points, but to  interject w ith  the ir perspectives to  
encourage the o ther participant to  reflect on the ir statements, although they sometimes 
'tuned out' when the o ther one spoke and had to  be brought back up to  speed. Interestingly, 
the participants interviewed as couple had met during treatm ent and had worked together 
to  develop support services and raise awareness therefore, the ir interview re-enacted 
hepatitis C as under resourced and poorly addressed.
Telephone interviews
Eight participants chose to  participate in an interview by telephone, at a tim e convenient fo r 
them. Historically telephone interviews have been perceived as better suited to  quantitative 
research (Shuy, 2003; Holt, 2010) and as in ferior to  face to  face interviews due to  the 
absence o f non-visual and nonverbal cues (Novick, 2008). However, I found tha t telephone 
interviews were a mode particularly suited to  generating accounts o f hepatitis C. This is not 
to  say tha t the telephone interviews did not present some difficulties. Sturges and Hanrahan 
(2004) state tha t telephone interviews offer a greater opportun ity fo r note taking as the 
researcher is not seen by the participants, but I found it extremely d ifficu lt to  make notes at 
the same tim e as trying to  listen, th ink and respond, and thus abandoned the practice early 
on, scrawling key words on 'post-its' where absolutely necessary. I also fe lt tha t it took 
longer to  establish rapport, w ith  the introductory question ' te ll me a little  about yourse lf 
requiring greater elaboration and reassurance that participants were giving the 'sort o f thing'
I wanted (Irvine et at., 2012). Upon reading the transcripts, I also fe lt tha t I had sometimes 
missed the opportun ity to  probe or fo llow  up on specific threads, having been reluctant to  
in terrupt and disturb the flow  o f the conversation (Stephens, 2007) this was easier face to  
face where a participant was able to  te ll by movement or facial expression tha t I wanted to 
interrupt, or via MSN where I could relate questions back to previous text (discussed below).
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There was little  noticeable difference in the length of the accounts generated by telephone 
compared w ith  those generated in face to  face interviews, (consistent w ith  Sturges and 
Hanrahan, 2004; Stephens, 2007). Indeed, the longest interview was conducted by 
telephone. I found tha t although the phone interviews required precise concentration, the 
everyday nature o f the telephone conversation (Irvine et al., 2012) encouraged participants 
to  ta lk openly. Further to  this, telephone conversations about hepatitis C m ight be 
considered more 'everyday' than a face to  face in-depth discussion, given tha t the 
participants often described interactions w ith  specialist nurses or consultants as brief. The 
suitability o f using the telephone to  ta lk about hepatitis C was fu rthe r reinforced by 
participant accounts o f supporting others by telephone; fo r example, at one support group 
the participants were planning to  develop a telephone buddying service.
In keeping w ith  my ontological position briefly outlined earlier, the methods outlined in this 
chapter participated in the enactment o f realities each interview enacted hepatitis C and the 
participants in particular ways. This was made clear in Grace's interview. I first met Grace at 
a hepatitis C support meeting. She in itia lly refused to  participate in the research face to  face, 
but le ft her number w ith the support group leader inviting me to  contact her. During the 
telephone interview Grace explained that she had disclosed to  very few people (as she fe lt 
intensely negative about her hepatitis C status) and attended support groups very rarely, 
thus she had not wanted to  risk missing any im portant and new information by participating 
in an interview  there and then. Grace indicated tha t she found it easier to  talk about her 
experiences o f hepatitis C knowing that I was physically a considerable distance from  where 
she was (Joinson, 2005; Buckle et al., 2010) and there could be no connection made between 
us, outside o f the support group leader. This afforded her a greater degree o f anonymity 
(Rose, 1998; Giles, 2006) and control, as well as side stepping a number o f awkward and 
potentia lly anxiety producing situations where my physical presence might have been 
d ifficu lt to  explain (Sturges and Hanrahan, 2004). Grace made it clear tha t there had been a
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number o f incidences where her hepatitis C status had been disclosed (or nearly disclosed) 
by others. Thus, interview ing by telephone simultaneously reinforces Grace's negative 
feelings around hepatitis C and challenges them, Grace could quite literally keep the 
interview, and hepatitis at arm's length, whilst simultaneously being able to  talk about it 
openly on her own terms. Similarly, Boab resided on a remote island o ff the coast o f the UK 
and thus, the telephone bridged the gap by reducing travel, but also highlighted the 
difficulties he had in travelling to  appointments.
Online interviews
Law's (2004) position that realities are the effect o f particular inscription devices (e.g. 
laptops and specific com puter programmes) is particularly visible in interviews w ith  tw o 
participants which were undertaken using synchronous online chat programmes (Windows 
Live Messenger previously known as MSN Messenger). Electronic typed messages are 
exchanged in 'real tim e ' between researcher and participant (Oppendakker, 2006). 
Throughout both interviews there was no audio or visual communication, only typed 
messages. This in itia lly fe lt both cold and very immediate: the typed medium and 'one off' 
nature o f the interview  meant tha t informal conversation fe lt minimal (even though it took 
the same am ount o f tim e as a face to  face or telephone interview) however, I fe lt pressured 
to  respond sw iftly, in order to  convey that I was interested and engaged.
This was both assuaged and heightened by the indication of activity in the bottom  corner of 
the screen, e.g. 'Laurie is typing'. This sometimes explained why there were long gaps 
between messages. However, lack o f any other forms of communication meant tha t it was 
impossible to  determ ine what the participant was thinking or doing. Thus, it was im portant 
to  convey w arm th and develop the relationship as much as possible in a lim ited medium. 
W hilst Opendakker (2006) pointed to  the use o f emoticons and text speak in developing this,
I found tha t I relied less on these (on reflection I was concerned about coming across as too
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inform al or not taking the interview  seriously), preferring to  be explicit in my responses to  
participants.
One o f the strengths o f this mode o f interview ing was the readymade transcript. This meant 
tha t I could scroll up and down the conversation, reading over previous answers in order to  
absorb and form ulate new questions, although this had to  be done quickly in order to  not 
feel as though I was keeping the participant waiting. As a result, I fe lt tha t my prom pting and 
probing was more thorough during the MSN interviews and these needed to  be carefully 
linked to  avoid confusion and loss o f the conversation thread.
Online interviews have been described as tim e and resource saving, reducing the need for 
travel and transcription, convenient fo r participants and providing a level o f distance and 
anonym ity (Davis et al., 2004). However, the length o f the accounts generated in the time 
period was considerably shorter (Oppendakker, 2006). An interview which was tw o hours 
and 45 m inutes long generated 15 pages o f typed text, w ith  answers tending to  be shorter. 
Davies et al. (2004) has indicated that the nature o f the MSN interviews necessitates closed 
and focused questions and negates the in-depth exploration of meaning, although this was 
not my experience as I found tha t participants shared sensitive and emotionally charged 
experiences. This is potentia lly connected to  refinements in the design o f MSN messenger 
and the development o f broadband internet, improving the speed and reliability o f internet 
connection since Davies et al. (2004) published the ir findings. Joinson (2005) indicates that 
the act o f typing means tha t both participant and researcher have to  th ink more carefully 
about the ir answers, and researchers may gain increased access to  attitudes and emotions. 
One aspect which I had not considered prior to  interview is tha t participating via MSN 
requires embodied work from  participants in a way which is d ifferent from  face to  face and 
telephone interviews. Both o f us were required to  type fo r prolonged periods which resulted 
in fatigue. W ith in the literature, online participation is often presented as being enabling for
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disabled participants, given that there is the opportun ity to  rest or break o ff (Seymour 2001; 
Bowker and Tuffin, 2004; Guise et al., 2009). However, the immediacy o f the interview  and 
the physical work involved is not extensively documented in the literature, but is im portant 
in considerations o f access.
As m entioned above, there is a lack o f visual cues, body language and even tone. This 
became clear in an unexpected way:
Freda: 7 am toying w ith the idea o f possibly jo in ing a support group...
Heather: Is there something holding you back?
Freda: Also because I am so labile a t the m om ent I cry so much
Heather: Really?
Freda: I have cried most the way through this
Heather: Through this interview? Freda, I'm so sorry. I d idn 't mean to  make you upset
Freda: No it  isn 't you upsetting me I would have stopped i f  it  was.
Heather: As long as you're sure. We can stop anytime/
I had absolutely no idea that Freda was crying at any point, highlighting the partial and 
constructed nature o f the interview (I only know what the participant chooses to  te ll me). 
The partial nature o f the interview mode means that certain aspects o f hepatitis C (such as 
depression and the side effects o f the treatm ent) are silenced, as they are via lack o f support 
provision -  explored fu rther in the data chapters.
Another clear example o f the intra-action between the method and participant experience in 
enacting hepatitis C is visible in the extended extract from  Freda below. In the excerpt (eight 
minutes o f the interview) Freda describes being unknowingly referred to  a hepatitis C nurse
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after experiencing bleeding from  her bowel (though it is not immediately clear the tw o  are 
connected) and proceeds to  recount the events that precipitated the referral:
Freda: 7 d idn 't even know I was being referred to a hep c nurse!!
Heather: Really?
Freda: Yes
Freda: I went to my GP as one morning I woke up went to the loo and there was so 
much blood i t  scared the life out o f me
Freda: I have had problems w ith painfu l bowels but ju s t assumed it  was Irritable Bowel 
Syndrome
Heather: Had tha t never happened previously then?
Freda: Had haemorrhoids but never blood like tha t
Heather: So w hat was the GP like when you went to see them?
Freda: He was fine  he asked about i t  the bleeding frequency etc. then said he would  
refer me to a specialist
Heather: Did he know about the hep C?
Freda: Received an appointment very quick fo r  a colonoscopy? Camera investigation 
Freda: Yes as it's  on m y records 
Freda: but he never mentioned it
Freda: I saw i t  on computer screen as he flicked through m y history
Heather: Right, so, was it  through the colonoscopy tha t the hep C came to the fo re  
again?
Freda: Heather this may sound stupid bu t I don 't know  
Heather: I t  doesn't sound stupid...
Freda: I went and had a couple camera things [examinations] a t one hospital then I 
had an appointm ent a t my local hospital then I had another appointment w ith the 
same doctor but a t the big hospital. It seems this doctor is the hep c doc
Freda: But I s till d idn 't know !!
Heather: So, can I ju s t clarify? You were being sent to see a hep C doc w ithou t really 
knowing you were going is tha t right?
Freda: So ju s t over a year ago I went to local hospital to the chest clinic a rea l!
Freda: yes
Freda: I was going fo r  my bowels.'
Here the short sentences exhibit aspects o f the experience being drawn together and 
enacted by both myself and Freda, bit by bit. It is slow, tentative and not immediately clear61. 
Freda indicates tha t the presence o f blood in the to ile t motivates a visit to  her GP, who 
knows about her hepatitis C, but does not mention it in the consultation. Freda is referred 
fo r fu rthe r investigations of her bowel at tw o separate institutions (the reasons fo r which are 
not clear), where along the way, invisible work (Law, 2004) is done by professionals who 
establish her hepatitis C positive status, which is dealt w ith  by the same doctor and thus, the 
specialist nurse joins them in the consultation. This highlights the contingent nature o f 
hepatitis C, and the fuzzy and uncertain nature o f the eventual engagement w ith services,
61 Cf. Applebaum's 'stop' in Law (2004:10)
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which is enacted in the short asynchronous dialogue. Here it is not possible to  obtain an 
overview o f the experience rather it is made visible slowly. This extract demonstrates the 
impossibility o f a single fixed tru th  there are multiple threads at work, only some o f which 
are visible.
Benefits of interviews
The potentia l fo r qualitative interviews to  be beneficial to  participants, as well as the 
researcher, deserves some exploration here. A number o f participants indicated, 
unprompted, tha t they had found it helpful, enjoyable or valuable to  participate in the 
interview, or had gained new understandings as a result.
'It's probably helped me talking to you more than anything ' (Boab)
7 am only ju s t realising tha t here now ' (Charlie)
It is well documented tha t talking to  someone who is genuinely interested in experiences - 
which participants may not get the opportun ity to  otherwise relate can provide catharsis 
(Hutchinson et al., 1994), validation that experiences are meaningful and worth listening to, 
(Elmir et al., 2011) and provides an im portant outle t fo r stories that may be otherwise 
silenced (Charmaz, 2002). This was particularly im portant fo r those w ith  hepatitis C who may 
not often have the opportun ity to  talk or whose experiences may be distressing this is closely 
intertw ined w ith  findings discussed in chapter five. Freda referred explicitly to  participating 
in the interview  so she could 'practice' disclosing. There was some evidence that these 
interviews had a therapeutic function given that the chance to  be introspective in a safe and 
secure environment was rare (Clark, 2010) fo r these participants62. This works to  enact 
hepatitis C as an experience which requires both emotional and social support as well as 
medical. Clark (2010) indicates tha t participants may also take part in order to  feel that they
62Although I am far from trained to be able to provide this - discussed further below.
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are contributing and tha t the ir experiences have a purpose. This was evident in interviews 
w ith  participants fo r whom it was clearly tiring or upsetting to  continue, but did so. Though it 
is im portant not to  be disingenuous here, I w ill be the one who benefits in terms o f career 
advancement and academic recognition (Oliver, 1997; Priestley, 1997; Mason, 2002).
Ethical issues
Here I explore in depth some o f the ethical issues I faced during the fie ldwork. These 
occurred in the fie ldw ork process and were d ifferent to  those I had in itia lly anticipated 
during the ethical approval process:
Travelling to participants
As I was aware tha t participants may be experiencing impairment and/or treatm ent effects, I 
indicated tha t I would be prepared to  travel to  them, both to  make participation as 
accessible as possible and to  send a clear message concerning the importance o f the ir views. 
This o ffe r was taken up by 11 participants who were interviewed face to  face in different 
parts o f the UK. One was interviewed in his workplace during working hours, one at a 
rehabilitation centre where he lived (in a meeting room) and four were interviewed at 
support meetings (where others were present or in close proxim ity).
Travelling raised a number of issues. My own impairment effects mean I do not drive, 
requiring me to  use public transport. Thus, in prioritising participants' own impairment 
effects, this meant compromising my own in order to  'get' the data. This was aided by 
funding from  my departm ent which covered travel costs (including taxis) to  help manage 
im pairm ent effects, but highlights how different identities (researcher identity) are 
prioritised over others (disabled identity) at times (Brown and Boardman, 2011).
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There were additional issues concerning researcher safety (see also Sampson and Thompson, 
2003; Bahn, 2012). Although I was aware tha t the possibility o f a dangerous incident was 
highly unlikely, and I do not wish to  'o ther' the research participants given tha t I travelled 
long distances alone by public transport, sometimes requiring an overnight stay, means that 
it was a frequent concern and is w orthy o f discussion here. The possibility tha t researchers 
may travel via public transport was not often considered (see fo r example, Patterson et al., 
1999 and Kenyon and Hawker, 1999) w ith  transport advice extending to  car maintenance 
and parking. A d iffe rent set o f issues arise fo r those on public transport, including: inclement 
weather, distances between stops and participants' houses which have to  be travelled on 
foot, unanticipated diversions which are not shown on route planners, and late or cancelled 
buses or trains. W hilst this may seem mundane, at times these issues were a source of 
anxiety and additional stress fo r me, both on my way to  and from  interviews, which I 
managed as part o f the fie ldwork process. Not including them in the w rite  up contributes to  
the silencing and marginalisation of these issues63.
However, there were some aspects o f travelling via public transport tha t proved beneficial to  
the fie ldwork process. In my case on buses, trains and in short bursts on foot. I particularly 
came to  value the tim e spent travelling on trains (Watts and Urry, 2008, fo r a fu ller 
discussion) when sitting was possible. I found tha t the motion, warm th and dedicated liminal 
(Turner, 1966) journey tim e, where I was between stops but unable to  be anywhere else 
facilitated thinking and writing, especially when taking notes after interviews and winding 
down. Travelling also enabled preparation fo r interviews or annotating articles and drafts, 
which u ltim ately helped me to  make connections between chapters or points o f interest. 
This could be interspersed w ith looking out o f the w indow which I found helpful in allowing 
ideas to  flow , and I often gained flashes o f insight. Sometimes travelling during rush hour
63 There is a link here with the often unspoken or unconsidered issues of transport in relation to 
attending welfare benefit appointments (cf Soldatic and Chapman, 2010), discussed in chapter nine.
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was unavoidable and this proved to  be both physically tiring and anxiety provoking, when 
neither sitting nor note making was possible. During these times, the need to  make notes in 
order to  document fleeting thoughts or questions meant I developed strategies, such as 
scrawling key words on post-its which were small enough to  be held in my hand whilst 
leaning against handrails in train vestibules and adhering to  surfaces to  enable w riting. 
When travelling on foot, this afforded a sense o f space, an opportun ity to  be in the fresh air 
and aid my clouded brain.
Safety
Participant safety was also paramount. I was aware tha t the people I interviewed were 
effectively allowing a stranger into the ir house. To provide assurances, all correspondence by 
post was on university headed paper and emails were sent from  a university address. I also 
provided contact details fo r both o f my supervisors. Although there are some suggestions 
tha t social researchers are underequipped fo r lone working, my social work training meant 
tha t I was able to  employ sim ilar strategies as I had when visiting service users at home. For 
every interview, I left the name and address o f the participant, w ith a colleague - also a 
close friend who would continue to  support me out o f office hours where necessary - in a 
sealed envelope w ith  the tim e of interview and expected tim e o f return, w ith agreed 
strategies in the event I had not made contact. I made contact via text or phone at the 
beginning and end o f every interview (Bloor et al., 2010). Interviews were arranged fo r the 
middle o f the day where possible, avoiding arriving or leaving in the dark. I developed clear, 
methodical and contingency route plans fo r areas I had never visited before and called a taxi 
to  collect me from  the address if I was unsure. Participants themselves were often aware of 
the risks taken by a lone female researcher on foo t w ith one participant (who was part o f a 
fem inist group) providing me w ith  a personal alarm during the course o f our interview.
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Safety concerns aside, travelling to  participants and meeting them face to  face - in one case 
even staying fo r the weekend64 - meant that I was more able to  continue conversations after 
the tape recorder had been turned o ff which provided additional insights and context, to 
share cups o f tea, to  chat and show my appreciation for the ir time.
Through staying w ith  one participant, I also experienced first-hand what another described 
as the benefits o f the 'physical presence o f others w ith hepatitis C' (JB) after attending an 
informal support meeting. This also meant that I was able to  advertise the research to  more 
participants, who could ask me questions in the flesh before agreeing to  participate. This 
proved invaluable as I was able to  snowball and interview four participants as a result.
Recruiting f ro m  a poo l o f  peop le  w ho  k n o w  each o th e r
As explored above, a number o f people who participated in the research were members of a 
forum  which existed both online and as a physical network which holds meetings at regular 
intervals. W hilst the snowballing o f people who knew each other was useful in gaining access 
to  participants who might not otherwise have seen the research or volunteered to 
participate, it also raised issues around confidentiality and the maintenance o f on-going 
relationships in this small supportive community. As indicated above, I spent one weekend 
w ith  a participant. On my return journey to  Lancaster, I planned to  take a detour to  interview 
another participant who had seen my advert on the forum. During the weekend I became 
aware tha t these participants knew each other, though not how well. As the weekend drew 
to  close and I was asked about my plans I fe lt unsure what to  say. Although I knew they were 
in contact I was unaware whether both parties knew I was interviewing them. I made a swift 
decision (cf. Punch 1994) not to  say anything about where I was going next in order to  avoid 
potential breaches of confidentia lity and awkward questions. As I was arriving at the second
64 Prior to this I got to know the participants over the phone and via email, and also received 
unsolicited assurances from other professionals who knew them personally.
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interviewee's hometown, I received a phone call from  her asking if I had arrived, indicating 
tha t she had spoken to  the participant I had stayed w ith, who was under the impression I 
was heading back to  Lancaster. Although I had done my best to  try  and maintain 
confidentia lity I fe lt as though I had deceived them  both. I was concerned tha t I may have 
damaged the relationship w ith  the participant I had not yet interviewed, and refuted the 
kindness and support shown to  me by the participant who had given up the ir weekend to 
host me, as well as behaved unprofessionally. I made it clear to  both participants why I fe lt I 
had been unable to  say anything about who I was interviewing and both indicated they 
understood. Reflecting on this, it would have been better to  indicate tha t I had additional 
interviews lined up and been clear tha t I could not indicate who these were w ith fo r reasons 
o f confidentiality.
In addressing issues around maintaining confidentiality, Clarke (2006) has pointed to  the 
importance o f not identifying the com m unity w ith in  the research, but the practicality o f this 
is questionable. W hilst the name o f the forum  is not included here and no location data is 
included fo r any participants, it is possible tha t in reading the thesis and the outputs, 
participants who know each other w ill be able to  identify others (either from  the ir stories or 
the contextual data included) even when data has been anonymised. This has implications 
not only fo r individuals but fo r networks too (Clarke, 2006). It is suggested by Morse (1998) 
that contextual data is removed, but this decontextualized form  of research may be o f little  
value or relevance to  services, and potentia lly neglects the personhood of the people who 
participated. I have managed this using a number o f strategies It has remained im portant 
throughout to  remain respectful o f participant accounts and to  be mindful o f the 
maintenance o f the ir relationships beyond the research.65 The thesis has been w ritten  as if 
participants would read it themselves, which has meant taking additional measures to 
protect participant identity in some instances e.g. not using the pseudonym in some extracts,
65 Especially given their importance, discussed in chapters five and seven.
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choosing to  hold back sensitive data [privileging participant wellbeing over potentia lly 
interesting findings (Damianakis and Redford 2012)]. Participants were also offered a copy of 
the transcript to  edit, and a summary o f findings and key themes. I also modified participant 
descriptors by removing some specific detail which could potentia lly identify them, for 
example the ir occupation or number o f children.
An additional im plication of recruiting from  a network of people who knew each other was 
tha t it became obvious that they were talking to  a potential audience (see Taylor, 2012) who 
they fe lt m ight read the ir contributions and took it as an opportun ity to  make the ir 
appreciation clear. One participant explained she was made aware o f the forum  fo llow ing a 
contact on Facebook. She stated: 'after I had accepted her request [on Facebook] and 
thanked her fo r  taking an interest in me'.
However, these on-going relationships can also affect the data and findings. One 
participant, who indicated tha t the online forum  was a vital source o f information and 
support, was so anxious not to  damage relationships that she removed all references to  it on 
checking her transcript (even though she had made no disparaging comments). This may 
mean tha t those who had negative experiences in the ir close knit community would have 
been reluctant to  disclose them, although other participants were more open about the 
lim itations as per see Keith's comment regarding forum participants 'having a hard tim e.'
P a r t ic ip a n ts  us ing  th e i r  ow n  names in the thesis
In the interests o f protecting participant anonymity, it was outlined in applications fo r ethical 
approval and participant inform ation sheets that no identifying information would be used 
and tha t participants could e ither chose or be assigned a pseudonym. In practice, this was 
more complex than I had anticipated. Some were happy to  choose a pseudonym; others 
were less concerned and were provided w ith a pseudonym by myself. There were a small
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number o f participants who explicitly chose to  use the ir own names in the research as part 
o f a political com m itm ent to  raising awareness o f hepatitis C, and w hat they fe lt was an act 
o f tackling the negative attitudes towards hepatitis C head on. Grinyer (2002) reported a 
similar experience in her study w ith  parents o f young people w ith  cancer who fe lt tha t the 
use o f pseudonyms provided a sense o f 'removal' from  the research process. Thus, I 
maintained the real names o f participants who requested this, in keeping w ith  the ir wish to  
identify as a person w ith  hepatitis C.
The limits of the consent process
Informed consent is considered to  be the cornerstone of ethical research although it has 
been recognised as problematic and debates continue over whether the role o f consent is to  
protect individuals who participate or the institutions tha t support the research 
(Hammersley, 2006;Dyer and Demerritt, 2009). Given that the on-going and complex nature 
o f informed consent has been raised in relation to  treatm ent and post treatm ent fo r 
hepatitis C (see Hopwood et al., 2006), recognising informed consent as an on-going process 
rather than a one o ff event (British Sociological Association, 2002; Alderson and M orrow, 
2011) was really important.
I obtained w ritten  consent from  each o f the participants, in line w ith  the ethical approval 
provided by both the UREC and NHS REC. However, in practice I fe lt uncomfortable asking 
participants to  sign the consent form  prior to beginning the interview, consistent w ith  Buckle 
et al's., (2010) observations about the difficulties o f anticipating in advance what w ill be 
disclosed. As a result I undertook consent in stages. I sent out information sheets, consent 
forms and interview guides to  all participants in advance, prior to  them agreeing to  the 
interview, and then w ent through the inform ation sheet and consent form  verbally before 
conducting the interview. Signed consent was given after the interviews had taken place.
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For the m ajority o f participants (some have not responded to  emails) I have been able to  
continue to  check consent through provision of transcripts and provision o f a summary of 
findings (discussed below). This proved d ifficu lt fo r tw o  participants who participated in the 
group interview  and were happy fo r the transcript to  be emailed to  the support group 
leader. Although I did this (and I was informed these have been passed on), I have received 
no additional comments although this may be because participants were interested in 
participating, but not necessarily in revisiting the transcript or the findings.
In addition, the lim its o f informed consent were made clear to  me via an interaction w ith one 
participant whom I lost contact w ith  a fter her interview, when her email address no longer 
functioned. Eventually, I was able to  re-establish contact w ith  her, via her online business. 
She indicated that she would like to  be sent her transcript and the summary o f findings. 
However, her response to  these was in itia lly disconcerting:
'It was a b it weird reading i t  to be honest, I am so fa r  away from  where I was 
then...TBH [to  be honest] I don 't remember the interview, was it  conducted face to 
face? I f  so was it  held a t my house? Guess tha t goes to show what the combination 
drugs do to your mind. Good luck w ith the PhD and please do keep me up to date.'
Here, issues are raised about the situated nature o f informed consent. At the tim e I had gone 
through inform ation and consent processes face to  face and she had made it clear she 
understood. Further to  this, she had made notes, and provided additional material, and had 
indicated how im portant it was to  her to  participate. Here, Hammersley's (2006) 
observations that situations may present multiple ethical quandaries, pulling in numerous 
directions are particularly pertinent. Given that the participant explicitly refers to  having no 
recollection o f the interview, this raises issues about whether her data should be removed 
altogether. I made the decision not to  do this. She clearly had some recollection of 
participating (she knew she had contact w ith me before) and the amount o f preparation she
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had done prior to  the interview (both in terms o f taking notes, managing childcare, and 
coping w ith  im pairm ent and treatm ent effects), coupled w ith  her on-going interest in the 
research, meant tha t I fe lt it would be more ethical to  keep it in. Furthermore, she did not 
ask fo r any modifications to  be made to  the transcript or indicate that she was 
uncomfortable.
It also points to  the ethical issues raised when interviewing people who are unwell, including, 
as the participant alludes, experiencing serious side effects from  treatm ent. There are ethical 
issues around interview ing people who are unwell (Kadushin, 1990) and side effects can 
influence tha t which is discussed or remembered (addressed below). However, Small and 
Rhodes (2000) indicate that illness should not preclude people from  providing an im portant 
contribution. Not including the data o f someone who is unwell (when they have voluntarily 
participated), or not interviewing those on treatm ent, fu rther silences the impact o f hepatitis 
C treatm ent (see chapter seven) and reinforces the perception tha t illness or d ifficu lt 
situations are individual issues which should not be explored in the public arena (Corbin and 
Morse, 2003). Furthermore, interviewing people on treatm ent made the experience much 
more immediate and reinforced the importance o f paying attention to  the embodied 
experience.
There is an im portant point to  be made here regarding the status o f the interviews w ithin 
research. The participants comments above, reinforce that the interview was a 'snapshot' of 
her life at tha t tim e, though it has played a central role in a significant part o f mine! It is both 
behind her and a significant part o f her biography. W hat can be taken from  the interview is 
clearly partial and situated, but nevertheless provides vital insight into the difficulties on 
treatm ent, and thus is im portant to  document.
The w ithdrawal of one participant
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Specific ethical issues around unanticipated participant circumstances, and the appropriate 
level o f support tha t can be provided by a researcher, arose in my interaction w ith  one 
participant who later w ithdrew  from  the study. The participant contacted me via email and 
we arranged a face to  face interview at her house in the south o f the UK. It became very 
clear from  the outset o f the interview that the participant had been very distressed by her 
experiences, which were entangled, messy and very immediate. I did not even have tim e to  
remove my coat before she began speaking. Not wanting to  lose her comments, I hastily 
obtained verbal consent and switched on the tape recorder. This was less o f a concern fo r 
the study and more in recognition o f the e ffo rt and difficu lty it was clearly taking fo r her to  
recount her experiences. I intended to  revisit the information sheet and consent form  when 
there was a break in her narrative. These d ifficu lt experiences literally flooded out. I barely 
spoke and she barely stopped fo r breath. She recounted fury at her treatm ent by 
professionals and extreme distress that she had not been provided w ith  greater mental 
health support w ith in  the community. The interview was intense, and I fe lt very affected by 
the difficulties and problems she had faced66.
Here the boundaries between an interview as research encounter and an interview as 
fu lfilling a therapeutic role were blurred (Dickson-Swift et al., 2006). I had very little  input; 
merely listening and indicating that anything which became too d ifficu lt could be moved on 
from . The ambiguous nature o f the interview as simultaneously beneficial and harmful 
(Morse and Corbin, 2003) became clear. Although some participants had found the 
interview to  be a positive experience, and my social work training proved valuable, this 
participant was deeply distressed and needed far greater support than I was able to  give, 
which le ft me feeling uncomfortable, inadequate and guilty (Dickson Swift et al., 2006;
66Here I am reminded of Smart's (2009) observation that interviews can enter unchartered emotional 
territory. This particular messy experience would have been very valuable to the research, but to 
include it would have been exploitative.
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M itchell and Irvine, 2008; Woodby, et al., 2011)67. It was also lengthy and I became aware 
tha t I would have to  leave, and wanted to  pay attention to  the phase o f emergence (Corbin 
and Morse, 2003). I indicated tha t I would have to  leave soon and that if she wished to, the 
interview  could be continued at a later date. Despite my efforts, it was very d ifficu lt to  bring 
the interview  to  a close. I attem pted to  address this via pointing to  support groups and 
services, offering to do some fu rthe r research into support, and returning to  the form alities 
o f the interview  by asking her to  sign the consent form . This proved very hard to  manage and 
I was conscious o f criticisms o f doing 'helicopter' research (McCauley, 1994), where 
researchers 'swoop in' to  ask questions and then disappear again.
I attem pted to  address this w ith  post interview support (Kavanagh and Ayres, 1998) by 
contacting her the day after the interview, thanking her and asking if I could provide 
anything further. In practice, I faced the difficulties M itchell and Irvine (2008) warn against in 
being able to  o ffe r very lim ited support (see also Dickinson-Swift et al., 2006) in my role as 
researcher.68 Particularly given the messy and intra-active nature o f the circumstances and 
difficulties she faced and the one o ff nature of our contact. The emails went on fo r some 
weeks as I suggested varying forms o f support and information, during which tim e she 
requested to  be removed from  the study and eventually severed the contact, indicating that 
I could not help her. This was frustrating fo r me the issues she faced stayed w ith me fo r a 
long tim e after the contact was severed and I continue to  be concerned about her wellbeing.
67 On reflection, it is possible that this participant, having seen my engagement with the online forum, 
was aware of my social work background and perhaps participated in the research anticipating that I 
might be able to offer support that local services had not.
68 In their interviews with people with hepatitis C, Conrad et al. (2006) provided participants with 
access to free counselling from an agency not involved in the study, as well as referrals into hepatitis C 
support and care. This is possibly as a result of their on-going relationships and involvement with local 
medical services. As a student not directly connected to services, I could only signpost and provide 
information. In addition, the one off nature of the interview and my lack of local knowledge also 
limited my ability to provide support. See Winter et al. (2008) for an excellent discussion of how the 
research team have developed support mechanisms over time with drug users in their local area.
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This issue was fu rthe r exacerbated by the participant later copying me into letters o f 
complaint (both personal and professional), and copying others into my emails to  her, after 
she had w ithdraw n from  the research, including others I had interviewed. The reasons for 
this were not clear and I was wary o f in itiating any fu rthe r email contact in the event that 
this too  was forwarded on. This created a very d ifficu lt and highly sensitive situation, 
whereby I risked damaging existing relationships w ith  other participants and breaching 
confidentia lity. In this instance, I was contacted by a forum  leader who had been copied in 
to  one o f my emails which gave us the opportun ity to  clarify the relationship. This shows that 
researchers are not in to ta l control o f ethical conduct given that this involves another person 
who makes the ir own ethical decisions (cf. Moore and Measham, 2012).
Tran scrip tio n
Transcription is recognised as a key phase o f analysis, an opportun ity fo r the researcher to  
immerse herself in the data (Bird, 2005) and an integral part o f the process o f data 
interpretation. Transcription involves numerous (political and theoretical) decisions about 
how to  transcribe, what to  include or leave out, and how to  represent information that is 
obscured in the typed transcript (i.e. crying, sarcasm, thinking time) (Hammersley, 2010). I 
made the decision to  transcribe interviews verbatim 69 and in full, w ith additional nonverbal 
communication or inform ation noted on the transcript. This was done as sw iftly as possible 
after the interview and was especially useful during early interviews, enabling me to  listen to 
and evaluate my own interviewing technique and make adjustments to  the schedule prior to 
the next interview. When immediate transcription was not possible, notes and thoughts 
were recorded to  refer back to  and placed alongside the interview transcript. I used the free 
software programme 'Express Scribe' which enabled me to  drop audio files from my digital 
voice recorder directly into the programme, ready to  transcribe.
69 This is not to imply that the transcript is a fixed representation of reality, but that it was transcribed 
word for word as I heard it.
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Initially, play back o f the recordings was attem pted using a foo t pedal connected to  my 
computer. I found tha t in practice this fe lt counterintu itive, w ith my preference being to  use 
my left leg to  control the foo t pedal. However, I did not have enough control in my foo t to  
operate the keys w ithou t shifting my whole body, meaning I was unable to  relax and focus 
on what I was hearing. A fter persevering w ith my right leg (the foo t pedal was expensive!), I 
eventually settled on controlling ('stop' 'play' 'rew ind') the recording w ith  specific keys on 
the keyboard which fe lt more comfortable. Although I do not th ink that this had an overall 
impact on the quality o f the transcription - as I found a strategy early enough which meant I 
could get on w ith  it - this was not an issue I had anticipated and highlights how the 
researchers' own body, as well as the laptop, recording device and programme, act as 
inscription devices to  bring particular realities into being.
Law (2004) indicates that it is not possible to  separate out the realities being made from  the 
inscription devices tha t make it. I treated the transcripts as somewhere between a 
construction (acknowledging tha t I had made interpretive decisions) and a reproduction of 
the event (it is not entire ly constructed, an event did happen), as discussed by Hammersley 
(2010). A transcript cannot be treated as a form  of raw data - interpretive decisions are 
always already being made and, w ith them, particular realties come into being. This was 
especially apparent in tha t during transcription I often experienced flashes of inspiration or 
realisation (Mason, 2011), or found myself questioning why I had not probed fu rther or 
asked a particular question noted in the margin; this shaped the research, enacting realities 
in later interviews and developing ideas fo r writing.
Selection o f quotations
Before exploring data analysis in greater depth, a brief word about the selection of 
quotations in the thesis is necessary. Quotations are widely used in qualitative research to
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provide insight or demonstrate a point, intended to  bring texts 'to  life'. However, how and 
why they have been chosen is not always clear (Taylor, 2012).
Smart (2009) points to  the use o f quotes in opening up space fo r m ultip le interpretations, as 
w ith  the above quote from  Grace concerning: 'mixing w ith people w ith AIDS'. Smart (2009) 
indicates tha t quotations leave traces fo r others to  fo llow  -  possibilities to  discuss and 
explore, which are only ever partly documented in the w ritten  form. Indeed, both Smart 
(2010) and St. Pierre (1997) indicate that they could have w ritten  something else and that 
only part o f the responsibility o f in terpretation lies w ith the w rite r -  there are also the 
interpretations o f the reader (Williams, 2005). In selecting and including quotations and 
extracts, I have tried to ensure that context is provided and that participants' accounts, 
where possible, have been included across the thesis. This has not always been presented as 
an even split in the final thesis, as some were more vocal about issues that have eventually 
constituted the chapters. In deciding which extracts to include, I have tried to enact and 
materialise the m ultip le nature o f hepatitis C via the inclusion o f conflicting or shifting 
perspectives, try ing not to  settle on one clear outcome70. In keeping w ith the 
poststructuralist influences, the perspectives presented are necessarily partial - meaning is 
flu id and changing rather than fixed and static - single resolutions are avoided, w ith 
participant accounts viewed as a single snapshot o f a stage in a journey which is on-going 
and in progress (Blumenreich, 2004).
I made a conscious e ffo rt not to  include quotations because they were exotic, consciously 
searching fo r positive aspects o f the hepatitis C experience in order not to  contribute to  
participant oppression. This was balanced w ith the inclusion o f aspects which may appear 
mundane, in order to  address the impact on everyday life.
70 The implications of this shifting nature are discussed in chapter ten.
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A note on ed iting
Where '...' appears in the thesis, this represents a portion o f the text tha t was removed 
because it was repetitive. I tried as far as possible not to  cut things because they seemed 
'irre levant', preferring to  retain these to  show the complexity o f the point the participant 
was making. Yet sometimes this was necessary fo r length. Transcripts were edited fo r 'urn' 
and 'e rr' noises to  improve readability, and succinctness. Although I am aware tha t this 
impacts on participant accounts, any editing and inclusion o f specific quotes makes decisions 
about what is im portant (Blumenreich, 2004).
Data analysis process
The process o f data analysis was on-going throughout data generation and w riting up. It was 
experienced as non-linear, contingent and involved back and fo rth  and circular movements 
between and around transcripts, recordings, literature, discussion, draft chapters, thinking 
and rethinking. Data analysis (recognising tha t it is occurring w ith in  the firs t interview as the 
researcher follows a particular line of questioning) was thematic in approach, and this was 
chosen because o f its flexib ility  (Braun and Clarke, 2006). This is not to  say tha t I undertook 
an 'ad-hoc' approach to  analysis - quite the opposite - but the variety o f ways in which I 
engaged w ith  the data whilst potentia lly unconventional, meant tha t each interview was 
treated thoroughly and as a whole. I remained connected to  the data throughout (Woodby 
et a l., 2012) and attem pted to  document what was happening by continuously writing.
My analytical strategies were broadly consistent w ith the six phase fram ework outlined by 
Braun and Clarke (2006):
1. Familiarizing yourself w ith  your data
2. Generating initial codes
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3. Searching fo r themes
4. Reviewing themes
5. Defining and naming themes
6. Producing the report' (Braun and Clarke 2006: 87).
These were often not clearly defined phases, but went back and fo rth  or circled a specific 
phase. None o f these phases occurred outside o f writing. Themes often became clearer as I 
w rote around an issue or occurrence. The inseparable and intra-active nature o f data 
generation, analysis and w riting  (see St. Pierre, 1997; Minkin, 1997) is discussed fu rthe r in 
chapter three.
It is im portant to  remember that data was being analysed and w ritten  up in the context o f 
other professional interviews - although these have not been included in the thesis they 
cannot be removed from  my analysis. Professionals shaped respondents' experiences and 
have in tu rn  shaped my research into those experiences. Thus, pertinent observations have 
been interwoven in the relevant data chapters.
Data analysis occurred through a number o f d ifferent practices. As indicated above, I made 
notes and observations at the tim e o f transcription. I also loaded interviews onto an MP3 
player (stored securely) and listened to these when I needed inspiration. I listened to  each of 
these at least tw ice. I made separate notes from  these listenings to  familiarise and immerse 
myself in the data, which had the added advantage o f checking that my interpretations were 
consistent71. It was this process which first alerted me to  the possibility (and enactment of) 
multiple and contingent interpretations o f the data. Listening to  the interviews as well as
71 Meaning they were consistent in that I maintained the political decision to focus on what I did, but I 
was aware of multiple threads that could be pulled.
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reading them  helped me get to  know them well72, meaning tha t I was able to  recall the data 
to  make links at later stages - consistent w ith phase one o f Braun and Clarke's (2006) analysis 
framework.
I read over completed transcripts using the 'comment' and highlight functions in M icrosoft 
Word to  develop codes and memos (phase tw o 'generating initial codes'). Here memos 
played a significant role in developing initial ideas and links to  other interviews. The 
'comments' function in M icrosoft Word proved to  be an invaluable reflexive tool, which I 
continued to  use throughout the drafting and redrafting o f chapters. I then made notes in 
my research diary concerning things that I fe lt were unexpected or tha t I had been drawn to, 
together w ith  references fo r any relevant papers - though these were eventually 
incorporated onto the transcript, or typed directly on there, so that I could see them in one 
place. As I fe lt more fam iliar w ith  the transcripts, I developed a summary o f each 
participant's interview to  refer back to  quickly, some of which was later moved into an Excel 
spreadsheet in order to  provide a visual table o f contextual details73. This helped me to  be 
able to  see themes and commonalties, as well as differences, across accounts.
Braun and Clarke (2006) critique the position that themes emerge from  the data in a similar 
way that Duffin (2004a), and later Fraser (2010), critique the discourse around the 
emergence o f hepatitis C. These did not exist fu lly formed waiting to  be found, but were 
shaped and made by my engagement w ith  the data, surrounding literature and other people.
72 Listening to the tone, intonation and texture of their voices as well as for pauses and changes in 
emotion.
73 For example: year of diagnosis, duration of treatment, employment status, place of diagnosis, 
experience of post treatment effects.
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The development of themes
As m ight be expected, themes and chapters did not develop chronologically. Analysis was 
greatly assisted by presenting my work at conferences throughout the PhD, both in 
encouraging me to  explore across the data and in developing and refining themes and ideas 
fo r chapters. A paper presented at the International Hepatitis C conference in early 2009, 
and the positive feedback on it, helped me to  develop the theme of talking about hepatitis C 
and the comparison between hepatitis C and cancer, and the difficulties on treatm ent, both 
o f which became key themes in chapters. The cancer comparison and the frequency w ith 
which it occurred, unprompted, in participant interviews (see chapter six) meant I became 
interested in why and how participants talked about cancer and the position it occupied in 
relation to  hepatitis C. The comparison w ith chemotherapy also contributed to  the 
development o f the key themes o f treatm ent and post treatm ent.
As explored in chapter seven, treatm ent was enacted as central in participant interviews. It 
was an area where they described needing vastly increased support and information. This 
contributed to  the development o f treatm ent support and particularly social work 
involvement as key themes. Post treatm ent developed as a theme after it was raised by 
participants in the firs t interviews I did. This was augmented by the realisation that post 
treatm ent was a marginalised area which needed to  be more robustly discussed w ithin the 
hepatitis C literature, social work literature, disability studies literature and health literature. 
Discussion at three fu rthe r international disability studies conferences (two at Lancaster, one 
in Iceland), also intra-acted w ith  w riting and developing ideas around welfare benefits, 
psycho-emotional disablism and post treatm ent effects.
As these themes and draft chapters took shape, my attention turned to  the structure of 
participant narratives around hepatitis C and to  the early phases o f participant experiences. 
This led to  the development o f themes of 'pre ' and 'post' diagnosis and the need fo r support.
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The chapter on social security benefits and employment experiences was developed last, 
although the themes o f employment, reasonable adjustments and financial support 
(including welfare benefits) were present in drafts and writings during the early stages of 
data generation. It was in 2010 and 2011, as changes in welfare benefits were announced 
and the coalition government came to  power, that the timeliness and pressing importance of 
the tw o themes became clear. As Law (2004) discusses, some patterns in the research were 
amplified and others were silenced, to  the point where it became d ifficu lt not to  listen to 
particular patterns. Presentation o f my work to  practitioners also helped. For example, 
discussion o f cancer and the moral aspects o f illness in 2010, followed by later discussions 
about the lack o f social support on treatm ent, were im portant in both reinforcing some 
findings (i.e. the lack o f social support) and interrogating and encouraging reflection on 
others (the cancer comparison)74.
Regular w riting  (and discussion o f that w riting w ith my supervisors) was a key component o f 
analysis, consistent w ith  Richardson's (1994) use o f w riting as a method o f inquiry. Indeed I 
was struck by the sense o f identification w ith the words o f Smythe et at. (2008), who indicate 
tha t themes are not necessarily the same sentiment expressed repeatedly, but are moments 
o f understanding about a bigger issue which is fe lt to  be im portant fo r the reader to know 
and understand. This kind o f understanding is achieved fo r students through the circular 
process o f 'reading, w riting, talking, mulling, re-reading, re-writing and keeping new insights 
in play' (Smythe et ol.,2008: 1393). As I returned to the data and to writing, I found that I 
was able link smaller findings w ith larger frameworks; participant comparisons w ith cancer 
connected to  feelings o f stigma and deservingness, which linked to  psycho-emotional
74 As will be discussed in the recommendations, I do have some concerns that the rapid development 
of the treatment and the major reform to welfare system, cuts to social services and NHS reforms will 
mean that the research is less useful and relevant than I had hoped (see Sampson al., 2008). For this 
reason I have made concerted efforts to indicate its situated nature, to look ahead to the future and 
to disseminate it as far as possible as a topic for discussion.
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disablism. Thus the thesis enacted particular aspects o f hepatitis which formed the thesis as 
Desai (2009 quoted in Smart, 2010) explains:
'You do not start w ith  the bigger issues; you start w ith some very tiny  details which 
have been in a way haunting you, tha t you have been thinking about and brooding 
over. Those are really the big issues.'
The starting point fo r notes and summaries which later developed into chapters, were 
issues the participants fe lt were im portant, or needed exploring or addressing. The 
transcripts were analysed as a whole rather than selectively, thus there are codes and 
enactments which would have been equally interesting and valuable to  include, but I 
found tha t as I w rote, presented and talked, the themes and thus the chapters took shape 
- this magnified the presence o f some aspects and reduced the presence o f others (cf. 
Law, 2004). This was political in nature and consistent w ith my overall aim o f exploring 
and addressing the support needs o f people w ith hepatitis C.
Data was analysed manually, as explored above. A combination o f factors influenced my 
decision not to  use a data analysis software programme, such as Atlas Ti., to  assist w ith  data 
analysis. By the tim e a place became available on the course, I had already developed an 
analysis strategy w ith  which I was comfortable and which allowed me to  look at the 
transcripts as a whole, together w ith the codes, as well as produce chapters. I attended the 
course, but fe lt tha t the need to  ready my data fo r input was counterintuitive.
The value o f early  dissem ination of the research findings
Presenting findings to  meetings o f professionals (county wide), was helpful in validating and 
interrogating the findings (specifically those in chapters, five, six and seven). However, 
fu rther discussion was potentia lly inhibited by reshuffling services and one cancelled 
presentation at a W orld Hepatitis Day event, due to  people being unable to  attend. I am not
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aware o f a sim ilar event being held since in the local area. Here the intra-action between 
validation, findings, priorities and funding is made visible. Something which I was (and 
remain) com m itted to, was the provision o f a summary o f findings both during and after the 
research. Participants were also provided w ith a link to  the Hepatitis C International 
Conference in 200975.
An in itia l summary which gave an insight into the 'threads' o f the research I had picked up 
was provided to  participants who responded to  my email, in early 2011. Three participants 
commented on how interesting it was to  read about the experiences o f others, and one 
participant made detailed comments on some o f my findings to  provide clarification and 
unpicking o f a point. A later detailed summary o f research will be provided as this thesis is 
completed. It was im portant fo r me to  share my findings w ith the participants in order to 
thank them  fo r the ir participation and to  show them that the ir perspectives were being 
utilised. This took much longer than I had initially anticipated, given the messiness o f the 
experience and the eventual decision to  focus on the perspectives o f those w ith hepatitis C. 
In future, I need to  be clearer about what I w ill provide and when, i.e. links to  any published 
abstracts and presentations, an initial summary of findings and then a final summary and 
access to  the final report.
It is im portant to  say at this point, tha t the analysis and interpretation o f the findings is my 
own and participants were not involved in this (Taylor, 2012). It is likely that I have 
interpreted d ifferently than they would have. The provision o f a summary was therefore less
75 Here, participants who both participated and did not participate commented on the slides and my 
brief summary. There was one particular exchange which sticks in my mind, where participants 
disagreed over the use of 'cancer' as a 'cover' on treatment. One indicated that they had never seen 
this, whilst another indicated she had. Further, their comments helped me to refine my interpretation 
(and perhaps unclear wording) that participants were not only 'passing' but that there was a hierarchy 
in place with regard to disease. In retrospect, it is unfortunate that I was unable to do this for every 
conference I attended. This was, in part, due to the messy and developing nature of the findings, 
which didn't feel 'finished 'enough to present as well as residual concerns about 'giving away' my 
findings at an early stage. Furthermore, I shared Reeve's (2008) concerns that instead of validation 
what I might end up with was more data!
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o f an opportun ity  to  validate my findings and more a means o f giving back what participants 
had given to  me76.
Lim itations o f the research
This final section o f the chapter highlights some o f the lim itations o f the research. As has 
been emphasised throughout, the perspectives presented in this thesis are partial and thus 
the research is inherently lim ited. However, it is im portant to  highlight some o f the specific 
constraints:
All o f the participants had taken up combination treatm ent at least once77 (some more than 
once). Thus the realities enacted by this sample, obscure some aspects o f the circumstances 
(and difficulties) around access to  treatm ent - a major area o f concern worthy o f fu rther 
research. In addition, none o f the participants were using illic it drugs at the tim e o f 
interview. W hilst this means that the research provides a unique insight into a group that are 
frequently overlooked w ith in existing research, the needs fo r support and information may 
be very d ifferent and there is a need to  explore the needs of those who use drugs and 
access treatm ent.
Participants frequently described poor experiences on treatm ent. All participants, except 
Pixie, described experiencing side effects, which may mean that treatm ent is presented as 
particularly difficu lt. However, my findings do appear to  be consistent w ith other research 
tha t emphasises difficulties on combination treatm ent (see for example, Hopwood et al., 
2006).
A number o f participants were heavily involved in activism and awareness raising, which may 
have been a reason fo r participating in the interview. Therefore, the ir views may differ from
761 have been unable to do so with the professional findings and feel guilty regarding this, especially 
given that I am not sure these will be written up - though I would like them to be.
77 In January 2012 at the time this thesis was being written up; triple therapy treatment was approved 
for use in the NHS by NICE. Thus the sample does not include any experiences of triple therapy.
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those who were less involved in activism - although the sample did include a number o f 
participants who were less open about the ir hepatitis C status. In addition, whilst these 
participants were key forms o f support to  others, and could potentia lly raise a richer range of 
issues, this should not be taken to  be any more representative o f the needs o f people w ith 
hepatitis C.
Most o f the participants had cleared hepatitis C future research is needed to  focus on the 
needs o f those who have not. Further, the sample o f co-infected men interviewed was small; 
fu ture  research needs to  include a w ider sample to  explore how it is possible to  best support 
those w ith  co-infection. The needs o f participants from  South Asian populations have not 
been included. This research focuses on the experience o f hepatitis C from  the perspective 
o f the person w ith  hepatitis C. There is a need fo r fu rther qualitative research exploring the 
experiences and views o f professionals -  both involved and not involved in hepatitis C - to  
explore and develop multidisciplinary responses.
This chapter explored the fie ldw ork process from  start to  finish. The fo llow ing chapter, the 
firs t o f five concerned w ith  findings, explores participants 'firs t encounters' w ith  hepatitis C.
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Chapter Five: She said you're positive - 1 thought positive for 
what? First encounters with hepatitis C.
In tro duction
This firs t findings chapter details participants' early experiences o f living w ith  hepatitis C. It 
follows on from  the theoretical position outlined in chapter three, by exploring how hepatitis 
C, and people w ith  it, are enacted and materialised through specific practices and intra­
actions, specifically prior to, during and immediately a fter diagnosis. Forms o f support and 
inform ation are discussed in greater depth, including inform ation requirements, peer and 
online support, and the role o f GPs. The chapter moves on to  consider how structural 
aspects o f available hepatitis C services enact the virus and those w ith it. The chapter ends 
w ith an exploration o f hepatitis C awareness messages and the need fo r a ttention to 
representations o f living w ith the virus beyond testing.
Before diagnosis
The first theme this chapter focuses on is participant experience prior to  diagnosis. Existing 
medical literature makes reference to  the possible experience o f symptoms for a number of 
years prior to  diagnosis (see Dolan, 1998; Foster, 2008), but the impact this has on eventual 
diagnosis, the way participants saw themselves and the level o f support required is under­
explored. However, undiagnosed hepatitis C is also described in the literature as frequently 
asymptomatic and indolent78 (Glacken et a!., 2001; Dore et al., 2003; Liang et o/., 2013) and
78 The dictionary definition of'indolent' (Oxford English Dictionary Online, 2013) acknowledges that 
within medical terminology this is used to mean 'slow moving', 'painless' or 'causing minimal pain'. In 
characterising hepatitis C in this way, clinical literature is not neutrally describing the experience of 
the virus, but imbuing it with a set of assumptions and expectations. This contributes to a reality 
where hepatitis C has a minimal impact on a person's life, which was not the case for many of these 
participants. This is further reinforced given that as an adjective, indolent, it is used as a synonym 
with 'lazy' 'slothful', 'idle' or averse to work - enacting those with hepatitis C as potentially 
undeserving of support (explored in greater depth in chapter nine).
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this is used as a reason to  encourage testing (RCGP, 2007; Duncan et al., 2012). Thus 
diagnosis is frequently enacted as the starting po in t in discussions and responses to  hepatitis 
C (RCGP, 2007; Duncan et al., 2012).
However, the diagnosis as starting point was not the case for almost half o f the participants 
in this study, who reported seeking support from  the ir GP fo r impairment effects, later 
attributed to  hepatitis C, and undergoing numerous tests and treatm ents prior to  being 
diagnosed. Participants frequently described knowing 'something was wrong' (Morgan). Holli 
estimated tha t she had been feeling unwell fo r about 20 years and had sought support from 
a variety o f help centres, including her GP and alternative health organisations (see also 
Glacken et al., 2001). Kerry described jo in t pain and constant fatigue. JB described visiting 
his GP repeatedly and Steve described being given treatm ent fo r scabies and fleas, before 
eventually being tested fo r hepatitis C. Similarly, Grace described:
'[The doctor] was a new one up from  [city].He was the only one who had sent o ff to 
test fo r  i t  [hepatitis C] because I'd  been not very well fo r  two years. I'm not one to go 
to the doctor79 but I kept getting high blood pressure. One doctor had tried to give 
me HRT30 fo r  menopause and another doctor said 'take Paracetamol'- but I knew  
something w asn't righ t and that's when he said we w ill try  fo r  this [test fo r  
hepatitisJ.You w on 't have it; I'll ju s t try it  as an o ff chance.'
Hepatitis C was not asymptomatic or vaguely felt, but participant experiences were 
frequently enacted as something else, prior to  being materialised in a test result as hepatitis 
C. Here, GPs are addressing a range of complex and intra-acting issues at diagnosis, rather 
than one single thing. The experience also appears to  be gendered, as all the women in the
79 In making it clear that she does not visit the doctor often, Grace is attempting to present herself as 
credible and 'genuine' (Werner et al., 2004), suggesting that she has absorbed wider ideas about 
chronic illness (see for example, Jackson, 2005; Barker 2011). Similar sentiments are expressed below 
in Morgan's need not to be seen as a 'hypochondriac'.
80 Hormone Replacement Therapy is used to treat menopause in women. It replaces female hormones 
that have stopped being produced by the body (NHS choices, 2013).
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study reported im pairm ent prior to  diagnosis and Grace's reference to  the menopause 
suggests tha t the possibility o f hepatitis C was obscured by gendered expectations (Dunne 
and Quayle, 2001; W erner and Malterud, 2003). Thus, rather than the virus being 
asymptomatic (cf. Fraser, 2012) as is reported in existing literature, participants suggested a 
range o f structural barriers which inhibited the ir diagnosis, including GPs' lim ited knowledge, 
or awareness, or not being 'tuned in ' (Morgan) to  the possibility o f hepatitis C. Here the virus 
is marginalised, or othered, in tha t it literally remains unthought (Law, 2004) by GPs it is not 
part o f the reality they are searching fo r in making the diagnosis.
Others pointed to  poor communication or flagging systems which delayed diagnosis or 
discussion o f it. Both Freda and David knew that hepatitis C was on the ir GP notes, but this 
was never discussed. There was a similar gap in communication fo r Keith (elaborated on 
below) and Morgan described not being given her results fo r six years after being tested, 
because these were not returned from  the laboratory.
The lack o f validation and the impact this had on participant confidence and wellbeing is 
explored below. These gaps in communication might be addressed w ith a recent suggestion 
made by the London Joint W orking Group fo r substance misuse and hepatitis C (LJWG,2012), 
tha t GP practices should im plem ent strategies to search records fo r indications o f substance 
use and invite patients fo r a hepatitis C test. This should also extend to  screening for 
previous tests and checking results have been shared w ith patients, simultaneously providing 
an opportun ity fo r discussion.
Diagnosis as a tool to access support
Despite participant experiences o f impairment effects and disabling barriers prior to  
diagnosis, the diagnosis as starting point is enacted and materialised as central in 
institutional and administrative processes, and thus receipt o f support (Dumit, 2006; Jutel,
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2009; De Wolfe, 2012). For example, care pathways begin w ith  the referral fo r a test or 
recommended actions based on the results o f a test (see fo r example Kent Health Protection 
Unit, 2007; RCGP, 2007). Thus, cumulative prior impairment effects and the need fo r support 
are not explicitly included. W hilst this is perhaps understandable in providing a clear, 
digestible tra jectory through testing and treatm ent on paper, in practice it contributes to  the 
marginalisation o f experiences which exist alongside the circumstances o f a test and 
contributes to  the enactment o f hepatitis C as a solely medical issue.
Pinder et al. (2005) maintain tha t rather than providing a neutral fram ework to  direct 
patients through a specific system, these frameworks impose the ir own order - enacting 
people (w ith hepatitis C) in specific ways to  f it  w ith organisational, or in the case o f welfare 
benefits, political and ideological priorities. For example, the period of undiagnosed hepatitis 
C is used as a reason fo r participants to  access treatm ent at the earliest possible opportunity 
(RCGP, 2007), but is not necessarily included when considering applications fo r benefits or 
support, because official diagnosis functions as a means to  access this. This is an enactment 
o f hepatitis C as a medical entity - enforcing the power o f medicine to  test and diagnose it, 
and privileging diagnostic testing over participant's knowledge o f the ir own body (Race, 
2001; Persson et al., 2003; Stoddard Holmes, 2006).
This is visible in participant descriptions of a lack of understanding from  family, friends and 
professionals (see also Dunne and Quayle, 2002). In the absence o f a clear diagnosis a 
number o f participants suggested the ir experiences were dismissed:
M organ: 7 th ink lots o f people ju s t kind o f thought 'get on with it'... One o f my very 
dear friends - 1 was saying 'there's ju s t something definitely wrong. I get really tired. I 
don 't fee l inspired' and she was saying 'oh its 'cause we're getting older' and I was 
saying 'no I don 't th ink it  is'... I knew it  was something else and I do think there is tha t
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thing o f 'well we a ll fee l aches and pains because we're getting older'. 81 it's  quite 
hard to say, 'yeah, but this is m ore.' So i f  you don 't get a quick diagnosis I think it's  
p re tty  stressful.'
Similarly, Steve's father-in-law  could not understand why he could not work, and other 
participants referred to  a sense tha t they were 'malingering' prior to  diagnosis (see below). 
Participants experienced a sense o f lim inality here (Turner, 1966; Murphy et al., 1988); the 
lack o f recognition from  doctors, friends and family, impacted on the ir self-belief and worth. 
Mendelson (2009) (in relation to  Lupus82) and Barker (2005) (in relation to  Fibromyalgia83) 
also reported a protracted period of diagnosis, w ithou t the validation provided by a medical 
label which damaged relationships and self-esteem.
For Boab, the lack o f diagnosis and subsequent validation led to  discrim inatory treatm ent 
from  nursing staff and had far reaching material and social consequences:
'For the last eight to ten years I'd  been suffering various nonspecific symptoms, 
lethargy, tiredness, depression, bowel problems. I went to see my GP who... took a 
blood test and said 'oh yes your liver functions are seriously deranged you're drinking 
too m uch' so I cut out alcohol completely....Year a fte r year I'd  report back and 'oh
81 The reference to ageing by Morgan's friend contributes to the ambiguity and multiplicity of the 
experience of living with hepatitis C. Though Morgan did not think her impairments were age related, 
they intra-acted and materialised in a context of age related expectations and assumptions. Siegel et 
al. (1999) in their research with older HIV positive adults, found that, like Morgan's friend, participants 
attributed illness to age as a more benign cause - preferring to see their impairments as part of the 
ageing process rather than the onset of serious illness. Yet this potentially delayed seeking medical 
support. This has important implications; the long term nature of living with hepatitis C and the ageing 
population in the UK means hepatitis C among older people is an area requiring urgent attention. In 
the US, this has recently been addressed with the Centre for Disease Control recommending 
mandatory testing for 'baby boomers' born 1945-1965 (CDC , 2012), although there are no similar 
plans to introduce this in the UK.
82 Lupus is a complex, fluctuating, long term autoimmune condition (where the body attacks its own 
healthy tissues and organs) which is still poorly understood. Symptoms can range from mild to life- 
threatening (NHS Choices, 2012).
83 Fibromyalgia is a long-term condition which is also poorly understood. It is also more commonly 
found in people with hepatitis C than in the general population (see Fransiscus, 2012). Impairment 
effects include severe pain and fatigue and sleep disturbance (NHS Choices, 2012).
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well you're s till drinking too much' 'I'm  not drinking a t a ll -or I drink very 
occasionally.' One practice nurse actually said to me a t one time 'oh well, you would  
say tha t because you're an alcoholic in denial.'
Despite the long term  nature o f Boab's experiences and his assurances that he complied w ith 
his GP's advice to  stop (any and all) drinking, alcohol use is the only explanation offered. This 
was recorded in his medical notes, enacting hepatitis C as an alcohol dependency and thus 
constituting him as potentia lly unfit fo r his job.
7 almost lost my driving licence actually. I had a heavy goods license and I went fo r  a 
medical and the guy examining me, looked through my notes and said, 'oh you've got 
a drink prob lem ' and to ld  the DVLA84 I'd  got a drink p rob lem '.
The constitution o f Boab's symptoms as related to  his perceived alcohol use, resulted not 
only in frustra tion and anger, but also a delay in diagnosis - w ith serious consequences. Later 
in the interview  Boab suggests tha t had he been diagnosed earlier, treatm ent might have 
been successful.
Experiences o f diagnosis
Participants in the sample were diagnosed in a number o f settings, including GP practices
(eight), NHS Blood Service (two), during a hospitalisation related to  HIV (one), prison (one),
drug services (three), sexual health services (one), HIV services (one), and during other
consultations (three). One participant's place o f diagnosis was not clear. The year of
diagnosis ranged from  1990 -  2009. Whilst the variety o f settings in which diagnosis takes
place m ight at firs t glance be considered encouraging, it also highlights the multiple and far
reaching nature o f hepatitis C and the need fo r testing from  a wide but informed and trained
range o f venues and professionals. A key finding is that participants frequently described
84Driving and Vehicle Licensing Agency responsible for facilitating road safety, maintaining registers of 
drivers and vehicles and collecting vehicle excise duty (Direct Gov, 2012).
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feeling underprepared or being diagnosed w ithou t adequate explanation, inform ation or 
aftercare (see also Gifford et al., 2003; Hopwood and Treloar, 2003; Crockett and Gifford,
2004).
The situated nature o f diagnosis was clear from  Freda's account. The earliest diagnosis in the 
sample, Freda was diagnosed by a nurse from  the NHS blood service after a routine donation 
in 1990. She describes being given very little  inform ation and support beyond being warned 
not to  have sex w ithou t using a condom. The tim ing o f the diagnosis, coupled w ith  the 
lim ited inform ation, enacted hepatitis C as the same as HIV and in this particular case clearly 
fu lfils a public rather than personal health function (Fraser and Seear, 2011). Freda was 
informed in the absence o f additional information, against a hinterland (Law, 2004) o f HIV, 
fo r the purposes o f not transm itting it to  others. This had serious consequences fo r her 
wellbeing:
7 was so ashamed I refused to acknowledge it  and hoped it  would go away... I ju s t 
associated i t  - same as HIV.'
Freda described feeling so ashamed that she had not disclosed her status outside o f the 
healthcare system to  anyone (apart from  me and her friend, a m atter o f weeks before the 
interview) and had not accessed any support in the intervening years. Here, Davis and 
Rhodes' (2004) observations regarding hepatitis C being understood in relation to  HIV are 
relevant. Freda does not understand hepatitis C as a disease in its own right. The intra-action 
between hepatitis C, HIV, media messages and ideas about contagion (Harris, 2009a) prevent 
Freda from  seeking out any kind o f support until she eventually accesses it by accident 
(discussed in chapter four). Freda later indicated that she was able to  forget about it fo r so 
long because it was never mentioned or visible which has implications fo r awareness raising, 
as explored below.
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Andrew and Carl, who estimate they were diagnosed between 1995 and 1997, similarly 
describe a lack o f support or even any fu rthe r information. Carl states:
'  I was kind o f handed it  on a plate... I went back to the hospital fo r  my liver function  
results and I was ju s t to ld  tha t in a room -  'there you go your liver's okay but by the 
way you've got hep C' and o ff you cop. There were no sitting down w ith anyone and 
discussing my options and w hat was available. Back in them days there weren't any 
options available to you -  you ju s t had to get on w ith it . '
While Carl's assertion regarding the lim ited availability o f information at the tim e is accurate, 
his use o f the phrases 'handed it  on a plate ' and 'o f f  you cop' suggest tha t he experienced 
the diagnosis as dismissive and it remained a marginalised issue prior to  entering recovery.
Three participants were diagnosed via telephone [Pixie (diagnosed 2000) JB (diagnosed
2005) and Grace (diagnosed 2007)]. Harris (2005) has previously drawn attention to  the way 
in which a telephone diagnosis enacts hepatitis C as being of little  concern not serious 
enough to  warrant a face to  face conversation. Pixie described never having heard of 
hepatitis C prior to  diagnosis, so she did not find out the implications until later when she 
researched it herself. She was to ld that whilst treatm ent was possible, 'there was no money 
fo r  it  in this area'. Here, hepatitis C is constituted as im portant only if it can be medically 
managed and Pixie was left w ith the 'weight' o f it in the interim.
JB described 'alarm bells ring ing ' when the doctor who diagnosed him began the 
conversation w ith  'I'm  sorry to have to te ll you this'. Here hepatitis C was enacted as serious 
and alarming (as bad news). W hilst JB reported finding a satisfactory level o f information 
himself on the internet and joining an internet forum, Grace reported a very d ifferent 
experience when she was diagnosed in 2007:
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'The receptionist from  the doctors phoned me to te ll me. She to ld  me...'you're positive' 
and I thought 'positive fo r  what? ' And she goes 'hepatitis C  and [I said 'w hat is tha t? '] 
and she said 7 don 't know you w ill have to make an appointment to see a doctor'... I 
went on the in ternet and looked it  up and that's when I saw what it  was. So by the 
tim e I got to the appointment, to the doctors, because they're rubbish up there, a ll I 
could do was cry. Then you have the fe a r o f your children and everyone around you 
have you infected them? Because i t  says on the internet it's  more contagious than 
AIDS.'
Here the insensitive conditions in which the diagnosis o f hepatitis C was given, enacted the 
virus as trivial, which was in direct contrast to  the information Grace absorbed from 
searching online. The diagnosis o f hepatitis C over the telephone should never have 
happened, especially not by a receptionist who was not trained to  participate in a post-test 
discussion85. Further to  this, the provision of such information via a disembodied voice on 
the phone enacts a distance between the GP surgery and the participants, and, as Grace 
later indicates ('they're a ll rubbish up there'), negatively influenced her perceptions of, and 
relationships w ith , services (see also Hopwood and Treloar, 2004).
Whilst some participants described the ir diagnosis as a 'shocking' (Steve) or 'd ifficu lt to 
absorb' (Boab), and Grace and Freda made explicit links between drug use and the 
transmissible nature o f hepatitis C, most participants described feeling shocked as a result of 
poor preparation and a lack o f information, rather than the diagnosis o f hepatitis C. Six 
participants had never heard o f it before being told they had it. Eight participants described 
not knowing they had been tested fo r hepatitis C at all when the diagnosis was given, as they 
were tested fo r a variety o f things, which enacted hepatitis C as unimportant. Others were
85 Although perhaps it highlights the lack of visibility and awareness among the general public and in 
General Practice if a receptionist in a GP surgery is unaware of the significance or implications of 
hepatitis C.
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aware o f being tested, but 16 participants described feeling unprepared fo r a hepatitis C 
diagnosis including not understanding what hepatitis C was, how many people have it or the 
implications o f a positive status. Grace described being tested fo r 'hepatitis ' (and was 
possibly tested fo r A, B, and C at the same time):
'Actually I don 't know i f  he said hep C I th ink he m ight have said hepatitis... He 
w ouldn 't have said hep C no.'
Grace subsequently believed that she would not receive a positive test because she had 
been vaccinated against 'hepatitis '. In her study o f the lived experiences o f hepatitis C in 
Australia and New Zealand, Harris (2009b) describes an even split between people who 
were completely shocked by the ir hepatitis C diagnosis, and others who fe lt it was a 
foregone conclusion, which challenged the notion of diagnosis as a biographical disruption or 
as inherently negative. The idea that diagnosis was troubling was also challenged by 
participants in this study; Ken and Richard both described anticipating that they might have 
hepatitis C before they were diagnosed. David described hepatitis C as an 'opportun ity ' to 
give provide support and inform ation to  others, and Daniel described being 'glad he knew he 
had it  so he could do something about it . '
Here it becomes clear tha t hepatitis C itself is not inherently troubling or bad, but it is the 
context in which the diagnosis is delivered which constitutes it as such. Hepatitis C is enacted 
and re-enacted as participants gathered information. This is illustrated well in Keith's extract:
7 got diagnosed w ith Diabetes f irs t and then I had what I thought was a diabetic
episode so I went to the GP. The GP basically decided to send me on fo r  a load o f blood
tests...In the meantime I was passing a tiny amount o f blood in my urine. I had been
referred to a consultant a t the hospital fo r  tha t - so you've got think I was being poked
about fo r  a couple o f things. I had gone to see the consultant a t the hospital which I
thought was the problem w ith my bladder and he jus t said 'oh by the way you have
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hepatitis C', .and i t  was like 'hey what? ' You know? And he said 'haven't you been to ld  
that? I was like 'no not a t a l l ' ... and then he to ld me to book an appointment with the 
hep C clinic. W hat I thought hepatitis was I got confused w ith tha t and dermatitis. I 
thought you got i t  from  playing about w ith concrete and s tu ff like tha t you know? I 
d idn 't th ink anything o f it. I came home tha t night and had a look on the internet -  
basically found  out what it  was but the same time, scared the living daylights out o f 
m yse lf'
At the tim e o f diagnosis, Keith was being treated fo r a number o f impairments, so hepatitis 
C was bound up and intra-acted w ith  a range o f other issues86 this led to  an unexpected 
diagnosis fo r which both Keith and the consultant were underprepared. Keith described the 
lack o f in form ation associated w ith  his diagnosis, and the subsequent confusion, as 
detrim ental to  his mental health. He described finding the online forum (from which he was 
recruited) as key in gaining understanding, though he described not finding this until part 
way through his second treatm ent and feels he should have been signposted there much 
earlier.
Diagnosis as a form  of va lidation
Although participants may not have expected the initial diagnosis, many described feeling 
that past and current embodied experiences made (new and different) sense in light o f new 
knowledge and inform ation (Aveline, 2006). For example Daniel stated:
'When I read tha t hep C could cause mood swings and depression -  tha t rang a bell fo r  
me because I had taken anti-depressants fo r  a number o f years before I knew I had hep 
C... and i t  ju s t made me wonder in what ways i t  affected my emotional stability really.'
86 Type 2 Diabetes can be an extra hepatic manifestation and is more common in people with hepatitis 
C than the general population (Franciscus, 2012).
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Here the contingent and messy nature o f hepatitis C diagnosis (and o f life) and participants' 
efforts to  make sense o f new realities are particularly visible. Understandings o f the past are 
revisited, revised or confirmed based on intra-actions between previous experiences and 
new knowledge (Aveline, 2006). This is particularly visible in chapter eight, in relation to  post 
treatm ent and chapter nine, in relation to  understandings of the ir experiences in the context 
o f welfare benefit applications. However, non-coherences are also visible other participants 
described experiencing no symptoms prior to  diagnosis.
Those who had the ir views confirmed, described feeling relief at 'not having to keep figh ting  
anymore' (Morgan). Holi described the diagnosis as a shock, but also a relief after such a long 
tim e. The sense o f validation and legitimacy (Nettleton, 2006) described at the point of 
diagnosis is illustrated by Boab below:
'I'm  sorry I've been o ff so long, but now we know why. There is something wrong with  
me I'm not taking the mickey out o f you or anything tike that. In a way i t  was a re lie f 
actually, tha t there was something wrong with me and I wasn't just, m alingering '
In a robust review o f the sociology of diagnosis, Jutel (2009) notes tha t diagnoses are the 
tools medicine used to  organise and stabilise embodied experiences and develop courses of 
action, granting status to  some and not to  others. Diagnosis is, maintains Jutel (2009), both a 
process and a label, central in maintaining medicine and associated professionals' powerful 
position in the lives o f people w ith hepatitis C. Though this is not to  say that this is static and 
fixed -  participants worked w ith and resisted medical understandings o f the ir experiences, 
as explored throughout the thesis.
Mendelson (2009) provides keen insight into the validation experienced by women w ith
Lupus after a protracted diagnosis. She too characterises the period prior to  'officia l'
diagnosis as lim inal (Turner, 1966), and documents participants' sense o f guilt and attempts
to position themselves as credible or as one of my participants, David, stated productive
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function ing members o f society'. The receipt o f a diagnosis can provide permission to  be ill 
(Nettleton, 2006; Jutel, 2009). It is a social process which makes visible societal beliefs 
concerning specific experiences and is often shaped and materialised by involvement o f 
those affected (see Zavestocki et al., 2004, in relation to  Gulf War illnesses and Moser, 2008, 
in relation to  Alzheimer's).
Although Hodge (2005), reflecting on the process o f diagnosis fo r parents o f children w ith 
autism, states tha t to  see diagnosis solely as helpful and validating is naive. Diagnosis can 
frequently lead to  feelings o f being deskilled - even if strategies o f dealing w ith the impact o f 
the im pairm ent have worked well to  the point o f diagnosis87 -  i.e. participant's concerns 
about transmission, or fear o f what lies in the future. Further, diagnosis can increase the role 
o f medicine in participant's lives. For example, the expansion of pharmaceutical treatments 
to  incorporate w ider swathes o f the population, thus vastly increasing profits made by 
pharmaceutical companies (Jutel, 2009) visible in the vastly increased number o f clinical 
trials fo r hepatitis C treatm ent or enacting and subsuming disablist treatm ent under the 
heading o f medical intervention (Aphramor, 2009; Beresford et al., 2002).
For many participants, the initial optim ism and relief associated w ith diagnosis proved to  be 
premature (Mendelson 2009), as they anticipated that the label would engender far more 
support, help and understanding, than they subsequently got. Participants found they were 
expected to  participate in everyday life in a way which was imbued w ith expectations 
concerning appearance, ability to  work and the need for support.
Support fo llow ing diagnosis
The need fo r support in the period follow ing diagnosis has been documented in the 
literature. Fry and Bates (2012), in the ir Australian study, stated that participants expressed
87 For example participants described changing hygiene or domestic practices (such as refusing to 
grate or chop food) following their diagnosis, when they had previously done it for years.
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anxiety and frustra tion around the lack o f information they were provided w ith at diagnosis, 
and that diagnosis was experienced as more positive if they had tim e to  talk it through w ith 
someone who was informed. Similar findings were reported almost a decade earlier by 
Gifford et al. (2003) who indicated tha t the most im portant aspect to  diagnosis was the time 
and space given over to  discussion o f the meanings and implications.
A fter diagnosis, participants described needing clear explanations and clear pathways of 
support. Daniel referred to  his diagnosis in 2009 as 'clinical'. He described being clearly 
informed o f his status and referred on to  a consultant fo r treatm ent, but spoke at length 
concerning the lack of formal, social and emotional support in the days and weeks follow ing 
diagnosis, and negotiating issues such as testing fo r his daughter and ex-wife w ith  lim ited 
help. Hopwood and Treloar (2004) indicate that upon diagnosis, services should be aware of 
and refer into key agencies o f support, in addition to  treatm ent.
Clearly participants may require support to  varying degrees. Laurie, Keith and Kerry pointed 
to  the need fo r clear, credible inform ation (see Stewart et al., 2012). In particular, they fe lt 
they needed printed British information which could be revisited and followed up, via 
accessible and digestible websites, w ith contact details fo r local and national services. A key 
d ifficu lty here is tha t services in the UK are lim ited in availability, funding and reach.
In a recent study o f specialist nurse support in Northern Ireland, Grogan and Timmins (2010) 
found that some of the ir survey respondents also reported receiving lim ited information 
after diagnosis. A small amount did not know what genotype they were or whether they had 
cleared the virus. The authors acknowledge that this is concerning and suggest tha t this is 
perhaps connected to  patients' health literacy, stress, or learning style. They acknowledge 
tha t patient education is complex and that even if extensive information is provided, some 
may feel tha t they have not been provided w ith enough. Thus, it is important to  provide
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signposting to  an organisation or form  o f support which can answer fo llow  up questions or 
provide clarification.
In contrast, Laurie spoke positively about his experience o f diagnosis by the National Blood 
Service.
They were excellent - called me in, described the virus - explained tha t I could have 
caught i t  via accident (probably from  my brother - 1 looked a fte r him many times), they 
were professional, non-judgemental and excellent - both to me and the wife... [Gave 
m e] leaflets, web sites - as much info a t hand tha t they had. Referred me to a 
consultant, recommended testing fo r  wife - vaccination fo r  hep B, excellent service.'
Notable in Laurie's description is the dedicated tim e and the provision o f a range of 
inform ation, paying attention to his fam ily life. In spite o f this, Laurie described setting up his 
own forum  because o f the lack o f social support around hepatitis C. Others described 
needing signposting and referral to  support services and support groups (see also Fraenkel et 
a I., 2006).
Participants frequently described being provided w ith a referral to  a consultant and hepatitis 
C specialist nurse and little  else. This enacts hepatitis C in particular (medical) ways and 
reinforces the authority o f medicine and treatm ent (Fraser and Seear, 2011) (discussed in 
chapter seven). Both Boab and Kerry received printed information from pharmaceutical 
companies:
Kerry: 'They [specialist team ] gave me the drug company books which had the side 
effects and management in them. I don 't think they are particularly practical tips, so 
tha t is why I have got involved in w riting my own book fo r  fam ilies because I don 't 
th ink the tips in there are particularly helpful you know. They are w ritten by the drug 
companies, so obviously they want to minimise the fa c t tha t you are going to be
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feeling a ll these side effects but especially, psychological side effects. It's very d ifficu lt 
to explain to a fam ily  member tha t a drug is going to cause you psychological effects.'
For Kerry, there was a need fo r information which addressed w ider issues and circumstances 
during trea tm ent and beyond. She fe lt that information specifically tailored fo r friends and 
fam ily was severely lacking and that this should be addressed urgently, particularly given 
that many reported receiving informal support from fam ily members or having to  answer 
questions. Participants fe lt tha t inform ation - w ritten  in partnership w ith fam ily and 
professionals as well as service users - should cover diagnosis and how to  provide (and 
access) support immediately after. Participants wanted information about the following; the 
impact o f hepatitis C and treatm ent effects (including the invisible nature of the 
impairment), forms o f support tha t may be required, advice on managing the impact on 
relationships, details on both local and national support services where they exist.
The next section o f the chapter explores the role o f GPs in supporting participants through 
diagnosis, given that the m ajority o f the sample was diagnosed by a GP. These findings are 
particularly im portant given that one o f the major concerns at present is accessing and 
testing those who may have been exposed to  hepatitis C through experimental drug use or 
ta ttoo ing a number of years ago, but who would not perceive themselves as needing a test 
(Hepatitis Scotland, 2013). Hellard et al. (2009) maintain that GPs are often the firs t point of 
contact fo r those w ith  hepatitis C or those who may be exposed to  it.
The ro le  o f  General P r a c t i t i o n e r s  in  d ia g n o s is  a n d  support
The role o f GPs in testing fo r and supporting those w ith hepatitis C has been explored both in 
the literature and in policy, w ith a specific focus on improving awareness and education 
among GPs (Department o f Health 2002a; 2004; Gupta et al., 2006; Treloar et al., 2010) 
which has historically been recognised as being poor. A systematic review of US healthcare
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provider knowledge o f hepatitis C, found that doctors did not ask about risk factors fo r 
hepatitis C and even in the event o f risks becoming apparent, 20% did not recommend or 
order hepatitis C testing. Others e ither over or underestimated the effectiveness of 
treatm ent, and even provided m isinformation (Zickmund et al., 2006). In Gupta et a l's. 
(2006) study, Australian GP participants identified educational needs related to  the 
interpretation o f tests and pre- and post-test counselling, but were less concerned about 
addressing social or cultural implications o f living w ith hepatitis C an im portant finding fo r 
this thesis.
Zickmund et al. (2006) conclude tha t brief education is im portant and effective in increasing 
knowledge among general practitioners, but simple distribution o f guidelines was not 
enough and required in-depth education. Particular efforts have been made w ith GPs in the 
UK, though D'Souza et al. (2004) found that knowledge among GP's fo llow ing a dedicated 
awareness campaign was still low. A recent consensus by The London Joint Working Group 
on Hepatitis C (2012) recommends tha t at least one GP in every practice should have a basic 
knowledge o f hepatitis C, through completion of the Royal College o f GPs certificate in the 
diagnosis and management o f hepatitis B and C in primary care.
Recent awareness raising by Hepatitis Scotland88 points to  the imperative o f testing those 
who may not perceive themselves as requiring a hepatitis C test (Stewart, 2012). This was 
borne out in this study a th ird o f participants in the study were diagnosed in the ir local GP 
surgery after a number o f tests, and there was a sense from  participants tha t diagnoses were 
unnecessarily delayed due to  a lack o f GP awareness or testing mechanism. As JB states:
'You know anyone going to the GP with something he can't immediately diagnose
should be doing a blood test. I believe they do it  in France, fu ll blood count, liver
88 An organisation funded by Scottish government to support the voluntary sector to engage with 
hepatitis.
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function test; a whole k it and caboodle...Because it  took six months fo r  me to be 
diagnosed -  and in all tha t time there was drugs and time and everyone... tha t blood 
test as soon as I went in I would have been diagnosed quicker, they wouldn 't have 
wasted the medication trying to cure something tha t wasn't there. So I th ink blood 
testing a t GPs. When people go in, w ith something that's tha t should happen.'
Here JB cites the model currently used in France to  test liver function, resulting in an 
increased diagnosis o f hepatitis C (The Hepatitis C Trust, undated), and this view was also 
shared by Boab. In a tim ely observation, given increasing funding constraints, JB refers to  
the money 'wasted' on medication that was erroneously prescribed to  treat what was 
eventually diagnosed as hepatitis C. Clearly the development and rolling out o f more 
expansive testing would need to  be accompanied by increased services and support, w ithout 
which testing would be o f questionable value.
Although some participants spoke positively o f the ir GP's involvement (Steve, Boab, David, 
Morgan, Holi), they frequently qualified this by indicating that GPs had lim ited knowledge 
around hepatitis C, but were realistic about the generalist role o f most GPs and that they 
worked under d ifficu lt circumstances.
Thus there is an acknowledgement that there may well be other factors apart from 
individual GP knowledge that affect hepatitis C testing, including: resource allocation, 
caseload and continuing professional development. Though Kerry and Steve both 
emphasised the importance o f the ir GPs in being aware of, and involved in, supporting them 
and acting as a point o f contact and information.
Kerry fe lt tha t her GP should be more involved in her care she described accessing fu rther 
testing regarding genotype via her drug service, when she fe lt this should have come through 
her GP. Steve suggested tha t the accessibility o f GPs meant that they could prove to  be a
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valuable and much needed point o f contact fo r those who have been diagnosed or are 
undergoing treatm ent:
'The GP they should give you maybe even a weekly check ju s t to make sure you're 
a lrigh t they're not psychiatrists I know that, but ju s t to make sure they can get to know  
the person they're treating and making sure there is no subtle changes tha t they can 
see'.
In an Australian context, Richmond (2004) points to the importance o f the GP in referring 
people w ith  hepatitis C to  d ietetic support, counselling and social work, but indicates later 
tha t a lack o f adequate funding potentia lly inhibits this response. Swan et al. (2010) 
described mixed experiences o f GP consultations some participants described the ir GPs as 
informed and supportive, whereas others used medical terms and jargon which proved to  be 
a barrier in the ir support seeking. RCGP (2007) guidance on prevention and testing notes the 
importance o f good communication between primary and secondary care, w ith a GP 
providing on-going support through treatm ent and prescribing fo r side effects. Similar 
findings have been recently reported by Harris et al. (2012a).
Ben indicated tha t his GP was kept informed of his progress but 'd idn 't get too involved 
really', although his involvement was helpful w ith respect to  prescribing anti-depressants 
and Ensure (nutritional drinks) when Ben experienced involuntary weight loss on hepatitis C 
treatm ent. This was very different to  Kerry's experience:
7 would like my GP to be informed o f the virus and o f the treatm ent and the 
medication and side effects because a t the moment he has no clue a t all...but because 
he doesn't know anything about the drugs he is unwilling to prescribe because he 
doesn't know interactions... He is saying I couldn't possibly help you w ith your weight 
loss and prescribe you Ensure because it  m ight interact w ith your drugs. What a load o f 
rubbish'.
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However the reason fo r the lack of involvement from GPs could be attributed to  the lack of 
presence o f hepatitis C in GP surgeries. A number o f participants referred to  the lack of 
advertising o f hepatitis C testing and support groups in the ir local GP surgery, or even its 
purposeful silencing:
Ken: 7 had a jo b  pu tting  up posters - going round doctors surgeries on my own back on 
[beha lf o f] the hep c support group and there are lots o f places tha t w ouldn 't even let 
you pu t flyers up -  tha t really disappointed me -  medical people as well...
Heather: When you went putting  your posters up did they give a reason why they 
w ouldn 't display them?
Ken: No they ju s t said - there would be various answers there would be 'oh the doctor 
thinks there is enough posters in here' -  or 7 never saw i t '  -  or 'it must have fe ll o f f  but 
most o f them stay in place now tha t was two year ago [in 2008] when I was having 
problems -  it  is getting better now the hospital itse lf -  there's big posters advertising 
the support group and our details.
Although Ken goes on to  say that the posters are now displayed more w idely89, other 
participants described a lack o f posters w ith in the doctor's surgery (see Morgan's comments 
below). The lack o f visibility o f hepatitis C had serious implications fo r David in terms of 
talking about hepatitis C w ith his doctor:
7 went to the doctors -  so many times after [being diagnosed] and never talked to him 
about m y hep C - now that's fa ir  enough I d idn 't bring i t  up, I d idn 't want him to talk  
about it, but it was like it was okay to keep it as a secret. I don 't know whether I 
would have been more receptive had there been made more aware' (my emphasis).
89 Ken's comments are supported by a recent Hepatitis C Trust Campaign where volunteers were 
recruited nationally to display and check the presence of posters in their local GP surgery which goes 
some way to combating the silence.
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Here David describes not raising the issue o f his (prison diagnosed) hepatitis C w ith  his GP in 
the intervening years. W ithout speaking to his doctor it is not possible to  know whether his 
GP was provided w ith  his results, but David indicates that not knowing how to  bring it up 
w ith  his GP meant he did not feel able to  talk about it.
This finding is supported by recent World Hepatitis Day campaigns, which have drawn 
a ttention to  the silence around hepatitis C by using the proverb 'Hear no evil, see no evil, 
speak no evil', usually represented by three monkeys each perform ing the related action. 
The W orld Hepatitis Alliance (2013) state:
'The monkeys have been chosen fo r our campaign to  highlight tha t around the world 
hepatitis is still being largely ignored. We are calling for people to  uncover the ir senses 
and confront the realities of hepatitis'.
In GP surgeries this could be combated through increased visibility in the surgery and 
inform ation which included 'conversation starters' about hepatitis C, both fo r GPs and for 
patients (Stoddard Holmes, 2006). The silence associated w ith  living w ith hepatitis C is 
expanded on below.
Online support
Given the lack o f support and inform ation at diagnosis, many participants described doing 
the ir own research online. As eight o f the participants were recruited directly from  internet 
forums, this is perhaps unsurprising. However, even those recruited via other methods 
described using websites, support forums and videos on YouTube to  research hepatitis C. 17 
of the 21 referred to  it explicitly. In a US based study around online information seeking, 
survey respondents in Bell et a!., (2011) reported seeking information, both when they were 
m istrustful o f the inform ation provided by the doctor and when they were curious to  know 
more. Online support and information has been recognised as highly im portant fo r people
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with hepatitis C (Grogan and Timmins, 2010), especially fo r those living in rural areas, both in 
terms o f access and anonymity (Richmond 2008). Mo and Coulson (2009) described how 
participation in an online HIV support forum  reduced participant isolation and addressed 
disabling barriers which m ight inhibit physical access to  support, although clearly this 
depends on having access to  the internet and raises additional issues concerning disabled 
people being 'hidden from  view ' in the ir own homes (Watling, 2011).
Many online support forums are illness and diagnosis focused90 (Jutel, 2009). Mendelson 
(2003) recognises online support as a non-judgemental and rich source o f information for 
women w ith  Lupus, using Turner's (1967) term  'Communitas' to  describe the sense of 
collectivity and belonging the women fe lt (Mendelson, 2009). Dumit (2006) also refers to  the 
validation and support from  the online community fo r those w ith medically unexplained 
symptoms. The practical support and freedom to  express thoughts that might be negatively 
received elsewhere has also been documented (Evans et al. 2013). W hilst this chapter was 
being refined, The Amy Winehouse Foundation issued a press release w ith Beat91 
announcing funding fo r an online support forum and other online services fo r young people 
(Beat, 2013), indicating that the value of online services is being increasingly recognised.
Despite concerns about the quality o f inform ation, participants in the above studies did not 
report receiving inaccurate information. Mo and Coulson (2009), and Bell et al. (2011), 
conclude by stating that participants should be signposted to  credible and accurate websites, 
and even that health centres could provide internet connections to  enable access to  online 
support. Contact w ith  others w ith hepatitis C emerged as a key benefit o f online support - 
see the section on peer support below.
90 There is a clear thread of exploration here concerning people with hepatitis C as biological citizens 
(Rose and Novas, 2001) and their role in the Disabled People's Movement (Hughes, 2009; Goodley, 
2011) - a robust exploration of which is beyond the scope of this thesis. The application, or not, of the 
concept of biological citizenship for people with hepatitis C has been discussed by Orsini, (2006; 2008), 
Harris, (2010) and Fraser (2010b), and the intra-action between the disability movement, hepatitis C 
and biological citizenship is worthy of exploration in a future paper.
91A charitable organisation supporting young people with eating disorders.
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Others pointed to  the need fo r caution and to  use it in tandem w ith  professional support. 
Professionals advised caution w ith  regard to  the information, as Boab explained:
' The nurse who to ld  me [she gave me] the website o f the British Liver Trust to contact 
them and advised me to keep clear o f the American websites because, well, too much 
hysteria. Basically her advice was to look fo r  facts and make sure they are facts'.
Fry and Bates (2012) noted that seeking out information fo r themselves was experienced 
by some participants as empowering and helped them to feel better about diagnosis. 
However, the authors stressed that this should not be something they are left to  do 
alone. For Grace, who was diagnosed w ithou t any accompanying inform ation, support or 
signposting, unmediated inform ation on the internet was experienced as extremely 
distressing. Ben, diagnosed at a tim e when there was lim ited information available 
(2003), was advised to  use the internet carefully, but he also had a strong and existing link 
w ith  a service which meant tha t he was able to  talk through information (in terms o f what 
was useful and credible) w ith his doctor:
'M y consultant was quite good, he said,' right, don 't panic over everything i f  you try  
and read everything you 'll drive yourself mad'....He said ju s t go and do some research 
and think about things before you come back and we discuss whether you go on 
medication'.
Specialist support
It is im portant here to  emphasise that a number of participants spoke positively about the 
support they received from  the ir specialist teams (see chapter seven), w ith some describing 
the ir consultants as particularly valuable in providing up to  date information. Many referred 
to  the vital support from  the ir hepatitis C specialist nurse. Examples given included: advice 
and encouragement to  begin treatm ent, advice to  family members, support w ith learning to
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inject Interferon, advice and inform ation on side effect management and access to 
prescribing,92 liaison w ith  other professionals, a listening and non-judgemental ear, 
encouragement to  keep going w ith treatm ent and letters o f support in applications for 
welfare benefits. Some participants described support which extended outside the 
boundaries o f working hours, as exemplified by Carl:
'But the thing about him [specialist nurse] is - he explored all the options and all the 
avenues he never le ft me with a problem he always talked me through it  -  i t  was a day 
or n ight thing w ith him as well i t  wasn't ju s t a turn up fo r  an appointment then o ff you 
go .
Others referred to  needing greater support than the specialist nurse was able to  provide, 
e ither due to  caseload, the nascent nature knowledge related to  hepatitis C, or requiring 
support tha t went beyond the boundaries o f the ir role. Here, participants referred to  the 
vital role o f peer support
Peer support following diagnosis
All participants talked o f the importance o f sharing the experience w ith others who had done 
it. Freda and Morgan referred to  the value of other people's stories. Similarly, JB referred to 
talking to  people who had gone through treatment, or were going through it, as 'good 
medicine' fo r those that might be thinking about it. Here the role o f peers provided a layer o f 
expertise which augmented and validated participant experience. As explored in chapter 
two, peer support workers can provide im portant insights into issues faced by people w ith 
hepatitis C (W inter et al., 2008) a trusted link to  facilitate engagement w ith services (Aitken 
et al., 2002) as well as emotional and practical support (Hopwood and Treloar, 2003; 
Norman e t al., 2008). Other studies have referred to  the shared knowledge based on
92 As explored below, the difference in costs and budget allocations meant that some medication was 
only prescribed by the GP.
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experience (Treloar et al., 2010; 2011). Pixie and JB described regular meet ups to  enable 
people w ith  hepatitis C to  make contact face to  face:
JB: 7 th ink it's the fa c t you realise you're not alone and not only tha t you had people 
who were on treatm ent together and they could sort o f compare rashes and compare 
side effects.'
This physical meeting provided the opportun ity to  compare the embodied experience of 
treatm ent. The body became a site o f comparison and validation, rather than merely being 
contagious or assessed. Interestingly, JB and Pixie also spoke o f making the 'm eet ups' 
accessible by providing 'qu iet rooms' (for resting) and nutritional food and drink fo r taking 
w ith medication. Here, peers are the ones developing accessible and supportive services 
rather than the services themselves.
Richard talked about the value o f 'creative lo itering ' w ith peers and Shaun fe lt tha t a local 
support group fo r gay men w ith hepatitis C provided a 'safe space to sound o ff'. David and 
Carl, as members o f 12 step support programmes93 talked about the importance of 
therapeutic identification: ' i t  was im portant fo r  me to have a network outside o f my close 
friends who have been through it  a ll' (Carl).
However, Richard emphasised tha t the support o f professionals is essential and suggested 
that the move towards increased responsibilisation fo r our own health (see Crawford, 1994; 
Harris, 2010) has undermined professional expertise.
Given that participants spoke at length about the need fo r post diagnosis support, Charlie 
pointed to  the value o f being tested by those who were actually living w ith the virus:
93 12 step programmes form the framework of a programme of recovery. Originally developed by 
'Alcoholics Anonymous' these programmes (based on 12 guiding principles) have now been adapted 
to providing support to a range of people including alcohol, drugs (narcotics) and gambling.
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'[HIV organisation] do po in t o f care testing and they use someone living w ith HIV to do 
the test because there is a huge impact o f someone who is living w ith HIV saying 'okay 
your test result is reactive' and tha t person [being tested] knowing tha t they [person 
doing the test] have HIV and actually they are sat there f i t  and well and not s itting  
there conform ing to some stereotype'.
Here, being tested by someone living w ith hepatitis C would enact the experience in an 
alternative (not necessarily medical) way; as one which is also experienced by others - 
thereby combating isolation - and which it is possible to  live well w ith. It could also provide 
an immediate link to  others living w ith the virus as well as a referral to  medical support. 
However, the co-infected gay men interviewed as part o f this study fe lt there was a lack of 
support and silence around the experience o f living w ith hepatitis C for gay men, as Charlie 
indicates:
'Just as I started treatm ent they had started up a hepatitis C support group which... 
was one o f only two support groups in the city a t tha t time. The other group actually 
ran during the day which meant it  was completely inaccessible because I was a t work.
The [  group] was run on an evening -  again d ifficu lt in some ways, because most o f the 
clients attending tha t had caught hepatitis C through substance misuse, rather than 
through sexual transmission. So one o f the things I have been quite able to do really is 
try  to be an advocate fo r  people living with hepatitis C in a m inor way... certainly 
national HIV conferences, you know mention it, make sure tha t HIV and hepatitis C are 
discussed'.
There are tw o pertinent issues here. First, a lack of acknowledgement o f co-infection and 
second, tha t those w ith  co-infection have different support needs. The lim ited availability of 
support groups (only tw o in a large city) marginalises the social support needs of those on 
treatm ent. In addition, the tim ings of the support groups during the working day, enacts
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hepatitis C as something that would impact on working hours, or indeed be d ifficu lt to  work 
w ith (see chapter nine.)
Accessing services and experiencing disablism
Chapter tw o briefly explored how lack o f funding fo r hepatitis C services is steadily being 
recognised as a form  o f institutional discrim ination (Butt et al., 2008a; Paterson et al., 2013). 
One o f the key ways in which hepatitis C was enacted and re-enacted as marginal and low 
priority was noted by participants in the ir descriptions of the structure and organisation of 
some services.
Morgan and Boab, recounted in detail the inaccessible and arduous nature o f the journeys 
they made to  the ir hospital and DWP appointments. For Morgan, this involved travelling by 
taxi and then catching tw o bus connections each way. There was both a high financial and 
physical cost to  this and Morgan described her disappointment w ith the lack of 
accommodations provided (i.e. patient transport, treatm ent at local locations). Here the act 
o f seeking treatm ent actually exacerbates impairment effects and structural disablism.
Boab recounted the spaces in which services were delivered:
'This one particu lar hepatitis clinic was appalling. The waiting room was tiny there 
were people in there in wheelchairs and pushchairs tha t couldn't get in and out, no 
windows in the waiting room. The nurse was embarrassed actually, she said 'I'm really 
sorry but the medical, the health trust don't take this seriously.'
Here experiences o f structural disablism and psycho-emotional disablism blend together -
what Reeve (2012a) terms indirect psycho-emotional disablism. The physically cramped
waiting room presents physical barriers and the inadequate space for patients, enacting
hepatitis C as begrudgingly accommodated w ithin the hospital, and people w ith it as
unwelcome and unwanted. The placement o f the clinic in a building w ith no windows is
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evocative o f a holding cell, suggesting that people w ith hepatitis C are herded together and 
literally hidden from  view. Kitchin (2000) indicates that this is an example o f space being 
used to  keep people 'in the ir place', and power relations being used to  maintain and re-enact 
oppression.
Similar observations were made in a support group in the south of England, when I was 
making initial contact w ith participants. One woman described requesting her treatm ent be 
moved to  a d iffe rent hospital because the 'dingy' nature of the clinic was depressing and she 
fe lt reflected the low level o f concern afforded to  people w ith hepatitis C. Similarly, a social 
worker I inform ally interviewed indicated tha t the placement o f the local drug and BBV 
service in a dingy and run down building on the edge o f the town, w ith infrequent litte r 
picking and d ifficu lt access by public transport, served to  segregate those who attended (and 
made it very d ifficult). She contrasted this w ith a recently built medical centre where services 
were provided under one roof.
Here I am reminded o f the arguments made by Fraser (2006) (see also Fraser and Valentine, 
2008) concerning the queuing practices o f people waiting to  pick up the ir dose of 
methadone. Fraser (2006) explores how the queuing practices implemented by services and 
followed by clients, rather than reflecting the marginalisation of these clients, actually enact 
it and fu rthe r undermine the ir recovery strict clinic opening times make it d ifficu lt to  secure 
employment and close contact w ith other clients in the queue means that they are 
frequently offered drugs. Similar findings are reported by Harris and McElrath (2012), in a 
Northern Irish context, where services provided in dilapidated buildings w ith segregated 
entrances and serving systems, enact methadone clients as unwelcome and unworthy of 
respect.
In the same way, people who attend hepatitis C services such as those described above, are 
enacted as afterthoughts, deserving o f poor treatm ent and lim ited resources. These spaces
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are neither welcoming nor acknowledging o f the effort and motivation required from 
participants to  attend. This is particularly im portant given the difficulties tha t participants 
described in continuing treatm ent and the push to  increasing the numbers o f people in 
treatm ent (Scottish Executive, 2006; The Scottish Government, 2008; Grogan and Timmins, 
2010; London Joint Working Group, 2012). Further, the cramped nature o f the service enacts 
hepatitis C as a materialisation o f the lack o f interested afforded by public services to  people 
affected by hepatitis C.
There is fu rthe r evidence o f the intra-action between indirect psycho-emotional and 
structural disablism (Imrie, 2002; Reeve, 2008; 2011) in both Carl and David's accounts. Both 
described being segregated in hospital (David) and in prison (Carl), which affected the ir self­
esteem: 'th a t sort o f treatm ent tells you how you're meant to fe e l' (Carl).
Other participants did give examples of spaces they fe lt were accessible and which 
combatted the ir previous experiences o f disablism. Freda attended the 'chest clinic' fo r her 
appointment w ith  the hepatitis C specialist. She described the degree o f anonymity afforded 
by sitting in an area which was not directly related to  hepatitis C and therefore, did not single 
her or others out. However, the structure of the appointments meant that people w ith 
hepatitis C were able to  recognise others on treatm ent:
'When I s it in the chest clinic waiting to see [the specialist nurse] I look a t others 
around me and think 'are you here fo r  the same reason?' One day I finished with [the  
nurse]...and went to get my bloods taken and was waiting there, when a bloke that 
had been s itting in the chest clinic started to talk to me and asked how long through I 
was in treatm ent! I was horrified a t f irs t!  Luckily the waiting area fo r  the blood clinic 
was ju s t me and him... This guy then proceeded to te ll me about his treatm ent and how  
a t time it  was aw fu l but he was so glad he done it  and he was a t the end o f his 
treatment...! then thought maybe a support group would be a good thing'.
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Although Freda is concerned about her anonymity, it also shows her the value o f speaking to  
others and was instrumental in her thinking about attending a support group. Other 
participants described the therapeutic value of shared space fo r people w ith hepatitis C, or 
the possibility o f the waiting room facilitating contact w ith peer support 'buddies'.
The postcode lo tte ry  of services
As indicated above, participants described a lack of information after diagnosis. Laurie fe lt 
tha t the support infra-structure fo r hepatitis C had not yet been developed and this was 
echoed by a number of participants who referred to  post code lotteries in provision o f care 
and support. Granley et al. (2011) maintain that such variations in services appear arbitrary 
and are not necessarily linked to  a perceived (lack of) need, indeed the existence o f a post 
code lo tte ry and a lack o f services have been recognised by the All Party Parliamentary 
Group on Hepatitis (2006, 2008).
Steve and Ken both referred to  being 'lucky' in terms of where they lived in accessing 
support, but confirmed that the ir participation on the forum  had clarified that this varied by 
region. Morgan described the lack o f support group in her area:
'There isn 't one. I am thinking o f starting one but my problem with tha t is tha t I think 
it's  a b it rura l here... I think it  would be better in [nearest city] and because I don't drive 
it's  p re tty  d ifficu lt fo r  me to work out you know how to do that.... Someone would have 
to come here, but I mean that's very d ifficu lt because I f in d  going up to [nearest city] 
on public transport [exhausting]'.
The disabling nature o f treatm ent made it d ifficu lt fo r Morgan and others to  drive or to 
travel. Here the geographical allocation of support services actually constitutes the 
experience o f hepatitis C in particular ways (cf. Fraser and Seear, 2011), possibly affecting 
adherence to  treatm ent and coping w ith side effects (including suicidal thoughts). A recent
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report by campaign group 'We Are Spartacus' (Campbell et al., 2012) found that transport 
was an area where disabled people already faced significant barriers - which are likely to 
increase fo llow ing welfare reform  - so this issue is likely to  be exacerbated, rather than 
relieved, fo r people w ith  hepatitis C.
As Charlie makes clear in the extended extract below, it is not just the physical existence of 
(in this case, HIV) services which matters there also needs to  be engagement from 
professionals w ith  those services (cf. Teague et al., 1999) and a higher profile o f these 
services w ith in  the w ider community:
'Certainly we have got clinical s ta ff who are deciding i f  when and to whom they are 
actually referring our clients... we provide courses; newly diagnosed courses, positive 
self-management programmes...and the referrals have been -  you know one or two  
people actually doing a favour to us. And it's  not enough to actually run the courses.
It's trying to get them to understand - the clinical s tu ff - and some o f i t  is down to the 
service users it's  like i f  you don 't use these services you are going to lose them. You 
know it's  really frus tra ting  because then you w ill get on the other hand -  'oh well we 
have no services round here' (laugh) so very frustrating. And often it  means actually 
ju s t going out... and doing it  myself... we have three support groups now and a ll o f  
those I have had a m ajor pa rt role in actually getting o ff the ground and it  takes hard 
work and a lo t o f perseverance and a lo t o f time you know fo r  a long time you w ill ju s t 
have two or three people attend and it  w ill take ages before the numbers start building 
up but eventually you do get them'.
Here the investment - financially, temporally, emotionally and politically - required to 
develop services and support is made visible. Solutions are neither simple nor 
straightforward and require com m itm ent at a number o f professional and personal levels. 
This is explored fu rthe r in chapter seven.
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Awareness and public representations of hepatitis  C
Many participants expressed strong views on the need fo r greater awareness and a greater 
public presence o f hepatitis C. JB pointed to  the lack o f funding provided fo r national 
campaigns. This links to  hepatitis C as a 'silent' disease, discussed in chapter six:
'You know the government can spend 14 m illion on the d ig ita l switchover and spend 
something like two m illion on awareness o f hep C and it's  usually targeted a t drug 
users. W hat about the poor woman tha t had a caesarean and a blood transfusion back 
when, who is not going to be looking a t the drug related advertising on illnesses? 
Those are the ones slipping through the net'.
Morgan fe lt awareness needed to  be raised in innovative ways:
'And I think buses like tha t should be in -  everywhere not even m ajor towns and cities I 
th ink they should kind o f tour round everywhere and I think festivals is a great way to 
get the word across to have the buses a t festivals. I've got a friend  who does 'drop the 
debt' a t festivals and that's what they do they ju s t give out postcards to people and I 
think, because you certainly couldn't be doing testing a t a festiva l really, so I th ink that 
would be a great way to spread the word would be to have a bus tha t goes round all 
the festivals in the summer'94.
The example given by Morgan would contribute to  embedding hepatitis C w ithin a broader 
cultural fabric, whereby hepatitis C knowledge and awareness is developed cumulatively as 
well as alongside more dedicated campaigns. As explained above, eight participants had 
heard o f hepatitis C prior to  being diagnosed. Kerry reported being aware o f hepatitis B (but 
not C) from  the posters in the probation office, but d idn 't really th ink about hepatitis C until
94 The Hepatitis C Trust has recently visited the 'Rewind' festival in Scotland providing information 
and raising awareness (Hepatitis C Trust, 2013f).
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her partner was diagnosed it only acquired meaning after it affected her personally95. Those 
who had heard o f it described only being vaguely aware o f it - similar to  Harris's (2009a) 
observations tha t awareness o f hepatitis C depends on social networks and groupings.
Ben made reference to  the silence around hepatitis C in the media which he fe lt added to  
its low profile:
7 do fee l the media always has a pa rt to play in most things and I fee l tha t HIV is s till a 
bigger issue to them than the hep C.'
This links to  an observation made by Martha Stoddard Homes (2006) in relation to  cultural 
representations o f ovarian cancer. The author indicates that she was unaware of 
representations o f ovarian cancer until after she was diagnosed and began to  look fo r them. 
Similarly, Morgan describes looking fo r a poster in her GP surgery:
'There's not enough awareness about it  a t all. I mean when you go into the doctors 
surgery, there's no leaflets a t a ll about hep C. I mean I'd been going to the clinic fo r  
months before I saw a little  notice tha t said 'Hepatitis C Trust', 'hep C fo ru m ' I'd been 
going fo r  months and I only got up because I was thinking 'god there is ju s t nothing ' 
and I walked around and read all the leaflets on the wall until I found something, 
(laugh) but who does that? Only somebody wonders why there's noth ing!'
The awareness materials that do exist privilege some enactments o f hepatitis C and make 
others absent. As was explored in chapter three, this is to some degree unavoidable, but it is 
im portant to  draw attention to  the particular political and material implications o f these. 
Recent hepatitis C campaigns have focused on the theme of testing. Example slogans 
included: 'Get tested. Get treated' (The Hepatitis C Trust, 2011a), 'Get tested' and 'Are you at
95 It is possible that the lack of awareness among these participants in the sample was connected to 
the situated nature of recruitment (and awareness raising).Participants recruited had experienced and 
been treated for hepatitis C prior to the first World Hepatitis Day (2011) and the launching of wider 
hepatitis C campaigns by the Hepatitis C Trust and the NHS, though these still vary geographically.
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risk? The more you know the better' (NHS Choices, 2012). Here, obtaining a test as a 
responsible health conscious citizen (Crawford, 1994) is the most im portant thing. There are 
no posters which provide insights into what it is like to  be diagnosed w ith  hepatitis C or 
undergo treatm ent, as Shaun indicates:
'It's interesting, there was a radio campaign about two years ago, I think, maybe a 
year ago, and it  was on the radio stations I guess targeted it  fo r  the younger people. 
You've probably heard o f it. It was the one tha t said: i f  you've done these things you're 
likely to have caught hepatitis C, there is a treatm ent available. It's interesting, what 
they don 't say is: there's a treatm ent available but it  is really horrib le!'96
Shaun refers to  inform ation being lim ited in order to  encourage treatm ent, privileging the 
medical response over a ttention to  the need fo r a holistic view o f living w ith hepatitis C. For 
David, who had already accessed testing, posters did not make him want to  act on his 
diagnosis or seek support:
7 used to see hep C posters and I had hep C and those posters d idn 't make me want to 
ju s t turn around and go and te ll someone about it  and make me go do you know what I 
want some help. Maybe we need graphical ones, maybe we need subtler ones, I don 't 
know.'
David's comments highlight the lack of poster campaigns (and the subsequent lack of 
visibility of) addressing the needs of people who might be living w ith a diagnosis, but have 
not accessed support. Posters which encourage testing, enact hepatitis C as something which 
immediately leads to  support, which David clearly indicates is not the case. There are no UK 
representations o f people living with  hepatitis C in awareness campaigns, apart from  the 
recent Hepatitis C Trust (2011a) campaigns which feature pictures of people who have
96 YouTube videos and treatment blogs are becoming more common, though it is likely that a person 
would not necessarily look for these until they themselves were on treatment.
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hepatitis C w ith  the tagline 'she/he shows all the signs o f hepatitis C97/. This campaign is 
intended to  highlight the unseen nature of the symptoms, rather than the experience as an 
embodied one. Participants fe lt there needed to  be an extension o f awareness campaigns 
beyond encouraging testing, to  ones that depict what it is like to  live w ith hepatitis C and to 
be on treatm ent. That said, these representations which only pay attention to  testing, can be 
seen as reflective and constitutive of current service realities in the UK, given that lim ited 
support exists post diagnosis and into treatm ent.
This firs t data chapter has introduced and begun to  explore the processes and social and 
political forces which enact the experience o f living w ith hepatitis C, prior to, during and 
immediately fo llow ing diagnosis. Chapter six explores participants' use o f metaphor and 
comparison when talking about hepatitis C.
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97 These posters, whilst highlighting the 'hidden' nature of hepatitis C, potentially simultaneously 
reinforce the role and authority of medicine in making it visible.
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Chapter Six: 'People with HIV and cancer get all the publicity'. 
Talking about hepatitis C - metaphors, comparisons and
implications.
In tro d u ctio n
The current chapter builds on chapter five, by exploring in greater depth how specific 
metaphors used by participants in the ir interviews actually constitute the ir hepatitis C. I 
begin by clarifying the reasons fo r the focus on metaphor. The constitution of hepatitis C as 
'low  profile ' both politically and socially, and the resulting sense o f 'invalidation' (Wendell, 
1996 2006; see Reeve, 2008; 2012a) experienced by participants, clarifies the participants 
management o f interactions, the focus on strategies used to explain the ir hepatitis C, and 
how these strategies enact and re-enact both the virus and the participants. Specific 
a ttention w ill be given to  the use of the metaphor o f hepatitis C as a 'silent killer' or 'silent 
disease' to  elucidate key ways participants gave the ir experience meaning (Fraser and 
valentine, 2008).
A major focus o f the chapter will be the way participants made comparisons w ith cancer 
and HIV/AIDS - both often described together owing to  the ir status as tw o o f the most 
prolific (and uncertain) diseases o f recent decades (see Sontag, 1991; Weiss, 1997 and 
Lupton , 2003). I w ill explore how HIV and cancer were both used as metaphors and became 
metaphors (Fraser and valentine, 2008) in participant accounts. This w ill be followed by a 
discussion o f the consequences (both intended and unintended) and the way in which all 
three illness concepts are enacted. The chapter will end w ith a discussion of the hierarchy of 
impairment (Deal, 2003; Reeve, 2008) and the implications fo r participants and services.
As explored in chapter three, I fo llow  Duffin (2004a), Fraser (2011) and Fraser and Seear 
(2011) in working from  the position that hepatitis C is not a fixed and a stable disease, which
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exists prior to  the discourses and methods which produce it (Law, 2004 and M ol,2002), but 
that it has been, and is, actively enacted and re-enacted by social, cultural and political 
forces. These forces impact how it (and the people it affects) are constituted, engaged w ith 
and responded to. This chapter is a response to  a call made by Fraser and Seear (2011) for 
the need fo r in-depth work which explores the way diseases (including hepatitis C) are 
shaped by such forces. The focus on metaphor is particularly im portant in illum inating the 
experience o f illness (Lupton, 2003), the ideological and cultural foundation o f a group or 
society's values (Froggatt, 1998), and the way that metaphor can work to  constitute 
particular groups (and viruses such as hepatitis C) in negative and oppressive ways (O'Brien, 
2009).
M etaphor
In her path breaking work on the use of metaphor in illness, Sontag (1991:91) uses Aristotle's 
definition, 'giving the thing a name which belongs to  something else'. Lupton (2003) 
maintains tha t m etaphor brings together tw o non-related entities and focuses on ways they 
resemble each other. In her essays 'Illness as Metaphor' (1978/1991) and 'AIDS as metaphor' 
(1988/1991), it was not Sontag's (1991) intention to describe what it was like to  experience 
illness, but to  explore the metaphors used to explain it. She maintained that metaphors are 
used fo r diseases (Tuberculosis, Cancer and later HIV/AIDS) which are poorly understood by 
medicine and the w ider public. She criticised the pervasive use of metaphor (particularly in 
relation to  cancer, when she was being treated for breast cancer herself), arguing that it 
contributed to  the sense of shame and oppression experienced by those w ith it and made 
them responsible fo r the illness and its cure (see also Stacey, 1997). Sontag (1991:3) argued 
that it was vital to  detach the metaphorical understanding from disease itself, w ith the aim 
of seeing disease as something 'purified from  metaphoric thinking . Whilst her work was 
pivotal in highlighting how metaphor shaped thinking and research around illness, Sontag s
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(1991) position concerning the possibility o f separating metaphor from  the disease has been 
critiqued. DiGiacomo (1992), Stacey (1997) and Fraser and valentine (2008), fo llow  Ricoeur 
(2003) and hold tha t this separation is not possible, that metaphor and reality cannot be 
prised apart from  each other and that metaphor should be considered not as a creative 
addition to  language, but fundamental to  making it.
M etaphor is central to  how we understand the world and function w ith in it. Lakoff and 
Johnson (1980) and DiGiacomo (1992) state that it is not possible to  see disease as a purely 
biological entity just as no one experiences cancer merely as the proliferation o f cells (see 
also Stacey, 1997), neither do people w ith hepatitis C experience it as the transmission and 
proliferation o f a virus - although the way that the virus is discussed w ith in medical literature 
(and recounted by professionals -  see Grace and Daniel's data) shapes both the participant 
and others' hepatitis C.
In recognising tha t metaphor is part o f everyday life and that our use of it is largely 
unconscious, (Lakoff and Johnson, 1980) the ubiquity o f metaphor necessarily means 
focussing on some metaphors so that others become obscured (Altman, 1990; Fraser and 
Seear, 2011). As was explored in greater depth in chapters three and four, all methods make 
some things present whilst making other things absent, and political decisions must be 
continually made about what needs to  be foregrounded. Thus the metaphors presented and 
explored here, have been foregrounded. They are necessarily culturally and temporally 
situated, and contingent both on the tools used in generating the data, as well as my own 
sensitivities to  what I fe lt (and what participants told me) was central to  the experience of 
having hepatitis C. These included the low political and social profile o f hepatitis C, the level 
(or lack) o f resource allocation, lim ited understanding from  friends, family and professionals, 
and the lengthy and debilitating treatm ent and post-treatment effects.
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As w ill be explored, metaphors were used by participants w ith the aim o f facilitating a 
change in perspective (M iller, 2006) concerning hepatitis C and its treatm ent. However, the 
work to  produce this change in perspective had consequences fo r participants' sense of self. 
I w ill discuss how this was experienced as beneficial, to  some degree, in managing 
interaction w ith  acquaintances and providing personal validation o f the ir experiences. I w ill 
also explore how tha t validation (and subsequent invalidation) intra-acted w ith professional 
responses (explored in chapters seven, eight and nine). In addition to  this, the diseases that 
participants used also became metaphors (for deserving and undeserving illnesses, and fo r 
entitlem ent to, and availability o f public and social support services) which had unintended 
consequences fo r the ir sense of self and organisation, and identification w ith other groups.
Stigma, psycho-em otional disablism  and hepatitis C
As was outlined in the literature review, stigma and discrimination are recognised as being 
one o f the main issues faced by people who live w ith hepatitis C (Hopwood and Southgate, 
2003). Although the concept o f stigma is frequently used w ithin the literature on hepatitis C, 
and is useful, in this thesis I use another concept developed w ithin disability studies -  
psycho-emotional disablism. This concept was first developed by Thomas (1999; 2007) and 
later expanded on by Reeve (2002; 2008; 2012a) as a means of understanding oppression 
that operates at an inner level as well as externally. I w ill use psycho-emotional disablism, 
not to  merely describe the experience, but to  explore how it gets made and to  recognise 
that oppression tha t people w ith hepatitis C experience -  disablism -  should be given equal 
weight as other forms o f oppression, such as sexism, ageism and racism (Thomas, 2007). The 
degree to  which people w ith hepatitis C identify as disabled will be explored in chapter nine.
I did not in itia lly intend to  explore the experiences of disablism among people w ith hepatitis 
C. This came about as I read Reeve's (2008) recently completed thesis as a means to  aid my 
understanding of what was required to  gain a PhD. I revisited Reeve's work as I generated
data and I could see more and more links between disability studies, psycho-emotional 
disablism and the disabling experiences my participants were describing. This was cemented 
by a serendipitous conversation w ith members of Lancaster University's Centre fo r Disability 
Research I noted tha t even though participants did not necessarily talk about being 
'disabled', they did talk about, or allude to, feeling ashamed or responsible fo r the ir illness 
and this impacted on the ir sense o f self, and sense of entitlem ent to  support. In interviews, 
this led to  participants talking about cancer instead of hepatitis C as a 'more acceptable' 
disease. Thus, although not all participants consciously called themselves disabled, naming 
the oppression they experience as disablism, potentia lly provides a validation o f the 
experiences, and a sense o f entitlem ent to  support, as well as a potential means of 
organisation.
The pro file  o f hepatitis  C
As was explored in chapters tw o and five, the level o f awareness and profile o f hepatitis C 
among the general public has been, and continues to  be, low. The low level o f awareness 
intra-acted w ith  participant illness and interactions w ith professionals, which resulted in a 
sense o f invalidation (Wendell, 1996; Hughes, 2012). The strategies and the use of metaphor 
both resisted and reinforced this described below.
Awareness o f the disease at the outset was most commonly reported by participants who 
had been in recent (or current) contact w ith drug services who worked in the area (Richard, 
Charlie).98 Others who disclosed the ir status, described a lack of awareness among friends or 
fam ily (an area which itself requires further research), as Daniel's extract makes clear:
7 am really open about it, to ld my fam ily  almost immediately and they did not know
what it  was. I f in d  tha t quite a lo t people look a t you and say 'hep c'? They don 't know
98 Employer awareness and knowledge of Hepatitis C is further discussed in chapter nine.
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what it  is - M y step fa th e r even got it  confused w ith a cold sore - he thought i t  was tha t 
virus, Herpes... so I had to explain and he had a look on the internet.'
For Daniel, this lack o f knowledge about the virus was explained as a potential reason fo r the 
negative perceptions associated w ith hepatitis C:
7 th ink [there needs to be] more awareness and understanding. I was surprised a t how  
many people who d idn 't know what it  was and d idn 't understand i t  and maybe there is 
some sort o f stigma attached to it  you know?'
For others, the link between knowledge o f hepatitis C and stigm a" was a complex one, as 
this extract between Andrew and Carl shows:
Heather: 'Do you think it's  stigmatised?
Carl: Not so much
Andrew: A lo t o f people ju s t don 't know about it  or i f  they do they stigmatise it.
Carl: [I Jnearly ended up figh ting  a t Christmas ac tua lly   I have known this guy fo r  a
lo t o f years and he knew I had hep C and was making sandwiches with him and he says 
'you need to be pu tting  some gloves on I don 't want to be catching tha t hep C'. And I 
thought 'how fucking rude are you? How ignorant are you?' it  really upset me that 
did'.
Carl in itia lly states tha t hepatitis C is not stigmatised; it is only when Andrew makes the link 
between knowing about hepatitis C and the potential fo r negative treatm ent that Carl recalls 
a d ifficu lt experience. This suggests that participants were not always immediately conscious
99 The term stigma is used when participants referred to it themselves or I used it in an interview. As 
is explored above, I did not set out to explore the concept of psycho-emotional disablism, so stigma (a 
term which participants understood) was often used to elicit experiences, which I then came to 
understand were accurately described as psycho-emotional disablism.
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o f the ir experiences and these were constituted, and made sense of, in interactions w ith 
others.
For Carl, knowledge (or a lim ited amount o f knowledge, such as an individual's status) is 
associated w ith  the experience o f stigma. For Laurie, this lack of awareness meant he fe lt 
there was no stigma because 'I found most people never knew what i t  was, never heard o f it'. 
This was also described by participants w ith co-infection in Lekas et o/.'s study (2011), who 
indicated a lack o f awareness o f hepatitis C negated some o f the negative feeling100.
The relationship between knowledge and stigma/oppression is a complex one. Academic 
work around hepatitis C often refers to  increased knowledge as a means to  address and 
negate stigma, (Van De M ortel, 2002, 2003; Day et al., 2004; Brener et al., 2007) though it 
depends how this inform ation is used. If it provides assurances to  individuals that they are 
unlikely to  have the virus, or as an issue which does not concern them, this may further 
reinforce individual responsibility fo r infection and fo r telling others about it.
The lin k  betw een know ledge and disclosure
The interlinked nature o f 'stigma', disablism and knowledge emerges in the interview w ith 
Pixie, who fe lt tha t 'knowledge to answer questions' was a key aspect o f being able to  
address negative feelings:
7 think people tha t ta lk about stigma and are those tha t don 't have enough 
knowledge to answer questions. I think that's what they're afraid o f  It's not having the 
righ t answers. I don 't think it's the fa c t tha t people are going to shy away from  them  
...sometimes I wonder whether or not the stigma's with tha t person because they have 
not got the answers o f the questions they think m ight be fired  a t them.'
100 Similarly Grace reported a lack of knowledge among professionals, particularly those working for 
the Department for Work and Pensions. This will be discussed in greater depth below and in chapter 
nine.
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Here Pixie states that having the answers to  questions is the key to  avoiding stigma, though 
as seen in chapter five, the connection w ith, and support from, other people w ith hepatitis C 
might also lead to  greater confidence in telling people about the ir hepatitis C status.
Whilst increased knowledge may lead to  improved understanding, and therefore reduced 
experience o f stigma in some instances, this overlooks the assumption that an individual 
should hove to  answer questions or act as a source of information to  others.
Disability studies scholar Lois Keith (1996), points to  the energy required to  take on the role 
o f educator, indicating that as a result she only engages w ith this if the other person is (or is 
likely to  become) a friend or colleague. Although people w ith hepatitis C are urged to 
disclose the ir hepatitis C status only if they undertake exposure prone procedures (DH, 
2002b; 2004), there were many other instances when participants fe lt they had to  disclose or 
at least 'say som ething' (Kerry) - what Krug and Hepworth (1999) refer to  as the moral 
imperative to  disclose.
This sense o f responsibility echoes UK and w ider western ideological focus on personal 
responsibility fo r health and wellbeing (Crawford, 1994; Lupton 2003; Fraser, 2004; Harris, 
2010; Cranshaw and Newlove, 2011; Paff-Ogle e to l., 2011) potentially constituting a form  of 
psycho-emotional oppression.
Sinclair (2005) developed the term  'self-narrating zoo exhibit' to  describe the experiences of 
autistic people who were often expected to act as sources o f information or to  tell the ir story 
to  interested parents or professionals. The impact o f this is that people may feel as though 
the ir experiences are merely being displayed rather than listened to, and that they are acting 
as a source o f inform ation (and reassurance) fo r other people (Sinclair, 2005), rather than 
having the ir own support and information needs met.
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Donna Reeve (2012a) describes this form  of continued questioning as a form  o f oppression - 
direct psycho-emotional disablism. Reeve (2012a: 81) states 'the questioner needs to  be 
reassured tha t [the person] is not contagious and that it w on 't happen to  them '. For people 
w ith hepatitis C, the need to  provide answers to  questions ' tha t m ight be fire d  a t them ' 
(Pixie) also constitutes a form  o f direct psycho-emotional disablism. Here, a lack o f culturally 
agreed rules fo r interaction about how to  treat disabled people (and people w ith hepatitis 
C), results in participants having to  te ll the ir stories to  anyone who wants to  know (Reeve, 
2008). For people w ith  hepatitis C (which is potentially transmissible) this is a complex issue.
Managing the in teraction
For some participants, reassuring others (acquaintances, friends) that they would not 
contract hepatitis C was not part o f the ir disclosure. If anything, the ir intention was to 
'normalise' hepatitis C by clarifying and emphasising the 'everyday nature o f transmission 
routes. Keith (and others) viewed this as part o f raising w ider awareness o f hepatitis C. This 
is a delicate balancing act, between explaining clearly that hepatitis C is transm itted under 
certain circumstances, w ithou t perpetuating the idea of contagion and the resulting 
'hysterical responses' (Crofts eta !., 1997). Thus, disclosure becomes a continual 'coming out' 
(Stacey, 1997), where uncertainty exists as to  the reaction of the person to  whom their 
hepatitis C status is being disclosed. Participants are not disclosing solely as a means of 
obtaining support or sharing experience (although this may well be part o f it), but to  address 
other people's concerns, w ith the overall aim of avoiding negative reactions. Similarly, the 
pressure on individuals to  answer questions ignores the structural factors (including the low 
public profile, lack o f easily available information and support services) and places 
responsibility fo r education firm ly at the feet o f individuals. Keith described employing a 
particular strategy in providing information and disclosing:
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7 was surprised [when to ld work colleagues] -  no stigma...Absolutely zip... I d idn 't get 
any false sympathy or anything and the m ajority o f the people tha t I worked with had 
no idea, what it  was about and I have developed a way o f telling it... you list the most 
amenable [ways o f transmission] f irs t so like sharing toothbrushes -  razors, and you go 
down the list and w hat you do is, you tackle the most unpleasant ones you know... 
anything drug related on the bottom. By the time you have got to tha t one -  people 
are too busy thinking about the firs t fe w  going, 'Oh I have done that, I done th a t,' to be 
even bothered about tha t one thrown in and people don't think about it  from  there so 
you don 't get any w hat do you call it? You have basically normalised it. Does tha t make 
sense?'
Here Keith is acutely aware o f the possibility o f negative treatm ent, but manages this 
through focusing his colleagues' attention on the ubiquity and possibility o f the transmission 
of hepatitis C via everyday items, such as toothbrushes or razors, before he introduces the 
possibility o f drug use. W hilst raising the profile o f hepatitis C as something which is not just 
contracted via drug use is no doubt important, this potentia lly has the unintended effect of 
reinforcing ideas about drug use, sidestepping rather than challenging them. Here, hepatitis 
C and people w ith  it become liminal via the act o f disclosure. Keith's strategy, whilst 
enacting hepatitis C as something which can affect people w ith a wide range o f life 
experiences, simultaneously acts to  reinforce the 'otherness' o f drug use. Hepatitis C and 
people w ith  it become both 'normal' and 'not normal'.
In fo rm atio n  and enactm ents of hepatitis C
There is an im portant point to  be made here knowledge about hepatitis C and knowledge o f 
transmission can become conflated and concerns about transmission become the overriding
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focus. Kerry shows how the delivery and type o f information can have an impact on 
perceptions o f illness (and even treatm ent). She described her initial appointment w ith a 
gastroenterologist, to  which she had taken her mum along fo r support:
7The Gastroenterologist] d idn 't even look a t me from  his file  - ... he d idn 't say, 'how do 
you think you got the disease?' he said, 'so I am assuming you're an IV drug user' -  I 
said 'was an IV drug user I'm not anymore' and I started like tha t to try and challenge 
him a little  b it and he literally, still w ithout looking up said 'my nurse w ill give you some 
prin ted out inform ation I w ill refer you onto (a nearby) clinic' (my emphasis).
Here the inform ation about treatm ent is used to inhibit any further discussion or questions 
(and Kerry's opportun ity to  challenge the doctor's discrim inatory treatm ent o f her), bringing 
the consultation to  an abrupt close. Fraser and Seear's (2011) observation that information 
makes hepatitis C in ways which both diverge from and reinforce enactments of it made 
elsewhere, is particularly relevant here. The information about medical treatm ent enacts 
(Kerry's) hepatitis C in a specific way -  as one that is carried by a (former) drug user and is 
therefore w orthy o f poor treatm ent by the gastroenterologist - yet also, as one which needs 
to  be treated but which is not worthy o f any further discussion of options. This re-enacts 
hepatitis C as a disease which is insignificant - which needs to  be eradicated via medical 
input, and not much else. Hepatitis C is enacted and perpetuated (Butt et al., 2008a) as 
negative, and the consultant's discrim inatory behaviour goes unexamined and unchallenged.
Later Kerry described being provided w ith information concerning transmission routes. This 
inform ation also enacts hepatitis C in a specific way:
'He gave me some pieces o f A4 paper w ith some s tu ff about side effects and interferon 
and blah this is another one o f my gripes the pieces o f paper tha t you are given are all 
about transmission to s ta rt w ith we know about transmission and when someone like
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my mum looks a t some pieces o f paper and the f irs t page is about drug addicts, 
homosexuals. It's ju s t the wrong way to present information'.
Here the provision o f treatm ent information slides into a discussion o f transmission 
inform ation, the usefulness o f which Kerry questions, when ‘we already know about 
transmission'. This echoes the findings o f M inuk et al. (2006), who observed that during 
appointments, consultants focused on transmission, when patient concerns and needs were 
much broader.
In Kerry's example, the inform ation concerning transmission enacts hepatitis C as a disease 
where transmission route is important, yet how an individual acquired hepatitis C has no 
bearing on the effectiveness of treatm ent. Though it may affect how the person w ith 
hepatitis C is responded to, (as in Kerry's example above), and injecting drug use may 
preclude individuals from  accessing treatm ent, despite guidance stating it should not (NICE, 
2006; Foster, 2008; APPGH, 2011).
Here it is possible to  see how information about transmission routes enacts different 
hepatitis Cs. There may be more robust services and information fo r those in contact w ith 
drug services, but compensation available fo r those who contracted it via blood transfusions 
(Duffin, 2004a). The construction o f hepatitis C according to  transmission route is explored 
again in chapter nine.
For other participants a perceived lack o f information and support around diagnosis 
(Hopwood and Treloar, 2003) meant hepatitis C was constituted using the metaphor 'silent 
killer/s ilent disease'. It is this metaphor tha t the next section focuses on.
'The s ilen t d isease'\ The silent k ille r '
Boab: 7 don 't think its stigmatised. I th ink it's  ju s t ignored. The medical profession call
i t  the silent k iller and there are probably a number o f reasons fo r  tha t one. It takes so
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long to manifest itse lf the symptoms are very nonspecific and can easily be ascribed to 
other things such as alcohol or lifestyle choices... and it's  not a dramatic illness, apart 
from  I mean, the last stages.'
As hepatitis C is still 'under construction' (Duffin, 2004a), metaphorical descriptions o f the 
virus as 'elusive', 'sneaky', 'insidious' or 'silent' are evident (Fraser and Seear, 2011). 
Metaphorical portrayals of hepatitis C as a 'silent killer or 'silent epidemic' are frequently 
used in medical literature (see Bockhold, 2000; Cole, 2007; El-Zayadi, 2008101). Here, it is the 
virus itse lf (rather than the structures surrounding it) which is silent, as it exhibits a 
(reported) lack o f 'dramatic ' and visible impairment effects until the disease is advanced, as 
Boab makes clear.
The 'silent killer' metaphor has also been explored in relation to  ovarian cancer. Jasen 
(2009) states tha t the metaphor 'silent killer' both reflected and reinforced understandings 
o f ovarian cancer by the tim e the symptoms themselves were recognised by doctors and 
diagnosed, the cancer had advanced and become difficult to  treat. Thus, the metaphor o f a 
'silent killer' was potentia lly dangerous, in that it obscured the barriers to  recognition o f the 
symptoms tha t the women faced and attributed the silence to  ovarian cancer. In a similar 
way, Kerry, Holli and Morgan constituted the 'silent or 'asymptomatic' nature of hepatitis C 
differently, suggesting tha t efforts to  determine the ir diagnosis were unsuccessful not 
because the virus was silent, but because there was a lack o f knowledge, poor 
communication or structural barriers in the ir interactions w ith health professionals -  
discussed in chapter five. Other participants used the 'silent killer/silent disease' metaphor 
to  suggest tha t hepatitis C is silenced through lack o f impetus to  take action, poor policy 
response and lack o f funding (Edlin, 2011):
101 These are all examples from medical journals which reinforces Stacey's (1997) point that medicine 
appears neutral because of the way medicine is organised, but that it too is imbued with metaphors.
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Charlie: 'Hepatitis C is different [from  HIV] it  is a silent disease - it's very quiet - we are 
not going to see the effects o f hepatitis C fo r another 10, 20, and 30 years and then it's  
going to be big. When you look a t the prevalence rate o f hepatitis C, they're 
guesstimates, but they're massive compared to HIV... You know it's  huge, but its silent 
-  it's  not knocking on the door to be dealt w ith yet and it's very convenient and even 
though tha t m ight be being sceptical it's very easy fo r  a politician to think well that's  
not going to happen on my watch'.
England's policy response, whilst being the first o f its kind in the UK, has been heavily 
criticised fo r being inert and inadequately funded and supported (APPGH, 2007; APPGH 
2008; K.Morris, 2011,). It has not been updated since 2004 and the National Liver Disease 
Strategy, repeatedly delayed102 (further silenced) by the uncertain economic climate and 
deep government cuts to  services. As Charlie indicates, the impact o f hepatitis C on health 
and social care resources may not be fe lt fo r some years, burying the need fo r urgent 
political response. Indeed, the conditions which exist presently are the opposite o f those 
which existed in responding to  HIV (adequate funding, urgent political response, 
involvement o f affected groups and community work - see Hulse, 1997). Funding fo r 
hepatitis C support (and the comparison which Charlie makes w ith HIV) w ill be returned to 
below.
Other participants used the metaphor o f hepatitis C as a 'silent epidemic' to  lend support 
and credence to  the ir own actions, but also to  enact hepatitis C and those it (potentially) 
affects in a particular way. As Morgan states:
'  It's a silent epidemic. I think people need to know tha t -  a lo t o f the time people don 't 
want to know but they need to know.
102 In December 2013 it was announced that plans for a dedicated National Liver Disease Strategy had 
been abandoned (UWG, 2013).
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Heather: The not wanting to know — what do you think that's connected with?
I th ink most o f us think it's not going to happen to us -  'tha t doesn't concern me that's  
going to happen to someone else and not me' you know we are quite good a t burying 
our head in the sand really about stuff. I'm amazed so many o f my friends have not 
gone and got tested. I ju s t think it's  crazy but that's up to them'.
Here hepatitis C is constituted by Morgan as 'silent' in order to  emphasise that there is a 
reluctance to  know about potential hepatitis C infection and the importance of being tested. 
However, Morgan's (and Ken's -  below) observation is constituted through a hinterland 
(Law, 2004) o f messages from  recent campaigns, such as The Hepatitis C Trust (2011a) and 
the NHS (NHS Choices, 2012), both o f which implore people to 'get tested' and 'get treated'. 
Thus, 'silence' is constituted as a choice and as self-imposed which obscures the difficulties 
o f accessing a test, the lack o f support post-diagnosis, the lim ited numbers on treatm ent and 
the enactment o f hepatitis C in negative ways all o f which may act as deterrents to  being 
tested. This also highlights the divergence between the public health benefits o f increased 
hepatitis C diagnosis and personal benefits, which may not be great, given that diagnosis 
may well be experienced as burdensome (Fraser and Seear, 2011).
Ken also emphasises the importance o f getting treated using the metaphor of the silent 
killer:
Heather: 'W hat did you - sort o f - think when you found out you had hep C?
Ken: Get treated, get treated stra ight away because I'd  heard o f it  being the silent 
killer. I had heard from  people like that woman who owned The Body Shop [Anita  
Roddick] she was brave enough to come out and talk about it  wasn't she, even though 
she couldn't be cured, so tha t sort o f highlighted, tha t gave people the momentum to 
go fo rw a rd  on it. Because there is s till a lo t o f stigma around in rura l areas like this 
place. So I ju s t had to get on with it  and get i t  done.'
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Here, the m etaphor o f the 'silent killer' was invoked in a complex way: Ken's response to 
finding out he has hepatitis C is tha t he needs to  'get treated stra ight away'. This enacts 
hepatitis C as something which needs to  be treated and cleared urgently, enforcing the 
dominance o f the medical response. Yet in the same extract, Ken uses the example o f the 
late Anita Roddick, founder o f high street chain The Body Shop, who did not clear hepatitis C, 
suggesting it may not necessarily be something that needs to be cleared because she lived 
w ith  it, until her death in 2007 from  a brain haemorrhage. Here medical treatm ent is 
simultaneously questioned and reinforced. Additionally Ken makes a direct link between the 
potential fo r negative treatm ent and the need to  get treated and 'get on and get it  done'. 
Treatment appears to  be fo r moral reasons, as well as medical ones. This also highlights how 
stigma does not pre-exist hepatitis C, but is made in intra-actions w ith medicine, personal 
experience and the public profile o f hepatitis C (Fraser, 2011). This is particularly apparent in 
Ken's later extract when he uses the metaphor o f the 'silent killer' to  emphasise that 
hepatitis C can affect anyone:
'It is well they say - the silent killer and it  is because it  spreads righ t through all 
members o f the public [consultant Hepatologist] explained tha t a lo t o f surgeons have 
got it. He said they wouldn 't thank him fo r  mentioning that, but i t  is a fa c t tha t a lo t o f  
surgeons have it. Through blood contact and tha t you know?'
Here the active enactment and re-enactment o f stigma in relation to hepatitis C rather than 
it being an inherent property o f the disease (Fraser, 2011) -  becomes clear: Because a 'lo t o f 
surgeons have got it', hepatitis C is enacted as something which can affect people who may 
have a higher personal and moral status than someone who uses drugs, but then the stigma 
is enacted when Ken (reporting the consultant hepatologist) states 'they wouldn't thank him 
fo r  mentioning it'. Here, the silence around hepatitis C is perpetuated, drug use remains 
'othered' and the moral connotations of the disease are reinforced (Sontag, 1991).
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The next section addresses a strategy that participants used to  discuss, and enact and re­
enact hepatitis C and its treatm ent:
M aking com parisons w ith  cancer
As w ith all illnesses, current understandings o f cancer are culturally and tem porally situated 
(DiGiacomo, 1992) and dependent on context (Clarke and Everest, 2006). Cancer has been 
described as ' the disease o f our tim e ' (Herzlich and Pierret, 1987; Weiss, 1997) and has 
historically been constituted as uncertain and unknown [the very reason fo r the proliferation 
o f metaphor (Sontag, 1991)], frightening, evil and associated w ith morally culpable 
behaviour (Lupton, 2003). The degree to  which cancer is perceived as shameful as Sontag 
(1991) suggested has been disputed (see Clow, 2001). Although it may still be seen as 
unwanted, there is evidence to suggest that cancer is being enacted in new ways, w ith a 
discourse o f fear being replaced by one of hope (Delvechio-Good et o i,  1993), and - 
specifically in the case o f (female) breast cancer - one of activism, (Klawiter, 2008) high 
profile public support and positive thinking (King, 2008; Ehrenreich, 2008). This activism and 
emphasis on positive thinking, survivorship and the opportun ity to  be remade (Stacey, 1997) 
has been heavily criticised (Engelberg, 2006; Abel and Subramanian, 2008; Ehrenreich, 2008; 
King, 2008) and highlighted as a form  of moral oppression (DeRaeve, 1997), but this 
emphasises how cancer is materialised through intra actions between participants, material 
conditions and public profile (Barad, 2003; Fraser and valentine, 2008).
Comparisons w ith  cancer were present throughout the interview process, from the pilot 
interview onwards, when Morgan stated '/ think the treatm ent fo r  hep C and the side effects 
are as bad as cancer really'. It is likely that the richness of this first example - which uses one 
o f the most culturally prolific (Weiss, 1997) diseases o f recent decades and evokes a 
comparison w ith  chemotherapy - had an influence on my sensitivity to  this comparison, and 
silenced others (Law, 2004). However, a tota l o f 11 participants made comparisons between
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hepatitis C and cancer in the ir interviews and nine participants made a comparison between 
hepatitis C and HIV/AIDS.
Although Fraser and Seear (2011) state that HIV and hepatitis C are symbolically linked 
(discussed fu rthe r below), my initial thoughts were tha t comparisons w ith cancer were 
peculiar to  participants who were recruited or received support from the same online forum. 
However, sim ilar comparisons (between HIV/AIDS and cancer and chemotherapy) also 
emerged in interviews w ith participants who were neither recruited from the forum, nor 
spoke o f it as a source o f support. Further to  this, when presenting my research to  tw o local 
(separate) professional meetings, the comparison w ith cancer and chemotherapy was also 
present. This suggests tha t such comparisons were not specific to  the online forum and thus, 
tha t these findings have relevance to  a w ider population o f participants w ith hepatitis C.
The cu ltu ra l position of cancer and chem otherapy
To date, the comparison between hepatitis C and cancer has not been extensively explored 
in the literature, though cancer and/or chemotherapy are mentioned briefly (see for 
example Glacken, 2001; Butt et a!., 2008b; Hopwood et o i,  2006; Harris, 2009a; McCreaddie 
et al., 2011). Fraser and Seear (2011:116) refer to  the frequent comparison between 
hepatitis C treatm ent and chemotherapy, acknowledging that whilst it may be useful in 
clarifying the challenges faced by people on treatment, it must be used cautiously. They 
continue:
'This is because, most obviously, chemotherapy is not delivered in the politically 
charged environment o f drug treatm ent and drug addiction. Nor do the recipients of 
chemotherapy figure as sources o f horror, disgust or shame in the same ways as do 
people w ith  hepatitis C.'
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Whilst I would agree that this comparison should be used w ith caution, the differing political 
and social values and assumptions attached to  cancer is precisely why such o comparison is 
made by the participants.
Cancer (as a single concept -  discussed below) was used in a variety o f contexts when 
participants talked about the ir hepatitis C. David used cancer as an example o f an illness 
which is (perceived to  be) w idely known about and understood when discussing the 'illness 
in recovery' groups he attended as part o f AA (Alcoholics Anonymous). Grace states 7 could 
be diagnosed w ith cancer tom orrow ' as a way of indicating an extreme form o f illness and 
Carl compares the lack o f information when he was diagnosed:
'There was no inform ation available you couldn't phone someone up it  ju s t wasn't
there - i t  was like being to ld you've got cancer and there is no cure fo r  it . '
Cancer was perceived by participants as one that currently garners significant public support 
and has a high public profile, complete w ith organised structured support services. The 
comparison was intended to  highlight shortcomings in the support available fo r hepatitis C in 
the UK, which participants perceived were based on cultural beliefs about particular diseases 
rather than support needs. In some respects this comparison was useful and hepatitis C was 
constituted in a particularly powerful way (see below). However, the comparison 
simultaneously created solidarity and divisions between people w ith cancer and people w ith 
hepatitis C. Additionally, in making the comparison, 'cancer' and 'people w ith cancer' 
became metaphors fo r 'moral w orth ' and 'being deserving of support', providing direction 
on how to  respond to  a particular person or group (O'Brien, 2009) and thereby enacting a 
hierarchy which impacted on how participants saw and described themselves.
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H ierarchy o f im p a irm e n t
Hierarchies o f impairment (discussed by Deal, 2003 and later by Reeve 2008 -  whose 
observations I am building on here) occur when one group o f people differentiates 
themselves from  another, effectively participating in a ranking o f experience, especially 
among groups tha t are marginalised. Both disabled and non-disabled people participate in 
the ranking. Participants in Reeve's (2008) research differentiated between themselves and 
people w ith  learning disabilities. In Crandall's (1991) study, a hypothetical HIV positive man 
attracted 'few er stigmas' if the HIV was contracted via blood products than if was contracted 
through being gay or injecting drugs. Golden et al. (2006) found that women who had 
contracted hepatitis C through blood products, steadfastly differentiated themselves from 
people who used drugs. Simmonds and Coomber (2009) observed a similar phenomenon 
among people who used drugs who made a 'downward comparison' w ith people who had 
hepatitis C perceiving them as immoral and less clean. Thus the hierarchy functions to  affect 
how people feel about themselves and how they feel about people w ith other diseases. It 
has clear implications fo r comparisons made w ith people who have cancer and those who 
have HIV -  see below.
Although Deal (2003) describes differentiation between groups o f disabled people, some 
participants in this study emphasised the similarities, creating solidarity between people 
w ith cancer and hepatitis C. For others the comparisons were less beneficial and revealed 
that w ider beliefs about diseases had been incorporated by participants, resulting in feelings 
o f worthlessness (Reeve, 2002). It is important to  note that this is neither fixed nor a definite 
outcome, but is made through intra-action between context, people and w ider cultural and 
social values.
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I am aware (as were the participants -  discussed below) that there may be significant 
differences between the ir experiences and those o f people w ith cancer. I am not merely 
trying to  map one disease onto another. However, in not exploring these comparisons and 
the ir meanings and implications fo r participants, I risk enacting the silence and low profile o f 
hepatitis C and thus perpetuating the hierarchy, where certain impairments are seen as 
more 'deserving' o f support. Furthermore, highlighting the widespread use o f the 
comparison w ith  cancer (and w ith  HIV below) emphasises that participants w ith  hepatitis C 
are not alone in thinking it (Beck, 2005) and thus, provides some validation o f their 
experiences (Abel and Subramanian, 2008).
The recognition o f cancer
Boab highlighted the instant recognition that the public now has around cancer (Abel and 
Subramanian, 2008) and its seriousness in comparison w ith hepatitis C:
'But it's  [hepatitis C] not like cancer it's  not you know obvious or in your face tha t 
people have it  or i f  they have got it. There's so much ignorance about how serious i t  is, 
the general population and even the medical profession don 't appreciate tha t it  needs 
dealing w ith -  am I making sense?'
A similar view was expressed by the support group facilitator who was present during a 
group interview w ith  Carl, Andrew and Brad:
'The general population thinks they understand what it  m ight be like to have a cancer 
and there is empathy around that, whereas someone with hepatitis C doesn't 
experience tha t empathy'.
Although cancer had previously been treated w ith trepidation, isolation and fear, the
situated nature o f knowledge and beliefs (Harraway, 1988) are evident here. In recent
decades cancer has gained a much higher public profile and much greater news coverage, as
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treatm ents have advanced and activists have gained a higher profile. Clarke and Everest 
(2006) found tha t latent themes in media coverage o f cancer are that cancer is uncertain but 
(almost) inevitable part o f life experience (which potentially exacerbates fear). Similarly, w ith 
the rise o f responsibility for personal health, media stories about cancer have a heavy focus 
on avoiding or engaging in certain activities meaning that cancer becomes ubiquitous (Clarke 
and Everest, 2006) and 'the new normal' (Mukherjee, 2011). Here, Susan Wendell's (2001) 
observation concerning disease as a reminder o f personal vulnerability is particularly 
relevant public empathy around cancer stems from the possibility and recognition that 
'anyone' can get it (indeed this is used by Macmillan as a means o f gathering funding and 
support -  see below), as the support worker present during the group interview indicated: 
'whereas cancer is something tha t you can't help getting '103.
For Richard, the comparison w ith the Department fo r Work and Pension's (DWP) treatm ent 
o f cancer enacts a disease that is treated as serious, as hepatitis C should be:
'I f  (the DWP) could ju s t trea t it  seriously tha t would be nice in the same way they do
with cancer and things like that'.
Although recent developments w ith the coalition government's proposed welfare reforms 
highlight tha t individuals w ith cancer also experience difficulties accessing financial support 
in practice (see Thomas et al,.2001; Wilson and Amir, 2008; M offa tt et al., 2010), cancer 
maintains its strength and weight as a 'deserving' disease. Furthermore, people w ith cancer 
have been used by the media as an example to  emphasise the unfairness o f the 
government's proposed welfare reform plans (Malik, 2012), which re-enacts cancer's status 
as 'deserving'.
103 Although Carla Willig (2009) has described the pervasive nature of discourses associated with 
positive thinking in cancer (see also the powerful critique by Ehrenreich, 2008), as well as the moral 
discourses which suggest a person got cancer because they did not look after their health. Chappie et 
al. (2004), in their study of people with lung cancer, found that blame was attributed because of the 
association with smoking - though these were not acknowledged by participants.
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For Ben, a perception around public awareness o f cancer co-constituted the legitimacy (or 
lack thereof) a hepatitis C diagnosis has in requesting a reduction in his hours at work:
7 spoke to [liver charity]... I said now how do I go about it  i f  I wanted to reduce my 
hours? And they said well you can reduce your hours, but they said it's  generally 
between you and the employer. Because I said i f  it  was something more recognised, 
like i f  i t  was cancer or something else most employers would ju s t say then you can 
reduce your hours and go on so many hours as sick, but because i t  was hep C nobody 
knew.'
The lack o f knowledge around hepatitis C, and the difficulties he faced w ith his employer 
when he requested a reduction in hours, meant that Ben actually continued to  work and 
thus hepatitis C remained low profile w ith in his organisation. I am not saying here that it is 
Ben's responsibility to  te ll his employer in order fo r them to be more aware o f hepatitis C, 
but rather highlighting the structural barriers and the lack of support from organisations to 
support w ith  disclosure to  his employer -  see chapter nine.
For others, the comparison w ith  cancer also served to  highlight the low level professional 
responses to  hepatitis C and the lack of available, organised support, as Boab makes clear:
7 think the whole support network is not there, i f  I had cancer, my wife said this -  i f  
you had cancer - the Macmillan trust [there's] all sort o f organisations who support 
cancer sufferers.'
Here cancer support (specifically tha t provided by Macmillan, a UK based cancer care and 
support organisation) is treated as the template fo r support services, represented as well 
structured, advertised regularly and widely publicly supported:
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JB: 7 mean i f  you have cancer, you do get your benefits, you get your Macmillan nurses 
and I know I can't compare hep C to cancer but there are sim ilarities and I th ink that's  
overlooked definitely overlooked'.
It is im portant to  state here that I am not intending to  depict those living w ith cancer as 
passive recipients o f support, or naively suggesting that Macmillan support services (and 
similar organisations) have adequate funding, staff and the same level o f service provision 
throughout the UK. Thomas et al. (2001) found that people w ith cancer had a wide range of 
unmet needs particularly around dedicated social support, information and support, and 
there is evidence to  suggest tha t this persists. M offa tt et al. (2010) in her exploration of the 
need and uptake o f welfare benefit advice among people w ith cancer and the ir families, 
indicated tha t although many received excellent support from Macmillan, there was a 
postcode lo ttery fo r welfare benefits advice -  some hospitals had integrated dedicated 
services, others did not.
Feedback from  presenting my research to a local network of harm reduction professionals, 
suggested tha t the stretched financial realities o f services provided by Macmillan were not 
being taken into account by study participants. However, the high profile advertising 
campaign (national TV adverts, billboards, posters, collections, coffee mornings) give the 
impression that they are available it is what these services represent culturally (in terms of 
wide ranging response to  the disease and an infrastructure of support) that participants 
were referring to. Thus, Macmillan advertising functions as an offer o f support, a request for 
fu rther funding in order to  provide it and a means of awareness raising. Through high profile 
advertising campaigns, cancer is enacted as a well-funded, publicly supported disease w ith 
widely available support services, no m atter where you are or what type o f cancer you have. 
Thus, the difficulties cancer support services may have in garnering adequate funding or 
meeting the needs o f people who contact them are also obscured.
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Participants made it clear they were not necessarily asking for support services from 
Macmillan, but rather highlighting the lack of meaningful structured support fo r people w ith 
hepatitis C. This was supported w ith an observation (on a separate occasion) from a manager 
present at a local network o f health and social care professionals, who highlighted lack of 
dedicated funding fo r people w ith hepatitis C and suggested that what was needed was an 
'Expert Patients Programme' (discussed in chapter eight) fo r support follow ing diagnosis 
and through treatm ent.
Cancer as a single concept
It is im portant to  note here tha t participants did not appear to  make comparisons w ith 
particular types o f cancer, but trea t it as singular in order to have a greater impact. Some 
have suggested tha t 'cancer' should not be treated w ith any kind o f homogeneity (Clow, 
2001), given it encompasses so many different diagnoses (Midtgaard et al., 2009). However, 
enacting cancer as a single disease, silencing the differences and variability associated w ith 
different types o f cancer, had a particular function producing cancer (and the people 
affected) in a particular way.
Fraser and Seear (2011) discuss how hepatitis C is enacted as singular in order to  give the 
impression o f progress and advancement in treatm ent o f the disease, in the same way 
cancer has historically been treated as a singular entity in order to  garner funding 
(Delvechio-Good et al., 1990; Muhkerjee, 2011b) and support. A number o f large, publicly 
visible UK based inform ation and support organisations e.g. Marie Curie Cancer Care, Cancer 
Research, Cancer Relief, Macmillan Cancer Support, do not differentiate between types of 
cancer. In explaining the ir brand and the support they provide, Macmillan Cancer Support 
(the only specific cancer organisation referred to  by participants) state:
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'Macmillan s ambition is to  reach and improve the lives o f everyone living w ith cancer.
No m atte r who they are what pa rt o f the country they live in, or what type o f cancer 
they have. We want to  make things easier fo r people w ith cancer, the ir friends, 
families, colleagues and carers. We do this by being a source o f support -  providing 
practical, medical, emotional and financial support. And we're a force fo r change -  
listening to  people affected by cancer and working w ith them to push fo r better 
cancer care. Cancer affects everyone. One in three people will get cancer, and each of 
them has friends, families and colleagues. So, we want Macmillan to be something 
everyone can be a pa rt of. A kind o f 'movement'. We are ALL affected by cancer and 
we believe we can ALL help.' (Macmillan Cancer Support 2012a -  my emphasis).
Here, cancer is used singularly so that no division is placed between different people, types 
and stages o f cancer, treatm ent, or regions of the country. This can have both positive and 
negative effects there is no implication of blame and Macmillan positions itself as 'being 
there' to  provide support fo r everyone,104 but this simultaneously obscures the processes 
that have constituted some types of cancer as historically much higher profile [and much 
more marketable - see King's (2008) discussion of breast cancer]. Mitdgaard et al. (2009) 
described a dearth o f qualitative research into anal cancer and thus, it is reinforced as low 
profile, shameful and stigmatised. Hughes et al. (2009) discovered a lim ited amount of 
primary research into the experiences of older people w ith cancer, suggesting that the needs 
o f older people are also being obscured and overlooked.
104 Indeed the last line of the extract 'We are ALL affected by cancer and we believe we can ALL help'
reinforces the ubiquity and possibility of being affected by cancer, ensuring that cancer becomes not 
just something which affects some families, but effectively places everyone in a risk group. An 
extension of 'worried well' (see Cranshaw and Newlove, 2011) and 'infected but not yet ill' (Sontag, 
1991, Stacey, 1997). This ubiquity and possibility of cancer affecting everyone also played a large part 
in participant's use of it as an example.
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Com parisons w ith  cancer trea tm en t
Cancer and cancer treatm ent were also used as means of explaining the disruptive, long 
term  nature o f the hepatitis C treatm ent, including the debilitating and varied effects o f 
treatm ent and the impact on the lives o f the participants. Bell (2009: 169) describes cancer 
as an 'extraordinarily culturally charged disease' and that strong cultural understandings 
exist around chemotherapy, informed by media representations as harsh, debilitating and 
feared (Clark, 1999) w ith  effects tha t may be worse than the disease itself (Abel and 
Subramanian, 2008; Bell, 2009). Thus, participant comparisons w ith cancer tap into existing 
cultural assumptions around what chemotherapy entails:
Keith: Over the past two years, because I have been going through chemotherapy -  it's  
not really chemo its immunotherapy but it's the same thing really...
Heather: The thing about chemotherapy -  I have heard a couple o f people say that. I 
know you're saying its immunotherapy but what is it? Is i t  about likening it  to 
something?
Keith: Well the thing is, everyone knows what chemotherapy is and everyone has heard 
o f chemotherapy and everyone knows how tough it  is. Even though they don't know  
directly - they haven't got a clue - but a friend  o f a friend  has had a relative, who has 
gone through horrendous chemo, where they lost all their hair and they have been 
bedridden and a ll this type o f thing and that's very much in the forefront. A lo t o f the 
side effects are very much like chemotherapy and i f  you introduce it  as tha t then tha t 
immediately gets the idea tha t what you have done is not a case o f taking a load o f  
antibiotic...I mean these are serious drugs.'
Keith invokes (perceived) public perceptions of what chemotherapy entails (Bell, 2009), 
(including visible side effects like hair loss and fatigue which also happened to  participants
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on hepatitis C treatm ent) to  make clear the impact o f the treatm ent on a person's life and to 
obtain empathy and understanding. Other participants suggested that the only other people 
who m ight have an idea what it is like to  be on hepatitis C treatm ent are cancer patients 
themselves:
Heather: 'Do you think the magnitude o f what you're doing is understood?
Carl: No...l was ju s t an absolute nightmare to be around. I can only put, talking to 
cancer patients and things like that, I can only pu t the medication on a level that's like 
chemotherapy. You know you lose your voice, your weight, your appetite you're angry 
all the time, you want to k ill yourself, you want to k ill others'.
Here, Carl elicits the potential fo r some solidarity between people w ith cancer and people 
w ith hepatitis C, as if they are a group that would understand the experience. Although it is 
im portant to  reiterate tha t not all experiences are homogenous, there is value in exploring 
how (some) cancer patients are supported, and this could be used as a tem plate fo r support 
fo r people w ith  hepatitis C, as suggested by Hopwood et al. (2009) -  explored in chapter 
eight.
For JB, the cultural association between chemotherapy and cancer, together w ith the 
'hidden' nature o f hepatitis C impairment effects, meant that he chose to  use chemotherapy 
to  garner a more helpful and supportive service from his local GP:
Heather: So you said they wouldn 't be treating us like this i f  we had cancer, so you 
think there is a difference in the way people are responded to?
JB: Absolutely, i f  I want a copy o f my blood results and I go to my GP, i f  I said 7 have 
hep C I'd  like a copy o f my blood results please?' they m ight be iffy. I f  I go in there and 
say 'I'm on chemo can I have a copy o f my blood results please?' As soon as you 
mention tha t word 'chemotherapy' - and Interferon is used to treat some cancers so I
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fee l quite entitled to use it105 -  as soon as I use the magic word 'chemo' people 
autom atically assume tha t I should get the best service possible and they bend over 
backwards to help me. And I do it  I use tha t word and I te ll people to use tha t word, 
'I'm  on chemotherapy', and the level o f understanding and care they get ju s t sort o f  
like changes up a gear. They are treated with a b it o f respect and dignity and care 
which you should get'.
Here 'chemotherapy', 'cancer' and the 'best service possible' are collapsed together, 
reinforcing the belief tha t people w ith cancer are entitled to  (and actually) receive a better 
service than someone w ith hepatitis C. Similar findings have been reported by participants in 
Butt et a l.'s (2008a;2008b) study where participants maintained they received a poorer 
quality health service than those who did not have hepatitis C (e.g. being made to  wait, not 
being provided w ith  adequate pain relief).
Yet there is also evidence to  suggest that a hierarchy (in terms o f priority, willingness to  
provide support and funding), exists fo r professionals too. Comparisons w ith cancer and HIV 
were echoed in an interview w ith a consultant gastroenterologist who stated 'things that get 
all the money are the sexy things like you know, 'p o o r kids,' you know, kids w ith cancer and 
HIV'.
In the quote above, JB is also 'passing'. Originally described by Goffman (1963), 'passing' is
the concealment o f an attribute considered stigmatising in social interaction. This can be
beneficial, fo r example, keeping his hepatitis C status concealed (and replacing it w ith 
something else) means that JB is avoiding 'iffy ' treatm ent and obtaining 'dignity, care and 
respect'. Other participants made the comparison w ith chemotherapy and cancer in 
interactions where they did not wish to disclose their hepatitis C. For Laurie, this was a 
means o f explaining his ill health w ithout going into detail:
105 See Bracarda et al., (2010) for a discussion of using interferon to treat cancer.
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'For people tha t weren't close and I d idn 't need to explain to I would ju s t say "I have 
six months o f chemo lined up" and leave it  a t that'.
Both Kerry and Keith (whose extracts are included below) described a similar strategy. Thus 
passing functions as a means to  halt conversations, so that participants are not drawn in to 
answering more and more questions concerning the ir illness. The opposite o f what Pixie 
describes on page 222.
Although this may provide only short term  reprieve. Feminist disability studies scholar, Jenny 
Morris (1991:28), states that to  'pass' is to  deny disablism and to  deny who we are. Thus 
'passing' makes and remakes the 'silence' referred to  above around hepatitis C and its 
treatm ent, and re-enacts hepatitis C's status as inferior to  cancer. Although participants did 
not make direct reference to  this, there is a possibility that passing w ith cancer might also 
mean that they miss out on information or support from friends, family and colleagues 
(Glacken et al., 2001), or may be drawn into more elaborate discussion about 'the ir cancer' 
by people who m ight also have had it [what Goffman (1963) terms 'in- deeperism1]. In 
addition, the current lack o f recognition around difficulties during treatm ent and post 
treatm ent continue to  go unrecognised. Similarly, the pre-existing ideas about how impaired 
people look and who disabled people are, continue unchallenged (Lingsom, 2008).
Here, hepatitis C and the people w ith it remain liminal prior to  and follow ing disclosure. They 
have (partially) disclosed the ir status (see Hopwood and Treloar, 2003; Fry and Bates, 2012) 
in order to  obtain support or understanding, but remain liminal as that which they receive 
may be lacking.
For people w ith  hepatitis C [like those w ith cancer, as Stacey (1997) highlights], the ability to 
'pass' may be part o f the problem; the lack of clearly visible and recognisable effects of 
hepatitis C have had a significant impact on participants beliefs about themselves as really 
ill and deserving o f support, as Kerry describes:
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'The g irlfriend I talked about, she'll say 'but you look fine  Kerry!' and I'll th ink 'yeah but 
I fee l like sh it! ' That is a b it o f a problem.'
Yet Kerry also explains the emotional weight conferred onto her as a result o f her 'passing' 
using chemotherapy:
'It's a double edged sword because I'm  campaigning fo r  awareness, but I s till fee l 
stigmatised and like I can't te ll people what's really wrong with me. I had to te ll the 
playgroup something was happening because (daughter's) behaviour started to 
change when she wasn't w ith me... and I had to say something so I to ld them it  was a 
chemotherapy, which it  is but, it's a shame, because I would have liked - on the one 
hand I'm  doing this campaigning about stigmatisation and tha t we shouldn't be 
ashamed and I wear a badge on my coat. Then on the other I am lying to people in the 
playground and school teachers....'! am having a course o f chemotherapy'. So they 
instantly think I've got cancer and they're going to fee l sorry fo r  me and i f  they fin d  out 
I haven't go t cancer, they're going to think I've lied - and I haven't - because i t  is, 
chemotherapy, the definition o f it  is chemical therapy. So I am not lying, but everyone 
associates chemo w ith cancer.'
Here, Kerry describes the difficulties associated w ith passing (Goffman, 1963), living w ith the 
constant concern that she might be exposed (Thomas, 2007), the pressure on her as a 
mother to  explain the changes in her daughter's behaviour, in a morally acceptable way 
given the way drug using mothers are frequently portrayed (Ettore, 2007), and in a way 
which elicits sympathy. Yet, also the difficulties (and possible guilt) she feels in terms of 
campaigning to  reduce the stigma and lack of knowledge of hepatitis C, whilst feeling 
stigmatised and unable to  talk about it herself. This requires what Samuels (2002) terms a 
high level o f cognitive dissonance, and a high level o f emotional work (Hochschild 1979; 
Thomas et al., 2002) in managing both personal responses and those o f others. Similar
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findings are also visible in Fry and Bates (2012) and Rodkjaer (2007).
Feedback from  a specialist hepatitis C nurse on this finding, suggested tha t this comparison 
w ith chemotherapy was also used among her patients, but tha t this comparison was 
unhelpful because it deterred people from doing treatm ent and caused unnecessary anxiety 
concerning side effects (see Munoz-Plaza et al., 2008; Lekas et al., 2012). The nurse 
acknowledged the real difficulties o f doing treatm ent - including the lack of financial support 
- but rejected the direct comparison between hepatitis C treatm ent and chemotherapy 
'have you seen people on chemo?!'. This highlights the difficulties inherent w ith in the 
comparison. It may be helpful in short term  management of interactions w ith acquaintances 
or health professionals, in conveying the severity o f the side effects and highlighting the 
oppression that people w ith hepatitis C face, whilst deterring people from doing treatm ent.
The m oral su p erio rity  of cancer
The comparison also serves to  reinforce the perceived moral superiority o f cancer as 
evidenced in participant's use o f caveats. Later in JB's interview, I asked him to  elaborate on 
his comparison w ith  cancer. He appeared aware o f the moral implications o f his comments 
and responded by justifying the comparison:
'People th ink o f chemotherapy, your hair fa lls out which it  does on treatm ent people 
think o f people on chemo as being tired, the parallels are the same. The treatm ent fo r  
cancer is really concentrated where treatm ent fo r  hepatitis C is similar. It's not as 
concentrated and its spread out over a longer period, you do get people who have 
interferon every day106 and they're in a bad way so it's  obvious - so yeah that's why I 
think the chemo, when you use tha t chemo word it  changes people's attitude'.
106 JB is referring to a clinical trial in the US.
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It is the end o f the extract which is most revealing when JB suggests that people respond 
more positively to  the comparison w ith cancer. Though participants in Janke's (2008: 497) 
focus group described the opposite, w ith one participant stating 'it's  almost like you are 
afraid to  te ll anyone, it is taboo -  it was like when I had cancer. People would say: you are 
walking around w ith  a big C on your head. Instead you've got a big H on you.'
The comparison between cancer and hepatitis C also conferred an additional emotional 
burden as Morgan makes clear below. Here, the enactment o f cancer in the public view, as 
something which is high profile and deserving (Kaiser, 2008), impacts on the constructions of 
self tha t are available to  people w ith hepatitis C (Fraser and Seear, 2011). This is a prime 
example o f disabling barriers affecting who people w ith hepatitis C can be, as well as what 
they con do (Thomas, 1999):
'/ think, I mean I think the treatm ent fo r  hepatitis C and the side effects are as bad as 
cancer really... I mean obviously I have not had cancer but knowing people who have 
had cancer treatment - which is horrendous - 1 would say that the hep C treatment is 
equally as horrendous actually. It's relentless. You inject yourself once per week I 
mean and I'm not saying you have an easier deal with cancer just because you have 
chemo once every three weeks you know but it is relentless - and as w ith cancer, the 
toxins really build up in your body and fo r  me that was what was most debilitating. I 
think tha t i f  there are a lot of allowances and special treatment for people with 
cancer... and the weight on their mind is just as negative as cancer, because cancer 
kills but I mean, hepatitis C kills. It may not kill as many people but it may. Because 
who is to say....I know o f two people, who've died from , three people, who have died 
from  hep C. And you know that's ju s t me there are millions o f people and I think 
hepatitis C treatm ent should actually be dealt with in the same way as cancer patients,
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that's something I fee l very strongly and have fe lt  during the treatm ent' (my 
emphasis).
Here, each tim e Morgan makes a comparison w ith cancer treatm ent, a caveat or 
qualification is added. This suggests that Morgan has aligned herself w ith public (and 
government) constructions of what it is to  be 'really ill' and deserving of, support to  the 
degree that she has anticipated a sense o f moral indignation and is compelled to  defend 
herself against any recriminations. Morgan ends by making the link between hepatitis C and 
death, suggesting she has absorbed and reproduced wider social beliefs about cancer and 
about hepatitis C, to  the degree that she feels the only way to  emphasise the difficulties and 
barriers faced by people w ith hepatitis C is to  highlight the worst possible (fatal) outcome. 
Another participant, Grace, also does this in relation to  welfare benefits (discussed in 
chapter nine).
Additionally Boab, a fter making his comparison w ith cancer, similarly feels compelled to 
qualify it:
7 mean I'm  not trying to make light o f cancer. You know it's  not a nice disease, but it's  
out there and it's very common and it's very well-known and there is a lo t o f support 
fo r  people w ith tha t condition whereas with this, there's -  i f  there is its pre tty  low  key -  
it's p re tty  kept under wraps'.
Thus although the comparison is useful in many ways, the negative values and assumptions 
related to  hepatitis C, and the (perceived) public view o f it, are turned back in on the 
participants through the ir use o f the cancer comparison, which creates and reinforces a 
hierarchy o f disease.
The com parison w ith  H IV
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As was explored in chapter two, HIV and hepatitis C have frequently been compared w ithin 
the literature. Their blood borne status means that understandings of HIV inform and shape 
understandings of, and responses to, hepatitis C (Fraser and Seear, 2011). Qualitative studies 
have noted tha t HIV is viewed more negatively that hepatitis C, as more visible, deadly and 
blameworthy (see Davis et a!., 2004; Munoz-Plaza et o i,  2010; Lekas et al., 2011). However, 
an im portant contribution made by this thesis is that it was actually experienced the opposite 
way fo r many o f the participants in this study w ith HIV seen as preferable to  hepatitis C, 
explored below.
HIV is part o f the hinterland (Law, 2004) which enacts hepatitis C. For participants in this 
study, the comparison w ith  HIV arose in a number of contexts. The position of HIV w ith in the 
hierarchy o f disease shifted between an 'in fe rior' (having HIV perceived as worse than having 
hepatitis C) and 'superior' (HIV perceived as better than having hepatitis C) position. As the 
data w ill show, HIV's position on the hierarchy of impairment was frequently enacted 
through personal experience and the historical legacy of HIV, and its heavily publicised 
nature in the UK in the 1980s (Wallis and Nerlich, 2003; Persson and Newman, 2008; Slavin, 
2006). As w ith cancer, these comparisons enacted hepatitis C and HIV in ways which both 
highlighted and obscured aspects o f living w ith both conditions, and promoted divisions 
between people w ith  them. Thus, this was both beneficial and potentially harmful, not only 
fo r the participants but fo r others w ith  HIV and the w ider disabled population.
Four participants I interviewed lived w ith (or had lived w ith) both hepatitis C and HIV. Three 
o f these participants described how they fe lt HIV was experienced as more socially 
acceptable and that living w ith  HIV had been embraced by (some) gay community members 
(Owen 2008):
Charlie: 7 mean i can only go from  what I have read and learnt and my own experience
which is certainly in terms o f tha t double stigma ... where people w ill almost use a
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different illness to cover i t  [hepatitis C] up. Where there is almost a feeling that, ok 
people w ill accept tha t I have HIV but once I te ll them I have hepatitis C they're going 
to be going fo r  the door'.
As w ith the cancer comparison, hepatitis C is silenced. This had clear effects in terms o f a 
lack o f inform ation and support:
Charlie:' And i f  there is a lack o f education about HIV then there is even more so about 
hepatitis C -  it's  the elephant in the room- no one talks about it. So as long as the 
health prom otion campaigns which are run by things like the (HIV health promotion) 
partnership in the gay press w ill talk about things like sero-sorting, and you know, and 
it's  like 'hang on a m inute I have this, no one ever says anything about, you know hep 
C.'
Here the messages that Charlie receives regarding safer sex, do not take account o f the 
experiences o f men who have sex w ith men, who have both HIV and hepatitis C (Owen, 
2008). This means tha t hepatitis C is enacted as something which does not concern gay men. 
Participants described a lack o f access to information and to  a visible community o f support: 
where Charlie fe lt tha t there had been a degree of protection associated w ith both his 
identity as a gay man and then as an HIV positive gay man, this 'safety net' was negated 
when he found out he had hepatitis C.
Here it is the lack o f a sense o f community and shared group identity [which Reeve (2008) 
states is threatened by the hierarchy o f impairment] which enacts hepatitis C as 
unacceptable. Just as hepatitis C is described as 'silent' in the section on metaphor above, it 
is similarly 'silenced' here. There is a silent community o f men living w ith both HIV and 
hepatitis C which places them in a liminal (Turner, 1966) position. As Charlie describes, they 
are both inside (because they have not disclosed) the gay HIV community and outside 
(because they have hepatitis C).
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However, there are incidences where this liminal position provides an advantage and 
opportun ity fo r resistance. Charlie describes attending HIV conferences and ensuring that 
hepatitis C is moved onto the agenda. Shaun describes raising the profile o f hepatitis C 
among gay men via social media, where online awareness raising affords both a degree of 
protection (Gilbert et al., 2010) and reaches a wide audience in an accessible way.
As w ith  the concept o f cancer above, HIV was often presented as a singular disease, 
obscuring im portant aspects. Both Ben and Charlie described differences between views and 
beliefs about HIV and hepatitis C. There was a feeling that in the west, HIV has become a 
long term  manageable chronic illness, whereas hepatitis C was treated w ith trepidation. Ben 
referred to  HIV as 'run o f the m ill' where hepatitis C was ‘the big doom and gloom'. These 
observations have been m irrored in the literature. Farrell and Comisky (2012) point to  the 
advances in medication and treatm ent which mean HIV is a chronic illness, whereas hepatitis 
C remains a low priority, experienced as uncertain (Sinclair et al., 20011).
For Ben, this was connected to  the legacy by the UK based HIV campaigns o f the 1980s and 
the subsequent high profile nature o f HIV, including the development o f effective treatments 
(available in the UK) to  control HIV and maintain health. Although Squire (2009) questions 
the 'normalisation' o f HIV in the UK and suggests that this obscures the uncertainty which 
exists around treatm ent and longer term  health outcomes, as well as access to  other goods 
and services such as appropriate housing. Charlie makes a similar point (included in chapter 
nine) in tha t there is a need to  address hepatitis C and HIV holistically, in terms o f needs that 
may not be directly related, but are vital fo r living well.
Daniel and Grace exhibited how hepatitis C is constituted through specific forms of 
information (from professionals and via websites) as contagious, given that hepatitis C 
survives fo r longer outside the body than HIV.
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'When we think tha t this virus is more it's able to survive longer outside the body than 
the AIDS virus. It's more deadly than AIDS in tha t respect...if I was to cut myself - blood 
on this table now [the hepatitis C virus] would - two months - it  could survive. That 
could spread, but the AIDS virus, 24 hours I was to ld .'107
Similarly Grace suggests that she fe lt HIV was less concerning than hepatitis C because 
she had read tha t HIV dies more quickly outside the body.
A major area o f comparison proved to be the differences between treatm ent fo r hepatitis 
C and HIV the difficulties associated w ith treatm ent fo r hepatitis C, made the less 
complex HIV treatm ent the preferable option:
Shaun: 'Now, w ith HIV I kept saying to my friends on the firs t time on hepatitis C the 
treatm ent was so aw fu l I said I'd  rather have HIV any day; it's  easy (laughs), it's easy to 
manage I take a handful o f pills every day and I stay alive; that's all I know. With 
hepatitis C it  is treatable, but my god, what a vile treatment. I mean, it's  really awful'.
For Ben, the prior experience w ith hepatitis C treatm ent left him well prepared when the 
tim e came to  go onto HIV medication:
7 think everybody was righ t in the medical circles i f  you can go through hepatitis C 
treatm ent you can go through anything was their policy, and they said, you know, this 
will be a doddle and it  actually has been. So in reality I've never gone through the 
people who have had the scary image o f going, oh I've got to do HIV medication, what 
do I do? What's i t  a ll mean? I've got to take a ll these tablets. I'm like, oh it's easy, ju s t 
take it, and life carries on'.
Conflicting reports on the lifespan of hepatitis C and HIV also exist and clearly depend on the 
conditions, environment and surface on which the virus is present (see for example, Dolan et al, 2009; 
Exchange Supplies, 2009; Doerrbecker et al., 2010),
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This was sim ilarly noted by Hopwood and Treloar (2007) concerning the development o f 
resilience in preparing fo r treatm ent. Later, Ben describes feeling as though he needed less 
inform ation in order to  undertake the HIV treatm ent. Ben makes reference to  the wealth o f 
HIV inform ation which did exist fo r hepatitis C.
When discussing the possibility o f notifying organisations of her hepatitis C infection, Grace 
succinctly describes and enacts the complexity and contingency o f her comparison w ith AIDS 
and its position on the hierarchy o f impairment:
'Labelled. You fe e l like a label. I fe lt  I may as well have AIDS except AIDS m ight be 
understood a b it more. I think I would have more stigma. I w ouldn't want to have AIDS 
don 't get me wrong, because tha t would be worse stigma, but people don 't know  
about hep C pu t i t  in the AIDS category anyway, and more than anything else because 
no one knows what hep C is'.
AIDS is simultaneously implied as the ultimate disease (and the ultimate label) which Grace 
would not wish to  have, because she perceives that this would attract 'more stigma'. 
However, she acknowledges that there is simultaneously a greater level o f understanding 
around 'AIDS' and that hepatitis C and HIV are often confused (Rhodes et al., 2004).
Lack o f inform ation around hepatitis C was also raised by other participants. Holli explained 
that she fe lt it was important that the general public's awareness of hepatitis C was raised 
and that there was more awareness around HIV. However, it is likely that this is connected 
to  participants tem porally situated nature -  given their ages, they are well placed to  recall 
the 'Don't Die o f Ignorance' (Central Office o f Information for the Department o f Health, 
1987) campaigns in the 1980s and witness the shifting position and material consequences 
of HIV in the UK and globally. It is highly likely that views around HIV among younger people 
are very d ifferent. Recent research by the National Aids Trust (2011) shows that public
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awareness is diminishing among young people: one in five young people did not know that 
HIV could be transm itted via heterosexual sex w ithout a condom.
As is described below, participants compared the level o f information and support available 
around HIV w ith  the support fo r hepatitis C. Indeed, as indicated below, there are existing 
funding sources as well as a degree of legislative protection fo r people w ith HIV, which does 
not exist fo r hepatitis C108 (see Munoz-Plaza et al., 2010) explored in chapter nine. This 
comparison may also be useful in the sense that high profile activism connected to  HIV (and 
some forms o f cancer) could prove a template fo r hepatitis C activism although Charlie fe lt 
that there is a lack o f political impetus to  do this:
'You know you look a t HIV that's a big issue in comparison to hep C , in terms o f the 
way its dealt with. You have a specific funding stream fo r  HIV social care. You've got 
HIV specific organisations, you have national awareness days and vigils about HIV and 
that's because the history o f HIV is very different. 25 years ago in the early 80s people 
were dropping down dead w ithin six months, people in the prime o f their lives with 
really nasty deaths. You look a t places like Africa where it's absolutely been decimated 
by HIV. But HIV has moved on, and in fact, in some ways, we haven't moved on to 
where HIV is now, whereas actually, you know, it's actually not tha t big a deal, 
certainly not in this country a t this time -  it's a different m atter in other countries 
obviously'.
Here Charlie's extract makes visible the contingent and shifting nature of HIV. He refers to 
being mindful o f speaking from  a western position on HIV (where HIV in increasingly being 
enacted as a manageable chronic disease) and that this is not the case in other parts o f the 
world. Yet enactments o f a hierarchy persist. Hepatologists, Lemoine et al. (2012), have
108 Though NAT (2011) indicate this is of limited use and point to the lack of understanding of the drug 
use practices of Men who have Sex with Men who inject drugs (NAT, 2013) within mainstream 
services.
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pointed to  the influx o f funding in sub Saharan Africa in relation to  HIV, which they argue has 
marginalised o ther health issues including Diabetes and hepatitis B and C.
One participant in particular (who had also worked in the HIV field) described the high profile 
nature o f HIV as 'well networked', supported by celebrities and powerful cultural institutions 
(although some o f these celebrity campaigns [notably Product (red)] have been criticised 
(Barnes, 2008; Anderson, 2008) in an African context, fo r obscuring the circumstances and 
social relationships which perpetuate the spread of HIV. However, the high profile and 
celebrity endorsed nature o f HIV and the relative absence of such fo r hepatitis C, highlights 
how people w ith  hepatitis C 'take the ir cues from society' (Munoz-Plaza et al., 2010: 525) 
which indicate and enact HIV as more important than hepatitis C. Indeed, workers in Munoz- 
Plaza (2010: 525) referred to  HIV as a 'cash cow':
Richard: 'I f  you look around you a t what there is fo r  HIV, compare tha t w ith the 
number o f people affected by liver disease or hep C and then think in sort o f every 
almost every large m arket town there would actually be an organisation with premises 
fo r  HIV, somewhere you could potentia lly drop into one or another day a week'.
Given that hepatitis C and HIV co-infection is emerging as a major issue, HIV organisations
are well placed to  provide additional hepatitis C support109. In a US context, Munoz-Plaza et
al. (2010) have drawn attention to  the discrepancy in funding between services fo r HIV and
hepatitis C among drug treatm ent services. The authors maintain that funding fo r support
provision fo r hepatitis C trails far behind resources and funding allocated to  HIV. Where
federally funded services exist across the US, the same does not exist fo r hepatitis C and has
thus, been addressed on a patchwork basis by local services. This includes where services
have been 'added on' to  existing models, w ithout adequate training or funding. This has
serious material consequences, similar to  the postcode lottery described in chapter five,
109 The Hepatitis C Trust (2013b) has recently highlighted the issue of HIV co-infection and need for 
development of support services.
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where concentrations of people w ith hepatitis C w ill materialise in areas w ith  poor 
responses, placing additional pressure on health services and social work services as a range 
o f needs begin to  emerge, which demand to be addressed.
These findings have recently been echoed in Deacon et ol. (2013), who point to  the need fo r 
community organisations that have traditionally focused on HIV to  incorporate hepatitis C, 
and to  widen the ir rem it to  support a diverse range o f communities. They refer explicitly to 
the partnerships formed between the government and the community in addressing the HIV 
community and the need to  do the same w ith regard to  hepatitis C. As explored in chapters 
five and seven, the level o f peer expertise that exists across communities needs to  be 
harnessed, trained and funded using peers w ith a wide range of backgrounds and 
experiences. In addition, there is also room to  forge stronger links between groups, not 
based on illness/impairment (or transmission route), but based on common barriers to 
participation the Disability Benefits Consortium is a good example o f this, as it brings 
together a range o f organisations to  advocate fo r a benefits system which recognises the 
rights o f disabled people and is fa ir and accountable (see DBC, 2013 fo r a full list o f members 
and aims). This w ill be revisited in chapter nine.
This chapter has explored how the ways in which participants spoke about the ir hepatitis C 
actually enacted the disease and those w ith it, w ith serious material and emotional 
consequences. The next chapter w ill explore participant's experience o f treatm ent in more 
depth.
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Chapter Seven: 'Left in limbo' Hepatitis C treatment experiences 
as pharmakon and pharmakos.
In tro duction
This chapter firs t and foremost explores the participants' experiences o f hepatitis C 
combination treatm ent in the UK. Treatment experiences have been emphasised as being 
particularly im portant by Korner and Treloar (2006), given that the voices o f those w ith 
hepatitis C are frequently absent from treatm ent research, or present only as subjects in 
clinical trials which fu rthe r enacts the current dominant medical focus in responding to  those 
w ith hepatitis C. As was indicated in chapter two, the meaning and the implications of 
hepatitis C trea tm ent are not extensively explored within social research in the UK.
My aims in this chapter are threefold. I w ill briefly outline how medical responses are 
enacted as dom inant in living w ith and addressing hepatitis C, and show how these 
responses constitute those w ith hepatitis C and those undertaking treatment. I open up a 
space fo r participants' enactments o f the hepatitis C treatm ent experience, which moved 
beyond hepatitis C as a solely medical entity, to discuss the ir social support needs on 
treatm ent and gaps in support provision. I then suggest possible ways in which we might 
support those living w ith hepatitis C who undertake treatment. This chapter responds to  a 
call made by Grogan and Timmins (2010) fo r further research into support centred on the 
needs o f people on treatm ent.
This is a particularly im portant tim e to  explore both how treatm ent is enacted and how this 
in turn, co-constitutes participant's experiences and needs. The current surge in the 
development o f new treatm ents (Trigg, 2012; Dusheiko and Burney, 2013; Kowdley et al., 
2013; Liang and Ghany, 2013;Stedman, 2013) and a renewed push to  encourage testing and 
treatm ent in the UK (NICE, 2012c; LJWG, 2012), together w ith increasing pressure on
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resources, is paradoxically utilised both as a reason to  increase treatm ent (to avoid future 
liver disease) and to  deny treatm ent and support to  some (i.e. injecting drug users). This re- 
invigorates the importance o f calls fo r an exploration of, and further research into, the 
experience (and enactments) o f treatm ent and post treatm ent (see Hopwood and Treloar, 
2005; Treloar and Rhodes, 2009).
In recent work, Fraser and Seear (2011:138) describe 'want[ingj to  unsettle the notion that 
treatm ent is always helpful'. My work takes this question further, asking whether treatm ent 
is always helpful, but also asking what else might be helpful. Interestingly, in exploring this 
question, Fraser and Seear (2011) use data from participants fo r whom treatm ent has not 
worked. In this thesis, the majority o f the sample experienced treatm ent that did  work, 
suggesting tha t even if the treatm ent is successful, it poses new and different challenges.
The im portance of trea tm en t
It is im portant to  note that in challenging the dominance of the medical treatm ent response,
I am not suggesting tha t treatm ent should not be offered to  people w ith hepatitis C 
(including those who use drugs), nor would I want this research to be used as a means of 
justifying the current patchy and unequal distribution of treatm ent and support in the UK 
quite the opposite. However, this should not obscure the recognition that the sole focus on 
treatm ent and cure im plicitly 'others' those living w ith hepatitis C and enacts them as 
abnormal and in need o f 'fixing' (Marks, 1999). Similarly, in focusing on the enactment and 
materialisation o f treatm ent in the lives of participants, I am not pathologising the 
experience o f treatm ent or post treatm ent (Grinyer, 2009), or reducing participants solely to 
their hepatitis C treatm ent experience. I want to continue to  break the silence and reduce 
the invisibility associated w ith these experiences (Persson, 2006). I wish to  challenge the 
current focus on scientific progress (described by Fraser and Seear, 2011) because this 
enacts a silence around the needs o f those on treatm ent and the context o f the ir lives.
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This chapter is intended as a call to  w ider professional disciplines and forms o f expertise 
(including counselling, social work and peer support) to  have an active, properly funded  role 
in supporting those w ith hepatitis C (whether they are on treatm ent or not), to  emphasise 
the importance o f a range of options and support mechanisms for those on hepatitis C 
treatm ent and to  push fo r more and new enactments o f living w ith hepatitis C.
The shifting nature  of trea tm en t
Hepatitis C and its treatm ent have been recognised as ambiguous (Harris, 2005; Treloar and 
Rhodes, 2009; Harris 2010; Hepgul et al., 2012), and difficulties and ambiguities around 
hepatitis C treatm ent w ill form  a central thread of the chapter. The interrelated concepts o f 
'pharm akon' and 'pharmakos' w ill be used to  explore the treatm ent experience. This marks 
an original contribution of this thesis, given that these concepts have not yet been used to  
explore the hepatitis C treatm ent experience. The concept o f pharmakos also draws together 
the experiences o f disabled people and people who use drugs, highlighting the intertw ining 
experience o f oppression.
It is im portant to  note that all participants had (eventually) been offered and taken up 
hepatitis C treatm ent and all had ceased using illic it drugs at the time o f interview. It is not 
unreasonable to  assume that this is an enactment and material consequence (Fraser and 
Seear, 2011) o f current institutional policies on candidacy fo r treatm ent (see Coupland and 
Maher, 2010), given that those participants who used drugs had ceased injecting drug use 
prior to  beginning treatm ent. Professionals who I spoke to  throughout the data collection 
indicated tha t current injecting drug users were not offered treatm ent (see also Harris et al., 
2012a) in the ir locality. Thus the views o f participants who were either not offered, or chose 
not to  take, the current recommended treatm ent have not been included in this study, and
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this constitutes the experience o f hepatitis C treatm ent in a particular way.110 This 
perspective is consistent w ith my ontological position which follows Mol and Law (2002) in 
emphasising the intricacies and tangles of the hepatitis C treatm ent experience. The 
perspectives introduced here are necessarily partial and cannot be everywhere at once, and 
an attem pt to  provide an overview o f hepatitis C treatments would necessitate trim m ing 
experiences in such a way that the rich ambivalence and ambiguity might be lost.
The dom inance of m edicine in hepatitis C
The pharmaceutical treatm ent o f illness and disease is a central and widespread feature of 
contemporary healthcare (Persson, 2004). Van der Geest (1996) states that medicines are so 
powerful because they are tangible and have a visible effect. The origin of the term 
'pharmaceutical' derives from  the Greek word pharmakon (meaning both remedy and 
poison, elaborated on below), but over time the 'remedy' aspect o f pharmaceuticals and 
pharmacology has been foregrounded and prioritised (Derrida, 1981; Gagnon, 2011).
Currently in the UK, the main response to  hepatitis C infection is one of remedy those 
deemed eligible are invited (and expected) to embark on a course of treatm ent w ith the aim 
o f eradicating the virus, or at least suppressing some of the virus for a short time. At the time 
o f interview, recommended treatm ent (hereafter referred to  as combination treatment) 
involved daily oral adm inistration o f Ribavirin tablets and a weekly injection o f Interferon. 
However, Montagne (1996) posits that medication should be considered cultural 
phenomena as well as chemical the experience of hepatitis C treatm ent is shaped by beliefs 
about hepatitis C, evidenced by one of the Hepatitis C Trust111 (2012) 'pros' fo r doing 
treatm ent: 'Knowing tha t you are no longer carrying an infectious and harm ful virus may also
110 Although this is not through lack of trying when I advertised the study, I sent flyers to local drug 
services, advertised at local user forums and spent time with a local drug service in an attempt to 
recruit those who were using illicit drugs.
111 UK national charity for hepatitis C.
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help you to fee l better about yourself. Although presented as a means o f improving current 
health and avoiding fu ture impairment, descriptions of hepatitis C as a 'silent killer, as 
'insidious' and 'sneaky' (see chapter six), and the association between hepatitis C and 
injecting drug use and infectivity (Harris, 2009a), also enact treatm ent as a solution and a 
means o f avoiding these associations. These will be explored throughout the chapter.
Persson (2004) argues for a need to  refocus on the ambiguous nature o f medication, one 
which is not solely focused on remedy, but which also takes account o f the unintended and 
often marginalised effects o f treatm ent (and the discourses and beliefs surrounding it). This 
is constituted in the concept pharmakon.
In tro duction  to pharmakon
Andrew: 'So i t  was a good thing going on it. It fe lt  horrible doing the treatm ent and 
but I had it  in my m ind...that it's  only fo r  a fe w  months. I was actually clear a fte r about 
three or fo u r weeks, but you had to carry on eating your poison'.
Andrew's quote above exhibits the ambivalence involved in taking hepatitis C treatment. It is 
both a 'good th ing ' (the reasons for which are explored below) and 'horrible'; indeed, 
Andrew makes reference to 'eating poison'. This ambiguity was heavily present across 
participant accounts and I argue, both opens up space to explore and explain the limited 
support given to  those on treatm ent and reinforces the need for it.
The Greek term  pharmakon, originally introduced in Plato's Phaedrus (and taken to  mean 
remedy, recipe, cure) was explored and analysed by Jacques Derrida (1981), who critiques 
the persistence o f dichotomies and polarities in western thought (Persson, 2004, Gagnon, 
2011). Good versus evil, tru th  versus error, man versus woman, absence versus presence, 
poison versus remedy. Derrida (1981) maintains that the possibility o f clear definitions and 
oppositions between these elements is actually an illusion one is always structured in
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relation to  the other (Johnson 1981) and they are thus messy and inseparable112. Derrida 
(1981) states tha t these dichotomies actually reflect politics o f meaning the one that comes 
first is the one tha t has priority, remedy is prioritised over poison, non-disabled over 
disabled, healthy over ill. Derrida's (1981) use of pharmakon disrupts these binaries 
pharmakon is undecidable, simultaneously beneficial and detrimental. The meaning o f the 
pharmakon is indeterm inate and depends on context (Persson, 2004), commensurate w ith 
enactment rather than pre-existing anteriority. Thus, hepatitis C treatm ent can be both 
beneficial and dangerous to  the same person at the same time, and can 'shape bodies and 
lives in both intended and unintended ways' (Persson, 2004:63). It is this shaping which we 
need to  pay attention to  and provide support for.
Treatm ent as a remedy
The severity o f side effects and the sense o f fear around treatm ent are outlined in the 
literature (see fo r example Munoz-Plaza et al., 2008) however, the pervasive view of 
hepatitis C treatm ent as remedy was frequently invoked in participant narratives. The 
privileging o f the remedy aspect and the dominance of scientific medicine is enacted though 
all participants in the sample having done treatm ent at least once. This is commensurate 
w ith Martin 's (2006) observation that the ambivalent nature of medication does not prevent 
the ir consumption on a massive scale.
Participants described undertaking treatm ent fo r a range of reasons. Some participants 
accessed treatm ent because hepatitis C had begun to  impact on the ir health, as JB, Boab and 
Morgan all described. This mirrors Harris's observations (2010) in relation to  her own 
treatm ent experience she stopped thinking of treatm ent as a year o f hell and started to 
imagine an improved life w ith hepatitis C. Others described taking treatm ent in order to
112 See Persson (2006) for a more in depth discussion of health and a messy and dynamic concept.
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avoid fu ture liver disease (Manns et al., 2007) or even a fatal outcome113, and some 
participants presented this as paramount:
Steve: 'I f  you get diagnosed get treated ...That is utmost. There is no reason why not- 
unless there are physical medical grounds why you can't be treated'.
In stating tha t medical contra-indications would be the only reason not to  do treatm ent, 
Steve's account reinforces the authority o f medicine114 (Marks, 1999) and tem porarily115 
displaces the difficulties associated w ith treatm ent (and the need fo r attention to  context 
such as housing situation, fam ily circumstances, employment), in favour o f prioritising 
medicine's capacity to  restore health. Displacement is described by Martin (2006) as a 
process where the dangerous or negative elements are removed from direct view. For these 
participants they were 'hidden in plain sight' (Martin, 2006) all described being aware o f the 
possibility o f side effects by the ir consultant, specialist nurse or via the ir own research - but 
these side effects were frequently displaced through the invalidation of treatm ent effects as 
'individual' (see below).
Given tha t Steve spoke at length concerning severe side effects and post treatm ent effects, I 
asked him why he recommended treatm ent so strongly:
7 want to live. That would have killed me and now I have a chance. I mean, I have liver 
damage but it's  not tha t bad... I am figh ting  something on a level playing fie ld...that i f  I 
do things righ t I can make it  better. I f  [the treatm ent] don 't work it  don 't work, some 
people i t  don 't bu t I must say the m ajority o f people are clearing no m atter what they
113 These enactments as hepatitis C are part of what Fraser and Moore (2011) refer to as scaling up 
hepatitis C in order to improve responses to it.
114 Here treatment is enacted as a means of reasserting control (Jenner and Scott, 2008) over health 
and addressing the uncertainty Steve felt was associated with diagnosis.
115 He acknowledges later in the interview he is lucky where he lives and to have a supportive family as 
did a number of participants.
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ore. I was geno [type] three...but whatever you are... i f  you le t i t  get hold o f you and i f  
you fo rg e t it  and pu t it  to the back o f your m ind it  w ill have you -  i t  w ill k ill you'.
Here hepatitis C is enacted as a 'silent killer', as pharmakos (scapegoat, explored below). It is 
the disease itself, rather than responses to it (as discussed in chapter six), which needs 
addressing (and w ill kill) and treatm ent is the only course o f action to  avoid (certain) death. 
Even though Steve makes it clear he is aware that there are those who do not attain SVR, he 
invokes a narrative o f scientific progress (displacing the uncertainty and lim ited effectiveness 
of combination treatm ent) to  indicate that the majority o f people are clearing, fu rther 
emphasising hepatitis C treatm ent as curative and transformative (Fraser and Seear, 2011). 
However, the ambiguity o f hepatitis C and treatm ent is also clear. Steve describes his liver 
damage as 'not tha t bad', but emphasises how im portant it is to  treat.116 Here personal 
responsibility (Crawford, 1994) to  undertake treatm ent is emphasised and suggests that 
those who do not do treatm ent (or fo r whom it does not work) are not doing all they can 'to 
make it  better'.117 This potentially places pressure on people living w ith hepatitis C to 
undertake treatm ent w ithou t any kind of attention to  context, and places an additional 
psychological burden on those who do not have access to  treatment, or who are not ready 
to  undertake it. It perpetuates the centrality o f treatm ent and virus eradication above 
personal health and wellbeing, and overlooks the role of other professions besides medicine.
Others made less reference to  wishing to  maintain their health. For Grace, medication as a 
cultural en tity (Cohen et al., 2001) is evident in her wishes to undertake treatm ent to  clear 
the virus as a way o f addressing feelings of stigma and contagion, and the (felt) judgements 
of others. At the tim e o f her interview, she was on treatm ent fo r the second time. She
116 This ties in with the ambiguity associated with hepatitis C degree of liver damage does not 
necessarily correlate with how long the virus is present.
117 De Wolfe (2002) indicates that there is a deep rooted set of assumptions regarding the accepted 
(temporary) nature of illness and an expectation that those who can 'overcome' illness through 
treatment or intervention are expected and capable of doing so. This intra-acts with discourses of 
blame to shame and marginalise those who do not address it for whatever reason.
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described receiving the news that she had not attained SVR at six months during her first 
treatm ent and starting treatm ent again:
'They [hepatology team] said, 'do you want to have this second lo t o f treatment, or 
you can have a year o ff... and I said, 'No! I 'll tick i t  righ t now ' and I was a t the hospital 
the next day starting the second l o t ... And i f  this lo t doesn't work, then I'll take tha t 
severe one tha t they do where you are literally bedridden fo r  three months but it's  a 
lo t shorter treatm ent118.1 mean I don 't like being ill and apparently the side effects are 
a lo t worse but I do not want that on my death certificate. That's something I do think 
about' (my emphasis).
Grace could not face the possibility tha t she might die w ith hepatitis C and there may have 
been perceptions that she used drugs: 7 don't want people thinking I died from  being a 
druggie'. Here hepatitis C is enacted as a powerful stigma which would mark her out after 
her death, and affect friends and fam ily perceptions of her. (This is not an unreasonable 
assumption given that during the course of fieldwork, I spoke to  a pathologist who indicated 
that he assumes those who have had a history o f injecting drug use have hepatitis C 
infection119). Thus, treatm ent is used as a means of addressing oppression and negative 
treatm ent, whilst simultaneously perpetuating it by re-producing normative assumptions 
about bodies (Rott, 2010); tha t they can and must be closed and clean (Treloar and Fraser, 
2004). This is fu rther compounded when Grace describes feeling 'blase' about her health, 
echoing Fraser and Treloar's (2006) findings regarding feelings of 'absolute contamination'.
118 Grace indicated that she had heard about a trial in the USA where participants increased the 
frequency of interferon from weekly to daily. It is not clear whether she is referring to a combination 
treatment trial or a new therapy.
119 Unfortunately a fuller exploration of this assumption and its implications are beyond the scope of 
this thesis.
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Messy feelings about trea tm en t
For other participants, reasons fo r undertaking treatm ent were similarly incongruent. Carl, 
Andrew and Brad all indicated tha t they did not necessarily feel unwell all the tim e o f taking 
treatm ent. For Carl and Andrew there was a strong sense of ambivalence around the 
treatm ent, even having cleared the virus.
Carl: 7 don 't know how I did it  or why I continued to do it. It was madness. It really was.
Andrew: Well you did it  because you knew it  was going to do you some good and you 
w eren't going to have to go looking fo r  a new liver in another 10, 15 years or 
whatever.
Carl: Yeah and tha t that's a plus. You know, today I don't go to bed... worrying tha t I'm  
going to die or I need a transplant or - and yeah maybe it's only added five  or 10 years 
to my life but it's  ju s t nice to know I haven't got hep no m o re ... it's ju s t a vile disease to 
have and a vile one to try and get rid  o f.'
This is a rich example o f the ambiguity associated w ith hepatitis C treatm ent. Both 
Andrew and Carl had attained SVR on treatment, which might suggest that they can 
afford to  be ambivalent about it in a way which others who have not cleared it cannot be.
Yet the ir ambivalence regarding the treatm ent may also indicate the ir resistance to  the 
power and authority o f medical responses. At the end of the extract, Carl suggests that 
whilst his fu ture health is indeed a concern, the most important thing is that he no longer 
has hepatitis C, implying that the social consequences of living w ith the virus are 
potentially as d ifficult, or even more so, than embodied impairment effects.
Here, treatm ent as pharmakon is enacted in that it paradoxically both creates and allays
anxiety around hepatitis C. The availability o f a pharmaceutical solution, w ith rhetoric o f
increasing effectiveness and eventual cure (see Grogan and Timmins, 2010; Kowdley et al.,
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2013) is promoted, but this im plicitly 'others' those w ith hepatitis C who have not accessed 
treatm ent. In addition, the promotion of pharmaceutical solution inhibits the development 
o f other forms o f support and closes down the possibility o f supporting people to  live well 
w ith hepatitis C (Harris, 2005). Similarly, the emphasis on starting treatm ent as early as 
possible to  achieve maximum effectiveness, creates anxiety and pressure to  access it:
Andrew: 'And I f  I'd  already had it  fo r  15 years like I say, you don 't know how much 
damage it's  done or how much longer before it  starts ripping into you properly'.
Here, hepatitis C is enacted as uncertain [m irroring Fraser's (2012) observations regarding 
the freighting o f responsibility onto the virus or the person, rather than scientific 
development], and the treatm ent is enacted as certain solution (which it is not); a means of 
stopping hepatitis C 'ripping into you properly'. The remedy aspect is prioritised. However, 
later in the focus group the toxic nature of treatm ent comes to  the fore:
Andrew: 'But it  is really odd innit? Like you soy, you don 't fee l any symptoms from  it  
until you're trying to get rid  o f it  and then it  does make you wonder why you do the 
treatment. I f  anything, you hove it  in your head, you think, 'you can't have i t '  so I 
better carry on trying to k ill m yself.
In addition, the ambiguous nature o f treatm ent is enacted in that efforts to  remove hepatitis 
C have actually made it more visible (cf. Persson et al., 2004). Andrew clearly states that he 
was not experiencing symptoms before he went on treatm ent and so, the concept of 
treatm ent in addressing health is challenged. Yet the prospect o f deciding to live w ith it is so 
unthinkable ['you can't have it ')  that Andrew keeps treating even if it feels like a form  of 
4trying to k ill' himself. This turns earlier comments from participants about the potentially
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fatal outcomes associated w ith not doing treatm ent on the ir head: Here the treatm ent is 
the killer not the virus120.
H epatitis  C trea tm e n t effects
A major area o f discussion in the literature and in participant accounts were the side effects, 
and exacerbation o f impairment effects, caused by hepatitis C treatments. The m ajority o f 
participants (20/21) described experiencing some side effects which had a serious impact on 
the ir mental and physical health, working life, personal relationships, and feelings about 
the ir body. The existing literature makes reference to  physical and mental side effects 
(Korner, 2010). Fried (2002) indicates that although severe side effects are rare (suicidal 
thoughts and attempts, panic attacks, onset or worsening of autoimmune and heart 
problems, loss o f vision or hearing, strokes, acute renal failure), less severe ones, like 
depression and insomnia, weight loss, anorexia, hair loss and jo in t pain were experienced in 
over 30% o f people, w ith 50% experiencing headaches, fatigue and muscle aches, which 
contribute to  discontinuation o f treatm ent (Hopwood and Treloar, 2005). Participants in this 
study described severe pain and aching joints, headaches, feeling cold, hair loss (even 
eyelashes and eye brows), anaemia and neutropenia (low white blood cells resulting in 
increased susceptibility to  infections), severe weight loss, nausea and vomiting, depression, 
rage and aggressive behaviour, feelings of isolation, being unable to  drive (or driving w ith 
dangerous consequences such as on the wrong side of the road), heightened fear and 
anxiety, suicidal thoughts and attempts, rashes and itching, feeling weak, fatigue, difficulty 
moving around (even in the ir home), burning scalp and skin, sensitivity to  light and noise, 
insomnia, feeling speedy and hyperactive, aversion to  particular foods and irritable bowel 
syndrome. In Daniel's case, a severe allergic reaction meant his treatm ent was term inated at
120 There is also the potential here to interpret Andrew's comments that life with hepatitis C is not 
'worth' living. There are links with ontological invalidation described in disability studies literature 
(see Reeve, 2012) and wider discussions concerning the 'value' of disabled human life (see for 
example Alison Davies, 1999).
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week 13. The treatm ent as pharmakon is especially clear here. In order fo r participants to 
maintain the ir long term  health, treatm ent materialised a form  o f embodied labour, w ith 
possible positive effects achieved through a gruelling process (Keane, 2011).
For some participants treatm ent was highly counter-intuitive. Charlie describes taking 
treatm ent fo r both hepatitis C and HIV:
'So they stuck me then on HIV treatments to try and sort my HIV out before I started  
the hep C treatm ent.../ had fe lt  ill fo r  so long and then when I started to have the HIV 
treatm ent it  was like 'wow I fee l really w e ll!' (Chuckles) I had tha t fo r  about three 
months and then they put me on this horrible shit! (Laughs) And stra ight back down 
again.'
As described in the previous chapter, participants regularly compared treatm ent w ith 
'chemotherapy'. Both are pharmakon; counter intuitive medications which require fu rther 
illness in the process o f becoming well. Stacey (1997:81) describes:
'Radiotherapy destroys as it heals, chemotherapy pollutes as it cleanses. To kill the 
cancer cells the body is pumped full o f poison...each chemical damages different parts 
of the body which are left in shock. All fast growing cells must die, benign and 
malignant, regardless of origin, regardless of purpose'.121
The ambivalent and ambiguous nature o f hepatitis C treatm ent was clear across participant 
accounts. Treatment was described as 'horrib le,' 'vile' and 'awful'. Carl stated 7 can talk  
about i t  fo r  days but I can't say no good things about it . ' This was qualified, as Charlie's 
example indicates:
121 The development of newer targeted treatments reinforces the chemotherapy comparison in 
relation to combination treatments.
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You know ond saying to my friend, 'you know it's not going to be easy. It's going to be 
horrible, it's  going to be nasty, but it's  a year and once you have got through it  and you 
have got rid  o f i t  you can get on w ith your life'.
The ambivalence surrounding hepatitis C treatm ent is evident in spite o f the severity o f side 
effects and the impact of treatm ent on participant's lives and wellbeing, participants 
frequently described the importance of doing it or supporting others to  do treatm ent122.
Morgan: 'Although the treatm ent fo r  80% o f people is bad, it's not as bad as a lifetime  
o f liver disease...! mean even people who has been symptom free said that when 
they've recovered from  the treatm ent it's  in really subtle ways tha t their quality o f life 
is much better... Some people clear it  [spontaneously] but I think tha t must be fa ir ly  
rare you know, your viral load is going to increase and therefore your chances o f 
success are going to decrease so it  is definitely worth being treated'.
Here Morgan invokes future health and subtlety as a way of encouraging treatment. Similar 
to  Steve, she invokes the rhetoric o f cure (in a different way) to  emphasise the importance of 
treatm ent. Although, ambivalence in relation to treatm ent is enacted again when some 
participants described holding information back about the experience, indicating that they 
would not te ll others fo r fear o f deterring them.
Laurie: 'It (treatment) was hell fo r  me, kicked the living sh*t out o f me - from  1st 
injection to the end. - Never really le t everyone know how bad it  was on forum s - d idn't 
want to pu t anyone o ff.
Laurie and Charlie described the need to  strike a careful balance when talking about 
treatm ent, wanting to  be honest but not wanting to  worry others unnecessarily. This form  of
122 Similar to the comments made by participants in Harris and Rhodes' (2012a) exploration of the role 
of methadone diversion in protecting against hepatitis C. Methadone Maintenance Therapy was 
viewed with ambivalence, as a 'necessary evil'.
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emotional labour, (Hochschild, 1979) managing the ir own and others feelings and reluctance 
to  explain just how hard the treatm ent is, conceals the amount o f work involved in being on 
treatm ent (Persson et al., 2003) and validation o f participant experience is inhibited. It is a 
reality made absent (Law, 2004). This may in turn be utilised as a reason for not developing 
support services.
Further, the ambivalent and difficu lt nature of treatm ent is also marginalised through 
reference to  treatm ent effects as 'individual', which places responsibility fo r managing it at a 
personal level, rather than at a w ider societal and structural level, the problem is not only 
that the treatm ent is difficult, but suitable supportive services do not exist.
This absorption o f w ider views that treatm ent must be managed personally was evident in 
participant's descriptions of treatm ent as 'individual' and 'unpredictable':
M organ: 7 mean you know everyone is different and I would advise (people on 
treatm ent) to hang on in there and on the days when you can't see the wood fo r  the 
trees you're going to fee l to ta lly different123 the next day.'
The erratic nature o f the effects meant that participants found it d ifficult to  plan things in 
advance, some managed the ir lives carefully to  make the most o f good days, others were 
unable to  work or gain support, but repeatedly described the impact o f treatm ent as 
'individual'.
Daniel: 7 th ink it's  a very individual treatment. It affects people in different ways'.
Whilst I am not suggesting that hepatitis C treatm ent does not affect people in a multitude 
of ways, this focus at the individual level fu rther isolates those being treated fo r hepatitis C 
and depoliticises hepatitis C treatm ent (Persson et al., 2003), placing responsibility onto
123 Here Morgan lends strength to the position outlined in chapter three that objects, in this instance, 
treatment, do not exist prior, independent and singularly, but shift and change based on their intra­
actions.
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individuals to  manage their illness (Race, 2001). Treatment becomes an exercise in self­
management (Race, 2001) where the individual is responsible fo r the ir own outcome on 
treatm ent (M artin, 2006:274, see also Keane, 2011). Yet, vitally, the positive outcomes of 
treatm ent are reaped w ith in w ider society. People may stay in employment longer, having 
avoided serious health issues; pressure on health service resources and human organs are 
reduced and the overall prevalence o f hepatitis C decreases. In the process, however, the 
individual and the ir support needs are overlooked.
Pharm akon, contingency and models of support
The d ifficu lt and unpredictable nature of hepatitis C treatm ent was acknowledged by 
participants as problematic in developing models o f support:
Pixie: 7 don 't even know i f  a hep C support line manned with 20 operators on - 1 mean 
know it  would be busy - but who would fund  that sort o f support? It's not personal 
enough... fo r  [some]. It's so d ifficu lt Heather to know what to do fo r  these people really 
there is no sort o f quick fix '.
The lack o f 'quick f ix ' means there is a danger that instead of highlighting the need fo r more 
holistic support w ith  social and emotional components, the needs of those with hepatitis C 
become fu rth e r marginalised they are deliberately made absent, because there are no 
consistent side effects fo r everyone and, therefore, no clear model o f support124.
This resonates w ith  w ider observations from w ithin disability studies. Sunny Taylor (2004) 
points to  the heterogeneity among disabled people and Patricia de Wolfe (2002) indicates 
that it is much easier to  advocate around issues which appear clear and stable. This 
acknowledgment o f messiness, and the lack of stability, was described by Charlie as a reason 
for the lack o f response to  hepatitis C:
124 There is the potential for this to be exacerbated given the development of new treatments.
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'There is a great deal o f uncertainty, the treatm ent fo r  it  is nasty, it's not a m atter o f 
simply giving someone a p ill a day and the treatm ent is uncertain. It's only going to 
work w ith certain people... it's  almost like it's  too big to deal w ith .'
Here, the ambiguous and uncertain nature o f hepatitis C treatm ent opens up an important 
gap to  th ink about additional forms o f responsive support and disrupt the dominant medical 
model.
Holistic and m u ltid isc ip lin ary  support
The importance o f addressing needs holistically for people w ith hepatitis C, especially those 
who use drugs, has been acknowledged in recent years. Treloar and Holt (2008) emphasised 
the need to  pay attention to  issues which may be inhibiting the uptake of hepatitis C 
treatm ent and Olsen et al., (2013) refer to how poverty, unemployment and poor housing 
dominated the lives o f the women who used drugs.
Similarly, participants in this study emphasised the importance of holistic support and the 
intra-active nature o f the phenomena of hepatitis C. Participants found it d ifficult to  separate 
out what was an effect of the hepatitis C, and what was an effect o f the treatm ent or 
previous life experiences related to  drug use.
Ken described not being sure whether the impairment effects he experienced (brain fog) was 
an outcome o f the treatm ent, past drug use, additional health problems, or age (see Morgan 
in chapter five). Kerry described the 'multiple health issues' she faced in addition to  her 
hepatitis C and, as is discussed in chapter nine, participants often lived w ith numerous 
impairments and life circumstances which intra-acted, requiring a diverse range and form  of 
support and inform ation. A key finding o f this thesis is that hepatitis C and its treatm ent are 
not standalone experiences or issues, but are intra-active and must be addressed as such. As 
Charlie states:
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'It's tha t thing about linking into common agendas and not viewing things in a silo. 
People -  everyone, doesn't m atte r what condition they have, has relationships with  
other people, has finances, has mental health, has housing, environmental, societal 
determ inants to their lives and i f  you jus t try and pick o ff one o f those and deal w ith it  
your rate o f success is going to be appalling. You look a t a whole health and welfare 
system then one o f the reasons why it  is not working the way it  should do is because 
you siphon everything off, you compartmentalise everything and link everything 
together, you know, hep C - big time - very, very clinical view o f hep C and there is no 
social input a t a ll? '
Models of in tegrated  support
In 2008 as I began this doctoral study, Foster noted, in an editorial in Addiction, that hepatitis 
C treatm ent fo r people who used drugs could be delivered successfully in the context o f 
integrated services. Since then, a number of studies have borne this out. Brener et al. 
(2013b) recently evaluated a New Zealand integrated care clinic fo r people who had hepatitis 
C and/or who used drugs. The clinic was staffed by a full time nurse and a GP, as well as a 
part tim e social worker. Attendees reported that the clinic was helpful in getting them ready 
for treatm ent, as well as addressing health issues they experienced in addition to  their 
hepatitis C. Health professional participants suggested that access to  a range of professionals 
meant it was better placed to  address the complexity o f client need. Attendees suggested 
one o f the main benefits o f the clinic was access to  digestible, current information, as well as 
the cultivation o f relationships w ith professionals. As a result, Brener et al. (2013b) proposed 
that greater attention should be given to delivering hepatitis C treatm ent in community 
networks and settings.
In a rare UK based qualitative study, Sinclair et al. (2011) described feeling compelled to  look 
beyond the current focus on the medical model, which dominates support provision (two of
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the authors were working w ith the client group as psychologists), to  explore support needs 
among co-infected gay men. They found that support focused only on treatm ent adherence, 
effectively overlooked participants' personal needs and priorities -  echoed by participants 
below. In Scotland, the development o f Managed Care Networks (MCN) have improved 
access to  hepatitis C treatm ent and care fo r people who use drugs, who might otherwise not 
have engaged w ith healthcare. MCNs developed as part o f the Scottish Hepatitis C Action 
Plans, acknowledge that people who use drugs often face daily challenges which require 
support from  a range o f agencies including health, social services, drug services and mental 
health services (Tait et al., 2010). Recent research by Harris et al. (2012a) found that there 
were a range o f issues which affected engagement w ith hepatitis C services, including 
negative perceptions o f hepatitis C, difficulties w ith housing, the availability o f social support 
networks, welfare benefits, caring responsibility and criminalisation. This very recent study 
(circulated publicly in 2013) is the first to explicitly address social support needs, though this 
(importantly) focuses on drug users.
This thesis shows there are other issues faced by people who are not current drug users, and 
who may not have contact w ith a similar level o f support. One o f the issues fo r participants 
in this study is tha t similar multi-disciplinary support services are patchy in the ir existence -  
it is the sheer lack o f services providing support to  people w ith hepatitis C which needs 
addressing first and foremost.
Forms of support
Participants most frequently described needing a clear point o f support. A number of 
participants named the Macmillan Cancer Support service as a model they would like to 
follow:
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JB: 'Yeah I mean i f  you had something like the Macmillan nurses fo r  people on 
treatm ent [they could] call round see i f  they're alright, even i f  it  was ju s t a chat, 
making sure they are doing the treatm ent correctly, they are having their tablets w ith  
food  which brings me back again to the benefits system i f  some poor sod's not got the 
money coming in he hasn't got a proper diet and is going to mess up his treatm ent 
because he is not eating righ t or taking the pills a t the right time so I think i f  there was 
something like tha t then it  would be a different show'.
Here JB makes reference to  the interconnected nature o f needs on treatment. Macmillan, 
aside from  being a high profile organisation, take account o f cancer treatm ent as pharmakon 
and crucially, acknowledge the illness involved in becoming well, as well as the nonlinear and 
contingent nature o f recovery (explored in chapter eight).
When an initial summary of findings was offered to  each participant, those that commented 
indicated tha t they would not want Macmillan nurses perse, but rather were pointing to  the 
lack of existing social support infrastructure:
Richard: 'One o f the really big ones is actually the complete to ta l and utte r lack o f any 
kind o f meaningful support tha t isn 't entirely originating by self-help. I mean the 
support group in (city) doesn't get a penny from  anyone'.
This lack o f recognition further invalidates and de-politicises the experience o f being treated 
for hepatitis C. Richard explained that he fe lt one o f the main reasons for lack o f support 
was the moral dimensions associated w ith liver disease and the culpability. This view was 
also shared by JB and Pixie who described liver disease as the 'tw o ugly sisters', either as a 
result o f alcohol or other drugs. This point is returned to  in the discussion o f pharmakos 
(scapegoats) below and in chapter nine.
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Counselling
Other participants pointed specifically to  the need for counselling support or the opportun ity 
to  talk things through. The importance o f counselling support has been acknowledged in the 
literature, though a key criticism has been the ad-hoc and unequal nature o f access to  it 
(Ehsahni et al., 2006; Swan et al., 2010; Fry and Bates, 2012). Treloar and Hopwood (2005) 
refer to  the vital role o f counselling in managing the impact o f side effects on mental health. 
Fry and Bates (2012) suggest that longer term  support may be required as treatm ent may 
bring forth  unexpected feelings and experiences as Morgan indicated, 'all this s tu ff from  my 
childhood has been coming up.' Peers were often cited as invaluable, but many participants 
referred to  the need fo r formal support:
Boab: 'There's been no emotional support, no counselling or anything like that. M y 
own GP - I've fina lly  talked them in to allowing me to have counselling - they d idn 't 
offer that. I had to ask fo r  it. The medical s ta ff and the liver specialist s ta ff made no 
mention o f i t  all... the clinical care has been excellent, it's ju s t the lack o f psychological 
care, lack o f em otional support'.
In emphasising only the physical nature of the treatment, the biomedical model dominates 
the human body is a machine which requires fixing (Lupton 2003; Harris, 2005) and the 
emotional and social dimensions of the experience of hepatitis C and treatm ent are silenced, 
until Boab amplifies them. Boab stated earlier in the interview that because he lives on an 
island w ith only a small population, he fe lt that counselling was relatively easily arranged, 
but acknowledged that in areas w ith greater pressure on their resources this might not 
always be possible. A similar point has been made in an Australian context by Hopwood and 
Treloar (2005). Here, the silencing of the need for counselling could materialise in highly 
detrimental or even life threatening ways (i.e. suicide attempts). Shaun described 
participating in a six week group counselling workshop which provided the opportunity to
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talk through his experiences w ith other gay men who had hepatitis C and HIV, and to  explore 
the connections, experiences and w ider structures which led to  contracting the virus. 
However, this group had recently lost funding due to  cuts, fu rther reinforcing the silence 
around hepatitis C, the impact o f treatm ent and especially the experience o f living w ith  co- 
infection (Owen, 2008).
Mental health support
The ambivalent nature o f hepatitis C treatm ent is also clear from participant descriptions of 
the effect o f treatm ent on the ir mental health. These effects are well documented in the 
literature (see Janke, et al., 2008; Sgorbini et al., 2009; Blacklaws et al., 2011; Evon et al., 
2011; Sinclair et al., 2011; Fry and Bates, 2012) and participants described these being taken 
seriously by the ir treatm ent team, w ith most participants being prescribed anti-depressants 
w ithout psychological or emotional support. Pixie and Charlie made reference to  the need 
for support beyond office hours, because of the impact o f treatm ent and suicidal thoughts:
Pixie: 7 think it  would be the 24 hour helpline manned by people that know about hep 
C as an emergency thing... Because there is so many that try to commit suicide. You 
know I had one night in 2007. I had someone sat in bed crying with a knife who kept 
saying 7 ju s t want to go through' and I talked to him all night and by the morning,
4.30am,he was starting to calm down the daylight was coming and it  had sort o f  
passed he has always said tha t i f  I hadn't been on the other end o f the phone he would 
have done it. He would have killed himself so that's the sort o f thing we need is jus t 24 
hour not a 9am-5pm. I ju s t hate 9am-5pm help lines fo r  something like this'.
This powerful example, where Pixie describes supporting someone through a particularly 
dark time on hepatitis C treatm ent (preventing him from seriously harming himself), enacts a 
treatment as a responsibility not only personally, but collectively shared by others w ith
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hepatitis C. However, this collective responsibility, whilst it has the potential to  be powerful, 
also involves intense forms o f physical and emotional work (Thomas et al., 2002) which may 
well be beyond a participant's capabilities. This simultaneously highlights the need for 
services which can provide emotional support and also the need for adequate funding, 
training and support o f peer workers in supporting those on treatment.
Peer support on treatm ent
All participants I interviewed made reference to  the importance o f support from those who 
had experience o f hepatitis C treatm ent (either in the form of a formal group, via the 
internet or from  friends). This is unsurprising given the lack of support from services beyond 
the provision o f treatm ent and the isolating experience of hepatitis C treatm ent (McCreaddie 
et al., 2011). The importance o f peer support has been documented in the literature review 
and in chapter five, and the importance of support groups in understanding illness 
experience is well documented fo r those w ith hepatitis C and w ith other chronic illnesses 
(Coreil et al.,2004; Mendelson, 2003; 2009; Schon, 2010; Travis et al., 2010; Peterson et al., 
2012). Support from  peers played a vital role in staying on treatment, as these participants 
made clear:
Kerry: 'It would be minutes after I'd  pressed the enter key [on the internet fo rum ] 
(support group leader) would be on the phone saying come on Kerry everyone's behind 
you keep going'.
Charlie: 7 have another friend  (edit) who is ju s t about to go on hep C treatm ent and he 
has always said he has had liver cancer and i t  was only when I went to [his hometown],
I hadn't seen him fo r  about 10 years and obviously he didn 't know I had had hep C, and 
I mentioned something about, you know, actually going through the treatment and he 
went, 'you have been through the treatm ent?' And it  was jus t like all o f a sudden his
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whole face ju s t l it  up it  was like 7 have found someone I can ta lk to ! Who knows what 
it's like.'
As mentioned above, participants often fe lt that the hidden and unpredictable nature o f the 
treatm ent made it d ifficu lt to  access support (discussed in chapters six and eight). M irroring 
the findings o f Harris (2010) and other chronic illness literature (Charmaz, 2002; Wendell, 
2002; Barker, 2005), participants made specific reference to the difficulties around asking 
others fo r support or indicating how they felt:
Steve: 'There are times when I would get, not so much fed  up it's like someone asks you 
i f  you fee l okay the general English answer is like,' yes'. But you also get fed  up o f  
saying 'no I don 't' so you ju s t say 'yeah I am a lrigh t' leave me alone and go away'.
The long term , rather than the acute, nature of the need for support also means that those 
who provide support initially may become fed up and fall away. JB explained that families 
might have a d ifficu lt tim e in understanding the experiences of treatm ent and thus pointed 
to the need fo r shared experience:
'People aren 't able to talk about it  as much as they would like to about how they're 
feeling, about the symptoms, about what's treatment going to be like fo r  me ... so 
thereby meeting people tha t have actually got it  and are in the same situation as you. 
Yeah they open up and there's this understanding and this common bond'.
Importantly, Charlie (who had also lived w ith HIV and been active in the HIV community fo r a 
number o f years) (cf. Persson et al., 2003) referred to treatm ent experience as:
'A sister, brotherhood thing ... you have lived with i t  you know what you are talking 
about even though my experiences m ight be a million miles away from  what your 
experiences are'.
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He described his experience as an HIV positive man as one he was proud of, partially because 
accessing the community and sharing experiences provided a means o f identifying and 
combatting oppression suggesting a 'protective' or 'strengthening' element o f identity. A full 
discussion o f this is beyond the scope of the thesis, but constitutes an im portant area of 
further research.
Lois Keith (1996) has pointed to  the value of the group setting as an im portant place for 
disabled people to  share frustrations and difficulties, particularly regarding non-disabled 
people. The above extracts indicate that this also applies to  those w ith hepatitis C. 
Participants' ideas concerning the best forms o f peer support were wide ranging. Richard fe lt 
that these organisations should be w ithin the community so that people can drop in and out 
of them, and Charlie made reference to providing more general blood borne virus support, 
which would support and raise awareness of co-infection as an issue. A key issue regarding 
peer support was appropriate and sufficient funding. JB and Pixie, who moderated an 
internet forum  and phone line, were entirely self-funded and ' tried not to think about' (JB) 
the cost.
Given that internet based support has been recognised as an important and cost effective 
way o f providing support to  people w ith hepatitis C (Richmond, 2008; Stewart et al., 2012; 
Grogan and Timmins, 2010), there is a need fo r urgent funding to  be provided here. As 
explore above, there was a need for out o f hours support for when isolation and suicidal 
thoughts were particularly prevalent. Keith, Richard and Ken made reference to  a 'buddy 
system' w ith in the ir local hospital:
Keith: 'We tried to extend the support group to being like... when you go to the 
hospital someone w ill approach you i f  you want to ju s t to have a chat and this is what 
we were trying to get fo r  (town) whereby when you go through your clinic you can say 
especially fo r  the newly diagnosed, you can get someone who has gone through
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treatm ent come down and say hold on a minute, it's not as bad as people make out,'- 
you know what I mean?
Heather: Some kind o f clear yeah, information from  someone who has done it
Keith You know, it  doesn't have to be a buddy thing, but there are people i f  that's what 
they w ant it  can be done its more o f a collective, rather than this secret little  
underground thing'.
The presence o f a buddy at hepatitis C clinics, where participants could draw on support 
from peers if they wished, enacts hepatitis C as a disease w ith social consequences. The 
physical presence o f buddies amplifies and materialises the need fo r social support and 
partnership w ith  medicine.
The main point here is that needs related to  hepatitis C cannot be extricated from the 
context o f a person's life. W hilst other studies have made reference to  the importance of 
multi-disciplinary support (Ehsahni et al., 2006; Sinclair et al., 2011; Stewart et al., 2012; 
Deacon, et al., 2013), a key finding of this thesis is that people w ith hepatitis C could be well 
supported by social work.
The need for social work support
M offatt et al. (2010) note that w ith in UK healthcare, it is frequently unclear who should take 
responsibility to  support people w ith the social aspects of illness, given that boundaries are 
contingent and blurred. A key finding of this thesis is that social work (both in statutory and 
increasingly in th ird  sector services) may be well placed to provide this. Social workers' daily 
involvement w ith circumstances and lived experiences which are ambiguous, cumulative, 
contradictory and d ifficu lt (Drayton, 2013), means they have transferable skills and 
capabilities to  manage the challenging and cross-cutting issues raised by hepatitis C and 
treatment. Indeed, I have argued elsewhere that social workers are ideally situated to
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provide a wide range o f support and information ranging from harm reduction, to  support 
through testing and treatm ent, as well as support fo r social issues raised by living w ith 
hepatitis C (Paylor and Mack, 2010).
In spite o f this, there has been very lim ited academic engagement w ith the role o f social 
work supporting those living w ith hepatitis C, exceptions being Paylor and Orgel (2004), 
Mack (2007), and Paylor and Mack (2010). Thus, this thesis makes a unique and im portant 
contribution in this area.
Interestingly, the role o f social work in supporting people w ith hepatitis C has been regularly, 
if minimally, referred to  in the literature fo r over a decade (Rowe et al., 2000; Glacken et al., 
2001; Edlin, 2002; Hopwood and Southgate, 2003; Balfour et al., 2004; Hopwood et al., 2006; 
Ehsahni et al., 2006; Hopwood and Treloar, 2007) and in policy (DH, 2002a; 2004), including 
some very recent policies and reports (Scottish Executive, 2008; Archer et al., 2009; HCV 
Action, 2012). This brief, but regular, inclusion of social work, contributes to  an (academic) 
reality where supporting people w ith hepatitis C is part o f the remit for social work.
For participants in this thesis, faced w ith the everyday reality o f hepatitis C, the opposite 
appeared to  be true. There continues to  be a severe lack of investment in education, 
awareness raising and dedicated funding w ithin social work related to  hepatitis C, likely to be 
exacerbated by the current constraints on funding and deep cuts to  services. The 
development o f integrated health and social care services proposed by the coalition 
government in the Health and Social Care Act 2012 may provide new opportunities fo r this, 
although this remains to  be seen. Further to  this, it has been suggested (Treloar et al., 2011;; 
Daddow and Broome, 2012; National Treatment Agency, 2012) that as funding becomes 
increasing constrained and local authorities set their own priorities fo r services, 
disinvestment in services becomes a distinct possibility.
283
Participants' accounts made visible, various junctures at which social work could have 
provided support. Social workers work across a range of client groups, all of whom have the 
potential to  be affected by the issues raised in the course of hepatitis C infection, especially 
those working w ith disabled people, people who use(d) drugs and older people, given that 
an ageing population w ith hepatitis C is increasingly becoming an issue (Grogan and 
Timmins, 2010). Thus, a level o f basic knowledge of hepatitis C, testing procedure, treatm ent 
availability and effects and the kinds of support required, should be rolled out across all 
social work teams. This should be linked w ith knowledge of contact points and services in the 
local area to  facilitate referral and smooth communication (Paylor and Mack, 2010). A major 
challenge here is the patchy and inadequate hepatitis C services available.
In light o f the support needs highlighted by participants throughout the thesis, and the 
ambiguous nature o f the treatm ent, there is an urgent need fo r social work support for 
those w ith hepatitis C in the UK. However, discussions and observations w ith social workers 
on various teams during fie ldwork (including a team working w ith learning disabled adults, 
one working w ith  physically disabled adults and a team working w ith older adults), all 
indicated that they were not aware of hepatitis C as an issue which affected (or might affect) 
the people they worked w ith. This is clearly an area which requires further research, but in 
the meantime, a lim ited knowledge of hepatitis C coupled w ith increasing pressure on 
services and increasingly constrained eligibility criteria means that participant experiences 
and needs fo r social support on treatm ent are 'othered' and invalidated. One (cost effective) 
way o f addressing part o f this issue would be to  extend the availability o f the RCGP 
certificate in the management and treatm ent o f hepatitis B and C to  social workers, and 
ensure that ideally all, but at least one, social worker on every statutory team has completed 
it.
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Participants in this study reported being unsure whether they could access support from 
social services. This may well be connected to not knowing which team to access, or 
concerns about being eligible fo r services, given that they struggled to  meet the criteria for 
welfare benefits. However, participants should still trigger local authority assessment 
obligations under section 47 o f the NHS and Community Care Act 1990 and at the very least, 
obtain signposting and information.
Participants described receiving no information about the social work support throughout 
their contact w ith  services, most likely because such support is rare w ithin the UK. Three 
participants did refer to  receiving integrated multi-disciplinary support, including counselling, 
although this was in the context o f a sexual health service. Here, hepatitis C treatm ent is 
enacted as a remedy fo r overstretched and under resourced NHS services in the longer term 
(i.e. a shortage o f livers for transplantation), whilst the attention to  the poison aspect (the 
creation o f needs as a result o f treatm ent) are othered. Participants are expected to go 
through treatm ent w ith  little  or no social support (relying on family and friends) which 
materialises them as threats to  public health, rather than human beings w ith support needs.
For example, Morgan described a range of debilitating side effects on treatment:
7 mean I couldn't run a bath. There was times when I d idn 't have a bath fo r  a week, I 
didn 't have the energy to run myself a bath I certainly couldn't have had a shower, you 
know, I was vulnerable to fa lling  over because I was sort o f dizzy and weird a lo t o f the 
time. And, you know, you should have someone can help you with tha t and you should 
have someone who can cook you a meal because you haven't got the energy to stand 
and chop veg or stand up I mean I couldn't stand fo r  very long a t a ll'125.
When I read this in the transcript I was struck by how similar it sounded to the questions and 
descriptors on an application for Disability Living Allowance, suggesting that Morgan is trying to 
present herself as 'eligible' for support in the interview.
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As a result, Morgan relied on existing social networks for help w ith shopping, preparing food, 
housework, supervision in the shower, to provide emotional and social support. Clearly this 
depends on the degree o f disclosure and the strength of support networks fo r individuals. 
Similarly, the long term  nature o f treatm ent may mean that family and friends are unable to  
provide meaningful support fo r the duration of treatm ent (Hentz, 2002) and particularly post 
treatm ent (discussed in chapter eight). Recently Harris et al. (2012a) has drawn attention to  
the invaluable support that can be provided by family and friends during treatm ent, but 
indicated tha t participants in her study also referred to the need fo r practical support (such 
as housing repairs) and help w ith finances, fo r which very little  support existed and which 
participants indicated drained what little  energy they had.
Ken and Pixie referred explicitly to  the need for childcare fo r parents on treatment, but made 
reference to  the financial constraints as inhibiting greater social care involvement. For 
example, Kerry was caring fo r her three year old daughter at the time of being on treatm ent 
and described a partial and fragmented response, despite there being numerous 
professionals already providing support to her:
7 really did need [support w ith ] childcare and I d idn 't get i t  I rang them [social 
services] and asked them fo r  an assessment a t the beginning o f the treatm ent and they 
said it  was not in their remit...they already knew about my mental health problems and 
I said the hepatitis treatm ent w ill then be on top and the lady did ask me 'what's that 
going to entail? ' And I tried to explain it  in terms o f basically like chemotherapy and 
there are very harsh side effects and I explained those side effects and I said obviously I 
don't know whether I w ill have those side effects yet, but fatigue and insomnia and 
s tu ff like tha t are quite common and as I already suffer from  those symptoms it  is likely 
they are going to be exacerbated and the same with my mental health, i t  could easily 
slip . M y [m ental health] team to begin with were not that sure about treating me
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because they were worried I was going to try and kill myself or I m ight not be able to 
cope w ith the treatment. Luckily I get enough support from  the mental health team  
tha t tha t hasn't happened. But I tried to explain to social services tha t because o f my 
borderline - we are talking minutes between me being fine  and me being in a complete 
crisis. And I tried to explain to social services, rather than calling the crisis team ten 
times, they m ight as well o ffer me ten weeks o f help you see what I mean it  hasn't 
happened I haven't had a major crisis, but I have been ill and my parents have had to 
take up the slack'.
This extended extract from  Kerry clearly shows the intra-action between her existing health 
issues, her family life and the addition of the treatm ent fo r hepatitis C. Here, preventative 
intervention is not an option, which as Kerry points out could prove to  be more costly in the 
longer term . Treatment as pharmakon, and as liminal (Rhodes and Treloar, 2008) and 
ambiguous, is visible here. Kerry describes receiving support from her mental health team, 
but struggling to  access support to  maintain her home life and care fo r her daughter. 
Hepatitis C treatm ent is enacted as very serious (the mental health team are concerned 
about treating Kerry, given her existing mental health issues and the possibility she might 
attem pt suicide) and simultaneously not serious enough to warrant support from social 
work. This resulted in Kerry relying on family to support her and her daughter, further 
silencing the impact o f treatm ent from a services perspective.
Harris et al. (2012a) in a report concerning the needs of people who use drugs on treatment, 
has also made reference to  the need for social support and the lack o f available services, 
thereby strengthening the findings o f this thesis. The authors indicate that caring 
responsibilities made hepatitis C treatm ent more difficult and recommended that people 
should have access to  subsidised home and care support.
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It is here tha t social work as pharmokon becomes visible. Social work continues to  occupy a 
position between enabling and disabling (Roulstone, 2012, Oliver, Sapey and Thomas, 2012). 
As explored above, social work intervention could make an important contribution to  
enabling participants to  maintain employment, undertake caring responsibilities, live well 
and maintain the ir fam ily relationships, before during and beyond treatm ent. In practice, it 
further contributes to  the disablement of participants, w ith narrow criteria, lack o f funding 
and lim ited awareness among social workers around hepatitis C marginalising and silencing 
their needs altogether. Ways this might be addressed include the embedding o f hepatitis C 
and other blood borne viruses into undergraduate and post graduate education, together 
w ith the involvement o f those w ith BBVs in modules and lectures (Clarke, 2010; Galvani and 
Hughes,2010). Roulstone (2012) points to the need for greater lobbying by, and w ith, social 
work in this case, in relation to  support and awareness around blood borne viruses. Possible 
forms this might take include developing special interest groups,126 expanding the rem it o f 
existing professional hepatitis C groups to  include social work and people w ith hepatitis C, or 
developing a group o f social care professionals and service users which crosses over w ith the 
remit to  encourage jo in t working.
A key issue here is the development and maintenance of trust and rapport w ith social work 
professionals (Harris et al., 2012a). Neale (2008) maintains that some people, particularly 
those who use(d) drugs, may be reluctant to engage w ith social work because o f concerns 
about the ir children being removed (cf. Galvani et al., 2013). Neale's (2008) participants fe lt 
that social services in intervention needed to be avoided, that social workers did not 
understand the ir problems, were unable to provide support and were not to  be trusted. The 
negative perceptions surrounding social work are also being addressed more widely by The 
College o f Social Work (2011) and, if adequately funded and supported, the development of
A British Association of Social Workers Interest group does exist for alcohol and other drug use 
under which hepatitis C could be subsumed.
288
the social work role in hepatitis C support services might also help to  change w ider negative 
perceptions.
It is im portant to  note here, that it is not my intention to  w rite a thesis which is not 
orientated to  the harsh realities w ith which it is intended to  connect (Roulstone, 2012:144). 
It is likely that cuts to  existing services will make engagement w ith hepatitis C particularly 
difficult at the moment increasing constraints on eligibility fo r services w ill mean that 
participants continue to  find themselves (or indeed may even become) ineligible fo r support, 
along w ith many others127. It is vital to  acknowledge that this is going to  be very difficult, 
but that this is no reason not to make the need for support for people w ith hepatitis C (and 
those on treatm ent) very clear. Clearly, an area of vital research is the development of 
models o f service w ith in such constraints.
A key commonality (indeed intra-action) between people w ith hepatitis C and (other) 
disabled people is tha t both groups have received what Roulstone (2012) refers to  as a 
'Cinderella service'128 -  w ith both often treated as an adjunct w ithin policy and practice. This 
highlights an im portant shared experience which could be used as a basis fo r organising 
together (see chapter nine).
Having explored participants support needs and the role o f social work in addressing 
participants needs on treatm ent, the chapter returns to  discussion o f another dimension of 
pharmakon, the concept o f pharmakos.
The implications of the redrawal of these boundaries are explored in chapter nine.
8 Services for hepatitis C have also been described in similar terms (see DH 2002) and the evidence 
presented in this thesis suggests that this is still the case.
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An in troduction  to Pharmakos
Eschotado (1998, in Acevedo et al., 2009), in his research into the etymology o f the term  
pharmakon, found that the term  pharmakos has been used to  describe cleansing rituals 
(used in ancient Greece and Rome) in which a scapegoat is literally or symbolically scarified 
(see also Szasz, 1974). The pharmakos were often human beings (sometimes animals) 
offered to  deities as a means of appeasing them, in turn alleviating a d ifficult situation w ithin 
the community, removing personal and collective impurities, and avoiding plagues and 
famines (Szasz, 1974; Acevedo et al., 2009). Szasz (1974) notes that the root meaning of 
words such as 'pharmacology' is not medicine or poison, but 'scapegoat'; it was only after 
these rituals o f sacrifice had been abandoned, that the words took on the new meaning.
W riting from  w ith in  disability studies, Bill Hughes (2012) discusses the enactment o f disabled 
people as pharmakoi, maintaining that the main response to disabled people has been to 
either correct or elim inate that which is not tolerated. Hughes (2012:19) traces the rejection 
of disabled people through history, noting that those who were perceived as different were 
mocked and excluded he maintains 'disability was positioned as a moral and ontological 
pollutant.' Over the years the boundary between what is acceptable and what must be 
segregated has been drawn, and indeed maintained, by medicine that defines 'pathology', 
but who allowed entrance into the mainstream via corrective treatm ent (in this case 
hepatitis C treatm ent).
Interestingly, fo r the purposes of this chapter, speaking in relation to  drug use and people 
who use drugs (but applicable to  people w ith hepatitis C and (other) disabled people), Szasz 
(1974:27) states tha t we have moved from 'cure alls through human sacrifice to  cure alls 
through chemistry', wishing to  expel from the community those who use drugs and pollute
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the community. When this is considered in relation to  hepatitis C treatm ent, both the 
treatm ent and the people undertaking it can be considered pharmakoi.
Participants made reference to  treatm ent administration as a kind o f ritual, the ultimate aim 
o f which is to  expel the virus. Carl and JB described preparing the ir interferon dose as a 
ceremony which evoked feelings associated w ith using drugs:
'And it's  tha t whole process o f going through that injection every week because you 
have to set i t  a ll up and you have a sharps bin in your f la t  and it's  like 'my g o d / it's  like 
I was s till using. I had to go through a process. I got used to it  a fter a couple o f weeks 
but I would get i t  and set a little  b it up and then have to sit down fo r  10 minutes and 
take deep breaths.'
JB: it  was strange because I had the Schering-Plough pen where you go through this 
ritua l o f getting i t  out o f the packet, you click it  together, you dial up your dose you 
screw on the needles - so there was this ritua l tha t you went through, which took me 
back to my drug using days. And I was actually getting a little  b it o f an adrenalin rush.'
Here, both the pharmakos ritual and treatm ent as pharmakon are enacted. The mode of 
administration o f treatm ent both attempts to  remedy the virus but evokes emotions 
associated w ith  preparing to  inject drugs and indeed, participants' identities as (former) drug 
users. Harris (2009b) also reported participant concerns about relapse to  injecting drug use 
associated w ith  interferon treatm ent, both in relation to  preparing the medication, injecting 
it and the side effects associated w ith the treatm ent (see also Ogawa and Bova, 2009; 
Sinclair et al., 2011). Further to  this, it is possible to  see the needle and injecting equipment 
(used in treatm ent) as symbols o f the inherent potential fo r drug use (once a drug user 
always a drug user, see Lloyd, 2010) that must be expelled from the community.
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D r u g  use rs  as scapegoats
Scapegoats are most clearly mobilised in times of distress or unsettlement (see also chapter 
nine) and Szasz (1974) states tha t illic it drugs, those who use them and those who distribute 
them, have become scapegoats w ith in society. He maintains that unlike those ancient 
societies perform ing a ritual, we no longer recognise when we use a scapegoat w ith the aim 
of cleansing or ridding society o f things which do not conform to moral order. Now we use 
'scientific' reasoning to  explain it [i.e. the medicalization of drug use, drug users and hepatitis 
C (Fraser and Moore, (2011)].
Thus, both those w ith hepatitis C and the hepatitis C treatm ent are enacted and materialised 
as scapegoats. Hepatitis C as a virus which is transmissible (infectious), long term (a 
significant cost to  the NHS if treated and potentially more so if untreated) and passed on via 
stigmatised practices (injecting drug use) does not conform to  the order o f society and thus, 
must be eradicated.
Moving on from hepatitis C
A significant number of participants enacted treatm ent as a way o f 'moving on ' (Daniel) from 
hepatitis C; o f leaving negative assumptions and an 'abject' identity behind though 
consigning drug use and hepatitis C to  the past, (explored below) was not always possible or 
desired by all participants. This focus on treatm ent as a part o f 'moving on ' re-produces the 
person w ith hepatitis C as someone who needs to  take responsibility for their health (Harris,
2010) and, thus, provides an opportun ity for a kind of scapegoating. This is particularly 
visible in Grace's te lling of an encounter between her and someone who was not accessing 
treatment:
'He weren't on treatm ent he said 'there is no point in me having treatm ent because I
don't have anywhere to live.' I goes 'tha t doesn't stop you having treatm ent so it  s all
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self-inflicted, street druggie refusing treatm ent who was sitting there actively 
contagious. A t least I am doing something to stop myself being contagious. I don 't 
want to s it next to someone who is rife w ith it  and who isn't doing anything. M ind you,
I was contagious fo r  years and d idn 't know it.'
Here, Grace reproduces discourses around treatm ent ['get tested, get trea ted / (NHS 
Choices, 2009)] w ith  a lack o f focus on the context o f the man's life. Treatment becomes the 
rational response and those not doing it are irresponsible. Grace expresses scorn fo r 'active 
druggies' (who become scapegoats) and not doing treatm ent is enacted as a personal 
refusal, rather than one which depends on taking a holistic view o f the person's 
circumstances and treatm ent by health professionals (see Fraser and Seear, 2011), in the 
context o f lim ited resources. There are parallels here w ith Anthropologist Murphy et al.'s 
(1988) observations of the way in which disabled people are treated as if they are 
'contagious' and that ostracism is increased when there is a perception that someone is 
responsible fo r the ir impairment and disablement (revisited in chapter nine.)
The ambiguous nature of hepatitis C is also visible here. Grace describes the man as 'actively 
contagious'. However, she later realises that it is impossible to completely separate herself 
from him and the disruption of separation and binary occurs again. Derrida (1981) explores 
the ambiguity o f the pharmakos noting they are positioned on the boundary between inside 
and outside. He states that the ritual ceremony of purification, referred to above, allows the 
community to  redraw its boundaries as closed, protected and cleansed of the threat (just as 
medicine positions treatm ent as cleansing the body). But, the pharmakos actually disturbs 
this. These scapegoats are both outsiders and insiders; the embodiment o f that which must 
be expelled, but an integral part o f the community for the role they undertake (Hughes, 
2000, Kumari-Campbell, 2009). For example, the ultimate aim of pharmaceutical treatments 
is to eradicate hepatitis C and, as argued above, this sole focus on eradication works to
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position people w ith  hepatitis C as outsiders. Yet, in order to develop effective treatments, 
people w ith  the virus (with increasingly complex life circumstances -  see Swan, 2013) are 
required to  participate in clinical trials and thus, are integral to  its success.
Similarly, people w ith  hepatitis C who undertake treatm ent are also on the border between 
inside and outside: there is evidence that both the participants and the treatm ent become 
pharmakos in the ir interactions w ith health professionals.
Treatment was referred to  as a 'turning point' by professionals I interviewed, (e.g. specialist 
nurses and drug services workers) (see also Hopwood, et al.,2006 for examples w ithin the 
literature), where drug users ceased using and accessed treatment, and this was often 
echoed by participants:
Carl: 7 did get to a place a couple o f years ago where I went into a treatm ent centre 
and got clean and it  kind o f came back to haunt me in a big way as well because it  was 
ju s t an on-going thing fo r  me was hep C . So there was a kind o f a thing I had to deal 
with as well basically I did'.
Here, hepatitis C and treatm ent are enacted as if it is something which participants face and 
decide to  do once they enter recovery. However, there is evidence o f the notion o f recovery 
being co-opted to  f it  w ith organisational priorities (see Pilgrim, 2008; Morris-Colton, 2011; 
Stephenson-Turner and Mayes, 2011). The focus on treatm ent as something which is only 
addressed in 'recovery' obscures the power relationship between the person w ith hepatitis C 
and the professionals who do not offer treatment until they participants stop using illicit 
drugs. Here the concept o f the 'turning point' narrative enacts drug use as being in the past 
and creates a false division between past and present, simultaneously marginalising the 
possibility o f treating people who still use drugs.
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As discussed in chapter six, this division is materialised in oppressive interactions w ith health 
professionals. For example, Kerry described being told at her first hepatologist appointment 
'I'm assuming you're an IVdrug user.' This meant Kerry was forced to  indicate that her drug 
use was in the past, before the interaction proceeded reinforcing drug use as 'o ther' and 
impacting on her emotional wellbeing.
This also enacts a false division between illicit drug use as 'bad' and treatm ent as 'good'. 
Recently explored in relation to methadone for people using drugs, as both a treatm ent for 
chronic pain and an opiate substitute, Keane (2013) highlights how the division between the 
two methadones is untenable. Nevertheless, this separation is visible in that participants 
described accessing support to  manage and recover from 'bad' (illicit) drug use, but not to 
manage 'good' drug use (hepatitis C treatment); silencing the ambiguous nature of 
treatment.
Elsewhere, both hepatitis C treatm ent and participants are enacted as pharmakos. In an 
interaction w ith  his orthopaedic surgeon, David describes being told that an operation would 
be postponed until after he finished treatm ent because ‘the consultant [d idn 't] want to put 
his surgeons a t risk1 (also described by Morgan and Ken). When David challenged this, the 
'turning point' narrative (i.e. the division before and after drugs) is used to  assuage David's 
anger:
'[The consultant said] we are leaving you here till we have done your shoulder. But 
then w e'll do your neck before we operate on your knees. He had operated on my 
knees twice before but d idn 't know I had hep C then. I jus t had this bad feeling. Anyway 
when I went to see my GP and I said 'is i t  okay i f  I see another specialist?' She turned 
round and said 'it's mad you think this [o f the specialist] because he has written a dead 
nice le tte r about you! Saying how you have turned your life around' and I did say 'well 
yeah he is really lovely and I fee l a b it bad but he is definitely not sympathetic to people
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with this blood borne disease, and should he not be treating everybody in the same 
category?'[By using universal precautions]
Here David is positioned both on the inside and the outside of the comrnunity (and the 
responsibilities o f the NHS). Having 'turned his life around' he is a compliant, responsible 
citizen and no longer a drug user. However, he is positioned on the outside because his 
blood poses an infection risk to the surgeons.
In bringing this section to  a close, the final point I wish to  make is that the current emphasis 
on doing treatm ent enacts those w ith hepatitis C as scapegoats (pharmakos) and reinforces 
treatm ent as the only way forward w ith hepatitis C. Additionally, the pharmakon of 
treatm ent becomes a kind o f pharmakos, enacted as the 'cure all' fo r hepatitis C, displacing 
the need fo r support.
As noted above, clear divisions between 'previous' lives which involved drug use and 
hepatitis C were not always desired or maintained by participants. Many participants fe lt 
that hepatitis C was an on-going part o f their lives (even if they cleared it) -  consistent w ith 
the concept o f recovery described by Deegan (1988), Daddow and Broome (2012) and 
Pilgrim (2008). Recovery is recognised as a polyvalent concept which is concerned w ith living 
well w ith this does not necessarily mean being cured and moving on, but incorporating 
experiences into life (discussed in chapter eight).
Many participants challenged the notion that hepatitis C could, or should, be left in the past,
by continuing to  support people w ith hepatitis C and those on treatment. They did this by
attending support groups, raising awareness in their local community, sharing their
information and experience and acting as a kind of 'living proof' of life beyond hepatitis C
and its treatm ent. Others indicated that it would remain part of their identity in the ir family
life and in future work. At the time o f interview, Kerry was writing her autobiography and
felt that her experiences w ith drug use and hepatitis C would be central to  this. Shaun and
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Ben also indicated that the ir hepatitis C status could not be relegated to  the past after 
clearing it, because negative judgements persisted about ever having had it.
Given this chapter's length, and the vital importance o f participants' experiences post 
treatm ent, a short chapter follows which explores this in more depth. Similar to  chapters 
three and four, this is not easily separated but is done to  ensure im portant points are not 
overlooked.
Chapter Eight: ‘It was an awful shock... to still feel like I did’, 
experiences beyond treatment
In troduction
This brief chapter describes and explores participants' experiences after they had finished 
taking combination treatm ent, a phase usually considered (and enacted) as being beyond 
the boundaries o f medicine (Fraser and Seear, 2011) and consequently poorly addressed in 
the existing literature (Hopwood, 2013). However, Van der Geest et al. (1996) indicate that 
medicines have a life after they are taken, specifically how they affect the wellbeing o f the 
person who took them. This will be the focus of discussion. As has been explored 
throughout, medical treatm ent is a key response to  hepatitis C in the UK. Current guidance 
recommends tha t participant blood is tested for the presence of the virus at the end of 
treatm ent (either 24 or 48 weeks), then at three months and then again at six months 
(Hopwood et al., 2006). If the virus is 'undetectable' at six months following treatm ent 
completion, this is considered a sustained virological response (RCGP, 2007; NICE, 2006) in 
other words, the virus is supressed or eradicated and hepatitis C is 'cleared' (Pears, 2010; 
NICE, 2006) or even 'cured' (Dusheiko and Burney, 2013; Liang and Ghany, 2013).
Here, I am reminded o f the words of Australian Sociologist Kane Race (2001:168), who, 
speaking in the context o f HIV, maintains that the (viral load) test result functions as a 
measure o f both individual and public health. He refers to the 'ability o f medical 
technologies to  determ ine tru th  and prescribe courses of action'. At present, if at six months 
post treatm ent the test no longer detects the hepatitis C virus, it is understood to be no 
longer causing damage to  the liver and no longer transmissible to others. For people w ithout 
severe liver damage129, professional input in relation to hepatitis C stops. However, fo r many
29 For people with Cirrhosis (permanent scarring of the liver, which cannot be reversed), monitoring 
and support from a liver specialist will continue even if the hepatitis C virus is cleared (RCGP, 2007).
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participants, attaining SVR did not necessarily equate w ith improved health. Here the 
hepatitis C treatm ent, test and result organise and enact participant experience in ways 
which are commensurate w ith what medicine can offer, rather than paying attention to  
forms o f support participants might need.
Race (2001) and Persson et al. (2003) also discuss the shifting contingent nature o f health 
and how the HIV test enacts a person as 'healthy7, or indeed treatm ent as 'successful7, whilst 
the embodied experience may be very different.
In a recent question and answer session in partnership w ith The Hepatitis C Trust, Graham 
Foster130 (2013) acknowledges that 'clearing7 the virus is still a controversial area. There is 
still some evidence that traces o f the virus can remain present in the blood (though he 
maintains tha t the virus is not transmissible or damaging). Foster (2013) explained that 
because it is impossible to  be sure that the virus will not return, those who attain SVR are 
still barred from donating blood.
In Foster's (2013) response, the reality enacted at the end of treatment hangs together with 
the attainment o f SVR (the virus is neither transmissible or damaging), whilst at the same 
time not cohering w ith regard to  future blood donation (it is impossible to  be exactly sure). 
In the same way, hepatitis C is enacted as 'cleared7 in the reality o f the PCR test but enacted 
very d ifferently in participant descriptions. As Persson (2004) indicates, a virus may not be 
clinically apparent, but is very much present, socially and in participant's bodies.
The discussion of post trea tm en t effects in the lite ra tu re
Clinical studies researching the effectiveness of treatment have reported that quality o f life, 
post treatment, improves both in terms of physical and cognitive impairment (Ware et al., 
1999). Further, at six months post treatm ent there is no evidence o f persisting impairment
30 London based Consultant Hepatologist and Professor of Hepatology
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compared w ith  before treatm ent (Thein et al., 2007). However, Hopwood (2009; 2013) 
points to  persistent interferon based neurotoxicity among people treated fo r hepatitis C, 
which results in a wide range o f impairment effects, both physical and psychological.
A small number o f qualitative studies have explored the on-going impact after treatm ent 
ends, and post treatm ent and support remains an under researched area (Fraser and Seear,
2011). To date, Hopwood (2009,2013) and Paterson et al. (2006) are the only published 
studies which explore post treatm ent experiences and these are in an Australian and New 
Zealand context. Some studies exploring qualitative experiences o f hepatitis C treatm ent 
briefly mention the post treatm ent experience w ithout elaboration. For example, Janke 
(2008) reports tha t participants fe lt that the anger they had experienced whilst on treatm ent 
did not dissipate as they had expected, and Sternhell et al. (2012) refer to the persistence of 
mental health needs after treatm ent. Similarly in a study carried out in the Republic o f 
Ireland concerning patient satisfaction w ith specialist nursing support, Grogan and Timmins 
(2010: 2871) surveyed patients six months after treatment, stating that they did not wish to 
'burden' patients on treatm ent and implicitly acknowledging a six month recovery period 
(though they make no justifications fo r this time period in the study.)131
Loveday and Dore (2009) indicate that the immediate period post treatm ent may require 
additional support, due to  on-going treatm ent effects and coming o ff treatment. They 
maintain that clinical contact should be on-going and that this should not solely be provided 
at the six month confirmation o f SVR. In the UK, the only acknowledgement or explanation 
of the post treatm ent experience, to date, exists in the form of a survey conducted by The 
Hepatitis C Trust (2010b) (discussed below); thus opening up significant space fo r exploration 
of the post treatm ent experience and support needs in the UK.
131 Though this might also be interpreted as an attempt to gain an 'overview (Mol and Law, 2002) of 
the treatment experience given that participants in this study described their needs altering from day 
to day whilst on treatment.
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It is im portant to  note that not all post treatm ent effects that participants experienced were 
negative. A small number o f participants in the sample who had finished treatm ent at the 
tim e (three o f the 16) described feeling better after treatment. This is what Hopwood (2009) 
refers to  as a sense o f renewal. As Charlie indicates he experienced a burst o f energy:
'As soon as I came o ff the treatm ent within two or three days it  was like someone 
switched a ll the lights on this amazing feeling o f energy and almost feeling hyperactive 
really and tha t lasted fo r  months -fee ling ... really, really excitable really, really good 
and I knew it  had gone.'
However fo r many participants, attaining SVR did not necessarily equate w ith improved 
health. Participants referred to  'post treatm ent effects' and the need for greater attention to  
this period was raised as a specific issue:
JB: 7 th ink there are lots o f issues post treatment which still need to be researched -  
not only emotional but physical, and people are still depressed even i f  the treatm ent is 
successful'.
In the most extensive qualitative exploration of post treatm ent to  date, Hopwood (2009; 
2013) found tha t although a m inority o f the participants he interviewed did feel better, most 
did not, and some fe lt worse after the treatm ent than before it. This finding was also 
supported by a recent Hepatitis C Trust survey (2010b) (of 500 participants) which found that 
90% of the respondents experienced on-going side effects and symptoms for longer than 12 
months post treatm ent. Only 31% o f respondents reported feeling better 40% actually fe lt 
more unwell, irrespective o f SVR. The survey found a low correlation between attaining SVR 
and feeling better, and pointed to  the need for further research in this area.
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My purpose in this chapter is to  explore participant experiences of post treatm ent and the ir 
support needs but also the way in which post treatm ent is effectively made absent, or 
'othered' (Law, 2004), from hepatitis C treatm ent realities, via specific social and cultural 
beliefs and processes. This leads to  the invalidation of participants' experiences and impacts 
on the ir psycho-emotional wellbeing (Reeve, 2002; 2004; 2012a).
Drawing on the suggestions o f Hopwood (2009), and given the links to  cancer already 
outlined w ith in  this thesis, cancer survivorship literature is drawn upon in order to  derive 
some lessons fo r the development o f post treatm ent services. The application o f the 
concept o f recovery is also briefly explored.
Defining post trea tm en t effects
Post treatm ent effects are defined as impairments which continued, or became visible, after 
participants finished the course of treatment. Of the participants who had finished 
treatm ent at the tim e o f the interview (16), 12 described post treatm ent effects. The 
duration o f post treatm ent effects ranged from 14 weeks to five years. It is acknowledged in 
some patient information that treatm ent can take up to six months to recover from (Porter, 
2008). However, many o f the participants I spoke to  described being unaware that this 
would be the case, or did not believe that it would happen to them.
Participants described a range of impairments after the end of treatment, including fatigue, 
jo in t pain, brain fog and memory problems, low mood and depression, gastrointestinal 
issues, rashes and feeling 'put through the wringer' (Laurie). Carl explained that fo r three 
and a half months after treatm ent, he experienced both physical and psychological effects:
'I fe lt  really low  and I fe lt  really shit and I fe lt  really jus t the same ...It was ju s t a re lie f 
when I used to wake up on a morning and put the kettle and get the milk out the fridge
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and yeah oh there s no injection. And that was the only way I could te ll fo r  the firs t fe w  
months tha t I wasn't s till on it, the side effects were still there'.
Although the treatm ent may be physically absent from his fridge, it continues to  be present 
and working in his body. Others reported much longer post treatm ent effects, fo r example 
Andrew stated 'sometimes I fee l like I'm still on it  and that's from  two years ago'.
All but tw o  o f the participants who reported post treatm ent effects in this study had attained 
SVR. Keith had attained SVR at the time of interview, but did not feel well enough to  return 
to  work due to  on-going treatm ent effects. Morgan and Steve also described feeling they 
could not return to  work due to  difficulty concentrating. Morgan was self-employed as an 
alternative health practitioner and described how feeling physically well, and present in her 
own body, was a vital part o f her job. Freda worked all through treatm ent, but in our last 
correspondence, having finished treatment, she was seeking support fo r depression. Pixie 
experienced the onset o f rheumatoid arthritis. All participants fe lt these effects were 
connected to  long term  effects o f hepatitis C and treatment:
Pixie: 'It's like I have been diagnosed with rheumatoid arthritis132, I finished treatment 
three years ago - so a lo t o f people w ill ju s t say well, maybe you were ju s t going to get 
i t  anyway... But being as it  is an autoimmune disease I also fee l tha t it  could have been 
treatm ent tha t set this o ff  because what I am getting is what other people I see a ll the 
time the jo in t pain and s tu ff like that so I think we need to be looking fa r  more a t post 
treatment. [People] need to be looked after'.
JB described being initially sceptical o f the long term effects of treatment (explored further 
below), but had taken an overdose in recent weeks whilst waiting fo r his six month post 
treatm ent SVR:
Ferri et al., (2012) discuss rheumatoid arthritis as an extra-hepatic impairment resulting from 
hepatitis C infection, again making the division between impairment related to hepatitis C, treatment 
and post treatment untenable.
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'It wasn't till I had fa llen in tha t black hole and attem pted suicide tha t I thought there 
was something in this.'
It is in JB's example tha t hepatitis C treatm ent as pharmakon is readily apparent; JB cleared 
the virus but also experienced serious mental distress alongside.
Participants who experienced post treatm ent effects described being placed in a similar 
liminal (Turner, 1966; Treloar and Rhodes, 2009) position to that they inhabited prior to  their 
diagnosis, where they knew that they still required support, but were disabled by existing 
structures o f services (no medically authorised 'label' which validated the ir experience, no 
clear information and lim ited support) and subsequently found a lack of awareness and 
recognition (see Jackson, 2005 for a similar discussion in relation to  people living w ith 
chronic pain). Furthermore, there was even less support available than when participants 
were on treatm ent, as they fe lt medical support was no longer an option.
There is a fu rther parallel between hepatitis C treatm ent and cancer treatm ent here. Stacey 
(1997) also reported falling into a post treatm ent gap. Once her cancerous tum our was 
removed, it was unclear whether she had cancer or not. A good example of this was present 
in the group interview:
Andrew: '  I f in d  i t  hard they [specialist team] said it  [hepatitis C test result] was clear, 
said it  was clear a fte r the firs t month and 6 months, then a year or so after... The 
results te ll you you're clear and that and then it  says you're less that 30 parts per 
million which counts as you not having it. Does it  mean you haven't got i t  [hepatitis C] 
or does it  mean there may s till be a little  fraction o f i t  there?
Brad: ...They count down as fa r  as 30 parts... They have no idea whether it  s there or 
not. It could be 29 parts or there could be no parts there, yeah, anywhere from  nought 
to twenty nine.
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Worker: ...It s because you don 't get a definitive answer as to you haven't got i t  isn 't it?  
It's the way it's  actually measured and there has got to be some sort o f line drawn as 
to how it's measured and that's how they do it. '
The worker's comments at the end of the extract regarding the lack o f 'definitive answer' 
make the fluid boundary between having and not having hepatitis C visible. Stacey (1997) 
discusses how cancer narratives never offer a complete resolution and Harrow et al., 
(2008), in the ir study of partners o f women w ith breast cancer, similarly describe 
difficulties and feeling 'in limbo' following treatment, wondering how and when to  move 
on. Schmid-Buci et al. (2011) in her study of the needs of people w ith breast cancer and 
their relatives, found that after treatm ent patients did not return to  the state o f health 
they had been in prior to  illness onset, but had a specific set o f needs (see also 
Hodginkson et al., 2007). Others referred to on-going impairment such as 'chemo brain' 
(Abel and Subramanian, 2008). Those living w ith different types of cancer have also 
highlighted the need fo r greater information and support (see also Thomas et al., 2001). 
Among these was the need fo r support w ith treatment related impairment and future 
health, as well as emotional support, practical assistance and financial advice. Post 
treatment, people w ith cancer reported feeling depressed, uncertain about the future 
and worried about recurrence (Oxlad et al., 2008). Whilst these problems are not exactly 
the same fo r people w ith hepatitis C, they do make a wider point concerning the impact 
of a long term  health condition and a d ifficult treatment. Both o f these groups [part o f 
Frank's (1997) 'remission society'] share common experience regarding disabling 
structures and barriers, and as such provide a potential point o f identification fo r jo in t 
work and activism.
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Feeling prepared  for post trea tm en t effects
A key finding o f this research was the variation in the degree participants fe lt prepared for 
post treatm ent effects and the ir long term nature. As Brad described:
'Yeah [the effects] went on fo r  ages afterwards months ... I assumed the week a fter I'd  
had tha t treatm ent tha t I was going to fee l on top o f the world. It was an aw ful shock 
after 48 weeks to still fee l like I did'.
Similarly, although Laurie described experiencing support and encouragement from  the 
specialist nurses, the only post treatm ent information he was provided w ith was the 
duration o f the wait until his PCR test (to see whether the treatm ent had worked):
Heather: And no one spoke to you about this?
Laurie: NO! - Not a word, ju s t 'x weeks to your PCR test'. The nurses were excellent, 
wished me a ll the best, to ld me how hard I had battled, hugged me, but counselling 
and advice on post-TX (treatment) d idn 't exist.
Here, in the lack o f information and support, the remedy aspect o f treatm ent is given 
priority, re-enacting the 'heroics' and authority of medicine (Fraser and Seear, 2011; Marks, 
1999.) The cure aspect o f pharmakon is maintained. Laurie finishes treatm ent and is 
congratulated by the staff, but should only return to confirm that the virus is cleared, no 
further support is offered and the toxic aspect of treatment o f pharmakon is silenced. Other 
participants reported a lack o f information from their specialist team until near the end of 
treatment, and only knew about it from their own research.
Morgan: 'Actually I knew how long it  took to get over treatment, you know, because o f  
the research I'd  done, but they don 't te ll you till the end o f treatment - and that can 
come as a horrendous shock to people. I mean my specialist - 1 knew it  was going to
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take three to six months to recover from  the treatm ent - but the specialist d idn 't te ll 
me tha t 't il my last session'.
As indicated above this raises a number o f pertinent issues. It mirrors Hopwood's (2009) 
findings tha t consent forms fo r treatm ent do not adequately cover the experience o f post 
treatm ent and raises ethical questions about offering treatm ent w ithout alerting participants 
to  the possibility o f long term  treatm ent effects. There are also implications fo r the 
relationship between Morgan and the consultant, and about how likely she is to  return to  
him fo r support. The lack o f information, advice and recognition also has very serious 
consequences fo r those participants who may be expecting (and expected) to (return to) 
work at a pace shared by colleagues, and raises questions concerning seeking and receiving 
accommodations or financial support (see chapter nine).
The failure to  acknowledge post treatm ent effects further undermines the experiences of 
those who experience them. Participants may not be aware that these are post treatm ent 
effects when they do occur, which may cause unnecessary stress or anxiety, and may place 
further strain on relationships w ith friends and family.
It is im portant to  note here tha t it may be that participants were informed o f the possibility 
of post treatm ent effects at various points. Indeed, both Brad and Andrew reported feeling 
that they had been given ample information and yet still not anticipating the effects, 
suggesting that more than information is required. As mentioned above, this could be 
connected to  participants believing that the post treatm ent effects would not happen to 
them [what Hopwood and Treloar (2008) term 'unrealistic optim ism ']. Yet it is also possible 
that the post treatm ent effects were not fully absorbed or considered by participants 
because they were not enacted and materialised as serious in the provision o f fo rm a l support 
services. Information indicating that post treatment recovery may take some time is difficult 
to absorb if it appears that in practice, no further support is required.
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Grinyer (2009), in her research exploring the longer term support needs o f young people 
who survived cancer, states that provision of information concerning the possibility o f post 
treatm ent effects is a d ifficu lt balance to strike. She highlights the dilemma o f informing 
participants about the possibility o f longer term treatm ent effects which they may not 
experience, potentia lly producing anxiety in the process or, alternatively, leaving them ill 
prepared and unsupported in the event they do experience late effects. Grinyer (2009) 
resolves this dilemma by recommending that professionals emphasise it is one possible 
outcome paying attention to  the multiple nature of treatment. Here, Mol and Law's (2002) 
observations regarding the 'overview' o f experiences are pertinent. It is d ifficult to  make 
wide ranging recommendations w ithout losing the nuanced nature o f post treatment. 
Observations are partial, contingent and dependent on a range of factors, thus 
recommendations should accommodate this contingency where possible (see appendix one).
Experiences of invalidation
The lack o f recognition and validation of the ir post treatm ent experiences, coupled w ith the 
expectation o f a clear division between being ill and being well (Frank, 1997) has implications 
for participants sense o f entitlem ent to  peer support. Pixie and JB described forum 
participants feeling that they could no longer post after attaining SVR. This led to  the 
development o f a 'post treatm ent' section on the forum, explicitly acknowledging It as a 
specific phase o f the hepatitis C experience:
Pixie: 'Lots o f people fee l guilty, because they have cleared the virus and there's no 
reason why they should be feeling like they're feeling - you know still tired and that. 
They are wrestling in their minds o f whether or not it's themselves and they're ju s t lazy 
and tha t they should be better motivated and s tu ff like that they do tend to fee l a b it 
guilty so I'd  like to see a t least tha t they could go and discuss symptoms after
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treatm ent w ithout fe a r o f being dismissed that they should really be getting on with 
their lives. Just a little  b it more care'.
Here, Pixie makes reference to  the possibility that forum participants have internalised the 
idea that they are lazy or weak, rather than unwell (also described by Glacken et al., 2001; 
Dunne and Quayle, 2001), and this is explored more in chapter nine. She further indicates 
that in contact w ith  others on the forum, she has found post treatm ent effects dismissed or 
not taken seriously by professionals. This highlights the need for fu rther longitudinal 
research into the experience o f post treatm ent and for clear information and training 
produced by governmental or charitable organisations regarding the possible longer term 
effects of treatm ent, which could be updated as more information becomes available, and 
which should be tailored and disseminated to GP's, DWP workers, family members and 
employers. The liminal status of participants' post treatm ent experiences also had serious 
implications fo r participants' own sense of self and social relationships, as Morgan describes 
below:
'Well I think, well once you've finished the treatment you should be fine, you know, 
you've got rid  o f the virus, you've finished the treatment, what's your problem?... Why 
you aren 't fine  now, get back to work what's wrong with you? (Laughs)'
Here Morgan's comment 'get back to work, what's wrong with you?' hints that she has 
absorbed w ider perceptions that she is somehow acting dishonestly by not working post 
treatment, explored in chapter nine. Importantly, Morgan described a lack o f support from 
some friends post treatm ent, describing a sense that she was somehow acting deceptively or 
manipulatively in experiencing on-going impairment when she was told to 'stop milking i t '
This is potentially linked to  w ider cultural beliefs and values around illness as outlined by
Harris (2009a). W ider society is less tolerant or accommodating of illness which extends
beyond a period o f tim e or does not have a clear or discernible end point. There are
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some commonalities here between hepatitis C experience and the grieving process 
explored by Patricia Hentz (2002). Hentz (2002) found that the non-linear experience of 
grief and its unpredictable nature was difficult for others surrounding the grieving person 
both to  accept or address (Hentz, 2002). For the person grieving, these experiences were 
subsequently silenced or hidden.
Further to  this, participants interviewed as a couple described initially being sceptical about 
the presence o f post treatm ent:
JB: 7 would diss it  [post treatm ent effects]. I would say 'oh that's a load o f rubbish it's  
because o f the ir lifestyle. They should get out and get a job, get up and do something 
you know get o ff their arses and get their head in gear', you know -
Pixie: I'm  not ju s t trying to say it's  drug users - what I'm trying to explain is the
people who had been drug users, I always fee l tha t you know - in a way - they have 
always got issues and that's why they went down that road. There is no getting away 
from  it  they had issues. So pa rt o f me wondered jus t because they have done the 
treatm ent and cleared the hep C whether these issues were still there in their 
heads...Then I got more and more into it  and I would ask them how they got hep C or 
we would discuss that'.
Pixie explained it was only when she realised the post treatment effects were experienced by
people who 'go t up every day, went to work, came home, d idn 't have any problems' that she
and JB took it seriously. Here the post treatm ent effects intra-act w ith participant's life
histories, circumstances, w ider cultural and societal values and assumptions related to
hepatitis C and drug use, to  enact them in persistently negative ways. The connection [or
conflation, Harris, (2005)] between hepatitis C and injecting drug use intra-act w ith w ider
public perceptions of people who use drugs, as weak, unproductive and deceptive (see Lloyd,
2010). Thus post treatm ent effects are enacted (and dismissed) as an inherent personal fault,
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rather than an iatrogenic im pairm ent. Similar observations have been made by Spandler and 
Calton (2009) in the context o f im pairm ent effects caused by mental health 'trea tm ents ':
'Patients' com pla in t about the secondary mental illnesses caused by medical 
in tervention (iatrogenic harm) are frequently interpreted as a facet o f the ir putative 
'd isorder', arising from  a 'lack of insight' or a 'sym ptom ' o f the underlying disease' 
(Spandler and Calton, 2009:247).
Here trea tm en t as pharm akon  is made visible again. It enacts those who experience post 
trea tm ent effects as pharmakos (scapegoats) fo r the 'failures' o f medicine. The lack o f 
in form ation and support silences post trea tm ent issues and relegates them  to  the individual 
domain. Further to  this, in the context o f hepatitis C, the mode o f transmission enacts those 
who use (or used) drugs as pharmakos (scapegoats) amplifying the connection to  drug use 
and silencing the w idespread nature o f post treatm ent effects among those who have done 
treatm ent. There is a need fo r w ider acknowledgement and responses to  the post trea tm ent 
period, although as Steve stated in relation to  support post treatm ent:
'It sort o f  stops, it  was about fo u r  days to a week and I fe lt  like I could run a marathon. 
Basically I was fu ll  o f  energy bu t you're le ft on your own and a fte r tha t in itia l spurt, 
you're le ft in a b it o f  a void there. It was' yes you've done it  yes you've cleared the 
virus, and now  it's  a m a tte r o f three months, six months and you're clear'. There is 
none o f  this 'in between you m igh t fe e l a b it down or you m ight fe e l a b it up, o r in- 
between you could fe e l to ta lly  depressed between here and there, you have been on a 
long course o f  heavy drugs.'It was just... 'you have done it, well done.'
Here, Steve describes the in itia l euphoria o f finishing treatm ent and then feeling as if he was
in a void (see also Hopwood 2009) w ithou t any kind o f support from  the professionals, or
any indication o f how he m ight feel, fu rthe r enacting hepatitis C trea tm ent as a public health
measure rather than a personal one. With successful treatment, the long term possibility o f
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needing a liver transplant or experiencing liver cancer or failure is reduced. However, this 
focus overlooks and marginalises Steve's current experiences and needs.
This kind o f response fails to  recognise the impact o f the treatm ent on the person, the ir 
social network and the ir w ider life circumstances. Steve stated he had a support network 
around him post treatm ent. Although support networks should have constituted an area of 
assessment and discussion w ith the specialist team (see Treloar and Hopwood, 2008 and 
Rolland, 2008) prior to  commencing treatment, the lack of acknowledgement o f post 
treatm ent effects by services, described above, raises issues about how well prepared 
support networks are fo r the post treatm ent period, and points to  the need fo r information 
and support fo r the individual and their w ider social network.
Nursing scholar Barbara Paterson et al. (2006) suggests this lack of post treatm ent support is 
indicative o f a bigger issue concerning the structure and delivery o f medicine: Three of the 
participants in Paterson's study indicated that even though they had cleared hepatitis C 
spontaneously or through treatm ent, they still fe lt that they had a chronic illness. Here the 
ambiguity between health and illness is enacted; there is not a clear division (Race, 2001; 
Persson et al., 2004; Harris, 2010) between being healthy and being unwell. Paterson et o/.'s 
(2006) participants described how they fe lt they were unable to  access support from doctors 
and specialists, both because they fe lt that they did not wish to return to  the clinic 
environment (Grinyer, 2009; Hopwood 2009) and also because they no longer had a tangible 
impairment to  'cure' the restorative power of the medical profession is muted (Persson, 
2004) and therefore, medical support is withdrawn. A similar phenomenon was reported by 
Abel and Subramanian (2008) in the ir study o f women who experienced post treatm ent 
effects fo llow ing breast cancer, and also by their partners (Harrow et al., 2008), which 
suggests it is perhaps not only about the 'high profile' nature of the disease (cancer), as
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posited by participants in chapter six, but w ider expectations concerning the dominance and 
authority o f medicine.
Paterson et al. (2006) (see also Harris, 2005) describe how this results from the medical 
model o f the body as a machine in need of fixing and the fragmentation o f the body into 
particular areas o f specialism. Thus, unless there is monitoring o f a liver or mental health 
condition required, lim ited support can be offered -  especially in the context o f lim ited 
services. This leads to  fragmented care and support which does not take account o f the 
whole person. Although in my view, Paterson et al. (2006) go on to  undermine the ir own 
observations, by indicating there may be some 'need fo r psycho-social adjustment' to  life 
after hepatitis C. This focus on 'adjustment' implies that it is the individual who needs to 
adjust rather than the surrounding structures.
W ithin disability studies, scholars have drawn attention to  the medical professionals only 
being interested in those people they can cure or fix (Oliver, 1990), referring to  the vast 
amounts o f money provided to  state of the art technological cures (Marks, 1999). Those 
who cannot be 'fixed' are not the recipients o f funding or support. In a 2004 paper, Reeve 
refers to  this as a form  of psycho-emotional disablism, enacting those who cannot be cured 
or effectively treated as being of limited worth.
Similarly, a hierarchy o f disease prestige has recently been reported by Album and Westin, 
(2008; see also Norredam and Album, 2007). The authors reported that higher prestige was 
afforded to  impairments which primarily affected younger people, were centred on vital 
organs in the upper part o f the body and involved technologically innovative intervention. 
Hepatitis C's conflation w ith injecting drug use, blood borne nature, impact on the liver, 
association w ith an older (and increasingly ageing) population, and until recently, relatively 
limited technological innovation, potentially explain its lack of prestige.
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Interestingly, the increase in the profile o f hepatitis C [recent features on hepatitis C 
treatm ent have appeared in The Wall Street Journal (Whalen, 2013) and the Financial Times 
(Knight, 2013)] may be connected w ith the increase in new treatments (and profits!) 
maintaining the authority o f medicine and its power to  cure, fu rther marginalising the need 
for social care funding and obscuring the differences in funding provided to  social care 
compared w ith  the NHS (Roulstone 2012).
Post trea tm e n t support models
In addressing the ir post treatm ent needs, participants indicated that they required w ritten 
digestible inform ation and advice on addressing the after effects both physically and 
mentally, along w ith support and validation from professionals that this was part o f the 
treatm ent experience:
Laurie: 'Explanations on how long it  would take to get the chemo out o f the system 
advice on cleansing the chemo, explanations and help on the symptoms o f post-TX 
(treatment). Lots o f people fin ish and go straight back on the bottle or drugs, swapping 
one chemical (chemo) fo r  another addiction It happens - frequently. Happened to my 
brother big time'.
Here Laurie raises concerns regarding a return to  drug use following treatm ent after he 
witnessed this happen to  his brother. Similar concerns have been raised by Harris, (2009b) - 
discussed in chapter seven - suggesting that support post treatm ent also needs to 
incorporate drug service professionals.
The treatm ent as pharmakon is again made visible when Laurie and Morgan highlighted the 
need for advice on clearing the treatm ent from their bodies. Laurie's request for information 
on 'cleansing the chemo' acknowledges the medication effects may feel worse than hepatitis 
C itself(Jenner and Scott, 2008). Morgan described needing to  know how long this would
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take, as well as advice and information concerning the itching and rashes she fe lt were 
caused by the seeping o f toxins through her skin.
Here the messy and unbounded natures of participant bodies, and of the treatm ent, are 
made visible. This links w ith Hughes's (2012) work, which draws attention to  the dominant 
understanding o f disabled bodies (and bodies w ith hepatitis C) as unruly and unpredictable - 
the opposite o f the ideal (but illusory) clean, contained (hepatitis C negative) body (see 
Shildrick, 1997; Shildrick and Price 1999). The extent o f this illusion is made visible in that in 
attempting to  achieve bodily cleanliness and closure, bodily leakiness and mess become 
more apparent.
Other participants referred to  the need for post treatm ent counselling '[because] a fter 
treatm ent you fee l in a way you fee l like you should be well and no one understands' 
(Morgan). Here, Morgan refers to the tentative nature of the wellness achieved through 
treatm ent and the w ider cultural expectation that medical treatm ent encourages wellness 
rather than further illness. Counselling support would recognise the commitment involved in 
treatm ent and looks beyond the treatm ent as a medical response, to  treatm ent as 
something which can affect a person's life in a much wider way.
Given the on-going need for support, Hopwood (2013) has suggested that this might be 
addressed via a post treatm ent protocol w ithin the liver clinic. Steve suggests that post 
treatm ent support could be provided via a GP:
7 think there should be an aftercare, it  should come through the GP -not through the 
hep C nurse, through the GP. They should give you maybe even a weekly check, ju s t to 
make sure you're alright. They're not psychiatrists, I know that, but jus t to make sure. 
They can get to know the person they're treating and make sure there are no subtle 
changes tha t they can see. That refer from  there. It m ight be fine, the person m ight 
finish treatm ent and not want to go but there, but there should be the option .
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This clearly this depends on GPs having adequate knowledge o f post treatm ent issues, which 
further reinforces the need fo r training and information.
It is im portant to  note here that this thesis has been w ritten in the context o f rapidly 
developing treatm ents and it is likely that interferon-free treatments w ill be widely used 
w ithin the next five years (Jensen, 2011; Rice 2011; Dusheiko and Burney, 2013; Kowdley, 
2013; Stedman, 2013), which may ameliorate some of these post treatm ent effects. Indeed 
Hopwood (2009:2) states:
'..Either the development o f a more efficacious and tolerable treatm ent is required, or 
significantly more resources need to  be allocated toward increasing the range of 
supports and health care services that are available to  people during and after 
treatm ent fo r hepatitis C infection' (My emphasis).
As has been indicated throughout the thesis, the availability o f new drugs should not be used 
to obscure the needs o f those w ith hepatitis C. There is a need fo r both newer treatments 
and adequate post treatm ent support fo r those who have been or will go through 
treatments in the future. In the context of severe funding constraints, this might be 
incorporated into existing hepatitis C services, via the addition of a post treatm ent service to 
an existing clinic, the expansion of a specialist social worker role or referral pathways to  local 
blood borne virus organisations.
Models o f support post treatm ent: inspiration and starting points
In developing post treatm ent support, Hopwood (2009) indicates that cancer survivorship 
programmes may provide a good model. The next section of this chapter will explore the 
features o f such models which could be applied to the hepatitis C treatment experience.
Attention to  cancer survivorship has increased in recent years following criticisms concerning
the lack of support after cancer treatm ent (Macmillan Cancer Support 2012b; Thomas et al.,
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2001; Abel and Subramanian, 2008). The development o f survivorship programmes and 
initiatives recognises that there are increasing numbers of people surviving cancer, together 
w ith the need to  develop integrated sustainable care and support in the context o f lim ited 
resources. Goytia et al. (2009) recognise post treatment as a distinct stage in the experience 
and this was reflected in the ir development of a cancer survivorship programme in the US. 
They described a link between the specialist services and the GP (a shared care 
arrangement), so that a range of services and information could be provided and easily 
accessible. Although this clearly depends on the relationship w ith the GP and clear 
communication between the specialist team and the general practice.
North American literary critic Emily Bartels (2009) traces the history o f what she terms a 
cultural shift in understandings o f cancer specifically the rejection of the simplistic division 
between 'sick' and 'cured' and the development o f the concept and movement 
communicating the experience being openly impaired (and disabled) after cancer. She 
acknowledges the usefulness of the 'cancer survivor' concept in highlighting the on-going 
impact o f cancer, but indicates that this too has potentially become oppressive, extending 
the reach and authority o f medicine (and pharmaceutical companies), w ith serious 
implications fo r attaining insurance and employment, and creating a long term  identity as a 
person who has had cancer.
Thus, it is not my intention to  extend the reach of medicine or pathologise the experiences 
of post treatm ent. Insights from disability studies are useful here in highlighting that 
previous impairments and experiences o f disablism, may mean that even when 'cured', a 
person may still experience disablism (see Beauchamp-Pryor, 2008).
In the UK, the National Cancer Survivorship Initiative, launched in 2010, is developing a 
support pathway specifically fo r the post cancer treatm ent experience. The Recovery 
Package' comprises o f a structured holistic needs assessment, and review, provision o f a
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treatm ent summary (DH, Macmillan Cancer support and NHS improvement, 2012; 2013), as 
well as dedicated patient support and information (Health and Wellbeing Clinics) (DH, 
Macmillan and NHS improvement, 2013). It is based on tw o key principles o f m ulti­
disciplinary working and supporting patients to  self-manage (explored below). Of particular 
value in the context o f this discussion is the recognition that 'the nature o f cancer treatm ent 
means that the subsequent consequences vary significantly between patients in frequency, 
timing, severity and impact on quality o f life -  the level and nature of support that patients 
require w ill therefore vary' (DH, Macmillan and NHS improvement, 2013:9).
Thus, some im portant lessons could be gleaned from the existing framework and piloted in 
relation to  hepatitis C, and some brief suggestions are offered as starting points.
An end o f treatm ent discussion and assessment process could be developed w ith those on 
treatm ent (to meet occurring needs there and then for instance, w ith housing or childcare as 
Keith and Kerry indicated) a specialist social worker attached to a team could help facilitate. 
This could be revisited post treatm ent to accord w ith participant experiences. This 
discussion could be multi-disciplinary in nature involving input from the medical team 
(including inform ation on fo llow  up, and on possible post treatm ent effects and how these 
can be managed, together w ith appropriate pathways for re-accessing support), as well as 
input from other involved professionals (such as substance use services and mental health 
where applicable). Importantly, this would include key contact, local service details and 
referral fo r social, emotional and financial support, as well as how to re-access the clinic if 
necessary. This post treatm ent discussion might also include discussion w ith family 
members, information on what to  expect, plus attention to  any needs that they have, 
including out o f hours support (National Cancer Action Team, 2010; National Cancer 
Survivorship Initiative, 2013).
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Each o f these areas has been shown to  be an issue fo r those on hepatitis C treatm ent. 
Whilst some o f this may already occur in part (i.e. provision o f contact details o f the 
specialist nurse), there needs to  be an easy way to  re-access support in the event this is not 
provided.
There are also parallels here w ith Marlize Moulton's (2011) study of social workers who 
identified the needs o f people on hepatitis C treatment, (though social work did actually 
exist as part o f a multidisciplinary team in this study). In the UK, social work could assist w ith 
clear information, signposting a referral to  emotional and financial support (support groups, 
peer support initiatives, Citizens Advice Bureaux), as well as providing enabling support 
during and after treatm ent.
The ro le  o f self-m anagem ent
Much o f the discussion around post treatm ent in the National Cancer Survival Imitative 
framework and increasingly, longer term  support for people w ith hepatitis C (see Groessl,
2011) is based on patient self-management. Expert Patient Programmes have been used in 
the UK since 2002. The programmes are based on the chronic disease self-management 
programme (CDSMP) developed by Professor o f Medicine, Kate Lorig, at Stanford University. 
Lorig (2002) maintains that the person living w ith the condition should be regarded as the 
expert though they may need education and training to fu lfil this role .
The CDSMP aims to  equip people living w ith long term conditions w ith the skills and 
knowledge to  manage it. Lorig (2002:814) goes on to state that the programmes are 
intended to  develop partnerships between patients and doctors (potentially challenging the 
dominance and authority o f medicine):
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Self-management programmes are focused on the problems experienced by patients, 
and disease-related problem-solving is a key self-management skill; learning to  solve 
one's own problems is very d ifferent from having health professionals do it'.
Although this suggests that it is possible to address the challenges of living w ith a chronic 
illness alone, and links to  responsibilisation.
There was little  discussion o f Expert Patients Programmes in the context o f this research 
(perhaps connected to  the barriers to participation outlined below), other than one 
participant indicating that he 'quite liked the idea' (Keith) as part o f a wider discussion o f the 
integration o f peer expertise into formal services. Yet, these are increasingly being used to 
support people w ith  hepatitis C. A recent grant to develop the programme in Bristol states:
'The courses are delivered by tw o trained facilitators who are also living w ith hepatitis 
C and/or another long-term health condition. Run over seven weekly sessions, each 
lasting three hours -  they are designed to improve quality o f life, reduce feelings of 
isolation, depression and stigma. They help deal w ith pain and fatigue, improve eating 
habits, understand how the condition can impact on your life, job and your 
relationships, reduce visits to  health care professionals and help people understand 
how to  manage the ir illness and the effects it has on their day-to-day life' (Expert 
Patient Programme, 2012).
The press release quotes the Hepatitis C Trust who state: 'Those living most successfully w ith 
the virus are those who have reached an accommodation w ith the virus in terms of 
treatment, diet and lifestyle but do not let it restrict them from the life they would otherwise 
choose to  live.'
The above extract evokes some of the concerns expressed by Medical Sociologist, Mike Bury, 
in 2010, who questions why those considered experts in managing their condition would
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need to  develop skills and training in this area. Furthermore, the focus on individual self­
management is firm ly rooted in the medical model where individual skills and abilities are 
invoked in managing problems which are seen to  be solely caused by impairment rather than 
attention to  the w ider context in which the person lives w ith a chronic illness. Indeed, the 
last sentence o f the above extract refers to  the virus restricting participants, rather than 
wider social or structural barriers, such as the low profile o f hepatitis C both among public 
and professionals, poverty, lack of flexibility in employment or lack of formal support 
services.
Whilst there may be a number o f important benefits derived from such a programme, not 
least meeting others w ith chronic illness, (which may highlight commonalities in experience) 
and improving communication and confidence w ith health professionals (which Zickmund et 
al., 2006 have noted as an issue for people w ith hepatitis C), the overall intention is to 
manage expectations and reduce pressure on resources. Indeed, John Chisholm (2012), chair 
of the self-care forum, referred to the need to  reduce 'dependency' on services, although 
Bury (2010) and Paterson and Hopwood (2010) note that this may not necessarily be the 
case and that Expert Patient Programmes may actually increase pressure on services.
In a recent review o f self-management programmes, Paterson and Hopwood (2010) 
indicated that EPPs attract and retain those who are already motivated to self-manage and 
thus, who may not be as in need of such a programme. There are also additional barriers 
attracting those from culturally diverse backgrounds or from lower socio economic groups. 
Vitally the authors found that reasons for leaving or not attending the programmes were 
closely related to  the barriers already identified in this study, including the costs of 
attending, lack o f transportation, practical and family commitments. In short, although EPPs 
may be considered a pragmatic response to severely reduced resources, rolling out these 
programmes locally fo r people w ith hepatitis C would not necessarily address the needs and
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challenges identified by participants in this thesis, indeed it may ingrain them and would 
further reinforce the individual focus on managing impairment.
The application of the concept of recovery
A pertinent difference highlighted by the widespread nature o f post treatm ent effects is the 
important d ifferentiation between recovery 'from ' and recovery 'in ' (Davidson and Roe, 
2007). Recovery 'from ' is based in a medical framework where a person's impairment, 
mental health or drug use progressively improves before reaching a clear endpoint. This is 
the current model o f support which hepatitis C treatm ent is based on. As the chapter - and 
indeed the thesis - has shown, recovery 'from ' has limited relevance. In contrast, recovery 
'in ' recognises recovery as a process which accumulates meaning w ithin the context o f a 
person's life. It does not necessarily mean being 'cured' (Deegan, 1988), but refers to  living 
well in the community.
Vitally, w ith in the context o f this thesis, Deegan (1988) maintains that recovery is not 
narrowly defined, and does not f it  easily w ith existing frameworks. Recovery is not a linear 
process but is fluid, contingent and back and forth, accommodating multiple enactments and 
the contingent nature o f the hepatitis C experience. Importantly, Davidson and Roe (2007) 
acknowledge the tw o forms of recovery can exist and intermingle. It is possible to  recover in 
some areas but not necessarily others. This would create a space to  recognise that although 
blood tests denote SVR, an individual might still face on-going impairment effects or 
disabling barriers.
However, this is not to  say that issues are not raised which need to  be further researched. 
For example, recovery has been described as a vague and polyvalent concept (Pilgrim, 2008), 
used differently by different interest groups. It becomes different objects in different 
practices (Fraser, 2011) and thus, there are criticisms that recovery is becoming increasingly
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colonised by services, especially in terms of getting people on Incapacity Benefit (now ESA) 
back to  work (Pilgrim, 2008; Morris-Colton, 2011; Stevenson-Turner and Mayes, 2011).
'Recovery in' developed from  the service user/civil rights movements of the 1960s and 1970s 
and is influenced by the recovery frameworks developed by Alcoholics Anonymous. The 
connection to  the civil rights and independent living movements are particularly im portant 
given that these recognise that the barriers faced by those in recovery are not caused by 
impairment133 but rather structural and social responses to it, and that the right to 
participation is realised not through improved impairment but by challenging disabling 
barriers (Davidson, 2008). Furthermore, the central role of peer support in supporting 
recovery (Corrigan et al., 2005; Davidson et al., 2006; Schon, 2010) has also been 
emphasised. Here new intra-actions between hepatitis C, recovery, disability studies and 
drug use (given the government's widely publicised focus on recovery) become visible. 
Clearly this is an area fo r fu rther research.
Thus, I suggest tha t the concept o f 'recovery in' might be a useful way of accommodating on­
going impairment effects and barriers related to  hepatitis C and its treatm ent -  and the on­
going need fo r support. If people on hepatitis C treatment (regardless o f drug use) were 
recognised as being 'in recovery' this would open up a space where they fe lt entitled to 
continue accessing support and address the impact on their psycho-emotional wellbeing 
w ithout pathologising them. Given the current focus on recovery w ithin both mental health 
and drug services, this might also open up a space for the development o f services both 
within the hospital and w ithin the community. Clearly these possibilities and ideas need to 
be explored further.
This chapter focused on experiences, support needs and social and cultural position of
participants a fter they had completed the prescribed course of treatment. The next chapter
133 The presence of impairment in mental health at all is disputed by some (see Plumb, 1993, 2011), 
though as indicated in chapter six, impairment may be intertwined with specific forms of disablism.
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builds on those preceding it by exploring the experiences o f welfare benefits and 
employment.
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Chapter Nine: ‘And you’re thinking, am I ill enough?’ Working 
and claiming welfare benefits with hepatitis C
In troduction
This final data chapter explores the experience o f living w ith hepatitis C in relation to  welfare 
benefits and employment. This is a major gap in existing literature and is highly pertinent, 
given the extensive and on-going welfare reform and the global economic recession. Cuts to  
welfare benefits and public services - including social care provision - will impact heavily on 
disabled people (Soldatic et al., 2012). This may further marginalise the experiences and 
needs o f people w ith hepatitis C, given the need for wider social support outlined in chapter 
seven. This chapter looks at how political forces, social and cultural beliefs around hepatitis 
C, disability, welfare benefits and drug use, intra-act and constitute hepatitis C and people 
with it, and the material consequences. The financial impact of living w ith hepatitis C and 
the process o f applying and being found eligible for welfare benefits are addressed first, w ith 
the second half o f the chapter dedicated to participants' discussion of employment.
Context
In the social research literature which is available, living in poverty and lack o f access to 
financial support is entwined w ith the experience of living w ith hepatitis C. Among people 
who use drugs, lack o f financial resources can contribute to hepatitis C transmission via the 
need to  share injecting equipment or drugs in the context o f relationships (Bourgois et al., 
2004) an area o f increasing academic interest (Dwyer et al., 2011; Seear et al.; 2012, Fraser 
2013). Limited finances frequently intra-act w ith other aspects o f living w ith hepatitis C, 
which make life more d ifficu lt (see Copeland, 2004; Banwell et al., 2005; Ogawa and Bova, 
2009; Olsen et al., 2013). In addition, pressures of living in poverty can affect ability to 
actually address hepatitis C or care (Crockett and Gifford, 2004), given the potential for
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increased expenses related to  accessing medication and support (Norman et al., 2008). In a 
US context, accessing hepatitis C treatm ent has been documented as leading to  debt 
problems (Blasiole et al., 2006). Money has also been highlighted as im portant in facilitating 
stable accommodation and the purchase of appliances and equipment to  assist w ith 
hepatitis C treatm ent (fridges, bedding, cooking equipment134) (Hopwood and Treloar, 2008; 
Harris et al., 2012a).
As outlined in the literature review, information on financial and employment status is often 
collected as a context (Balfour et al., 2004; Crockett and Gifford, 2004; McNally, 2004; 
Banwell et al., 2005; Harris, 2010; Sternhell et al., 2012), but there is little  focus on 
participants' feelings about applying fo r welfare benefits, their experience o f the process and 
the impact it has on the ir sense of self. Given the crossover between welfare policies in 
Australia -  where the most extensive body of literature around hepatitis C exists and in the 
UK (Grover and Soldatic, 2012), this chapter makes an important contribution in an area of 
research where there has been lim ited academic engagement to date. The chapter uses 
social policy and disability studies literature to explore the views of participants around 
welfare benefits. It covers how hepatitis C was enacted in interactions w ith DWP staff and on 
welfare benefit applications, along with participants' and workers' knowledge and 
understanding o f hepatitis C and benefit entitlement. In addition, it explores how 
increasingly restrictive criteria constitutes people w ith hepatitis C as being outside the 
boundaries o f support.
The enactments and arguments w ithin this chapter are necessarily situated and partial. They 
are made possible and visible in what Barad (1998) terms a 'cut' - a temporary halt o f the
134 However, it may be difficult to access such support given Community Care Grant provision ceased 
on the 1st April 2013, Crisis Loans have been dissolved (with alternatives for both provided by Local 
Authorities, suggesting that they will be provided to varying degrees) and Budgeting Loans depending 
on duration of income related benefit claim (Gov.uk, 2013).
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process o f enactment and re-enactment, which makes it possible to  look at things more 
closely.
At the tim e o f generating data, Employment and Support Allowance (ESA) had recently been 
introduced. As the thesis has taken shape and been written, major reforms to  welfare 
benefits (and services) have been announced by the coalition government; notably, fo r the 
purposes o f this chapter, to  Disability Living Allowance (DLA) (the introduction o f Personal 
Independence Payment -  PIP), Housing Benefit and the lim iting of contributory ESA fo r those 
in the WRAG135 to  12 months. In addition, newer treatments for hepatitis C are being trialled 
or have been approved (Hopwood et al., 2010; Rice, 2011; Jensen, 2011, Stedman, 2013), so 
enactments o f hepatitis C, its treatm ent and people living w ith it, w ill alter in the coming 
years.
Following the exploration o f welfare benefits, I discuss the impact o f hepatitis C treatments 
on participants' bodies and working lives. To date, much of the literature has focused on how 
hepatitis C has affected participants' ability to  work. Accounts o f obtaining adjustments in 
the workplace are scarce and little  reference is made to  the coverage of people w ith 
hepatitis C under anti-discrim ination legislation. This thesis thus makes a vital contribution 
here.
Interviews w ith participants were conducted between late 2009 and early 2011. In May 
2010, a general election took place and a coalition government (Conservative and Liberal 
Democrat) came to power. It announced that given the UK deficit and global economic crisis, 
there was a need to  drastically cut spending and services, and during the period o f writing 
this thesis huge reforms to the NHS, reduction in welfare spending and cuts to  services as 
well as mainstream public services (Williams-Findlay, 2011) have occurred. The government 
maintain that they intend to  reduce the economic deficit whilst protecting those who need it
135 Work Related Activity Group .
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(HM Government, 2010.) In reality, as discussed below, the result appears to  be the 
opposite. Williams Findlay (2011), writing on behalf of the campaign group Disabled People 
Against Cuts (DPAC), indicates that the cuts will increase the disablement o f those who 
receive services. He maintains that the cuts are ideological, rather than concerned w ith 
addressing the deficit and will fu rther oppress disabled people (among others), hindering 
their abilities to  expose disabling structures and barriers.
W elfare  benefits in the UK past and present
The next section o f the chapter briefly explores some aspects o f welfare provision in the UK, 
beginning w ith  the 1601 Poor Law and tracing to the present day. This is because some have 
argued (see Grover and Piggott 2012; Patrick, 2012; Garthwaite et al., 2013) that current 
enactments o f welfare provision represent a return to the division between 'deserving' and 
'undeserving' poor. In tracing these enacted divisions between deserving and undeserving, 
the contingent and shifting nature o f disability and disablism is exposed, it does not pre­
exist, but is brought into being though specific practices, depending on time, place, social 
and cultural beliefs.
The Poor Law: enacting and m aterialis ing the 'deserving' and  
'undeserving' poor
The Poor Law o f 1601 required local parishes to  bring up orphaned children, provide work 
for the 'able bodied' poor and support the 'aged' and 'im potent' (Borsay, 2005). The elected 
'overseers o f the poor' in local parishes were charged with putting the 'able-bodied' poor to 
work (the 'undeserving poor'), and punishing them if they did not comply, whilst providing 
outdoor relief136 to  the 'deserving poor' (those deemed unable to work). Borsay (2005)
136 Money, sustenance and clothing without the requirement to enter a workhouse (referred to as 
indoor relief).
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indicates that a postcode lottery existed in terms o f support and enforcement, which was 
further impacted by the lack of definition as to what constituted 'deserving'.
The Poor Law Amendment Act o f 1834 was built on concerns that the provision o f relief 
would deter families from  taking responsibility for their relatives and thus, reduced support 
to  such a degree to ensure it would be sought as an absolute last resort. It introduced the 
principle o f 'less e lig ib ility ' (that those receiving support should receive less than the worker 
earning the least) and ensured that the only form of support available fo r 'able bodied' poor 
was in the workhouse. Borsay (2005) maintains that these reforms were based on the 
imagined abuses o f the system (always a small minority). Further to this, concerns about 
increasing expenditure on outdoor relief led to a stringent 'workhouse test' (creating a place 
for medical assessment, discussed below) applied to everyone, which determined which 
people should be eligible fo r outdoor relief.
Grover and Piggott (2012), and Garthwaite et al. (2013) maintain that similar principles are 
visible in current government rhetoric and policy, the stance that no one will be better o ff on 
benefits than working, increasingly stringent tests (the WCA and PIP criteria) and high profile 
claims concerning fraudulent benefit claimants (Campbell et al., 2012). It is important to 
note that being determined to  be 'deserving' o f support under the Poor Law did not entitle 
the recipient to  a comfortable life. It was intended as a deterrent to others to prevent 
fu rther claims. Similarly, those in receipt of current benefits are by no means comfortable. 
Borsay (2012) and Patrick (2012) indicate that claiming benefits today continues to  carry 
w ith it a set o f assumptions that even as a 'deserving' claimant, a person is a 'lesser' citizen.
Vet, it is im portant to  note that disabled people have not always been positioned as 
'undeserving' (Bambra and Smith, 2010). Indeed, Van Oorshot (2006), in his study of the 
Swedish public found that disabled people closely followed elderly people in being perceived 
as deserving of state support. Until the 1970s disabled people were provided w ith means
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tested assistance in the same way as other non-disabled people who were unable to  work. 
However, in the 1970s, disabled people were distinguished from other claimants upon the 
introduction o f Invalidity Benefit (IVB). This was replaced by Incapacity Benefit (IB) in the 
mid-1990s and eventually by ESA in 2008 (Grover and Soldatic, 2012).
Where being on sickness benefit was previously viewed by the Thatcherite government as 
preferable to  claiming unemployment benefit (Garthwaite et al., 2013) [and used by 
government to  obscure high unemployment levels (Foster, 2007)], at present the opposite is 
true (Garthwaite et al., 2013). Unemployment is enacted by the government as preferable to 
receipt o f IB/ESA (see also Bambra and Smith, 2010), and policies and claimants are infused 
w ith conditionality - w ith the receipt o f benefits based on fu lfilm ent o f specific obligations 
and responsibilities. This has its roots in Workfare, developed by the Regan administration in 
the US and furthered by Clinton in the 1990s (see Soldatic and Chapman, 2010). Now, 
instead o f seeing disabled people as deserving of state support, claimants are further divided 
into those who are disabled but able to  work ('just disabled') and those who cannot (the 
'really' disabled) (see also Grover and Piggott, 2010). Implicit w ithin these processes and 
divisions is the assertion that those claiming incapacity benefits 'are able to  be somewhere 
else' (Garthwaite et al,.2013;2).
These perceptions are augmented by media and wider societal discourses around benefit 
claimants 'scrounging' (Garthwaite, 2011) from the state indeed, the official Conservative 
Party website outlines the ir principles and refers to people 'languishing on the dole' 
(Conservative Party, Undated) and George Osborne, in an interview w ith BBC Radio 4's 
Today programme, ahead o f the Conservative conference in 2012, invoked the image of a 
neighbour on benefits having their blinds drawn as others go out to work (see Sparrow and 
Owen, 2012), implying that recipients are lazy (see also Kingfisher, 1998). De Wolfe (2012) 
challenges the perception that benefits amount to taking the 'easy option', maintaining this
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obscures the constant stress, anxiety and pressure that people who need to  be on benefits 
experience, as well as structural barriers to  employment. As will be discussed below, there is 
evidence tha t the language used in relation to benefit claimants (Garthwaite, 2011), and the 
negative perceptions, had been absorbed by participants.
An in troduction  to Em ploym ent and Support Allowance
Employment and Support Allowance (ESA) was introduced by the Brown Labour government 
in October 2008 (the same tim e as I began my PhD and made tentative contact with 
potential participants). ESA is an 'income replacement benefit' (Burchardt, 1999) as it 
supposed to  provide financial support fo r those people deemed incapable of working. The 
intention o f ESA was to  move claimants o ff Income Support and Incapacity Benefit, which 
was perceived as 'too easy' to  get on and stay on (Grover and Piggott, 2010), and attach 
work related conditions to  receipt of benefits (DWP, 2008). In 2010, the Coalition 
government announced the ir plans to move forward w ith ESA and to move all IB claimants 
onto ESA by 2014 (Patrick, 2011). The introduction of ESA in October 2008 has been 
described as a major change in how individuals experience claiming (Houston and Lindsay,
2010). In order to  be eligible fo r ESA, claimants need to be sick and/or impaired to  the 
degree that it affects the ir ability to  work for two or more out o f seven consecutive days 
(Department fo r W ork and Pensions 2010). On application for ESA, claimants undergo a 13 
week assessment period (paid at same rate as JSA), which comprises of three mandatory 
stages: a work focused interview (WFI), a work focused health related assessment (WFHRA), 
and a work capability assessment (WCA). The WCA is intended to  focus on individual 
capabilities and will be discussed in greater depth below. Based on this information, 
claimants are then assigned to  either a Work Related Activity Group (WRAG) or a Support 
Group (SG) (DWP, 2008; Grover and Piggott, 2010). Those assigned to  the WRAG are 
expected to  participate in fu rther work focused interviews and in the development o f a
personalised plan of employability activities. Recipients are expected to participate in work 
related conditions and activities or risk losing their benefits (Patrick, 2011). In return they are 
provided w ith  tailored 'support' to  return to  the workplace, though Patrick (2011) questions 
the suitability o f this. Those people who are allocated to the SG have been assessed as being 
too impaired to  work. ESA is soon to  be replaced w ith the single benefit Universal Credit 
which is intended to  simplify the benefits system (Department for Work and Pensions 2011).
According to  Houston and Lindsay (2010), this major reform is premised on some key (false) 
assertions; first, tha t there has been a decline in work ethic, so that people must be forced 
through mandatory measures in order to  gain employment. Second, that most people 
currently on incapacity benefits are not sick or disabled 'enough', so a medical test that 
toughened the elig ibility criteria was deemed necessary and introduced. Third, that it is the 
demand side, rather than the supply side, causing major issues within the labour market. It is 
individuals who do not want to  work, rather than the work not being available.
The organisation of w o rk
ESA has been criticised for its individualist focus on the person claiming and Patrick (2011; 
2012) maintains that the model the government works from in developing policy and reform 
is rooted in an individual model o f disability. She maintains that sanctions are problematic, 
given that the barriers to  participation in employment are primarily structural, but rarely 
mentioned (cf. Soldatic and Chapman, 2010). Patrick's (2011) participants also described a 
strong sense o f motivation to  work and although some indicated their current impairment 
effects prevented participation in the workplace, they emphasised that focusing on 
increasing claimants' employability was misguided, given the issues that face disabled people 
(including people w ith hepatitis C) concerning the structure of work, negative and 
discriminatory treatm ent and issues around access (Roulstone and Barnes, 2005; Patrick,
2011).
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Key to  this (but under addressed in current policy reforms) is the configuration o f work. 
Barnes (2003a; 2003b) maintains that disabled people are disadvantaged as a result o f the 
value-base on which employment is built - including expectations o f speed, productivity and 
regular contributions - and notes that during the period of the Second World War when 
employment was to  some degree, built on reciprocity, there was more o f a place fo r (some) 
disabled people (see also Borsay, 2005). As disabled artist Sunny Taylor (2004) indicates in 
her discussion o f not working, it is important to recognise the inherent value of disabled 
people (see also deWolfe, 2012) and not to measure them by their financial contribution. 
Taylor (2004) maintains that current government responses place the value of citizens on 
their employment and represent it as the path to  financial freedom, despite the available 
employment often being low paid, part time and insecure. There is also currently a limited 
understanding on behalf of the government about what exactly constitutes 'work'. A recent 
consultation undertaken by Disability Activist Sue Marsh (2012) on her Diary o f a Benefit 
Scrounger blog, indicated that there was a need for a much more flexible definition and 
forms o f work, including increasing working from home, a work bank for those who are able 
to work at unpredictable times and support to  develop micro businesses for those whose 
hobbies have become more (see Marsh 2012 for full details). Patrick's (2011) participants 
described fu lfilm ent through unpaid work, such as volunteering and childcare, which links to 
a wider discussion by Barnes (2003b) that for some disabled people work is constituted in 
personal care, shopping or indeed explaining their experiences to  others (cf. Keith in chapter 
six).
In the context o f this study, participants who were not working described providing support 
and information to  others via support groups, telephone, or online support. Thus, people 
w ith hepatitis C and (other) disabled people make contributions for which they do not 
receive wages, but which are still highly valuable. Indeed, awareness raising activities and 
the development, and maintenance, of support groups were self-funded by participants and
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were described as key to  getting people though treatment, or to  accessing testing -  thereby 
saving vast amounts fo r the government and public services.
In troduction  to D isability  Living Allowance and Personal 
Independence Paym ent
Disability Living Allowance (DLA) is an 'extra costs benefit' (Burchardt, 1999) intended to  help 
disabled people meet the additional costs that often comes with impairment and disability. 
The benefit is not affected by employment status and has been recognised as highly valuable 
in enabling disabled claimants to  stay in employment (Thomas and Griffiths, 2010). In spite 
o f this, the government have repeatedly represented it as an out o f work benefit and, 
indeed, as an impediment to work (Campbell et al., 2012; see DWP, 2012).
The coalition cited huge increases in claimants as need for reform, claiming there has been a 
30% rise in DLA claimants, even though the figure is actually 13% (Campbell et al., 2012). The 
statistics used included those under 16 and over 65, who will not be affected by changes 
brought about by PIP. Further to  this, under claiming is recognised as being greater than over 
claiming (Macmillan, 2004; Campbell et al., 2012), which is related to limited knowledge 
concerning entitlements and a dearth o f advice and support from formal services. In 2010, 
the government announced plans to  replace DLA with PIP and cut spending by 20%. This 
means some existing claimants w ill go from being defined as disabled to  non-disabled 
overnight (Soldatic et al., 2012), having experienced no change in the level o f impairment or 
experience o f disablism. The very system meant to enable people who are impaired is 
further disabling them (Malacrida 2010).
The effect o f the increasingly stringent criteria for ESA (and PIP) is that the category of 
disability is redefined, forcing some groups into a 'netherworld...not knowing whether they 
have classified as genuinely disabled, being encouraged to go for jobs but in the absence of 
jobs they have this strange paradoxical situation o f not fitting into normal or disabled
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categories (Roulstone, 2011). This redrawn boundary (as explored below) and subsequent 
lim inality, is likely to  disproportionately affect those w ith fluctuating or hidden impairments 
(Bambra and Smith 2010).
Although the coalition government maintain they are committed to  supporting disabled 
people to  'lead independent lives and exercise choice and control' w ith the introduction of 
PIP (Department o f Work and Pensions, 2011:2), Campbell et al. (2012) maintain the 
opposite is true. Consultation respondents fe lt that the withdrawal o f support would 
significantly disable claimants further, including being unable to  meet costs for care, support 
and even food and fuel impeding access to social life. Further, many were concerned about 
the removal o f M otab ility137 vehicles upon reassessment and the impact on access to 
employment (Young et al., 2013)138.
Personal Independence Payment will still be a cash benefit available for the same age group 
o f applicants (aged 16-64) and payable to  those both in and out o f work, and the 
government emphasises that it w ill provide a much simplified process139. Specific reference is 
made to  the social rather than the individual model of disability in establishing eligibility for 
the benefit and ensuring disabled people's independence, though this appears to  be 
superficial and insincere. First the depth of understanding of social model principles is 
doubtful, given that the press release refers to  the 'individual disability' (rather than 
impairment). Second, the proposed system of descriptors which focus on level o f functional 
ability 'end up being a proxy fo r the level o f impairment rather than a meaningful measure of 
barriers to  participation or an indication of how assistance in the form of PIP could facilitate 
greater independence and inclusion' (NAT, 2011: 3). Critics maintain that the language of
137 The Motability Scheme enables disabled people to use the mobility component of DLA to lease a 
new car, scooter or electric wheelchair (Motability, 2013a).
138 As this thesis was being proofed, Motability announced a package of transitional support (see 
Motability 2013b) to combat some of the difficulties for those who may no longer be eligible for the 
Motability scheme after reassessment for PIP.
39 The current system has been criticised for being arduous and complex, see Banks and Lawrence 
(2005), Shildrick and Price (1999) and Reeve (2002) -  revisited below.
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'independence' has been co-opted to  f it  w ith government priorities (Morris, 2011; Patrick, 
2012).
PIP criteria are even more stringent which means it w ill be more d ifficult to  qualify and for 
those that do, the level of financial support will be much lower (Soldatic et al, 2012). This is 
exacerbated by an increased timescale fo r eligibility. In order to be found eligible fo r DLA, 
participants must have been disabled for the last three months and be likely to  be disabled 
for the next six months. Recent guidance notes on PIP (DWP, 2011) state tha t the 
retrospective eligibly test will mean that a person's impairment must be expected to  last a 
minimum of 12 months, before they are eligible for PIP, moving even further away from the 
provision o f support at the point o f diagnosis enshrined in the DDA and the EQA (Campbell et 
al., 2012).
The reform o f the eligibility criteria was almost unanimously opposed in the government's 
consultation (Campbell et al., 2012). While those who responded to  the consultation fo r PIP 
supported the proposition that DLA should be reformed, they fe lt this should happen to  the 
existing benefit. Campbell et ol.,{2012) point to  the costs o f development and 
implementation o f the new benefit when the money might be more appropriately spent on 
improving support. The shifting from three rates of eligibility to two will mean some people 
no longer receive any support. One consequence of this will be the additional pressure 
placed on Social Services, given that components are currently used to  self-fund fo r some 
aspects o f care, and receipt o f even a low level o f benefit can be beneficial in promoting 
health and preventing crises (Campbell eta l., 2012).
The experience of financial support
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Initially, the experience of accessing welfare benefits was not included as a topic for 
exploration on the interview schedule, but rather, it was raised by participants during the 
course o f the interview [thus giving strength to  the finding as this area was not directly 
enquired into, but was enacted in discussions between myself and the participants (Conrad 
et al., 2006)]. JB described benefits as a hellish road' and Ken described the need fo r support 
particularly on treatm ent:
77/ te ll you what does need addressing big time, that's the Department o f Health and 
Social Security, whatever they're called now...You should get extra support... they w ill 
not recognise DLA fo r  tha t and that's wrong because you're incapacitated, you can't do 
very much fo r  yourself you have to have help to get your shopping done - ju s t about 
everything really -  you need support and that includes financial and they (DWP) won't 
recognise it . '
Given that realities are multiple, it was necessary to  make political decisions to  bring specific 
ones into being, paying particular attention to those which are 'othered' both in Law's (2004) 
sense o f being unthought and in the sense of being defined as different and marginalised 
(Johnson, 2004).
The need fo r welfare benefits when living w ith hepatitis C, or on hepatitis C treatment, is 
mostly absent from  w ider discussion in the existing literature. In addition, the rapid 
development o f new treatments and the forward-looking rhetoric of treatm ent discussions 
(both in print and online, see for example Chung, 2012; Lok et al, 2012; Swan 2013) means 
there is the potential fo r the financial and employment impact o f current treatments to  be 
obscured, or side-lined, as no longer important in the face of increasingly effective 
treatment.
This data does not a ttem pt to  generalise the findings to the population in the UK, or even in
England, living w ith hepatitis C this would be particularly difficult given the widely
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documented postcode lottery in services (All Party Parliamentary Group on Hepatology 
2008) however, there is evidence to  suggest that welfare benefits and financial support are 
important issues fo r those living w ith hepatitis C. The January 2013 newsletter from  the 
Hepatitis C Trust reported a vast increase in calls made to  the ir helpline concerning welfare 
benefits (Hepatitis C Trust, 2013a) and recent reports, both from Harris et al., (2012a) and 
NAT (2012), also point to  the vital role o f financial support.
W hy do people w ith  hepatitis C need financial support?
Participants frequently made reference to  the additional costs associated w ith living w ith 
and being treated fo r hepatitis C. Ken described the importance o f diet and fresh fru it and 
vegetables. Loveday and Dore (2009) indicate that diet is an area of self-management that 
can improve health for those living w ith hepatitis C. Crockett and Gifford (2004), in their 
interviews w ith  women living w ith hepatitis C, also found that in spite o f knowing that a 
healthy diet was important, participants were unable to afford it and relied on cheaper fast 
food. In the ir recent response to  the PIP consultation, The National AIDS Trust (2011) also 
emphasised the importance of diet and drew attention to, the increased costs of fresh fru it 
and vegetables, stating this was not fully recognised in the PIP guidance140. Participants also 
described the additional costs o f alternative therapies. Morgan described using her savings 
to fund support fo r the treatm ent and to  manage the side effects, and fe lt that alternative 
therapies should be more freely available. Some participants did describe accessing some of 
these therapies from  a multidisciplinary service which maintained strong links between the 
hepatitis C treatm ent team. Scottish services 'C-Plus' (C-Plus, undated) and 'C Level' (now 
Waverley Care, 2013) offer complimentary therapies and healthy eating programmes, 
although this was not available across the UK, as Morgan describes:
140 In addition the emphasis on food preparation, or the ability to plan a meal, overlooked the 
difficulties associated with physically shopping for a meal. The emphasis on being able to prepare a 
small meal by any means also means that if claimants could prepare a ready meal (which would be 
more expensive and less healthy) then this would mean they would score less points (NAT, 2011).
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I mean I d been using my savings and all in all it's been quite an expensive business 
because I've chosen to have healing and I've chosen to have massage and I choose to 
eat really well bu t they are all the things you should do to support the treatm ent.'
Additionally, Freda makes specific reference to raised fuel costs whilst on treatm ent (her lack 
of knowledge around what she could claim is also returned to  below):
7 don 't know about benefits and I would love to know although I am working i f  I can 
get anything fo r  extra heating as I am so cold'.
Costs associated w ith heating and diet are consistently named as the main ones DLA 
recipients spend the ir benefits on (Berthoud 1998). Recent research by the Papworth Trust 
(2011) found that survey participants fe lt food and bills would be areas most affected if they 
were not found eligible fo r PIP or had the ir payments reduced. Similarly a few participants 
made reference to  severe fatigue and difficulties w ith public transport, travel to  hospital 
appointments and hospital parking which incurred additional costs and were a source of 
stress.
Participants frequently referred to DLA and ESA. At the time of interview, two participants 
reported receiving Job Seekers Allowance (JSA), one as a result o f being found fit  fo r work 
after applying fo r ESA and the other as he fe lt he did not require ESA. Two received 
Incapacity Benefit (IB), two reported receiving ESA and being placed in the WRAG. Eight 
participants were employed and six participants reported applying fo r Disability Living 
Allowance. Two other participants were already in receipt o f DLA, related to  other 
impairments. Three participants described being found eligible for it on appeal, one 
participant ceased the ir appeal and tw o were too ill to pursue it. One participant w ith HIV 
reported choosing not to  claim DLA. Finances were not discussed extensively w ith five 
participants, though two of these indicated a lack of knowledge concerning what they might 
be entitled to.
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M eeting the e lig ib ility  criteria
A significant problem fo r participants was that hepatitis C did not appear to  f it  the criteria for 
ESA and, particularly, DLA. The ambiguous, contingent and d ifficu lt nature o f hepatitis C as a 
chronic illness, is at odds w ith the processes required fo r gaining support or welfare benefits. 
Participants often experienced the ir impairment as variable. Boab stated it 'depends on 
which day o f the week you get me on' and Grace stated that treatm ent effects 'come and 
go.' Others described having 'good days and bad days' (JB) which were exacerbated on 
treatment, or not being able to  tell what was an effect o f hepatitis C treatment, or existing 
impairment or age. Here, hepatitis C is bound up w ith other aspects o f their lives and 
experiences.
There is evidence in social research literature to suggest that people w ith other chronic 
illnesses experience difficulties claiming benefits. Cathie Hammond's (2002) research into 
DLA claims for people w ith ME, found that there were particular types of impairments which 
were awarded less often, including blood disorders. Though this data is some years old, the 
impairments shared a number of common characteristics which are particularly relevant for 
people living w ith hepatitis C. Benefits were less likely to be awarded if impairment effects 
were d ifficu lt to  articulate under the categories on the DLA form, fluctuated or varied widely 
from person to  person. For people w ith hepatitis C, this flu id ity and contingency was difficult 
to articulate to  others141 and was exacerbated by brain fog and cognitive impairment.
In a Canadian context, Lightman et al.'s (2009) research with people w ith 'episodic 
disabilities' who had been refused welfare assistance, found that the fixed vocabulary o f the 
process invalidated participants' claims to financial support (see also Shildrick, 1997) and led 
to  feelings o f illegitimacy. Echoing Hammond (2002) Lightman et al., (2009) point to  the
141 McFarland et al., (2009) have indicated that metaphors help to bring into being that which is 
difficult to express, hence the cancer and chemotherapy metaphors.
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need to  acknowledge the fluid nature of benefits and disablement, that individuals may 
move back and forward between being more or less impaired, disabled and able to  work 
(consistent w ith  being 'in recovery'). Interestingly, one o f Lightman et al.'s (2009) 
participants lived w ith  hepatitis C and described how the hidden nature o f her illness meant 
she was frequently not recognised as a disabled person. She too made specific reference to 
the lack o f understanding of social services and the difficulty in accessing support.
Yet, this lack o f f it  between experience and process has an express political purpose the 
'othering' o f tha t which is difficult, intangible, or which does not easily f it (Law, 2004), enacts 
people w ith  fluctuating illness/impairment as non-disabled, ultimately resulting in a reduced 
number o f people on benefits.
The restric tive  and disabling assessment process
For others, the process o f assessment did not f it w ith their experience:
Daniel: 'W ell i t  was all physical i t  was touch your toes -  do your lace up, do this and do 
tha t and it  was s tu ff tha t d idn 't relate to my illness, can you make a meal fo r  yourself, 
can you take a shower, can you walk to the shop, can you use the telephone I was 
going 'yes, yes, yes, yes'. So all 'okay you're f i t  fo r  work' it  was nothing that related to 
the hep C treatm ent or the drugs I was on.'
Though guidance states clearly that the assessment is not dependent on condition, but how 
it affects the person (DWP, 2013). Daniel explains how the WCA enacted a reality where his 
experiences o f the effects o f treatm ent were not taken account of. Given that Daniel is 
referring to  the WCA here, it is important to note that concerns have repeatedly been raised 
about it. NAT (2010) in the ir review of the WCA (for people w ith HIV, but which is also 
applicable to  people w ith hepatitis C) state that the assessment does not account for some 
of the major impairment effects including fatigue, fluctuating symptoms, treatment side
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effects, pain and mental health issues. The Citizen’s Advice Bureau (2010) question whether 
the WCA is f it  fo r purpose given that seriously ill people are called fo r assessment, no 
account is taken of the barriers or discrimination that people face in looking fo r work and 
there are concerns about the number of people being found fit fo r work, who then go on to 
successfully appeal the decision. The Harrington (2010; 2012) reviews o f the WCA 
acknowledge these concerns and note that some health conditions are more 'subjective and 
evidently more d ifficu lt to  assess' (Harrington, 2010: 6) and that some of the descriptors may 
not fu lly capture the complexities o f health conditions in establishing fitness for 
employment. At the most recent review, progress w ith addressing these descriptors is on­
going (Harrington, 2012). Patrick (2012) notes that in spite o f these reviews, the government 
have not paused to  implement any recommendations and further to  this, that real change 
may not be seen fo r three years (Campbell et al., 2012). The result is that relationships 
between claimants, staff and the government are fragmented and characterised by mistrust 
(Patrick, 2012).
As explored above, eligibility criteria for ESA and DLA are becoming increasingly restrictive. 
Houston and Lindsay (2010) state that the eligibility criteria has been set increasingly high 
and one of the major concerns regarding the welfare reform is that the bar fo r entitlem ent is 
now set impossibly high (The Broken of Britain 2011). The move to a face to  face assessment 
fo r PIP suggests tha t these problems outlined in relation to the WCA, w ill persist in relation 
to  PIP. The assessment criteria fo r PIP does little to suggest that the government are aiming 
to  move away from  the culture of 'box ticking', which Daniel experienced during his 
assessment given that it contains a range of very specific and rigid descriptors, w ith highest 
scores attributed to  those w ith the 'greatest need'. In reality, this equates to  those w ith the 
most visible, clearly understood impairment effects. There is little to  suggest any shift in the 
way disability is understood - as called for by Roulstone nearly ten years ago (2004). NAT 
(2011) draw attention to  the lack of open questions w ithin the assessment criteria which
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does not give people the opportun ity to define their own needs, but forces thern to  be 
defined by others (i.e. the ATOS assessor). Daniel recounted his frustration at the 
irrelevance o f the assessment to  his experience of treatment, echoed by the evidence o f a 
second year review o f the WCA put forward by the UKDPC (2011). Daniel was subsequently 
found fit  fo r w ork143 and moved onto Job Seekers Allowance (JSA).
Others referred to  not fitting  into the 'disability category':
Morgan: 7 think it's  too rigid. I think i f  you don't f i t  into their boxes and there isn 't a 
box fo r  you to tick, then there's no space fo r  your own individual process. I don't think 
it's  a particularly fa ir  system, because I know people who are fa r  healthier than I am 
who are on DLA'.
Morgan's observation regarding 'fitting  into a box' is particularly interesting in light of 
Stone's (1986) work, which situates disability as an administrative category determined by 
the government, which affords particular privileges to those deemed disabled. However, it 
also has a severe impact on those who do not meet the category, simultaneously outlining 
what impairments and barriers individuals will be expected to live w ith unsupported. Stone 
(1986) maintains tha t the boundary is enacted in combination w ith the political and 
economic climate. In periods of high unemployment there is a restriction on benefit 
eligibility and the boundaries are drawn tighter to include less people, to  create a reserve 
army o f labour (Grover and Piggott, 2005; Grover and Soldatic, 2012).
142 At the time of writing ATOS was the private company commissioned by the government to 
undertake independent medical assessments on behalf of the Department for Work and Pensions. 
They have since ceased to provide them. These assessments determine eligibility for welfare benefits 
in particular Employment and Support Allowance, Disability Living Allowance (ATOS Healthcare, 2011) 
and PIP in some parts of the UK.
143 Another parallel with cancer is that people on chemotherapy are also being found fit for work, thus 
facing similar problems (Soldatic et al., 2012). Although the third WCA review notes that support and 
provision for people with cancer is improving (Harrington, 2012).
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M u ltip le  hepatitis  Cs
It is im portant to  note that the enactment o f hepatitis C treatm ent in the WCA as not having 
an extensive effect on the body or ability to  work is very different from the one enacted by 
the hospital staff who advised Daniel to use two forms of contraception during treatm ent 
and fo r six months after, due to  the possibility o f teratogenic effects in pregnancy. This 
enacted treatm ent as serious w ith long term effects.144 These two enactments overlap for 
the person on treatm ent, but are kept separate or rationalised (Law, 2004) by the 
professionals involved (i.e. the DWP and the Specialist Nurse), meaning that both realities 
are maintained145.
Other participants found that they occupied a similarly liminal and contradictory position, 
where they were enacted as too impaired to  undergo routine surgery but not disabled 
enough to  be awarded DLA w ithout an appeal. Participants suggested this was likely to  be 
connected to  concerns regarding infection, despite existing policy on the use o f universal 
precautions. In being denied surgery until treatment was over, participants experienced 
exacerbated impairment effects, as well as increased psycho-emotional oppression, as David 
described in chapter seven.
Psycho-em otional disablism  and feeling entitled to benefits
As well as the obvious financial implications of not fitting  into the disability category, not 
being found eligible fo r welfare benefits impacted on the way participants fe lt about 
themselves. Indeed, Bambra and Smith (2010:8) indicate that being 'sick but able to  work' is
144 The same advice is given both to women and men. This also raises a wider issue concerning advice 
against the creation of a potentially disabled foetus but a fuller exploration of this issue is beyond the 
scope of the thesis.
145 The enforcing of the separation between these realities is also visible in the recent advice to GPs 
not to provide written support with welfare benefit applications unless requested by the DWP (see 
BroTaf, 2013; Birmingham Local Medical Committee 2013).
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3 particularly stigmatised status. Others have made reference to the negative perceptions 
associated w ith claiming benefits more generally [see Green and Shuttleworth, (2010) and 
M offa tt et al., (2010)]. Both are visible in Steve's extract:
So on tha t side o f things when someone says they can't go to work they really can't 
go to work and you fin d  a lo t o f people that are on treatment that are ashamed o f not 
being able to support themselves when they are so they don't need the stigma and the 
disbelief from  the social security'.
Here, Steve refers to  people made to feel dishonest by claiming, or that they have morally 
failed. Interestingly, Steve (who was not working at the time) does not indicate that he feels 
ashamed, but rather than others do. Here, he is possibly participating in the interview fo r a 
political reason, raising awareness of the experiences of others beyond himself and resisting 
oppression by distancing himself from negative perceptions of benefit claimants. Beatty et 
al,. (2010) found that participants were embarrassed about claiming benefits. Grover and 
Piggott (2007) also make reference to the perception that the majority o f claimants who are 
impaired are somehow playing the system (cf. Malacrida, 2010) (returned to below).
These moral undercurrents are visible in this information contained on the website of The 
Hepatitis C Trust. While the trust have a part time benefits advisor and provide information 
concerning specific benefits on a section of the website (see The Hepatitis C Trust, 2011b), 
the generic nature of this means that there is little indication of how this might apply to 
people w ith hepatitis C. Whilst this may be connected to the individual and variable nature 
of the virus, it contributes to  the enactment o f a reality where people w ith hepatitis C should 
not be claiming benefits. On the page providing information on welfare benefits they state:
'While access to  financial assistance via the benefits system may be essential a t times,
it is worth considering that becoming dependent on benefits can, in some cases, not
work to  your overall advantage. Naturally if your ability to work is severely hampered
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by your health then there may be little  choice obout whether to apply. However, 
becoming dependent on benefits can be part o f a vicious cycle o f dependency. For 
some people this can lead to  lowered self-esteem or feelings of lowered self-efficacy.
In these instances it may be wise to consider whether depending on benefits is in your 
best interests overall...If you are diagnosed w ith hepatitis C this does not automatically 
give you entitlem ent to  benefits from the Benefits Agency. However, if your condition 
affects your ability to  carry out day-to-day activities, continue to work or the condition 
is having a significant impact o f your physical or mental health then you may be 
eligible fo r certain disability benefits.' (The Hepatitis C Trust, 2011b - my emphasis).
Here, the assertions that benefit claiming may be essential fo r those living w ith hepatitis C is 
undermined w ith rhetoric around welfare 'dependency' - a term which is overwhelmingly 
present in this short paragraph. Benefits are enacted as a trap. Rather than facilitating 
participation, preventing crises and reducing the impact on formal services (Corden et al.,
2010) or promoting health through providing support to  do treatm ent146. The act o f claiming 
benefits is enacted as something which should be avoided or accessed only as a last resort. 
References to  lowered self-esteem and self-efficacy imply that benefits are damaging to  the 
rational autonomous human being, who is ideally earning a wage and thus independent 
(Stone, 1986; Fraser and Gordon, 1994).
Following on from  the exploration of metaphor in chapter six, and the way in which words 
used actually help to  constitute hepatitis C and people w ith it in specific ways, Fraser and 
Gordon (1994) indicate the same is true for use of the word 'dependency'. They state that it 
is an ideological term  which reinforces the focus on the individual, w ithout focusing on the 
structural or economic aspects which both create the need fo r financial support and 
maintain it.
146 Which, given the content of the website, the regular updating and explanation of available 
treatments would appear to be (rightfully) highly important.
346
It could be argued that the use of the word 'dependence' by the Hepatitis C Trust has some 
echoes o f drug dependency, although this is not made explicit. Fraser and Gordon (1994) 
indicate that perceptions and understandings of welfare dependency are built on and 
in tertw ined147 w ith beliefs about drug dependency. Those receiving welfare support are 
assumed to  be drug users, which enhances negative perceptions. Indeed, they indicate that 
dependence is perceived in solely negative terms -  as an encumbrance or a drain. There are 
similarities here in discussions of dependency in the disability studies literature - 
dependence is often understood negatively to be synonymous w ith 'burden', but this ignores 
that everyone is (inter)dependent on others to some degree, in provision and receipt of 
support or services (see Thomas, 2007). Further to this, the 'dependency' o f pharmaceutical 
companies, medical staff, substance use workers, DWP staff, policy makers and researchers 
on people w ith hepatitis C is rarely discussed.
Indeed, many o f the participants described requiring financial support fo r a short time whilst 
on treatm ent, in order to  save NHS funds in the longer term. Bambra (2008) indicates that 
the shift to  ESA does not acknowledge that participants claiming it are actually sick and 
disabled, and may be in recovery. She indicates that addressing health should be prioritised 
over return to  work. Vick and Lightman (2010) similarly maintain that in regard to  welfare 
benefits, the demand fo r productive bodies is prioritised over the reality o f participants' 
changing and unpredictable bodies. This marginalisation of what participants actually need, 
together w ith the absorption of beliefs about benefit claimants as workshy, is illustrated in 
the extract below from Grace. She reports taking a job after being found fit fo r work:
7 have always worked. Not a t the moment because I am still on treatment. Been on 
treatm ent fo r  the last year and a half. Last time I spoke to you I had ju s t started a new  
job  hadn't I? Part time, five  hours a day. I lasted three days on that one, I was so
147 Fraser and Gordon (1994: 325) actually use the term 'infect' to describe the way perceptions about 
drug use shape perceptions of receipt of welfare benefits, pertinent in the context of hepatitis C.
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physically sick I couldn't do it  a fter three days. I realised I can only do so much, but 
m entally I am ahead o f my body i f  you know what I mean?... I got to the point where I 
was physically pulling over in the car and throwing up. So I had to give it  up, I was jus t 
doing too much, but I ju s t presumed I could because I needed the money.'
Despite having done a d ifficu lt treatm ent for 18 months (she described going 'straight back 
on the trea tm ent' as soon as it became clear the first course of treatment had not cleared 
the virus), Grace is mandated to  attend a Pathways to Work programme but finds that she is 
unable to  work, even part time. When she states 'mentally, I am ahead o f my body' this can 
be taken as a sign that Grace is motivated to work (often understood as a barrier to 
employment), but her impairment (and the type of employment made available) prevent 
this. She positions herself as someone who is 'genuinely' ill when she says ' I have always 
worked' and 7 did try  and work' she is aware of the 'benefit scrounger' rhetoric which 
permeates the media (Grover and Piggott, 2010) and how people who receive benefits are 
labelled and portrayed (Garthwaite 2011).
Lastly, Grace states '/ ju s t presumed I could because I needed the money'. Grace indicates 
that a need fo r financial support coerced her into work though she was not fit. NAT (2010;
2011) draw attention to  the processes of applying for ESA (and also potentially PIP) which 
forces people who are sick and/or impaired through a system which actually worsens their 
impairment effects, whilst simultaneously reinforcing the idea that they are not 'ill enough'.
Grace described actively resisting the perception that she was not entitled to benefits or 
tim e o ff to  recover during treatment, because she had paid national insurance 
contributions. For this reason, she described being honest in assessments, although this 
turned out to  be counterproductive due to  the fluctuating impairment and treatment 
effects:
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I to ld  them - I said - I don t  fee l too bad today, I goes, I haven't fo r  the last couple o f  
days but last week I fe lt  this, I fe lt  that...I to ld them everything, so you know I have 
horrendous back pain. I don 't know i f  that's got worse or i f  it's nothing to do w ith what 
I've got (hepatitis C)'.
Grace's assertion that she doesn't fee l too bad' echoes Banks and Lawrence's (2005) 
findings that people had a tendency to describe their situations more positively than they 
actually experienced them [see also Wilson and Amir (2008)], but which led to  them being 
refused welfare benefits. De Wolfe (2012) (see also Reeve, 2008 - below) indicates that in 
order to  make a successful application, the reverse approach is necessary. This was echoed 
by a number of participants who stated that being honest about the impairment effects and 
experiences of disablism was ineffective. Participants referred to needing to  'play the 
system', including dressing in certain ways or using particular words or vocabulary on 
application forms, enacting themselves as impaired and 'disabled enough' for the process in 
ways tha t f it  the category. Paradoxically, this forces them to be dishonest and makes them 
feel as though they are stretching the truth, perpetuating the perception they are 'not really' 
entitled to  benefits (Reeve and Soldatic, 2012).
Applying fo r welfare benefits is described by Reeve (2002; 2008; Reeve and Soldatic, 2012) 
as a key site o f psycho-emotionally disablism, given that claimants are forced to  define 
themselves using a deficit model, describing what they cannot do, rather than what they can. 
Reeve (2002) and Shildrick (1997) highlight how the process of applying fo r benefits is an 
exercise o f disciplinary power. Using Foucault's (1977) work on the Panopticon (an ideal 
institution where prisoners regulated their own behaviour as a result o f incorporating the 
belief tha t they were being watched at all times by prison guards) the concept o f self­
surveillance developed. Self-surveillance, where the individual polices themselves and their 
own behaviours, rather than being policed by an external body and which Reeve (2002) links
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to  ideas around responsibility for personal health, operates to construct applicant’s bodies as 
disabled enough or not. In order to access benefits such as DLA, participants are forced to 
become the ir own oppressors through turning the surveilling gaze on themselves (Shildrick, 
1997) and describing in detail the physical limitations of their own bodies in order to  qualify:
M organ: Because you're feeling incredibly ill and you're thinking am I ill 
enough?...while you are really ill you're trying to be really positive and then you have 
to do this thing where you're showing the worst side o f it  all.
Being forced to  question if she is 'ill enough' to qualify fo r support, is both anxiety producing 
and psycho-emotionally disabling for Morgan. This experience can be described as 'sapping 
the strength’ (Reeve, 2002:494) of disabled people beyond the presence o f structural 
barriers.
Enacting a hierarchy: re in forc ing  perceptions of hepatitis C
Not meeting the criteria enacts participants as non-disabled. Grover and Piggott (2010) state 
that ESA claimants (like Daniel and Grace) are subject to social sorting (Lyon, 2003) which 
leads to  the development and maintenance of hierarchies of entitlement, where only 
severely impaired people will be entitled to benefits and others will be consigned to living in 
poverty. This is likely to  worsen further given the recent announcements that no ESA will be 
paid during a period o f 'mandatory reconsideration’ (which must be gone through prior to 
appeal). Though claimants can 'choose' to claim JSA or Universal Credit during this time, 
(Freud, 2013), this presents distinct challenges for those who are not f it for work, forcing 
participants into a liminal space where they can neither work, nor access support. This 
fu rther marginalises the needs of those with hepatitis C, and subsequently affects the 
opportunities available to  them, determining their life chances (Lyon, 2001).
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Iden tify ing  as disabled
Being found fit fo r work (like Grace was) simultaneously undermines participants' feelings 
and knowledge of the ir own bodies, enforces a feeling of being undeserving of support and 
reinforces stereotypical notions of disability. For example, that impairments are static, visible 
and unchanging -  see Grewal et a i, 2002; Mueller et a i, 2010). This drives a wedge between 
people w ith hepatitis C, (other) disabled people and the non-disabled population. Indeed, 
Grace later stated ‘i f  I was an imm igrant I'd get everything.' Here, I am reminded of the 
observations o f Peter Beresford at the Lancaster International Disability Studies Conference 
in 2012, tha t the welfare benefit reforms encourage division rather than unity, which 
weakens collective political power. Despite clearly facing structural disadvantage in terms of 
access and participation, experiencing psycho-emotional oppression (chapters six and seven) 
and living w ith an impairment fo r which they undertook gruelling medical treatm ent (see 
Shakespeare et a i,  2010), a small but significant number of participants explicitly referred to 
not seeing themselves as disabled:
Heather: 7 was going to say, do you see hepatitis C as a disability148?
Grace: No not in tha t way, I think disability to be is having a limb missing that sort o f 
no I don 't think o f it  as a disability. I think while you're on the treatment you've got - do 
you know what I mean? You're lim ited what you can do while on treatm ent but w ith it  
generally no it's not a disability it's a blood disorder. I wouldn't even take away. I 
wouldn't compare myself you know people have limbs missing, blown up, blindness, 
but then again maybe. I don't know anyone who has died from  it'.
148Here I follow Thomas (1999) who used the commonly understood term disability instead of 
referring to impairment and disablement with participants, given that they may not be familiar with 
the differentiation.
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Here, Grace alludes to  visible and stereotypical notions of impairment and disability (Grewal 
et ai., 2002) whilst at the same time acknowledging the disabling effects of treatment, 
before revealing the extent to  which she has absorbed the oppressive views around hepatitis 
C and disability. Even to  the extent that a person would have to  be severely impaired or even 
dying before she thought o f herself or others w ith hepatitis C, as disabled.
That being said, the concept o f not being 'ill enough' to qualify for support is materialised in 
the condition related information on hepatitis C on the DWP's website, which indicates that 
there are few symptoms prior to  the onset of cirrhosis or fibrosis (which participants in this 
study contested). Further support is only indicated in progression of cirrhosis :
'Even those known to have progressive disease (chronic hepatitis C) may have few 
symptoms w ith minimal disabling effects for up to 20 years or more. With the 
development o f cirrhosis and progressive impairment o f liver function  functional 
restrictions may be attributable to  severe fatigue, weight loss, muscle weakness, 
jaundice, anorexia, ascites etc. Help may be needed with personal care, moving 
around, rising from a chair, preparing food etc. and walking may be restricted.
The side effects o f the drug treatm ent for hepatitis C can be debilitating. They may 
increase the degree of functional restrictions experienced by someone who already 
has clinical features of liver damage. People w ith hepatitis C of moderate severity 
however may have few symptoms or functional restrictions when drug treatm ent 
commences. In these cases any resultant care need, or difficulties in walking 
attributable to  drug side effects such as fatigue, flu like symptoms etc. should be 
carefully evaluated. In many cases they w ill not be sufficiently severe to affect 
personal care or to restrict mobility, and w ill only persist fo r  the lim ited duration o f the 
trea tm ent' (DWP, 2009, my emphasis).
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Here the emphasis is on people experiencing 'minimal' impairment effects prior to  the onset 
of cirrhosis (permanent liver scarring and reduced liver function). However, Sutton and 
Treloar, (2007) and Thein and Dore, (2009) indicate that there may be little correlation 
between impairment effects and degree of liver damage. Further to this, the information 
concerning treatm ent is the opposite to what participants in this study described, particularly 
around the severity o f treatm ent effects and their persistent nature post treatment. Whilst 
treatm ent (and post treatm ent) effects are not inevitable -Pixie reported not experiencing 
any - this is vastly different to  the reality enacted in the DWP information149. This 
information should be updated as a matter o f urgency, including links to more detailed 
guidance. This information enacts people w ith hepatitis C as not very impaired until they 
have cirrhosis enforcing its own kind of hierarchy and disabling barriers.
Further to  this, the information on the DWP website about hepatitis C, begins w ith a brief 
description o f the virus, genotype and symptoms, and then moves onto transmission routes 
and prevalence, w ith long term impacts on the left hand menu of the website. The 
presentation o f this information, aside from being highly individual and medicalised, enacts 
transmission route as more im portant than the effects. It raises the question as to why DWP 
staff would need to  know about transmission route in detail, given that a description of its 
blood borne nature and the need to  avoid exposure prone procedures (i.e. deep cavity 
surgery) in employment would be more than sufficient. This is revisited below.
Returning to  Grace's example above, the absorption of oppressive ideas about what it means 
to be being 'genuinely ill' or 'really disabled', could in part, be explained by public 
perceptions around what is covered under disability legislation or what disabled people look 
like Grewal et al's. (2002 study) found that participants perceived impairments as physical or 
sensory, static and permanent. Mueller et a i (2010) found that visibility was also associated
149 Another overview where the nuance and contingency is lost also for a political reason.
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with perceptions of legitimate disability. Watson (2002) found that many o f the people he 
interviewed would not define themselves as disabled, either because the ir identities were 
shifting or they just thought o f themselves as 'normal' and Grue (2012) maintains that even 
though one billion people live w ith impairment, only a small percentage are likely to  define 
themselves as disabled people this often depends on the benefits o f doing so. Furthermore, 
Watson (2002) indicates that there may not be benefits in the same way as there might be 
fo r a gay man to  be explicit about his sexuality150.
For Grace, being enacted as f it  fo r work and receiving no financial support compounds the 
negativity she feels around having hepatitis C. In addition, the push towards treatm ent and 
the possibility o f eradicating hepatitis C may mean not only that participants are less likely to 
identify as disabled people, but that living w ith hepatitis C is marginalised as an experience.
This is not to  say that every participant rejected a disabled identity. Ken indicated that he 
thought o f himself as disabled, 7 am anyway', due to  existing impairments. A significant 
number made specific reference to being defined as disabled either in relation to legislation, 
for example, coverage under the Disability Discrimination Act, or as a result o f receiving 
Disability Living Allowance. Banks and Lawrence (2005) state that receiving DLA may be 
considered a sign that an individual is disabled as defined under the Disability Discrimination 
Act (1995), although the DLA claim form itself indicates that individuals do not have to 
identify as disabled in order to  claim or qualify (Disability and Carers Service 2011). There is 
a need here fo r dedicated information which enacts people w ith hepatitis C as entitled to 
apply fo r welfare benefits in a way which does not promulgate ideas about dependency and 
which makes clear that an individual may not necessarily need to self-define as disabled. 
Although an engagement w ith wider disability issues may well encourage those with
150 Although this has been problematised by Fraser (2008).
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hepatitis C to  identify as disabled and thus, recognise the oppression faced by them and 
other disabled people.
Drug use and identify ing  as disabled
Reeve's (2012a) observations that cultural understandings o f impairment are intimately 
linked to  the experience of psycho-emotional disablism, and that impairment and disablism 
are interwoven, are particularly pertinent to the discussion that follows. Briant et al., (2011) 
indicated tha t impairment type affected how deserving benefit claimants were perceived to 
be in relation to  the type of impairment they had. People w ith physical and sensory 
impairments were more likely to receive sympathetic treatm ent by the press, whereas those 
w ith mental health conditions were mentioned far less in the 'deserving' stories [people with 
mental health issues in particular are seen as 'fakers' Bambra (2008)]. Individuals with 
impairments which were less visible, or to which society was 'unsympathetic' (Briant et al., 
2011: 12), were more likely to be seen as unworthy of the benefit, w ith serious implications 
fo r individuals who have contracted hepatitis C through drug use.
It has been documented in hepatitis C social research literature that people w ith hepatitis C 
may accept or absorb negative views about themselves specifically in relation to 
infectiousness and injecting drug use (Butt, 2008a; 2008b; Harris, 2005; 2009a). This, 
combined w ith issues of blame and responsibility (Lloyd, 2010), work to constitute hepatitis 
C and people w ith it in specific ways.
In Copeland's (2004) study, participants who used drugs described feeling unable to  claim or 
access support feeling they were not entitled to  call themselves 'sick' in the same way the 
general population might, because of the sense of personal responsibility they fe lt fo r their 
hepatitis C status. Similarly, Herek et al., (2002) in relation to  HIV, and Sgorbini et al., (2009)
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in relation to  hepatitis C, have referred to  the lack of support from others fo r illnesses that 
are perceived as 'self-inflicted'.
Participants in Mueller et al's. (2010) study, indicated that substance use, including alcohol 
or drug dependency, should not be covered under the Americans with Disabilities Act (as is 
currently the case) and that the more likely a person was perceived to  have some role in 
the ir impairment (emphysema, HIV, obesity), the less likely they were to  be seen as 
protected under the ADA. These individualising responses ignore the w ider structural forces 
which lead to  hepatitis C transmission (e.g. poor treatm ent by medical staff which leads to 
disengagement, lack of policy and service response, inadequate needle exchange coverage). 
Nevertheless, there is evidence that participants have absorbed these wider views. These 
issues were brought into sharp focus in the group interview with Carl, Andrew and Brad, 
when I asked if they would see hepatitis C as a disability:
Carl: 'In fa c t I can even say I have tried this one on with the benefits system when I 
have gone fo r  medicals and things like that the reason can't work is because I am an 
addict and I've got hep C and it  doesn't come under their...it's not recognised as a 
disability.
Worker: Do think tha t is because they don't actually understand and haven't had it  like 
we were saying before unless you have had it, you don't understand how debilitating it  
is?
Carl: No I think it's  because it's self-inflicted. The way they look a t it  and the way this 
addiction is. And because you're not born with it  or you haven't contracted i t  through 
what's the word?
Andrew: No fa u lt o f your own
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Carl. Yeah and they kind o f say you know what and they don 't le t you use i t  as a 
disability. Because I always thought it  would be a good one that 'who is going to 
employ me with hep C? O f course, I need to be on the sick. And I am a heroin addict as 
well -  I'm  really ill. ' I kind o f got thrown o ff the sick and they wouldn't accept the sick 
notes and the reasons on it... they s till classed me as f i t  fo r  work and although I'm  
physically f i t  they don 't - the benefits system don't look at the mental side o f things - so 
physically yeah, mentally no. The government and such people don't recognise things 
like that.
Worker: It [the hepatitis C experience] doesn't f i t  in a box though does it? '
In this extract, Carl describes being found fit for work (though it is not clear which benefit he 
is claiming,). 7 have tried this one' and 7 always thought it  would be a good one, th a t' implies 
that he has absorbed the belief that past claims may not have been 'genuine' and that he 
may not have 'deserved' benefits. However, later on Carl indicates that his experiences of 
mental distress were not adequately recognised in the benefits process151 (Bauld, 2010; 
Rethink, 2013). When challenged by the worker present, Carl indicates that he does not 
identify as disabled w ith hepatitis C due to the 'self-inflicted' nature of the virus.
Here, hepatitis C intra-acts w ith social and cultural beliefs about drug use it is an individual
issue which must be personally managed rather than something which is connected to  wider
structural forces, and given that the individual is to 'blame', they are not entitled to support.
The link between hepatitis C and drug use is particularly pertinent here. The UK Drug Policy
Consortium (UKDPC) (2011) refer to the way in which people with drug problems are heavily
stigmatised or treated differently than other claimants. They are targeted to  fulfil special
requirements (see Grover and Paylor, 2010) but not afforded protection under legislation
and are specifically excluded from the definition of disability under the Disability
151 Though Beresford et al., (2002) indicate that for some experiencing mental distress, obtaining 
welfare benefits depends on subscribing to medical model views of illness , which not all wish to do.
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Discrimination Act or the Equality Act 2010. The idea that participants were responsible for 
hepatitis C permeated the narratives of many participants152. This affected the ir sense of 
entitlem ent and, implicitly, the degree to  which they fe lt it was the ir responsibility to  clear 
the virus.
In addition, just as Simmonds and Coomber (2009) found that drug users operated a 
hierarchy o f comparisons depending on the method of drug administration, (i.e. injecting 
was fu rther down the hierarchy than smoking, participants internalised (incorporated into 
their self-beliefs) a hierarchy in relation to  the method of transmission of hepatitis C -  as 
evidenced in Pixie's comments in chapter eight. Carl's status is intertwined w ith his 
(previous) heroin use. Here, there is evidence of the comparison of two different forms of 
hepatitis C: the kind acquired through 'no fa u lt o f your own' (Andrew) - what Duffin (2004a) 
associates w ith  the 'innocent' form (blood transfusion) - and the 'guilty' or 'self-inflicted' 
form (injecting drug use). These separate enactments of hepatitis C could have serious 
impacts on the material circumstances of people with hepatitis C, particularly if they do not 
claim based on perceptions that they do not feel they qualify for or deserve support (Bauld, 
2010).
There is also evidence that this division by transmission route is being perpetuated by the 
provision of services which are provided based on method of transmission. In October 2011, 
The Hepatitis C Trust announced that it would facilitate counselling fo r individuals who 
contracted hepatitis C via contaminated blood from the NHS (The Caxton Foundation 2011). 
Whilst this is an im portant step forward in the recognition of the needs o f people affected by 
the NHS contaminated blood, there is an implication that those who do not contract 
hepatitis C through contaminated blood, do not require access to counselling. Seear et al. 
(2010) in the ir exploration of emotion and hepatitis C, maintain that emotions in this context
152 Both Holli and Morgan actively resisted this (though it may be significant that they were both 
unsure how they had contracted the virus).
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obscure the structural factors at work specifically the link between poverty and problem 
drug use (Seddon, 2006), which the moralising responses o f the welfare benefits system may 
perpetuate (Grover and Paylor 2010).
The disabling process of applying for w elfare  benefits
Another disabling barrier (both structurally and psycho-emotionally) was the poor levels of 
knowledge and understanding of the experience of hepatitis C and treatm ent from  those 
making the assessments:
Daniel: 7 couldn't have gone and done a day's work when I was on tha t treatment... 
Basically what they were saying to me was 'you're fine - you jus t have a virus in your 
blood', so tha t really annoyed me....I have jus t been through a punishing treatment... 
so the benefit agencies could do with knowing more about this illness and the way it  
affects you.'
Grace also highlights the apparent lack of knowledge and information around the impact of 
treatm ent on impairment effects:
'When it  comes to hep c they [s ta ff making the assessment] can't see what it  is - or 
they are not to ld what the treatm ent is. A ll i t  ever says on the paperwork is 'they have 
hep C, they have liver damage'...It only ever says 'and is receiving treatment'... That's 
the problem because to them it  could be Paracetamol. It names it, but no one knows 
what i t  is . ... i t  says has usual symptoms, has aches and pain but that could be old age, 
they don 't seem to have enough information maybe some people do get really bad, but 
i f  stopped taking painkillers I can't walk I tell you that'.
Here the hidden nature of hepatitis C and the lack of information provided to staff making
the assessment have serious consequences for Grace and others, especially given the
information provided about hepatitis C on the DWP website. Further to  this, has usual
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symptoms is particularly worrying in a treatm ent context, given that the symptoms can be 
variable. Similarly, Grace feels that the 'usual aches and pains' does not accurately describe 
her embodied experience of the treatment. At the end of the extract, the shifting and 
contingent nature of living w ith hepatitis C, and how Grace feels about living w ith it, are 
made visible. By stating 'maybe some people get i t  really bad' she implies that her 
experience is not 'bad enough'. However, at the same time she indicates that she is unable 
to  walk w ithou t high doses of pain medication. Her health is therefore described in 
contradictory terms (Persson et al., 2003).
A similar sense o f uncertainty and contingency is evident in Richard's extract it too begins 
w ith a lim ited understanding on the part of the assessor:
'I tried to get DLA and the doctor who came to do the medical examination quite 
clearly knew absolutely nothing about liver disease. I d idn 't get it  and I was too ill 
appeal a t the time... I'm pretty sure over the last couple o f years I was in a state where 
I certainly, arguably should have had it'.
Richard uses the terms 'certainly, arguably' as though he is not entirely sure of his footing or 
entitlement. He indicates here that he is not 'desperately hard up' and he talked about giving 
up work and experiencing some serious post-transplant and treatm ent effects. Just as 
Richard was too ill to  appeal the decision concerning his DLA application, Hammond's (2002) 
participants also stated that they were too ill to attend the tribunal to appeal, or even to fill 
in the form. Paradoxically, the more unwell they were, the less likely they were to (be able 
to) make a claim.
In addition, when asserting the ir entitlement to benefits, other participants made reference 
to  the disabling nature o f the medical — including the exacerbation of treatm ent effects and 
worsening impairment (see also de Wolfe, 2012). JB specifically highlighted the lack of
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knowledge end the dangers of forcing claimants w ith hepatitis C to  travel to  assessments 
which, given the ir weakened immune system, might put them at risk o f infection:
'you know people who ore on treatment with low neutrophils, low white blood cell 
counts being made to go fo r  medicals, who should not be out and about because 
they're a t risk o f catching infections'.
Interestingly, this same point is made by Macmillan Cancer Support (2011a) who indicate 
that there is a lack o f awareness or understanding associated w ith expecting individuals who 
have compromised immune systems to  travel to assessments.
Anecdotal evidence from an informal interview I carried out w ith a welfare benefits advisor, 
suggests that the overall numbers of participants claiming DLA in relation to  hepatitis C (and 
disclosing it) is only small - so small that it is not included on the list o f conditions in the DWP 
statistics. However, this may not be because few people w ith hepatitis C require financial 
support. Rather, it may be that individuals do not know they can claim benefits and that they 
have lim ited knowledge about the process and little support, as a significant number of 
participants reported ( see also Bauld et al., 2010 and M offatt eta l., 2010). Further, the UK 
Drug Policy Consortium (2011) draws attention to people who use drugs not being included 
as a specific statistical category in DWP statistics, rendering them (like those w ith hepatitis C) 
as an invisible group. This can have serious material consequences in that it could be used to 
justify a lack o f support services in times of financial pressure.
It has been well documented that the system of applying for benefits is complex and 
confusing (see Lawrence and Banks, 2005) and constantly changing. As described in chapter 
six in relation to  Macmillan Nurses, Morgan describes the difficulty in filling out the forms 
which requires a lot o f e ffort when unwell (de Wolfe, 2012) and may worsen impairment 
effects (see Reeve, 2008 and Shildrick and Price, 1999) Malacrida (2010) reported how even
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participants who had worked in benefits advisory roles were unsure what they could claim 
and what they were entitled to.
Morgan s experience o f contacting the Disability Benefits Unit to stop her DLA appeal bears 
this out in practice. Morgan experienced severe post treatm ent effects which significantly 
impacted on her wellbeing and would have meant that she may have been eligible fo r DLA 
however, a lack o f professional support meant she stopped the progress o f her appeal. 
Keith's experience highlights the importance of professional support when he states:
7 know I was surprised the length o f time they gave it  (to me) anyway but I mean I 
mentioned tha t to (local welfare rights organisation) and they turned around and said 
'Oh no you don 't know how long it's going to take you to recover from  your medication 
- 1 wouldn't give it  back until you know you're going to be fine  -  because o f how hard it  
is [to  claim ].'
Malacrida (2010) states that disability benefits policies are w ritten for an 'ideal' individual 
who is confident, literate, who has time to go over the forms and few other responsibilities 
or demands on the ir time - or indeed their health. Concentration was highlighted as being 
key when completing benefits forms successfully, and completing the form in short bursts 
could be detrimental and lead to  inconsistencies (Banks and Lawrence, 2005). Thus, for 
individuals w ith hepatitis C who experience fatigue and 'brain fog', the process itself is 
disabling. A few participants reported receiving support from friends or peers w ith regard to 
benefit applications, although Keith does later describe approaching formal services. 
M offa tt et al., (2010) found that people w ith cancer also had limited knowledge of the 
benefits system, no one alerted them to what they could claim and they only described 
finding out either from  specialist nurses or online forums.
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H epatitis  C and em ploym ent
For many participants, an area which was significantly affected was employment most 
commonly during and post treatment. A few participants described either stopping work 
prior to  beginning treatm ent, due to  increasing hepatitis C impairment effects or intra-action 
between hepatitis C, recovery, other impairment effects and parenting responsibilities. 
Participants who were working, or looking fo r work, described the impact o f the impairment 
and treatm ent effects on the ir ability to  work (Patrick, 2012), intertw ined w ith structural 
barriers w ith in the workplace.
This part o f the chapter makes an important contribution in a number of areas. As was 
explored in chapter two, accounts of employment experience w ith hepatitis C are scarce, 
particularly w ith in  a UK context where few qualitative studies are available. Two standout 
areas o f discussion in this chapter are the degree to which individuals fe lt protected in 
disability legislation (i.e. the Disability Discrimination Act, 1995, 2005, now part o f the 
Equality Act, 2010) and the ir experiences of receiving reasonable adjustments in the 
workplace. It has been noted that in exploring disability discrimination legislation, much 
literature focuses on the perspectives of employers and not employees (Foster, 2007), thus 
this chapter makes a contribution here. It is an important time to  document participant 
experiences, given the reported low rates of impairment disclosure in employment 
(European Human Rights Commission, 2012) and the current instability in relation to the 
labour market (Patrick, 2012).
As was explored above, employment and making an economic contribution is understood as 
a key marker o f citizenship (Taylor, 2004). Employment plays a key role in developing 
economic and social status, and exclusion from the labour market means that some groups 
continue to  be marginalised (Kitchin, 1998; Zucker, 2006). Paid employment has been 
recognised as beneficial (Wendell, 2001; Roulstone and Barnes, 2005), not only financially
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but in terms o f an increased sense of self-worth, structure in daily life and connection to  the 
local community (Platt and Gifford, 2003). I follow  Edwards and Boxall (2012) in recognising 
that both impairment effects and disabling barriers affect the experience of employment and 
contribute to  experiences and enactments of disablism - and that many o f the experiences 
documented here have commonalities w ith the experiences of other disabled people.
Negotiating w o rk  and treatm ent
All participants who were working on treatm ent (or started treatm ent while working) 
described needing to adjust working hours and patterns o f work. This depended on 
disclosure to  employers to  varying degrees (discussed below). Freda was the only participant 
who continued to  work the hours she did before treatment, despite experiencing severe 
treatm ent effects, including debilitating fatigue and emotional instability. She described 
managing these effects by sleeping during her lunch hour w ith her office door closed. She 
explained that her reasons for non-disclosure related to her perceptions of her manager 
whom she fe lt  'couldn't hold his own water, let alone a confidence'. This echoes Roulstone et 
al.'s (2003) findings that reasonable adjustment negotiation depend on relationships w ith 
line managers.
Shaun, who was on treatm ent fo r the second time at interview, described taking the final 
weeks o f his 24 week treatm ent o ff work:
'I was doing okay fo r  the firs t half... Then I started (laughs) -  I'm laughing, it's not 
funny - 1 started picking figh ts with people at work, and that's when I thought it's time 
to back off... There would be days when I'd  go in and I'd jus t be like a zombie: I d stare 
a t the screen, I couldn't talk to anybody...! was getting aggressive and 
snappy...Ordinarily I'm  someone who's very, very motivated... I have to be very astute.
I have to talk a lo t o f directors. So, that fe lt horrid because... over a period o f time I d
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avoid people, I'd  avoid meetings, I wouldn't take phone calls because I thought, I 
haven t  got the energy to think about what you're telling me or asking me. The other 
thing, I'd  describe it  as my brain wading through treacle ... Typically I would go into 
work eight, nine o'clock in the morning, but by two o'clock I was toast; I ju s t couldn't 
function a fte r tha t tim e.'
Shaun's rich description of the effects of treatm ent on working makes visible not only the 
embodied experience, but the impact on wider relationships. He described raising a 
grievance against his employer on treatment. Whilst Shaun indicated that he probably 
would have raised this grievance in due course, he felt that treatm ent exacerbated this. Holi 
also described reducing her hours to part time in her role as a counsellor, whilst on 
treatm ent. Ben, who was treated for hepatitis C infection twice, reported reducing his hours 
on both occasions -  but this was affected by his employer at the time.
Redundancy
Two participants described being made redundant whilst on treatment, possibly a marker o f 
the time period during in which this data was generated. Whilst it is unlawful to  make 
someone redundant due to  disability, it is questionable whether this occurred for Laurie 
(discussed below). Both Keith and Laurie described taking voluntary redundancy when their 
respective companies needed to  make savings. Keith indicated that redundancy was part of 
a range o f options, (although the degree to which these were meaningful or suitable is 
debatable, as one option was to take an 18 month sabbatical unpaid). The uncertain nature 
of the treatm ent meant that Keith took redundancy:
7 decided I was going to take redundancy so they gave me a big fa t  cheque and I 
walked away and basically I have been on a holiday since. So I am not — my doctor 
keeps signing me o ff anyway so I am not due to go I have been signed o ff until the end
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o f September. But I need to go back to work anyway because I quite fancy earning 
some money. But I don 't really care what I do... Because I think the importance o f a 
career is gone.'
Whilst Keith spoke positively o f his employer (see below) and described his changing views 
on the importance o f a career as a good thing, he later described finding it d ifficult to  survive 
on the redundancy payments given that he had parenting responsibilities. This also had 
knock on effects fo r his housing. Keith reported that eviction procedures were started when 
he informed his landlord he had lost his job. This was only resolved w ith the involvement of 
his MP, his local council and his liver consultant. Here hepatitis C treatm ent intra-acts w ith a 
number o f areas o f his life and paradoxically, obtaining support actually required that Keith 
put in a great deal o f 'work' whilst on treatment. The 'work' required is also likely to 
increase fo r those subject to  the size criteria or benefits cap (DWP, 2013a, 2013b) where 
individuals find they can no longer afford to live in their home and have to  move away from 
social networks and incur additional financial expenses and the stress of moving.
Laurie described a particularly difficult experience of being made "redundant" (his use of 
parentheses) from  his job in a legal environment:
'/ had to drop my working week to 3 A days, then my company made me redundant 
1/3 way thru - blessing really cos I couldn't cope a t that point and my health was 
getting progressively worse...Work-wise - totally started to strip me o f ability to 
function. Aggressive, absent-minded, short o f breath - couldn't sleep, obsessive at 
times'.
When I later clarified this arrangement w ith Laurie, he explained:
'Going part-tim e fo r  me was basically my employer allowing me a ha lf day fo r  the 
chemo shot, and a half-day recovery the fo llow ing day - so part-tim e o f one day off.
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The chemo laid me so low that this was problematic. Being slightly naive I relied on 
their generosity on this issue and didn 't request under the Disability Act. They made me 
"redundant" two months into chemo.
Laurie indicated that although his employers provided him w ith a generous redundancy 
payment, and the tim e o ff gave him the opportunity to recover from treatment, he fe lt their 
specialised legal knowledge had enabled them to make him redundant despite this being 
unlawful under the DDA (1995, 2005, now under Equality Act 2010).
Laurie indicated that he did not think to  ask for reasonable adjustments under the DDA, 
although his employers, given the ir profession, might perhaps have suggested this to  him. 
This could be interpreted as a lack of knowledge on Laurie's or his employer's part 
suggesting the need fo r greater information, training and awareness around applications of 
disability discrimination and equality legislation. It is possible that the impact o f the 
treatm ent on Laurie's cognitive ability, and the increased stress he experienced on 
treatm ent, might well have influenced his willingness to pursue an adjustment. It is also 
possible tha t Laurie's employers were unsure about his entitlement to an adjustment under 
the act given the contingent and shifting nature of the treatm ent effects and duration. 
Further, Laurie's phrasing suggests that his employer determined how much time he needed 
to  recover from treatment, rather than asking Laurie, which proved inadequate for Laurie's 
needs. This echoes Roulstone's (2003) observation that power to apply the DDA rests w ith 
professionals.
V oluntary  w o rk
David, who was in recovery at the time of interview, described working as a volunteer w ith a 
substance misuse organisation. He was also working towards professional qualifications at 
the time and reported tha t participating in the interview w ith me was an important part of
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his recovery. He indicated that the voluntary nature of the position functioned as a 'safety 
net' regarding the effects of treatm ent:
7 sometimes think morally I am having...an easy time o f it  [on treatment]. How can I 
be reliable to be working on a daily basis i f  I don't even know i f  I am going to be able to 
get out o f bed in the morning?...That's like my worst fear. That's why I have it  [inject 
interferon] over the weekend so i f  I need to recuperate I am alright. I have to have this 
safety net o f 'its ok i f  I am not able to do i t '  and being a volunteer that's great I don't 
have to worry about losing my job  or letting people down'.
There are a number of important points here. In spite o f the voluntary nature of the role 
David works in, he reports taking actions similar to those completing paid work, i.e. injecting 
interferon over the weekend to  minimise impairment effects in the working week. His 
observations about the need to  avoid 'letting people down' or losing his job, overlook his 
own comm itment to his recovery (both in the context o f hepatitis C and from drug use) and 
to  the organisation. Though David is working in a voluntary, academic and recovery capacity, 
this is enacted as 'lesser' than paid work (Ferguson, 2013). It also implies that David has 
absorbed beliefs that sickness in the workplace 'lets people down' and enacts those with 
hepatitis C as potentially unreliable rather than highlighting the need for reasonable 
adjustments from employers. For David, his concern w ith not 'letting people down' (i.e. 
being reliable) may also intertw ine w ith his awareness of oppressive assumptions associated 
w ith drug use; 'morally I know I am having an easy time o f it', implies that since he 
contracted hepatitis C through drug use he should be experiencing more difficulties on 
treatm ent.
Obtaining reasonable adjustm ents in the w orkplace
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Some participants did describe receiving reasonable adjustments under the Disability 
Discrimination Act (now under The Equality Act 2010). The DDA requires employers to  make 
'reasonable adjustments' under section six of the act to facilitate the employment of 
disabled people in the workplace; including: providing equipment (chairs, laptops, software), 
making adjustments to  the workspace or to the structure and timetable of work (working 
part tim e, working from home, working a different routine) (Crooks 2007; Foster, 2007; 
Crooks et al., 2009). However, as Crooks (2013) notes in a Canadian context, even though 
these rights are enshrined in legislation, adjustments may be unevenly available and the 
concept o f reasonable adjustments remains vague (Bruyere et al., 2004).
Keith described receiving a formal reasonable adjustment and a very positive response which 
he fe lt was related to  the national reach of the company and the size of the organisation he 
was employed by:
'They installed a broadband line in my house; they gave me a computer...so I could 
work from  home. A ll I had to do was go into the office on a Friday, they insisted on 
tha t because they d idn 't want me to be isolated from  the team -  which is fa ir  
enough...they were wonderful, absolutely superb but they are a big company. They 
can't be seen to discriminate'.
Here Keith is provided w ith equipment to work from home a mechanism which, if expanded, 
could increase access to  the labour market for many disabled people (Foster, 2007; Marsh, 
2012). This experience fits w ith a survey by Bruyere et al., (2004), who found that equipment 
provision was the most easily accommodated adjustment.
Similarly Shaun reported a positive response, which he fe lt was connected to the informed 
and specialist nature o f his role and his employer being in the public sector:
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I ve got a good job. I ve got o good employer as well because they're a public sector 
organisation they're very good about things like people with HIV and other 
conditions...they've been fine  about giving me time off. During the in itia l pa rt o f my 
treatm ent they said they would give me a reasonable adjustment, so I explained how I 
could work best and they worked around me. So, from  that po in t o f view I can't 
complain. But I could well imagine there are loads o f other employers who would say: 
what's wrong w ith you, well on your bike i f  you can't perform'.
As Shaun indicates, this positive response is perhaps connected to  the large nature o f the 
organisations, and the size and specialisms of their HR and legal departments, who may be 
better informed than smaller organisations. Although as Richard's example (below) shows, 
this is not always the case.
Charlie described a positive response which he too felt was related to  the nature o f his 
employer and the type of work he did, which made adjustments relatively straightforward:
'Because (my employer) is a [blood borne virus organisation] they had a fu lle r  
understanding o f what was going through. It would have been impossible in a physical 
type job  fo r  me to carry on... There was a huge amount o f flexibility. I luckily had an 
employer who rather than restrict that actually expanded that. So things like being 
able to work from  home was a major bonus because sometimes i f  I couldn't get out o f 
bed I could turn the computer on and just go through my emails.'
Charlie makes an important point here about the forms of work that are amenable to 
adjustments of this type, indicating that this may have been more difficult if it involved 
physical work or attending somewhere every day153. Those working in roles which are
153 This raises issues regarding recent proposals to require claimants to look for work 35 hours a 
week in order to receive benefits (Citizens Advice Bureau, 2013).
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insecure and low paid - the current nature of available employment (Garthwaite et al., 2013) 
- may find this is much less the case.
Similarly, Daniel, who was training to  be a counsellor, described his college tu to r making 
adjustments to  enable him to  continue to participate, which he fe lt was related to  his strong 
relationship w ith  his tu to r and the flexibility o f the course and the college.
It was perhaps no coincidence that most o f the participants who received a reasonable 
adjustment were well informed of their rights, either through working in a disability advisory 
role or working fo r an organisation which provided some advice and training on these issues 
(cf. Roulstone et al., 2003). However, for Richard, specialised knowledge (both on his part 
and on the part o f his employer) did not lead to a positive experience when employed by his 
local authority. He described disclosing both his liver transplant and the second course of 
hepatitis C treatm ent (and the impairment effects and adjustments needed) at the interview, 
and was offered the job. Despite this honesty Richard reported:
'[The employers were] absolutely diabolical. They tried to sack me when I became ill 
and eventually I won but it  was like, you know, unions and it  dragged on fo r  about 
three quarters o f the year ... exactly what I d idn 't need because at that time I was 
going through treatm ent...if I had been slightly higher up the organisation, I guess my 
union m ight have thought it  worthwhile suing them, because I would have loved to 
have done that. I d idn 't regret leaving it  but its put me o ff my local [authority] fo r  
life... they ju s t could not understand that they were dealing with someone who had a 
disability and they refused to accept that...They saw me as someone swinging the 
lead...even when Unison quoted the discrimination act a t them they s till refused to be 
impressed by tha t and i t  got really nasty. It took over my life fo r  some months ...And a t 
the end o f the day it  wasn't jus t the shit o f a line manager I had I was dealing w ith - 1 
d idn 't speak to her fo r  about nine months - I was dealing with their HR who should
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know something about this! They tried to get rid  o f me w ithout even referring me to — 
they actually ended my contract a t one point, I got a le tte r saying I was no longer 
employed by them w ithout having gone through occupational health.'
This extended extract highlights the difficulties Richard faced and the intra-action o f these 
difficulties which materialised him, and his impairment, in both directly and indirectly 
psycho-emotionally disabling ways. The extract makes visible the lack of clarity around 
hepatitis C and liver disease and the coverage of the DDA. Although it is difficult to see how 
a person recovering from an organ transplant would not be considered disabled fo r the 
purposes o f the act. It also highlights the stressful and long term nature of the process of 
challenging this using the DDA, which became even more disabling (Roulstone, 2003). Whilst 
Richard described resisting and challenging this, there is evidence that others do not 
(Edwards and Boxall, 2012). There are also serious implications given that Richard indicates 
that he would be deterred from seeking local authority support, potentially affecting how 
much he engages w ith regard to  social work support and information in future.
As Fry and Bates (2012) have noted, responses from employers can be uneven and 
contingent. Ben described two very different responses. When he underwent treatm ent the 
first time, he disclosed his HIV status and eventually his hepatitis C status to  his line 
manager, w ith whom he had a positive relationship, and came to an arrangement where he 
went home if he fe lt unwell. Ben described that he fe lt this was a result o f the size of the 
organisation which could temporarily absorb his work responsibility during difficult periods 
o f treatm ent. However, after the company was sold to a smaller organisation, Ben reported 
a less proactive response from employers, deterring him from seeking a reasonable 
adjustment:
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Yeah, the f irs t time round they were supportive because I suppose when you're a big 
HR team you know the rules and everything else. The second time around the onus was 
put on me to go and get the information. I thought 'well I'm not going to have the 
wrangle, I'm not making myself any more ill by trying to do a ll the homework'...! ju s t 
thought, 7 don 't need any more at tha t point'...I was fo u r months into the medication 
and I was tired. And o f course on top o f that the company had been taken over and I 
don 't need any more stress, trying to hold onto our jobs and everything else.'
Here, Ben indicates that he did not pursue reasonable adjustments under the DDA because 
he would have had to  research and negotiate this w ith his employer. He described seeking 
advice and support from a national charity, who explained that adjustments need to  be 
negotiated on a personal basis. Ben described not feeling well enough to do this due to  the 
effects o f treatm ent. Crooks et al., (2013), in the ir study of Canadian academics seeking 
employment adjustments, similarly found that participants did not ask for reasonable 
adjustments, because they expected it to  be stressful and felt too ill to take on the additional 
work they fe lt it would entail. There is a parallel here w ith participant experiences of 
accessing welfare benefits, where participants reported being too impaired and disabled to 
pursue an appeal paradoxically, this means that those who are the most in need o f support 
are the least likely to  access it. I am reminded here of Barnes' (2003b) observations that anti- 
discrimination legislation and support should be highly visible, its implementation 
adequately funded and that responsibility for enforcing it should not be left to  disabled 
people themselves.
Further, Ben indicates that he had concerns about the stability and security o f his 
employment if he was to have made his hepatitis C status clear in his workplace. He 
described shredding his personal file, which disclosed his HIV status, out o f concern that this
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may well have affected the way he was treated and his career trajectory. Similar sentiments 
were echoed by untenured academics in Crooks et al.'s (2013) study.
Coverage under legislation
Hepatitis C was described in the context of disability legislation in Australia fifteen years ago, 
(Crofts et al., 1997) and in the US Grace Moore (2009) makes explicit reference to  coverage 
of people w ith hepatitis C under the Americans w ith Disabilities Act. In the UK, Mack (2007) 
and Paylor and Mack (2010) have suggested that those w ith hepatitis C (and on treatm ent) 
should be protected under disability legislation, but there has been no exploration of the 
extent to  which people w ith hepatitis C fe lt they were covered. A person is covered by the 
Disability Discrimination Act as if they have 'a physical or mental impairment which has a 
substantial and long-term adverse effect on the person's ability to carry out normal day-to- 
day activities'. For the purposes of the Equality Act (2010) the wording is very similar (HM 
Government, 2011).
The Disability Discrimination Act, which most people referred to in their interviews, has been 
criticised fo r being based on a medical model (Pearson and Watson, 2007). Although recent 
efforts have been made to  cover fluctuating impairments in the Equality Act, many 
participants described feeling uncertain about whether they were covered w ith hepatitis C. 
Ben described feeling that people w ith hepatitis C were covered under disability legislation, 
but that the difficulties he faced in employment were a result o f hepatitis C not being 
explicitly included under legislation from the point of diagnosis in the same way HIV is; which 
contributed to  its enactment as unimportant. Though Ben acknowledged the contingency of 
hepatitis C experiences, he described how acknowledging hepatitis C from the point of 
diagnosis would be validating and helpful:
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And I know hep C is kind o f short term, fo r  some people it's short term, fo r  some 
people it  s long term, but I thought fo r  that period o f medication it  would be helpful i f  
i t  was classified because then it  makes it  easier, because my employer, they ju s t d idn 't 
know. Even when I asked a t the hospital they said it's between you and your employer, 
they d idn 't know either'.
Though it is important not to  reinforce the medical model by stating that those w ith hepatitis 
C should be covered on the basis of impairment alone, the structural and psycho-emotional 
barriers described by participants in this thesis suggest that they should be included explicitly 
under the Equality Act (2010). This contributes to a reality where hepatitis C is not 
depoliticised and individual, but a responsibility shared by employers and wider society.
As was explored above, significant work may be required on the part of the person claiming 
under the act. Making increased reference to  the DDA in wider information, campaigns and 
training is not intended as a panacea, especially given the findings of a recent National Aids 
Trust (2009) survey which indicated that even with legislative protection, one fifth  o f people 
w ith HIV questioned fe lt they had experienced discrimination in the workplace. Further, 
recent cuts to  legal aid may also impact on the possibility of bringing cases to court and 
could entail fu rther difficulties fo r participants, contributing to the silence around rights for 
those living w ith hepatitis C. However, in spite of the problems with it, the DDA has enacted 
the needs and rights o f disabled people as important (Roulstone, 2004) and the Equality Act 
represents a step forward regarding recognition of the cross cutting nature of oppression. 
Though the DDA (2005) incorporated people w ith fluctuating impairments from the point of 
diagnosis - including HIV, Multiple Sclerosis and Cancer - there has been limited 
acknowledgement o f the rights and entitlements of people w ith hepatitis C under the 
Disability Discrimination Act, and later under the Equality Act (2010). NHS Choices (2012d) 
and The Hepatitis C Trust (2011b) only briefly mention legislation, indicating that employers
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may have an obligation under the DDA. Only NHS Health Scotland (undated) explicitly and 
firm ly acknowledges that those w ith hepatitis C are disabled and are entitled to  reasonable 
adjustments. Thus, there is a need for greater attention to employment, reasonable 
adjustments and coverage under the DDA.
'W ork life ' (2010), as discussed by Boyd (2011), provides employment support and guidance 
fo r people w ith chronic and fluctuating conditions, including MS and HIV. W ork life's remit 
could be widened to  include the experience of hepatitis C, enabling people w ith hepatitis C 
(and those w ith co-infection) to garner employment related information and to  be able to  
signpost others. In addition, specific information could be developed fo r employers to 
explain the impact o f hepatitis C and treatment, and their obligations, such as the too lk it 
developed by Macmillan Cancer Support (Macmillan Cancer Support 2011b).
Being self em ployed
The final area where there were specific issues raised around employment was the 
experience o f self-employment. Both Morgan and Grace reported being self-employed and 
giving up the ir businesses due to  treatm ent effects. For Morgan, having to  give up her 
business was cited as the major impact o f hepatitis C treatment as she lost clients and her 
working premises.
'No m atter how positive [you are] and how much you do fo r  yourself I think it  is going 
to take time fo r  my body to recover, so financially, and, who I am and what I do is 
affected very definitely by it  [the treatment]'.
Here Morgan's comment 'no m atter how much you do fo r  yourse lf resists the pervasive 
position tha t what those who are not working need is 'motivation . The treatment effects 
impair her body and the unpredictable nature means that she needs to  recover before she 
can begin practicing again and building her client base back up. Grace, described selling her
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business due to  a combination of information she had read on the internet concerning 
difficulties on treatm ent and beginning the treatm ent itself:
I didn t  understand it  or I couldn't take it  in what they were telling me, because I s till 
didn 't have a clue what i t  was, and I'd read so much on the internet tha t I was 
struggling to take any o f it  in. Only the highlighted bad bits were the bits jum ping out 
at me which I supposed would happen if  you're not feeling well. It was all sort o f 
people you know saying 'do the treatment, don't do the treatm ent' and now  - it  was 
ju s t a horrible drug - 1 couldn't even think straight. That's why I sold my business, sold 
my work and I tota lly regret that. I fee l stupid fo r  doing that...that was all 
scaremongering I got o ff the internet'
Here the need for clear and accurate information about the treatment, the implications for 
her self-employed status and the opportunity to  discuss it w ith a business advisor or w ithin a 
hepatitis C support group (which Grace did not find unit much later in her treatment), may 
have prevented Grace from making the decision she later regretted. Later in the interview, 
the complexities o f being on treatm ent and having to survive financially after being found 
ineligible fo r welfare benefits were made visible. Grace used the profits from the sale of her 
business to  survive on treatment. This echoes her earlier comments regarding being 'in 
lim bo' she did not f it  the eligibility criteria for welfare benefits, but was too impaired work.
Ben and Charlie described the importance of continuing to  work because of the structure 
and distraction, and the sense of purpose afforded by the working day. Whilst this has been 
recognised in the literature (Platt and Gifford, 2003), and other participants described 
looking forward to  going back to  work, Ben's extract indicates how this sidesteps the issue of 
the ir entitlem ents under legislation:
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'[The Consultant]  said i f  you sign yourself off, fo r  six months or three months, he said 
a t the end o f it  you've got to go back to work and you've got to build all tha t strength 
up to go back to work, he said fo r  some people that's quite hard. He said you're better 
o ff staying a t work so I did in the end. I jus t gave a mental two fingers to my head 
office, and 'I'll ju s t get through it  and s tu ff you'. So I did'.
Here the idea that Ben will eventually have to return is used to encourage him to  continue to 
work. W hilst it is important to acknowledge that return to work after a period o f absence 
may be difficult, this advice is divorced from Ben's specific circumstances and appears to  be 
highly variable (i.e. Keith referred to  his doctor signing him off).
This chapter has explored participants' experiences of living w ith hepatitis C and the impact 
on welfare benefits and employment. This is a vastly under researched but tim ely area of 
exploration, given the current reforms. The next chapter draws the thesis together and 
presents conclusions.
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Chapter Ten: Concluding thoughts
In troduction
This final chapter draws together the main findings and discusses how the thesis addresses 
the research aim and questions. It also describes the unique and original contributions that 
this thesis has made. Recommendations for practice are made in appendix one.
O rig ina lity  o f research
The thesis makes a number of novel contributions to knowledge, above and beyond that 
which I anticipated at the outset. Vitally, the process of fieldwork w ith all its difficulties was 
discussed honestly across chapters three and four. Specifically, how this challenged the way I 
saw the world and hepatitis C within it. It has made visible how and why the realities 
presented in this thesis have come into being and in doing so, opened up the possibility of 
change. Specific theoretical concepts have intra-acted with participant experiences to 
contribute to  theoretical discussion and make contributions to practice.
The thesis explores the experience of living w ith and being treated for hepatitis C in a UK 
setting, particularly w ith in England, where literature remains scarce. Social research which 
does exist is authored by academics and practitioners in medicine (Copeland et at., 2004; 
Grogan and Timmins, 2010; McCreaddie et a!., 2011) and whilst this is both highly relevant 
and valuable, attesting to  the central role o f healthcare, it further enacts and materialises 
hepatitis C as a medical issue. In contrast, writing about hepatitis C from within applied social 
science - specifically social work - enacts hepatitis C as an issue which has significant social 
consequences, which social work can and should be addressing.
This thesis has added to  areas of research which have been largely overlooked in academic 
literature to  date, specifically the social and cultural implications of living w ith the virus and
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being on treatm ent. The post treatm ent experience, the implications fo r employment and 
participants views and experiences around welfare benefits have also been addressed.
Where existing literature around hepatitis C in the UK (vitally) focuses on harm reduction 
and on encouraging those who use drugs to  access testing and treatment, the sample of 
participants in this study provide an important insight into the support and information 
requirements of those who have been assumed to be relatively well supported by existing 
services (ACMD, 2009) finding that in practice, this was far from the case. The inclusion of 
data generated from men w ith co-infection made visible a reality in need of urgent research 
and service attention, adding to the value of this work.
A unique aspect o f this thesis is its exploration of living with hepatitis C as an area of interest 
fo r disability studies, and its explicit acknowledgement that people w ith hepatitis C 
experience disablism. It highlights the intra-active nature of needs of participants, noting 
that the oppression experienced by participants related to  their (former) drug use, intra-acts 
w ith the disablism experienced in relation to hepatitis C with serious consequences for 
participant wellbeing and in terms of structural barriers.
This thesis intersects w ith a number of bodies of work. It contributes to the literature which 
explores participants' use of metaphor to describe experiences of illness and disease, and to 
an emerging body of work which investigates how hepatitis C is materialised through social 
and political forces (Fraser and valentine 2008; Fraser and Seear, 2011). It applies research 
and theory which had only previously been applied to hepatitis C in an Australian context, to 
a UK setting. It illuminates in new and important ways the experience of living w ith hepatitis 
C (and its treatm ent) in the UK, including how people w ith hepatitis C see themselves, how 
culturally prolific diseases (Weiss, 1997) are made and remade depending on context, the 
people they affect and material conditions.
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It contributes to  calls (Harris, 2005; Suarez, 2006; Paterson et al., 2006) to  treat hepatitis C as 
a chronic illness. The context and time period during which this research was completed is 
bound up w ith, and augments, the important contributions it makes, particularly in relation 
to  employment and welfare benefits.
The diverse nature of the chapters, the broad range of experiences and the use of a number 
of bodies o f work evoke and enact the contingent, multiple and complex nature of living w ith 
hepatitis C. This explains (in part) the difficulty in responding to  hepatitis C, but also the 
highly political and ideological way in which services are constituted. The thesis has a 
distinctly political aim, to call fo r greater response to  hepatitis C in the UK (including co- 
infection) and in making comparisons w ith other experiences of impairment and disablism, 
to  emphasise the commonality o f experience and service requirements among (other) 
disabled people and those affected by wider welfare reforms.
D iscip linary contributions
The thesis makes a contribution across a number of different disciplines, which fo r clarity, 
w ill be addressed in turn. However this is not to suggest that these disciplinary contributions 
are discrete.
The thesis makes a contribution to  disability studies in exploring both the structural and 
psycho-emotional barriers people with hepatitis C face in everyday life. It begins a 
conversation which explicitly includes people with hepatitis C within disability studies and 
flags this up as an area fo r further research and discussion, as well as potentially providing an 
opportunity fo r identification and organisation among people w ith hepatitis C and (other) 
disabled people.
In exploring the experience of diagnosis, treatment and post treatment, as well as the use of 
metaphor and lim inality in participant accounts, the thesis makes disciplinary contributions
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to  health research — specifically that concerned w ith the social, qualitative aspects o f health. 
Social needs related to  health, (among those with hepatitis C and others) are an area which 
has historically been marginalised as a result o f the blurring o f boundaries between 
professions and a lack o f clarity about which services might address which needs (Findlay, 
2014). This thesis embraces this lack of clarity, in arguing for greater use o f multidisciplinary 
and holistic support.
In light o f this, the thesis also makes a number of bold disciplinary contributions in relation 
to  social work and hepatitis C in the UK. It, for example, argues for both the expansion of 
specialist hepatitis C social workers and the integration of hepatitis C support and 
information provision into w ider social work teams. It recognises the uniquely beneficial role 
that social work services could play in supporting people with hepatitis C and maintains that 
this marginalisation o f social work and social needs cannot continue.
The thesis also makes im portant contributions within social policy, specifically around social 
security benefits and employment. There are important insights for those working w ithin 
human resources and employment studies. The lack of f it between the needs o f people w ith 
hepatitis C and (other) disabled people and the current social security benefit system are 
highlighted together w ith the needs of those with hepatitis C in relation reasonable 
adjustments in the workplace.
M ain findings
The aim o f the research was to  explore and address the (professional) support needs of 
people w ith hepatitis C and the understandings, experiences and social implications o f living 
w ith the virus.
Whilst the research has fulfilled this aim, I found that in undertaking the research, the 
exploration o f the experiences o f living w ith hepatitis C was far more complex, nuanced and
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w orthy o f discussion than I had initially anticipated. The process of undertaking the research 
itself co-constituted the findings and their materialisation in the thesis, both on a micro level 
(i.e. in the interaction between myself and the participant) and macro level, in terms of 
raising and discussing issues that both my participants and I fe lt were important.
W ith this co-constitutive nature in mind, the research questions are reiterated:
1. What are the support and information needs of people living w ith and being treated for 
hepatitis C in the UK154?
2. What do participant accounts reveal about the cultural position o f hepatitis C in the UK at 
present and how can this improve our155 understanding and response?
3. Do people w ith hepatitis C experience stigma and discrimination?
Each chapter includes elements of all three key research questions and cannot be viewed in 
isolation. For the sake o f clarity, I have addressed each of the key research questions in turn, 
w ith an emphasis on cross-cutting themes.
Research question one
What are the support and information needs of people living w ith and being treated for 
hepatitis C in the UK?
This research question was developed in response to  the consistently documented 'low 
profile' o f hepatitis C w ithin the UK (particularly within England) and the accompanying lack 
of political and adequate service response (Copeland, 2004; APPGH, 2006; Agarwal et a!., 
2007; Frazer et a!., 2011b). The period during which the research was carried out and 
w ritten up (2009-2013) was one of considerable economic and political change, proved to be
154 20/21 of the participants resided and received treatment in England so this is the main focus. 
Particualrly given the service development and responses to hepatitis C require serious work and 
invigoration.
155 As academics, professionals, members of the public and family members/friends who may live 
with, or have to support someone with, hepatitis C.
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a particularly fertile  time for the development of new pharmaceutical drugs, and was 
accompanied by renewed calls for greater numbers to enter testing and treatm ent (UWG, 
2012). It was against this backdrop that the research question took on renewed importance.
Succinctly stated, the main finding relative to this research question is tha t current 
enactments o f hepatitis C have a much wider range of social consequences and participants 
have a much w ider range of support and information requirements than are currently 
recognised, in the literature and in service provision. Participants' needs both intertw ine 
w ith, and diverge from, the medical focus which dominates current responses to hepatitis C. 
The experiences and participants' lives are much messier than is currently recognised and 
hepatitis C cannot be understood in isolation, requiring a multi-disciplinary response. 
Participant support and information needs identified in the thesis are now revisited.
Awareness and representation
A key finding is that a low level o f awareness around hepatitis C persists. Participants who 
described being aware of hepatitis C prior to  diagnosis were those who had contact w ith 
drug services or worked in the blood borne virus field. Other participants described a vague 
or partial knowledge of hepatitis C, prior to diagnosis. Whilst some of the vagueness can be 
explained by the time period during which they were diagnosed (1990s or early 2000s), there 
is evidence that even those diagnosed later (mid to late 2000s) had minimal awareness of 
hepatitis C. Overall, participants described an absence of representations of hepatitis C in 
everyday life and a subsequent lack of awareness about its effects and implications, from 
family, friends and professionals who were not specialists (i.e. GPs social workers, 
Department fo r Work and Pensions staff, welfare benefits assessors and housing staff). This 
absence o f hepatitis C in public arenas enacts hepatitis C as an illness which only concerns 
particular proportions of the population (i.e. people who access drug services), not
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something which should concern w ider society, materialising in lim ited services, w ith 
adverse consequences fo r those diagnosed.
Though the current information focused on exposure and accessing a test is important (DH, 
2004b; Hepatitis C Trust 2010a; NHS Choices, 2012a), there is a lack o f visibility o f the 
experience beyond diagnosis and treatm ent initiation. This both constitutes and mirrors 
participants' own experiences in this study. The (limited) resources currently expended on 
hepatitis C focus on surveillance, testing and treatment, with far less focus on those living 
w ith the virus or going through treatment.
As well as a general lack of awareness and profile in public, the men living w ith co-infection 
indicated that hepatitis C was frequently ignored or silenced in gay and HIV positive 
communities and organisations. Here, support and information needs intra-act w ith the 
cultural position o f illness. Hepatitis C was perceived as less socially acceptable than HIV and 
participants described reluctance to enfold people w ith it into gay and HIV positive 
communities and organisations, and thus acknowledge it as a health issue they should be 
concerned w ith. This has implications for participants' self-esteem and sense of identity, and 
exacerbates and re-enacts the sense of unacceptability that participants recounted (see 
research question three).
Testing and diagnosis
The majority o f participants in this research did not necessarily identify themselves as 
requiring a test fo r hepatitis C, but were nevertheless experiencing illness and sought 
support from  a GP. A key finding is that low levels o f awareness and knowledge amongst 
GPs, intra-acted w ith age and gender related expectations, making visible the multiple and 
contingent nature o f the virus w ith serious consequences for participants feelings about
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themselves, the ir relationships and even their employment. This lack of awareness functions 
as a structural barrier to  diagnosis.
Here, issues identified in relation to  research question one intra-act w ith, and enact, findings 
in relation to  research question two. Descriptions of hepatitis C as a 'silent killer' or 'silent 
epidemic', frequently used in medical literature (see Bockhold, 2000; Cole, 2007), enact the 
virus itself (rather than the structures surrounding it) as silent (see Fraser and Seear, 2011) in 
order to  emphasise the importance of testing and treatment. However, other participants 
suggested that hepatitis C is silenced through lack of impetus to take action, poor policy 
response and lack o f funding (Edlin, 2011).
Participants described absorbing dominant views about 'responsibility' fo r their health and 
using the 'silent' nature of the epidemic to emphasise the importance of accessing a test and 
being treated - and the irresponsibility o f those who had not done so - which obscures the 
lack o f support and structural response, the challenges of treatment and the w ider cultural 
associations o f hepatitis C diagnosis.
Participants described occupying a liminal (Turner, 1966; Murphy et al., 1988) zone prior to 
diagnosis, 'knowing something was wrong' but not being given a clear diagnosis, or receiving 
numerous diagnoses. This protracted process not only meant that participants were not 
accessing support for the ir hepatitis C, but also that they absorbed wider beliefs that they 
were 'malingering'. Participants described invalidation (Wendell, 1996; 2001) from family, 
friends and professionals (and for two participants, discriminatory treatment) which 
undermined the confidence they had in their knowledge of their body (Mendelson, 2009), 
and placed strain on existing support networks - with implications fo r treatment and post­
treatment.
The impact that living with undiagnosed (untreated) hepatitis C might have on a person s
family, social and working life, and the subsequent need for support is not taken into
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account when the diagnosis is eventually given, ignoring the cumulative impact (Reeve, 
2008) o f living w ith long term impairment and disablism.
A key finding here is that although some improvement in the experience o f diagnosis was 
visible in participant accounts, over a decade after diagnosis experience began to  be 
explored qualitatively (Crofts et al., 1997; Glacken et al., 2001) there is still a need fo r major 
investment and attention. Participants frequently described being poorly prepared -  not 
being aware they were being tested or unsure of what hepatitis C actually was. Participants 
who fe lt the ir diagnosis had been handled well, described being given time, clear 
explanations o f the virus, the implications and treatment, along w ith the offer o f family 
testing, vaccination against hepatitis B, information and a sustained point o f contact. Most 
participants diagnosed by their GP or in unexpected settings (i.e. when seeing a consultant 
fo r something else) described being provided with limited or no information.
These experiences enacted hepatitis C as of little importance, which directly contrasted with 
participants' own experiences and the information they accessed, leading to unnecessary 
stress and anxiety ultimately reinforcing the need for a medical response. This finding 
mirrors Harris's (2009b) observations that reactions and responses to  diagnosis are 
contextual. The contingent and enacted nature of hepatitis C comes to  the fore again. It is 
not inherently d ifficu lt or troublesome, but is co-constituted though social forces and 
support surrounding it.
Diagnosis simultaneously functioned as a form of validation and a source of oppression . 
The initial relief participants described on diagnosis dissipated when they did not receive the 
support they had hoped for, and thus experienced further liminality (Murphy et al., 1988). 
When nothing else is forthcoming, medical responses provide a kind of stability (Jutel, 2009) 
contributing to  specific medical (and individualising) realities.
156 As pharmakon (Derrida, 1981) both beneficial and detrimental.
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Post diagnosis
The post diagnosis period required specific support and information, notably the opportunity 
to  talk through the diagnosis and its implications w ith someone knowledgeable. A key 
finding in relation to  information and support was the vital role o f peers, including face to 
face support groups, online, telephone support and annual gatherings. This meant that 
support was available in a variety of mediums and allowed peers to  compare experiences, 
read each other's stories, 'sound off' and compare bodies, though a lack o f support groups 
outside o f major cities and inadequate funding inhibited this. An important finding was that 
peer support was often located by participants in the course of the ir search fo r information, 
rather than being signposted by professionals.
W ider support
The input o f specialist hepatitis C nurses (or specialist teams) was highly valued fo r the 
majority o f the participants in the study, especially during treatment. Some participants 
emphasised the availability o f their specialist nurse, and their flexibility and speed of 
response, when they had problems. Others described difficulties in getting in touch with 
the ir specialist nurse or in getting answers about difficulties they were having on treatment. 
Participants fe lt that this was in part connected with hepatitis C's status as 'under 
construction' (Duffin, 2004a), where information is constantly developing. Others fe lt that 
that this was due to  caseload or because their support needs went beyond what a specialist 
medical team could (and should) provide. A key finding is that input is required from a much 
w ider range o f professionals and services (detailed below).
Despite a clear need fo r the development of services, the research found a postcode lottery 
continues to  exist across all services (including medical ones). Participants were aware of the 
financial and other resource constraints, and that any improvement would require strong
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relationships between professionals in multiple organisations (i.e. substance use services, 
social work services, health services, sexual health services and peers w ith varied 
experiences of hepatitis C).
If hepatitis C is not addressed locally, this could potentially lead to health inequalities and 
different materialisations of experience, including concentrations of hepatitis C (genotypes) 
in particular areas (Fraser and Seear, 2011). Ongoing reforms to housing benefit, including 
the introduction of the size criteria or 'bedroom tax' (DWP, 2013a) and the migration of 
families into different areas of the country, may mean that specific geographical areas find 
themselves w ith increased numbers requiring support and treatment, further reinforcing the 
need fo r consistent (minimum) local services. The lack of accessible services was explored in 
the thesis as a form o f structural and indirect psycho-emotional disablism (see research 
question three).
Central to  all o f these findings is the rhetoric o f 'increasing effectiveness' (Fraser and Seear, 
2011), which is perpetuated in the development of new drugs. This potentially obscures the 
needs o f those undergoing treatm ent now, and allows services and a wider range of 
professionals to  elide the responsibility to  provide support and information to those living 
w ith, and on treatm ent for, hepatitis C.
T re a tm e n t
Participants described long and arduous treatment experiences, a form o f 'embodied labour 
(Keane, 2011). Treatment impacted on the majority of participants' bodies and lives 
mentally, physically and emotionally, and their discussions of treatment were characterised 
by ambivalence. This ambivalence was explored using Derrida s (1981) concept of 
pharmakon, meaning simultaneously poison and remedy. The thesis explored how the 
remedy aspect o f treatm ent was frequently privileged by participants, professionals and in
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wider structural responses to  hepatitis C, w ith the 'toxic" aspects under supported and 
invalidated. Treatment is presented as a means of avoiding future ill health (such as liver 
damage, cancer or even death), whilst at the same time creating impairments (both short 
and long term ) around which participants received limited support.
All participants were aware of the possibility of side effects, but these were displaced either 
as 'individual' (i.e. not likely to  happen to  everyone) or a small price to pay in pursuit o f the 
w ider goal o f clearing. The thesis found that this displacement was enacted and materialised 
on a micro scale during interviews and on a macro scale with the lack o f support services on 
treatm ent. This ambivalence needs to be materialised through structural service responses, 
which acknowledge the illness involved in becoming well, and that divisions between ill and 
well, disabled and non-disabled, are not fixed, but depend on enactments and contingent 
realities.
A key contribution to  knowledge made by this thesis was the potential role for social work in 
supporting people w ith hepatitis C. These findings show that social work (both statutory and 
third sector) support fo r people w ith hepatitis C exists sparsely in the UK. There is an urgent 
need to  build capacity here, as the thesis highlighted the intra-active nature of hepatitis C 
w ith life circumstances, ageing, additional impairments and disabling barriers. If these 
additional needs are not adequately taken account of and responded to, then the sole focus 
on treatm ent enacts hepatitis C as a public health problem which individuals need to  take 
responsibility fo r (Fraser and Seear, 2011), rather than an experience which impacts on, and 
is affected by, w ider social networks and structures.
The thesis highlighted a vital and unique role for social workers given their skill set and 
expertise. Social workers are ideally placed to deal w ith the ambiguity and complexity of 
supporting service users w ith the issues identified in this thesis, both as a specialist role and 
as part o f an existing team where hepatitis C may not be the key focus.
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The thesis highlighted specific areas where social workers could and should become 
involved, ranging from the provision of information and referral to  testing, through 
treatm ent and post treatment. Social workers' daily contact w ith those who have the 
potential to  be affected by hepatitis C and their engagement w ith 'messy' issues faced by 
people who use services, mean they are well placed to address hepatitis C whilst paying 
attention to  the w ider context of service users' lives.
The thesis highlighted that those w ith hepatitis C could benefit from social work 
involvement, from information provision and discussion, to facilitating access to  treatment, 
advocacy and peer support. Most importantly, social workers could address needs which at 
present are the most under supported - those relating to housing, finances, childcare, family 
and relationship issues. There is also a unique role fo r social work in the post-treatment 
phase where medical support is limited.
However, current cuts also risk disinvestment in services as local authorities and health 
boards set the ir own priorities (Daddow and Broome, 2012; Hepatitis C Trust, 2013d). This 
may mean that services are reduced to such a degree that social work involvement becomes 
disabling, rather than enabling (Roulstone, 2012). Given that social workers are taught to 
critically reflect on current systems and to challenge oppression (Findlay, 2014) they could 
(and should) play a role in lobbying for improved responses to and services fo r hepatitis C 
and against cuts to  services.
Participants acknowledged that there was no 'quick fix'. The danger in times of austerity is 
that the lack o f a quick or easy solution in responding to hepatitis C means those living w ith 
it are marginalised altogether. By recognising and taking an active role in the lives o f people 
w ith hepatitis C, social work can challenge the hidden and silenced nature of hepatitis C 
(and indeed co-infection).
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Finances: e m p lo ym e n t and w e lfa re  bene fits
The financial aspects o f living w ith hepatitis C formed a central finding w ithin the thesis. 
Whilst money has been recognised as vital in maintaining stability (Hopwood and Treloar, 
2007), and poverty can be intertw ined w ith drug use (Seddon, 2006), there has been less of a 
focus on participants applying for welfare benefits or their experiences of employment.
Most participants described changes to  their work patterns during the treatm ent and post 
treatm ent period, so this is a specific area where information and support are required. A 
few participants described obtaining a positive response from employers who made 
reasonable adjustments or allowed them to work flexibly. Others described a lack of 
knowledge and understanding (both themselves and from their employers) regarding 
entitlements under legislation, or the degree to which they were covered. This highlights 
that the process intended to enable working, is actually vague and difficult to  apply in 
practice (Crooks et al., 2013), particularly when combined w ith the hidden nature and the 
lack o f awareness around hepatitis C.
As explored in chapter nine, the process of pursuing rights under legislation can result in 
greater disablement. Those who did report reasonable adjustments fe lt that this was due to 
the size and nature of their employer, as well as the requirements o f their job. This may 
prove even more difficult fo r those who find themselves in low paid and insecure 
employment (Patrick, 2011). There is a notable lack of publicly available information 
regarding participants' entitlements to reasonable adjustments at work under the Disability 
Discrimination Act (now covered under the Equality Act, 2010), adding to  the silent and 
marginalised nature o f hepatitis C as a political (as opposed to medical) issue. It further 
enacts hepatitis C as a virus which does not affect those in employment and is o f marginal 
concern in the workplace.
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Limited perceptions around what constitutes work were also made visible, given that the 
m ajority o f participants were working unpaid, providing support and information and raising 
awareness o f hepatitis C - both w ithin their social networks and in a w ider arena -  in a way 
which potentia lly saved vast sums of money for government and services.
Those who encountered disabling barriers in employment, or im pairm ent/treatm ent effects 
too severe to  continue working, described attempting to claim benefits. This was a particular 
area o f difficu lty fo r participants and the findings of this thesis m irror the experience of 
many (other) disabled people. Participants described occupying a liminal position, enacted 
in applications as f it  fo r work, or ineligible for benefits, when in practice the opposite was 
the case.
The experience o f claiming welfare benefits was not an area I initially set out to  explore. This 
adds to  the value of the research in terms of exploring and raising issues which are current 
and im portant to  people w ith hepatitis C. Participants described specific costs associated 
w ith living w ith hepatitis C, including diet, support, fuel and travel. This placed a strain on 
resources, which is arguably detrimental to a positive (and potentially successful) treatment 
experience.
The findings related to two benefits in particular ESA and DLA. Almost half o f the sample 
reported applying fo r benefits, with a significant number being found eligible on appeal 
(where this was pursued), although they reported a lack of professional information and 
support concerning their possible entitlement. Just two participants had accessed support 
and information from formal services or helplines. Others described gaining support and 
advice from peers, concerning entitlements and attending medicals, though they described 
this as adding to  the sense that they were acting fraudulently (Reeve and Soldatic, 2012) or 
'd idn 't deserve' support, see research question three.
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A key finding related to  the participants' sense of entitlem ent to  claim welfare benefits 
participants fe lt (mirrored in other chronic illness literature) that the processes used to 
determine eligibility did not take account of the hidden or fluctuating experiences o f living 
w ith hepatitis C. The liminal experiences of pre diagnosis and post treatm ent are not 
adequately accounted for, either in services or captured in processes such as DLA/ESA 
applications.
The application process was disabling on tw o counts. First it forced participants to  detail 
the ir impairments in a way which enacts them as incapable; this is an example o f direct 
psycho-emotional disablism (Reeve, 2002; 2008). Second, that not being found eligible 
enacts them as not 'ill enough' for financial support effectively ignoring the ir experiences of 
impairment and disablism (Bambra, 2012) and that providing financial support to some 
people now, ultimately saves money and resources in the longer term.
Participants fe lt that the descriptors and assessment did not take adequate account o f the 
impact o f the hepatitis C treatment, which is when they most needed support. The fixed 
nature of the forms effectively 'others' that which does not f it and makes it absent. Changes 
to  benefit entitlem ent and increasingly restrictive criteria, will mean those who may have 
previously been eligible fo r a small amount o f financial support [integral to  their 
participation in society (Campbell et al., 2012)] will no longer have this, placing greater 
pressure on local services, further reinforcing the need for knowledge among social workers.
Post tre a tm e n t
A central finding of the thesis related to the post treatment experience. Many participants 
indicated that SVR did not necessarily equate w ith improved health and instead, enacted 
new impairments and challenges which have only recently begun to  be recognised (Foster
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2013). Participants described needing information concerning the possibility and duration of 
effects, as well as support and services, to  address the post treatment period.
Those who reported post treatm ent effects described being unaware how long the 
treatm ent would take to clear from the body, or only being told towards the end of 
treatm ent. The remedy aspect o f the treatm ent is privileged where the toxic aspect is 
silenced. Others acknowledged that they had been informed of the possibility o f post 
treatm ent effects but had not expected it to happen to them, exacerbated by the focus on 
the 'individual' nature of treatm ent and the lack of formal support services. The thesis 
suggested tha t the marginalisation of the post treatment experience by services, makes a 
w ider point about the dominance of medicine, given that there were clear differences in 
what medicine was prepared to  provide support for and the embodied experiences o f the 
participants (cf. Persson, 2004; 2006). Currently hepatitis C is treated using an acute model 
o f care w ith very little  acknowledgement of the long term or lasting impact (Paterson et al.,
2006).
These findings opened up discussion of the design of post treatment support service. It was 
suggested tha t im portant lessons could be learned by looking at support provided to cancer 
survivors, including: an end of treatment support pathway, contact between the GP and 
specialist team to deal w ith any on-going medical and social needs, the provision of 
multidisciplinary support and information, signposting to support w ith finances and 
returning to  work, along with peer and emotional support.
This thesis explored the application of self-management programmes (National Cancer 
Survivorship Imitative, 2013; Expert Patient Programmes, 2013), given that these are a key 
component o f cancer survivorship programmes and Expert Patient Programmes are being 
increasingly rolled out within hepatitis C services. The thesis argued that the focus on self­
management potentially perpetuated the individualising responses which already dominate.
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While these forms of support may be valuable in some respects, they are still rooted in the 
belief tha t impairment causes disability rather than the barriers faced by people w ith 
hepatitis C. Further to  this, existing research found that many of the barriers faced by 
participation in EPPs were similar to  the ones already faced by participants fo r example, 
related to  transport and childcare (Paterson and Hopwood, 2010). The aim o f EPPs is to 
reduce 'dependency' on services and manage costs - counter to the philosophical, ethical 
and political commitments of this thesis. I suggested that the concept o f 'recovery in' 
(Davidson and Roe, 2007) might be more useful as a means of capturing the messy, 
nonlinear nature o f post treatment. This potentially has added value given its increased 
currency in both drug use and mental health fields, which may contribute to  more high 
profile enactments of hepatitis C and treatment.
The next research question focuses on how participant accounts contributed to, and drew 
from, current cultural understandings of hepatitis C.
Research question two
What do participant accounts reveal about the cultural and social position o f hepatitis C in 
the UK at the moment, and how can this improve our understanding and response?
Whilst talking about their support and information requirements, it became clear that 
participants' needs (and perceptions of them) were shaped by understandings and 
expectations related to  the cultural position of hepatitis C. With this in mind, the thesis 
foregrounded selected aspects o f participant accounts and discussed how these elements 
co-constituted hepatitis C, its treatm ent and the participants. Insights were offered as to 
how these understandings might enable reflection on, and improvement of, service 
responses.
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Chapter six, in particular, explored the dominant values and assumptions associated w ith 
specific metaphors and how they constitute groups in positive and negative ways (O'Brien, 
2009). The participants' use of the metaphor 'hepatitis C as a silent killer' established that 
although it was originally intended to refer to the silent nature of individual symptoms, it 
actually served to  highlight the structural silence (lack of political response, lack of funding, 
lack of awareness) surrounding hepatitis C. Participant accounts also made visible the intra­
action between the 'silent killer' metaphor w ith cultural beliefs around 'self-inflicted' 
hepatitis C, drug use and personal responsibility for health, which serves to re-enact and 
reinforce the dominance of medical treatment.
The support and information needs of participants were related to  the low profile of 
hepatitis C and the lack of support, and necessitated comparisons w ith other high profile 
illnesses, ultimately both resisting and reinforcing oppression and psycho-emotional 
disablism. A central and unique finding was participant's use of the comparison between 
hepatitis C, cancer and chemotherapy across a variety of topics. Though the comparison 
between hepatitis C treatm ent and chemotherapy appears in some literature (Hopwood et 
al., 2006; Harris, 2009; Leavitt, 2010), this has not been extensively explored.
Cancer was perceived and re-enacted by participants as a serious, well-funded, publicly 
supported, high profile illness, involving an often lengthy and difficult treatment. This was 
used by participants to  illuminate the cultural position of hepatitis C as trivial, blameworthy 
and vastly underfunded w ith a treatment which is inadequately understood and a poor 
service infrastructure.
Participants' comparisons w ith cancer were useful because they helped convey the 
seriousness o f treatm ent and enabled participants to access support and information from 
friends and services though the comparison as pharmakon was also made clear. The 
chemotherapy comparison involved significant emotional work (Thomas et al., 2002)
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compounding participants anxieties about being exposed and ultimately re-enacting the 
silence associated w ith hepatitis C; which makes concealment necessary. The perceived 
inferiority o f invisible impairments remains unchallenged. In making comparisons between 
hepatitis C (treatment) and cancer (chemotherapy), participants augmented and maintained 
a hierarchy o f impairment whereby people w ith cancer were seen as 'deserving', whilst 
those w ith hepatitis C were 'less deserving' of support. There was evidence that participants 
had internalised this as they consistently added caveats in their discussion o f the 
comparisons between cancer and hepatitis C.
However, positioning cancer as 'superior' also obscured the difficulties experienced by 
people w ith cancer that were similar to those experienced by participants, including limited 
support due to funding constraints in local areas, the fear and isolation associated w ith a 
diagnosis, the unmet needs (Thomas et al., 2001), and difficulties in being found fit fo r work 
or not knowing about welfare benefit entitlements. The implications of this on their sense of 
self are discussed in greater depth under research question three.
Comparisons were also made between HIV and hepatitis C. This is perhaps less surprising 
than the comparison made w ith cancer, given that HIV and hepatitis C are both blood borne 
viruses frequently compared within existing literature (Treloar et al., 2002; Copeland, 2004; 
Davis and Rhodes, 2004; Korner and Treloar, 2006; Harris, 2009b; Treloar and Rhodes, 2009; 
Swan et al., 2010; Farrell and Comisky, 2012). The comparisons made by participants in this 
study reveal im portant insights into the current cultural position of HIV, offering insights for 
HIV services as well as those associated w ith hepatitis C.
Unlike cancer (which maintained a position of superiority in the hierarchy of impairment), 
HIV's position shifted between being 'better than' having hepatitis C and being worse than 
having hepatitis C, fu rther exhibiting how stigma, oppression and disease are temporally, 
discursively and intra-actively constructed depending on social, cultural and political forces
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(Fraser and Seear, 2011) and social group (Harris, 2009a). Furthermore, these phenomena 
can be enacted, re-produced and remade, via intra-actions between policy, public responses 
and people affected. This shows that oppressive treatm ent is not inevitable but, rather, is 
dependent on context and thus open to  change (Reeve, 2008). The shifting nature o f the 
comparison also means that hepatitis C may need to be addressed differently among 
different groups (see also Lekas et o i, 2011)
Most o f the gay men I interviewed who were co-infected described HIV as ‘more socially 
acceptable' and better understood than hepatitis C. HIV was perceived as easier to manage 
than hepatitis C and treatm ent was perceived as less arduous - helpful fo r those who go onto 
HIV treatm ent after treatm ent for hepatitis C. The amount o f information available around 
HIV treatm ent threw  into sharp relief the lack of hepatitis C information. Here the 
comparison w ith HIV highlights important lessons that can, and should, be taken from 
strategies to  support those w ith HIV.
The thesis found that the pride some of the men with HIV felt regarding their status, did not 
exist in the same way for hepatitis C. Participants fe lt that there was a silence around 
hepatitis C w ith in communities and organisations (both in terms of health messages and 
visibility in the community), further contributing to its unacceptability and creating a cycle of 
stigma, shame and silence (Owen, 2008). Participants pointed to the need for an increased 
profile, and ownership (Owen, 2008), of hepatitis C within the gay and HIV communities, but 
described concerns over the relevance and effectiveness of a campaign like the one which 
existed fo r HIV in the 1980s.
For participants who did not live with HIV but had been exposed to the hard hitting UK
campaigns o f the 1980s157, the shifting and contingent nature of understandings of HIV was
made clear. HIV/AIDS (frequently referred to as AIDS -  a legacy of the campaigns and media
157 Notably the TV and leaflet campaign by the British Government 'AIDS Don't die of Ignorance'
(Central Office of Information for the Department of Health, 1987).
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messages and indeed the lack of contemporary presence) was simultaneously used as an 
example o f an blood borne virus which is serious and stigmatised and perceived to  be well 
understood and supported (cf. Munoz-Plaza et al., 2010). HIV was seen as culturally more 
significant than hepatitis C, both in terms of actions that have been taken to  raise awareness 
and the visibility o f illness and death from HIV globally. As w ith cancer, the comparisons w ith 
HIV obscure as well as highlight issues or difficulties for those w ith hepatitis C and w ith HIV, 
including: cuts in funding to  local and national HIV support services, waning public 
awareness, the differences in global responses to  HIV and the need for a holistic response.
H epatitis C as a d isability  issue.
This thesis made an important contribution in initiating discussion in academic and practice 
arenas around hepatitis C as a disability issue. This thesis acknowledged hepatitis C as a 
chronic illness and raised the possibility of including people w ith hepatitis C within the 
disabled people's movement in order to build on areas of common experience, and 
challenge the individualist focus that currently predominates.
Participants held mixed views on identifying as disabled with hepatitis C. The hinterland of 
messages around impairment and disability as 'personal tragedy' (Oliver, 1990; Thomas,
2007), and largely static and physical (Grewal et al., 2002), meant that a disabled identity 
was enacted as simultaneously undesirable and not applicable to people w ith hepatitis C, 
given it is a fluctuating and hidden impairment. Additionally, the current enactments of 
disabled people who claim benefits as 'shirkers and scroungers' (Garthwaite, 2011) means 
that adopting a disabled identity, might further enact people with hepatitis C in negative 
ways.
This thesis has made a unique contribution in initiating a discussion around the inclusion of 
people w ith hepatitis C within disability studies and argued that there should be greater
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recognition of the disabling processes and barriers they face in accessing information, 
support, recognition and treatment. At present, the institutional processes used to  define 
the ability to  work (for ESA) and determine eligibility for Disability Living Allowance (soon 
PIP) frequently exclude and marginalise the experience of people w ith hepatitis C. There is 
little  (if any) guidance around the application of legislation (e.g. protection under The 
Equality Act, 2010) to  people w ith hepatitis C, or people undergoing treatment. The lack of 
acknowledgement of their needs and the absence of publicly available information and 
support concerning how the legislation could apply, further enacts hepatitis C as something 
which must be addressed and managed individually. A consequence of this individualism is 
tha t hepatitis C becomes depoliticised (Persson, 2003) and an exercise in self-management 
(Race, 2001), which is further reinforced through the proliferation of EPPs.
There were a small number of participants who described themselves as disabled people or 
referred to  incidences where disability legislation and entitlements might apply to 
themselves and others. This is explored in greater depth under research question three.
In exploring the cultural position of hepatitis C, the role and position of treatm ent is key. 
Treatment was recognised as cultural, medical phenomena (Persson, 2003) used to  address 
participants' liver damage and impairment effects, but also to enact and re-enact discourse 
around (moral) responsibility for health and wellbeing. There was evidence that participants 
undertook treatm ent for ontological, as well as health reasons, particularly where treatment 
was one way of addressing the oppression, stigma and blame associated w ith hepatitis C. 
Paradoxically, this reinforced its unacceptability and reinforced normative ideas about the 
clean, closed body (Fraser and Treloar, 2006), as well as binary understandings of 
health/illness, disabled/non-disabled, good drugs/bad drugs.
Pharm akon and pharm akos
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The concept o f phormakon was used to challenge these binaries and unfold the ambiguities 
participants expressed around treatment, and those which were present in the structure of 
services. Pharmakon acknowledges the contingent enactments o f hepatitis C (and 
treatm ent) and how these enactments shape those who are living w ith, and being treated 
fo r it.
Participants' accounts o f treatm ent as being simultaneously damaging to health and 
necessary fo r attaining it were explored. Discussion took place around the marginalisation of 
the inseparable 'toxic' aspects of treatm ent which are ignored by current services. A key 
finding is tha t the current focus on increasing effectiveness and medical progress, w ith 
regards to  treatm ent (see Fraser and Seear, 2011), obscures the impact o f treatm ent and the 
need to  pay attention to  the wider implications and barriers when living with hepatitis C. The 
singular nature o f the treatm ent response makes living w ith hepatitis C an increasingly 
invalid ontological status (Hughes, 2012).
The privileging of the remedy (and the silencing of the poison) became particularly clear in 
participant discussions of the post treatment experience and the way in which this phase of 
living w ith the virus is poorly addressed and acknowledged. This is a materialisation of the 
politics and authority o f medicine - effects of treatment which cannot be managed with 
medication are marginalised. Acknowledging treatment as pharmakon forces us to  think 
through ambivalence, the need to accommodate illness in becoming well, and develop this 
w ithin services fo r hepatitis C.
The related concept o f pharmakos, meaning scapegoat, was also used to explore the intra­
action between hepatitis C, injecting drug use, treatment and treatment effects. Pharmakos - 
a concept I discovered fortuitously in reading both disability studies literature and literature 
from the drugs field - was used to highlight commonality between those with hepatitis C and
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(other) disabled people. The crossover in these two bodies of literature lends weight to  my 
argument that hepatitis C should be considered as a disability issue.
The concept o f pharmakos is both timely and relevant given that scapegoats are most 
commonly utilised in times of difficulty and unsettlement to rid the community o f that which 
does not conform to  moral order. At the time of writing, the coalition government has 
planned, or implemented, deep and enduring cuts to services which provide support to 
those who most require them (Soldatic et al., 2012; Patrick, 2012), together w ith increasing 
pressure on resources and services. The focus on depleted and stretched resources (within 
the NHS, local authorities and government spending) enacts and materialises hepatitis C 
participants and treatm ent as pharmakoi at various points. Treatment as pharmakos is 
visible in that it acts as a remedy for overstretched services. Those with hepatitis C are 
enacted, and re-enacted, as pharmakos for the needs of the wider community, by reducing 
pressure on NHS resources, available livers for transplant and the potential spread o f the 
virus in the w ider community. The limited attention paid to post treatment effects in service 
responses also enacts participants as pharmakos for the 'failures' of medicine.
The concept was also used to  highlight parallels between people w ith hepatitis C and the 
historic treatm ent o f disabled people. As those with hepatitis C exist on the margins, so too 
do (other) disabled people. The increased scapegoating of disabled people who attem pt to 
claim benefits - which extended to  participants with hepatitis C - directly influenced their 
willingness to claim and identify as disabled, and re-enacted a disabled identity as 
undesirable (Garthwaite, 2011). Scapegoating was also particularly visible in the pressure 
participants fe lt to  do treatm ent (via discourses of uncertainty, infectiousness and 
responsibility fo r health), particularly in light of participants internalised perceptions of 
hepatitis C as 'self-inflicted'.
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The thesis highlighted how those who take treatm ent existed 'inside' and 'outside' of 
communities and institutions; for example, the current emphasis on treatm ent (and the 
experiences of both structural and psycho-emotional disablism) enacts hepatitis C as 
something which must be eradicated. Yet, people with hepatitis C remain integral to  clinical 
trials, professional development and employment of a diverse range of professionals.
Furthermore, treatm ent was described by participants and professionals as a 'turning point' 
when this actually occludes the power relations which only make treatm ent available to 
those who have stopped using drugs. For those who had previously used drugs, a clear 
division was not maintainable given the crossover w ith the drug use ritual evoked in 
treatm ent preparation, and the blurring of boundaries between good and bad drug use. 
Treatment fo r hepatitis C was frequently prioritised over other medical investigations or 
surgery. Whilst this may be connected to contra indications associated w ith anaesthetic or 
viral load, others described being told that doctors did not want to put themselves at risk, 
potentially pushing them further onto the margins and ultimately further into treatment.
It is im portant to  say here that research questions two and three are co-constitutive and 
have mutually informed each other, hence the focus on psycho-emotional disablism 
explored below.
Research question three
To what extent do participants experience stigma and discrimination?
Stigma has been recognised as a key component o f the experience of living w ith hepatitis C 
(Crofts et al., 1997; Treloar and Hopwood, 2003; Richmond, 2008) and I initially set out to 
explore experiences o f stigma and incidences of discrimination among people living w ith 
hepatitis C in the UK.
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I have been informed by Harris (2009a) recent work which explored how stigma is 
constituted for people w ith hepatitis C and that of Fraser (2011) which highlights that stigma 
does not exist prior, but is enacted and materialised through specific practices. The thesis 
has built on this work, recognising the power relations and forces which constitute hepatitis 
C as stigmatised and undeserving. For example, the hidden and fluctuating nature of 
impairment and treatm ent effects, the 'individual' and variable nature of treatment, and the 
association between drug use and hepatitis C, all of which impact on participants' wellbeing 
and shape w ider (perceptions of) entitlement to support.
A key finding is that although participants made frequent reference to  stigma and did 
describe serious incidents o f directly stigmatising treatment (for example, having their blood 
labelled as infectious, being avoided by professionals, being deterred from surgery), these 
incidences were less common than participants accounts of knowing and feeling  that 
hepatitis C was stigmatised irrespective of whether they had experienced it. Many 
participants described feeling shocked, embarrassed or inferior in interactions w ith friends 
or professionals, which was enacted on a macro level in the structure and funding of 
responses. This, coupled w ith the frequent referral to the 'individual' experience of living 
w ith hepatitis C, limited infrastructure and the lack of awareness or profile of participant 
rights and entitlements under legislation and guidance, opened up an opportunity to 
recognise and discuss participants' experiences in terms of oppression and disablism, rather 
than stigma - specifically the experience of psycho-emotional disablism.
The decision to  theorise the experience of hepatitis C using disability studies is 
commensurate w ith the political and ethical commitments outlined throughout the thesis 
concerning the kinds o f realities I want to enact. The move away from stigma, (which can be 
individual and has pervaded the hepatitis C literature) was an important aspect o f this thesis.
405
Talking about hepatitis C as disablism breathes new life into participant experiences and the 
action to  be taken.
Recent work by Harris et al., (2012), Paterson et al., (2013) and Butt et al., (2008), has made 
the links between stigma and wider social and institutional structures, which meant that the 
tim e is particularly ripe to initiate a discussion around disablism and hepatitis C. The 
concept o f psycho-emotional disablism, which recognises that oppression operates at an 
inner level affecting not only what people can do but what they can be (Thomas, 1999; 2007; 
Reeve, 2008; 2012a), was highly relevant to  the experience of living w ith hepatitis C.
Participants described experiencing structural disablism in the services they visited. They 
referred to  inaccessible and remote services, cramped and run-down clinics, segregation 
from others, difficulties w ith transport to and from appointments, lack of information and 
support, and lack o f reasonable adjustments in employment. These barriers were rooted in 
poor understanding and inadequate recognition of the needs and experiences of people w ith 
hepatitis C. These structural barriers and challenges functioned as a message that people 
w ith hepatitis C were unworthy of support and needed to be hidden from view, thus re­
enacting hepatitis C as trivial and unwelcome in wider society; what Reeve (2012a) terms as 
indirect psycho-emotional disablism. Given the current constraints to services and lack of 
available funds, it is possible these experiences will increase rather than decrease.
The thesis has explored how frequently in attempting to address or circumvent stigma, 
participants both resisted and became complicit in their own oppression. The hierarchy of 
impairment, a manifestation of internalised oppression and a central component in psycho- 
emotional disablism, has been explored at length under research question two, but is clearly 
a central component in addressing research question three, as the comparisons w ith cancer 
can be interpreted as a manifestation of absorbed negative perceptions and a form of 
resistance.
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Participants also described passing' (explored above) or using disclosure strategies which 
concentrated on more acceptable (i.e. household) transmission routes - thus marginalising 
drug use. This may have implications for some participants' sense of self by denying, or 
maintaining, the unacceptable nature of their former drug use in the w ider goal o f telling 
people about it. Further to this, the focus on transmission route means that participants are 
fulfilling a w ider education role rather than garnering support for themselves.
Here participants' information and support needs, intra-act w ith cultural position and 
psycho-emotional disablism. Participants described information (what little there was) 
enacting hepatitis C, and therefore themselves, in particular ways (Fraser and Seear, 2011). 
For example including a focus on transmission at the treatment stage, maintains hepatitis C 
as transmissible and negative and carried only by people using drugs. Further, media images 
related to  'scrounger rhetoric' inhibit participant sense of entitlement to  benefits enacting 
them as scapegoats for poor government spending plans and priorities. Information on the 
DWP/Hepatitis C Trust website which enacts benefits as a form of dependency reinforces the 
dominant position that they should not be claiming. This overlooks that benefits can be a 
form  o f maintaining work and marginalises the daily challenges which those with hepatitis C 
face.
There was evidence that although many participants were concerned fo r their health 
(connected to  the 'uncertain' nature of hepatitis C and its im pact) other participants sought 
treatm ent for moral and ontological reasons; this suggests that living w ith hepatitis C was 
not acceptable158, that taking treatment was part of taking responsibility, or was a way of
158This sense of ontological invalidation is unlikely to be assuaged by messages from the national 
hepatitis organisation, The Hepatitis C Trust, which state: knowing you are no longer carrying an 
infectious and harmful virus may help you to feel better about yourself . Whilst it is not my intention 
to dismiss that this may be the case for some people (indeed, was the case for my participants) here 
contagiousness is prioritised over harm and there is an increased sense of responsibility to do 
treatment.
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addressing feelings of shame and dirt, and the concern that it might be passed on to  others, 
rather than explicitly having concern for their own health.
Furthermore, the marginalisation of the post treatment experience discussed above, enacts 
those who can no longer be treated w ith available drugs or whose impairments cannot be 
quantified through testing, as of limited concern and 'w orth ' to medicine (see Reeve, 2004). 
In practice, the lack of support enacts those for whom treatment failed as o f little interest 
unless they can participate in newer clinical trials.
Disclosure (or not) o f hepatitis C status proved to be a key element and event in the 
experience of stigma, discrimination, and what I subsequently theorised as incidences of 
psycho-emotional disablism. Participants described protecting others from what they fe lt 
was an unacceptable diagnosis or a diagnosis acquired via unacceptable behaviour. Some 
described feeling compelled to disclose for the safety and wellbeing of others (see above); 
others described taking a more balanced approach and were better informed o f the 
requirements to  disclose.
Naming the experiences of people w ith hepatitis C and the subsequent impact on them as 
disablism, enacts and materialises it as recognisable and unacceptable, and connects 
individual feelings and experiences to wider societal, cultural and political structures. It also 
opens up the possibility for collective action with other disabled people and organisations 
lobbying for the rights and possible ways to address it (i.e. improved relationships with 
workers and lessons from existing services). It also highlights the cross cutting nature of 
experience, such as those described by co-infected gay men and offers the opportunity to 
explore the intersection between disablism related to  hepatitis C and that faced by those 
who use drugs, where little research exists.
Participants described resisting negative views, although this often depended on how the
initial diagnosis was handled, their previous experiences and messages from peers. This
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reinforces M ilton's (2012) findings that positive relationships w ith others can combat 
psycho-emotional disablism. Reeve (2012b) points to the importance of teaching student 
professionals (specifically social work students) about the impact o f psycho-emotional 
disablism and how to  combat it in the course of their work. Opening up this discussion to  a 
w ider number of students and professionals, not only addresses disablism on a micro level, 
fo r the individual service user, but helps move hepatitis C into an arena where it can be 
discussed as a disability issue.
This chapter has brought together the key findings from the research and addressed each of 
the three research questions in turn. Research findings are intertw ined and overlap, 
testament to  the messy and complex enactments of hepatitis C as experienced by those 
living w ith  it. Drawing on these conclusions, and acknowledging the intertw ining of hepatitis 
C services, appendix one makes important recommendations for practice.
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Appendix one: Recommendations and areas for further
research.
The findings presented in this thesis support a number of recommendations at an academic, 
practice and policy level, to improve responses to living with, and being treated for, hepatitis 
C. Before discussing these in greater depth, an important point must be made:
This thesis has explored the multiple, messy nature of living w ith hepatitis C: how the virus 
and people w ith it are co-constituted and enacted via social, cultural and political forces 
(Fraser and Seear, 2011). It has emphasised that understandings presented here are 
necessarily partial, thus raising issues and questions regarding the development of 
recommendations, which imply stability.
The theoretical commitment to  contingency is balanced with the commitment to positive 
changes for people w ith hepatitis C - something which inspired and sustained this research 
from  the outset - and the need for actionable points which can be absorbed, and 
implemented, by services and policy makers in these 'messy' times.
Thus, recommendations are based on the enactments of hepatitis C made visible within this 
thesis, w ith the aim o f contributing to  realities and enactments with new social and material 
consequences159 although is important to acknowledge that these recommendations have 
the ir own agentic qualities (Moore and Measham, 2012). In managing this, I have paid 
attention to, and reflected on, the kinds of realities I want to contribute to, w ith a 
mindfulness (Warin, 2011) about my choices.
The chapter is organised into areas of recommendation. This is then subdivided into sections 
fo r relevant groups, though clearly recommendations in one area intra-act with others.
159 For example, challenging the dominance of a medical response and bringing into being realities 
which acknowledge the role of social support and social work alongside this.
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Although co-infection is covered in a specific section below, all recommendations should be 
considered in the context of addressing co-infection.
Key recom m endation: Developm ent of local and national services and  
in frastructures of support across the UK.
This thesis has shown that there is a vital need for the development and improvement o f an 
infra-structure o f support, both locally and nationally, w ithout which the silent nature of 
hepatitis C is fu rther reinforced. Given the current changes to  public services, the NHS and 
welfare, these recommendations are particularly important and timely.
All stakeholders
1. Adequate funding and investment in hepatitis C awareness, education, testing, 
support and treatm ent should be addressed as a matter o f urgency. This is the 
cornerstone of the recommendations which follow, w ithout which the 
recommendations will be difficult and even impossible to  implement, ultimately 
leading to  longer term costs both at a micro and macro level.
2. Addressing hepatitis C and co-infection needs to be recognised as a priority by 
service commissioners, including new NHS Health and Wellbeing Boards, Clinical 
Commissioning Groups and Local Authorities.
3. Local hepatitis C and/or blood borne virus strategies need to be developed in all local 
areas as a m atter o f urgency, w ith clear delegation of responsibility for development, 
implementation and review. Links to existing cross cutting strategies, teams and 
actions should be made. As this thesis has shown, participant needs went beyond 
drug services, so inclusion only in drug strategies is inadequate.
4. Local multidisciplinary networks of services, including sexual health services, social
work/care services, HIV services, housing services, drug services, financial support
services, and health (including mental health) services, should be brought together
411
to  explore the issues in their local areas and to plan and develop services which 
acknowledge social, as well as medical, consequences of hepatitis C.
5. There is a need fo r adequate recognition and funding for support around the issues 
raised by hepatitis C (and its treatment) more widely. This includes funding for 
treatm ent, but also extends to  support around housing, benefit changes, 
employment and co-infection w ith hepatitis C.
6. Social workers, as professionals who are trained to challenge oppressive systems 
and to  enable service users to empower themselves, should be lobbying for 
improved and expanded hepatitis C services, included integrated services and 
specialist social work teams.
7. Social workers should also be emphasising their unique role in supporting people 
w ith hepatitis C across user group,. This has the potential to be mutually beneficial in 
terms of addressing negative perceptions given that hepatitis C and social work and 
social workers are potentially poorly understood in the media and in wider society.
8. Specific, tailored information should be developed for various professional groups 
(e.g. housing service and social workers) and made easily accessible, to highlight 
where and how hepatitis C is relevant to them and junctures where they might 
become involved.
9. Consideration should be given to expanding the remit o f HIV services to  incorporate 
hepatitis C. This enfolds the needs of people with hepatitis C into an established and 
high profile service. This is not to obscure the differences in need or services for the 
different viruses, but to improve the availability o f support and to  promote the 
recognition of hepatitis C among HIV services. Clearly this requires adequate funding.
Key recom m endation: Increased awareness, in form ation and 
know ledge
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Based on the findings of this thesis, specific recommendations here relate to  the 
development and enhancement of awareness of hepatitis C, the distribution of 
inform ation and the development of knowledge.
General public
In addition to  current campaigns, there is a need to:
1. Expand campaigns to  highlight the nuanced and complex experience o f hepatitis C 
w ith a range of representations. Those that identify the need fo r testing should sit 
alongside representations of what it is like to live w ith hepatitis C on a daily basis, as 
personal and embodied experience160, which includes representations of how a body 
w ith hepatitis C (and on treatment) might feel. This is intended to  encourage testing, 
highlight the need fo r support and garner greater attention from a wider range of 
organisations.
2. Greater attention to the context of living w ith and being treated for hepatitis C, and 
the structural and psycho-emotional barriers, should also be addressed in 
information and awareness campaigns, including the subsequent impact on 
employment, social relationships, and finances.
3. Specific attention should be paid to the assumptions inherent in information 
provision and information should be developed in ways which do not perpetuate 
negative views around hepatitis C.
4. There is a need for a greater cultural presence of hepatitis C. This clearly requires 
further research but might include sensitive and accurate media portrayals, including 
characters in radio plays, soap storylines, medical dramas, as well as a greater 
number o f billboard campaigns and 'real life' stories.
160 Lesley Jenkins Radio 4 appeal is an example of this (see BBC Radio 4 appeal for the Hepatitis C
Trust, 2012).
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5. The presence of hepatitis C in a greater number of public places., emphasising that 
hepatitis C is a part of life, not just part of a health campaign which people perceive 
as relevant or not. This might include partnerships with chains or brands which 
display messages and information about hepatitis C on products, or leaflets which 
can be picked up. This could build! on recent progress made by the World Hepatitis 
Days over the last three years, with targeted campaigns to' tie' in with this.
C o -in fe c te d  gay m en
Further research' is needed here, but as a starting point the following recommendations are 
made around increased awareness among the gay population, specifically those who are HIIV 
positive:
1. Press and poster campaigns highlighting hepatitis C and HIV co-infection, both online 
and offline in public places.
2. Harnessing social networking to raise awareness and provide signposting to  support.
.3. Combatting the structural silence around hepatitis C via inclusion of it in gay men's
health surveys, local awareness campaigns and! academic social research literature.
4. The development of specific drug use and harm reduction messages, and 
information messages available locally.
5. Development of local and national strategies around co-infection.
6. Specific training and' awareness around co-infection fo r professionals such as drug 
workers, HIV support workers and social workers.
7. Personal stories in the gay press, hepatitis C specialist organisation websites and HIIIV
specialist orga nisation websites.
m  For WHO 2013, Scotland's "big red C  campaign which, ran alongside the Hepatitis C Trust's big, 
purple C campaign in England displayed giant {two metre high} 'Cs' in public places across Scotland, in 
areas where local NHS boards were involved in the campaign. These were accompanied' by volunteers 
who answered questions and provided information. In England these were accompanied by members 




1. Specific information and guidance should also be developed across a number of 
areas fo r family, friends and carers; including clear and realistic information 
regarding transmission and the implications of a diagnosis, on treatm ent and post 
treatm ent, highlighting the fluctuating and hidden nature of hepatitis C impairment 
effects, as well as managing the impact on relationships and emotions.
2. This should be developed in partnership w ith current and previous families who 
support people w ith hepatitis C, and be made available both in w ritten formats and 
online.
3. Adequate support should also be available for those caring fo r people w ith hepatitis 
C.
Professionals
This research found that living w ith hepatitis C impacts in multiple ways and that specific 
guidance and training should be developed and delivered specifically fo r the professionals 
outlined below:
Department for W ork and Pensions and ATOS staff
1. There is a need fo r greater training and specific guidance for DWP and ATOS staff
around hepatitis C (and co-infection) impairment and treatment effects.
2. Ideally this would take the form of dedicated organisational training, but as a 
minimum should extend to accurate updated information on the DWP website.
3. This should address the cumulative impact of illness experienced before diagnosis
and before treatm ent (which may affect eligibility for benefits), the effects of
treatm ent and post treatment, and the impact this can have on a person s life.
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4. This should be regularly updated in line w ith welfare reforms and treatm ent 
developments.
Welfare Benefits Advice Organisations
1. These services should also be provided w ith easily accessible training and guidance 
on hepatitis C in order to inform people about possible forms of support and welfare 
benefits applications, and to  assist with completing and appealing these where 
necessary.
2. Cuts to  legal aid and funding for welfare benefits organisations should be 
reconsidered urgently, given the disproportionate impact o f the cuts upon those 
hepatitis C is likely to  affect.
Social w ork teams
1. There is a need fo r UK specific guidance and information for social workers (team 
specific), explaining where and how hepatitis C (and co-infection) might be an issue. 
This might include providing support to parents on treatment w ithin children and 
families teams, acknowledging the additional needs materialised on treatment which 
may interact or exacerbate existing impairments. It might also include supporting 
older people to  access testing and treatment, as well as those working on specific 
substance use teams. Guidance should be developed in partnership w ith specific 
service user groups.
2. There should be a greater presence of hepatitis C on professional social work 
education courses - at undergraduate, postgraduate and continuing professional 
development levels. This might be included on courses that deal w ith substance use, 
immigration and asylum seeking, child protection as well as disability and ageing.
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3. This might eventually be extended to  broader health and social care courses, such as
National Vocational Qualifications, for those who may work in support
worker/personal assistance roles.
GPs
There is still an urgent need to  raise and augment awareness among GPs across the UK.
1. There should be a greater presence of hepatitis C within GP surgeries - posters,
support groups, televised messages on electronic noticeboards, and availability of 
oral and dried blood spot tests.
2. 'Conversation starters' should be developed to enable patients and GPs to  discuss a 
test, treatm ent or diagnosis.
3. Greater awareness of the availability o f training for GPs. Ideally all, but at least one
GP in each practice should have the Royal College of GPs hepatitis B and C
certificate.
4. Contact details (e.g. to a local liver specialist, or specialist support service) should be 
easily available fo r GPs delivering test results or who have questions.
5. Training and education around awareness of extra-hepatic manifestations of 
hepatitis C should be rolled out and testing offered to  those w ith common extra- 
hepatic manifestations.
Key recom m endation: Access to swift testing
Stakeholders with responsibility for testing
1. Consideration should be given to the expansion of innovative testing practices, such
as mobile testing, dried blood spot testing and testing by peers as part o f local
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strategies. Clearly this would need to be accompanied by seamless and easily 
accessible aftercare and adequate training.
2. Consideration should also be given to incidences where routine testing should be 
offered, including routine annual testing to those over 40 years old, pregnant 
women and those presenting w ith common extra-hepatic manifestations162.
3. In addition, GPs should check annually whether a person has ever been tested for 
hepatitis C and whether they are aware of the results. This could also provide an 
im portant juncture to  discuss treatment and support for those who may not have 
fe lt ready to  address it.
4. Local services (including social work services and substance use services) should be 
aware of local referral procedures for testing and support.
Key recom m endation: Support around diagnosis
Greater attention should be paid to the post diagnosis period.
All stakeholders
1. There needs to  be clear preparation for a diagnosis every time someone is tested. 
Participants should be aware when they are being tested, why and what the 
implications of a test (both positive and negative) are.
2. Post diagnosis support should include provision of clear, printed information and 
signposting to  relevant websites.
3. Participants should be clearly directed to relevant sources of peer support, including
support groups and forums.
162 Clearly this is highly dependent on the existence of a solid infrastructure of support to deal with 
increased diagnoses, one which is not focused only on clearing the virus, but supports people to live 
with it.
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4. A point o f contact should be provided to  address questions and issues between 
diagnosis and referral to treatment.
5. Social workers could play a key role here in acting as that point o f contact and 
consideration should be given to how they could become integrated into services 
providing diagnoses. A key observation here is that social workers are uniquely 
placed to  understand hepatitis C in the context of participants lives, as something 
that (with the correct support) it is possible to live well w ith, rather than something 
which needs to  be cured or fixed.
6. Counselling following diagnosis should be offered routinely as an available option for 
those who feel they need it, irrespective of transmission route.
7. A number o f participants suggested that 'buddying' (the pairing of someone living 
w ith hepatitis C w ith someone recently diagnosed) could function as a valuable 
source o f support here. Consideration should be given to developing these services 
in local areas.
Key recom m endation: Providing holistic support
There is a need fo r multidisciplinary involvement and support o f people w ith hepatitis C 
w ithin the specific context o f their lives, particularly the cumulative impact o f treatment.
1. Multidisciplinary teams and networks of support need to be developed and piloted 
in order to  contribute to  a more even coverage of support across the UK. These 
should include medical and social work staff as well as trained peers. Examples of 
integrated services already exist in the literature and these should be trialled at the
earliest possible opportunity.
2. Specific attention and support should be provided with regard to  childcare, 
maintenance o f tenancy, employment and financial stability. Support services in the 
local area should be developed across the UK, including the expansion of the role of
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specialist hepatitis C (or blood borne virus) social workers and the integration o f this 
support w ith in wider social work teams. Specific areas of support are addressed 
below.
Mental health services
1. Psychological/counselling support should form a component o f a consistent 
multidisciplinary service, available for those who need it.
2. Funding should be provided for out o f hours support, specifically a telephone 
helpline which provides social and emotional support fo r people on treatment. This 
could incorporate HIV and other BBV support to be cost effective. Further research is 
required into how and where this should operate, though it was fe lt to be important 
tha t this was staffed by people who have had experience o f hepatitis C and its 
treatm ent.
The role of social work
As well as the recommendations that have gone before:
1. Funding, training and development of specialist social work roles (both fo r hepatitis 
C and for blood borne viruses), as part of a multi-disciplinary response to  hepatitis C, 
should be developed across the UK to facilitate access, to support through treatment 
and to  recognise the messy and contingent nature of the experience.
2. Consideration should be given to how social work (both statutory and third sector) 
can take a greater role in supporting people with hepatitis C, including the provision 
o f self-directed support and alliances between local authorities and new NHS and 
wellbeing boards.
3. The valuable and unique role that social work can plsy in the lives of those with 
hepatitis C needs to be urgently recognised both by those within and outside the
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profession. Social work involvement needs to go beyond basic information and 
signposting towards a more active role in discussing hepatitis C in the context of 
service users lives.
4. Social workers have a clear potential role at every stage of the hepatitis C 
experience, from supporting w ith undiagnosed chronic illness, to  supporting through 
a test and post diagnosis, referring to  treatment, advocacy and peer support and 
supporting through treatment. Specifically social work could provide support w ith 
issues that participants in this research maintained were overlooked; issues related 
to  co-infection, housing, finances, childcare, family and relationship issues and the 
emotional impact. There is also a unique role for social work in the post treatment 
phase where medical support is limited.
5. Brief training and information on hepatitis C and its treatment should be distributed 
to  those who take social work referrals, emphasising the potential role fo r social 
work support.
Housing services
1. The impact o f hepatitis C (treatment) needs to be made clear to  housing support
services so that people can be assisted to find suitable housing and maintain their 
tenancy to  avoid extra stress.
Welfare benefits
1. Specific, easily accessible guidance should be developed around available benefits for 
people w ith hepatitis C (including PIP and ESA).
2. A ttention should be paid to  the assumptions and enactments contained in 
information. Guidance should not perpetuate the idea o f welfare benefits as a form
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of dependency and recognise that it can in fact facilitate a return to  work and 
address disabling barriers.
3. Those undergoing treatm ent should automatically be placed in the Support Group 
when claiming Employment Support Allowance.
4. Those w ith compromised immune systems should be provided w ith home visits.
5. Applications fo r Disability Living Allowance (and later Personal Independence 
Payment) should take account of the amount o f time a person may have been living 
w ith illness and the cumulative impact this will have on their wellbeing.
6. The possibility o f post treatment effects should also be included and this should be 
made clear in guidance and information.
7. W ider recommendations commensurate w ith the findings of other disabled people's 
organisations are relevant here, including the implementation o f recommendations 
regarding taking more adequate account of fluctuating and variable impairments.
8. Links between hepatitis C services and other disability groups (i.e. Disability Benefits 
Consortium) should be forged to  provide a unified voice addressing issues o f concern, 
including cuts to  services and difficulties around welfare benefits. This would also 
raise the profile o f hepatitis C as an issue which should not be addressed solely by 
increases in medical treatment.
Peer support
1. There is a need for greater formalised and funded roles fo r peers in supporting 
people w ith hepatitis C at every stage, and in a variety of innovative ways alongside 
professionals.
2. This includes the development and maintenance of local support groups, social 
events and 'buddying', as well as online support, telephone support, and links to 
w ider multidisciplinary networks.
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3. Peers should be adequately funded, trained and supervised w ith a clear professional 
job description and boundary.
Transport
1. Patient transport to  appointments, or funding to cover the costs o f taxis, should be 
provided to  enable participants who may be experiencing impairment, treatm ent or 
post treatm ent effects to travel as comfortably and easily as possible.
2. Consideration should be given to providing services more locally to  reduce travelling.
Key recom m endation: Support around em ploym ent 
All stakeholders
Those who wish to  continue to  work should be supported to do so through provisions such 
as:
1. Reasonable adjustments under the Disability Discrimination Act 1995, 2005 (now 
covered under the Equality Act, 2010) including flexible working arrangements, 
working from home where possible and provision of equipment to facilitate this.
2. The work that participants are already doing unpaid (i.e. awareness raising and 
support via online forums) should be recognised, not least by DWP staff and local 
hepatitis C services.
3. Information regarding benefit entitlement for those who continue to  work should be 
developed and easily accessible.
4. Specific guidance, information and training should be developed for employers 
around employing someone with hepatitis C and supporting someone on treatment 
— similar to  the recently developed Macmillan Toolkit fo r employers. This would
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enable those w ith hepatitis C to stay in work and to  increase the visibility o f hepatitis 
C treatm ent in the workplace, w ithout necessarily requiring disclosure.
5. Paying attention to  the education, training and responses of employers and staff 
would take the sole focus from the person disclosing.
6. Specific guidance and support around employment rights should be developed and 
easily accessible.
Key recom m endation: Attention to post treatm ent effects
The post treatm ent phase needs to  be explicitly acknowledged through provision o f both
formal and informal support.
All stakeholders
1. Information on possible post treatment effects should be provided before the end of 
treatm ent by the professionals involved in their care, so that appropriate post 
treatm ent arrangements can be made (i.e. continuation o f agreements w ith 
employers, childcare arrangements).
2. Digestible information which can be referred back to should be available. This might 
take the form of a post treatment guide written by service users and professionals.
3. Models o f support may be derived from existing services where post treatment is 
acknowledged as a specific phase requiring information and support (i.e. cancer 
survivorship services/application of the concept of 'recovery in').
4. Post treatm ent support protocol should be developed, such as: buddying for 12 
months post treatment, contact details for a specialist nurse, routine follow  up 
appointments or telephone conversations beyond attainment o f 6 month SVR to 
establish post treatment requirements. . This could also include referral to  and
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support from a social worker working alongside medical professionals in addressing 
post treatm ent related issues.
5. Awareness o f post treatment effects needs to be raised among professionals who 
may come into contact with people in the post treatm ent phase, including: GPs, 
social work staff, DWP (and ATOS) and welfare benefits advice staff. Clear guidance 
and information regarding post treatment effects should be provided, including how 
these may impact on a person's life. Information on post treatment effects should be 
updated as new information is gathered.
6. Post treatm ent effects should be adequately taken account o f in applications for 
welfare benefits. Participants should be informed that they should continue 
applications and appeals of welfare benefits because of the possibility o f on-going 
treatm ent effects.
7. Support networks of family and friends may be expecting those who have finished 
treatm ent to feel better immediately. Clear information and guidance about post 
treatm ent effects should be provided to them in advance of the end of treatment.
8 . Adequate support should be available for those providing care and support post 
treatm ent, via telephone, online and in person. This could also take the form of 
support from social work staff.
Key recom m endation: Discussion as a disability issue
Hepatitis C could benefit from being discussed in both academic and practice arenas as a 




1. There is a need for greater academic attention to the qualitative experience of 
living w ith hepatitis C, which goes beyond current medical focus, particularly in 
light o f the development of new treatments.
2. A ttention should be paid to  exploring how greater numbers o f (disabled) people 
w ith  hepatitis C can participate in the research process, including the development 
o f peer researcher training programmes and steering groups, so that pertinent 
areas of research can be identified.
Activist groups and movements
1. In order to  promote solidarity and action over issues that cut across groups who face 
similar barriers to  participation, consideration should be given to how to develop 
links between people w ith hepatitis C and other chronic illnesses (i.e. Fibromyalgia, 
Cancer, Lupus), and other disability organisations (i.e. DPAC, We Are Spartacus) and 
blood borne virus organisations.
Key recom m endation: Addressing disablism
1. Explicit acknowledgement and publicising of hepatitis C as impairment covered 
under the Equality Act (2010) may provide validation and support to  people living 
w ith hepatitis C.
2. Specific guidance should be produced which details and explores where, and how, 
people w ith hepatitis C would be covered; this should be easily accessible and widely 
distributed.
3. Poor treatm ent experienced by people w ith hepatitis C should be recognised as 
disablism, elevating it to a similar status as racism and sexism. Acknowledging the 
impact o f disablism, specifically psycho-emotional disablism, means that participants 
gain recognition of the experience and validation.
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4. This should comprise a specific area of training for organisations involved w ith 
people who have hepatitis C. As Reeve (2008; 2012b) has noted, this could begin 
w ith  education of undergraduates and master's students, trainee social workers, 
nursing and medical students.
5. Comparisons that participants made with cancer and HIV should be used as points of 
reflection and discussion among professionals concerning the current cultural 
position of hepatitis C. This should be used as a starting point for developing services 
and raising awareness.
6. The focus on newer treatments should not be used as a reason to  elide 
responsibilities fo r developing support (not least because of new treatment costs). 
Even in the event that hepatitis C becomes a curable virus w ith a very short 
treatm ent, w ith no side effects, those living w ith hepatitis C will likely still require 
support (including treatment advocacy) by virtue of the cumulative and intra-active 
nature of living w ith hepatitis C, their life circumstances and existing impairments.
7. Information which focuses less on transmission and more on how people with 
hepatitis C can be supported combats the internalisation of negative beliefs.
Areas for fu rth e r research
There is a lim ited body of qualitative research exploring the experience of living with 
hepatitis C in the UK. This needs to  be expanded as political and service reforms and drug 
developments continue, and services change.
In particular this exploratory study could be expanded to incorporate those whose views 
have not been made present in this thesis, including those who have immigrated to the UK 
and encounter both cultural and language barriers, as well as structural ones. There is also 
an urgent need for an expansion of research into the experience of living w ith HIV and 
hepatitis C co-infection, including awareness raising, support needs and treatment
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experiences. The support and information needs of family, friends and carers fo r people w ith 
hepatitis C also need to  be researched.
There is a need for research w ith professionals, including social workers, DWP staff, GPs and 
hepatitis C specialist staff, specifically w ithin the UK, to explore their understandings of their 
roles and responsibility around hepatitis C; this is especially important in light o f the major 
changes and cuts to  services.
The support needs of those currently using drugs could be further researched, specifically in 
the context o f life history interviews exploring the incorporation of hepatitis C and its long 
term  impact on the ir lives as a whole - both for those who have done treatment and those 
who have not. The intersection between hepatitis C, impairment, disability, drug use and 
recovery should also be explored. Vitally, models of multi-disciplinary support fo r those living 
w ith hepatitis C should be further researched and developed.
I  Support P r l  p r p  p
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Appendix Two: Request for participants
REQUEST FOR RESEARCH PARTICIPANTS
Do you have hepatitis C? 
Have you cleared hepatitis C? 
Do you work w ith  people who have hepatitis C? 
Where do you access support if you need it? 
What do you th ink about hepatitis C services?
I am a postgraduate research student from Lancaster University. I am researching how 
health and social care services are responding to people with hepatitis C.
I am looking for volunteers to take part in my research. I would like to talk to people who 
live w ith or who have cleared hepatitis C about their experiences of living with the virus and 
the support and services they have received. I would also like to speak to people who work 
w ith people w ith hepatitis C about the support and services they provide.
The research will involve one, possibly two interviews. The research is an opportunity for you 
to  give your views on the experience of hepatitis C. Interviews will take place between 
September 2009 and December 2010. All information you provide will be treated 
confidentially and will be anonymised.
If you are interested or would like to know more, please feel free to contact me.
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Heather Mack, Department of Applied Social Science, Bowland North, Lancaster University, 
LAI 4YTEmail: h.mack2@lancaster.ac.uk
Telephone: 01524 594118 (answer phone available)
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Appendix Three: Participant Information Sheet
Project: Exploring personal and professional responses to Hepatitis C (HCV)
Researcher: Heather Mack
PARTICIPANT INFORMATION SHEET (V2. September 2009).
About the researcher:
My name is Heather Mack and I am studying for a PhD in the department of Applied Social 
Science at Lancaster University. I would like to invite you to take part in my research.
Aims of the research:
The overall aim of the research is to explore the experience of health and social care 
services, from the perspective of people who are living with (or have cleared) Hepatitis C and 
from the perspective of health and social care professionals in the field, in order to develop 
an understanding of how the two perspectives can contribute to improved responses to 
HCV.
The participant's role
I would like to  invite you to take part in an interview (either in a group or by yourself,
whatever you prefer). The interview will take approximately 1 — 1.5 hours. I would like to
conduct all interviews face to face, but I am happy to conduct individual interviews over the
phone or the internet (via email, MSN, or webcam) if that is easiest for you. We can
negotiate a suitable time date and place for the interview. I have access to rooms at
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Lancaster University but would be happy to travel to a location which is most convenient for 
you.
I intend fo r the research to have two stages;
Stage 1: Focus groups/interviews with people like yourself, who have experience o f living 
w ith Hepatitis C and receiving Health and Social care services.
Stage 2: A fter I have conducted Focus Groups/Interviews I would like to  use the general 
findings to  help me develop questions to ask a range of Health and Social Care professionals 
in interviews. All information you provide will be used anonymously and confidentially.
A fter these interviews have been carried out I may ask you if you would like to participate in 
a second focus group/interview to discuss the (anonymous and confidential) findings and 
how they will be used in the final piece of work and beyond.
Please remember that your participation in this research is entirely voluntary, you have the 
right to  w ithdraw  at any time during the interview process and do not have to give a reason 
for doing this.
All interviews will take place between September 2009 and August 2010. Before we meet I 
will send you a copy of the interview questions, so that we can discuss any topics/areas 
which you might be unsure about.
All interviews w ill be tape recorded and written out in full (transcribed). During the interview 
you have the right to  stop, start or rewind the tape at any point. The recording will be 
confidential and I w ill be the only person who has access to it.
A fter I have transcribed the interview, you will be sent a copy so you have the opportunity to 
review the transcript and amend your comments.
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Before we conduct the interview I w ill ask you to sign a consent form to show you have 
received this information sheet and are willing to take part in my research. I w ill provide you 
w ith a copy of the signed form. On this form you will also have the opportunity to  choose a 
d ifferent name (pseudonym) which I will then use when quoting you in the final piece of 
work (thesis) and any publications or reports.
How the interview data will be used:
The information collected during the focus group/interviews will be used as part o f my PhD 
thesis. It might also be used in some future presentations, publications or reports. All 
information w ill be used anonymously.
A fter the first focus group or individual interview I will produce a summary of the main 
findings and how these have informed the questions for the interviews with health and 
social care professionals. Please make sure that you have provided the correct email or 
home address if you would like to receive this. Your comments on this will be welcome.
Confidentiality and anonymity
I w ill trea t all the information you provide as confidential (in accordance with the Data 
Protection Act 1998). The data you provide will be stored securely in a locked filing cabinet in 
a locked office on Lancaster University premises. I will be the only person who has access to 
it. When the research has finished all confidential information will be destroyed.
If you disclose that you intend to cause harm to others or to yourself this will result in a 
discussion of fu rther action.
The final PhD Thesis and any resulting publications will not contain any information which 
will identify you as a participant, when you complete the consent form you can choose your 
own pseudonym, this will be used in the final thesis and any additional publications. This
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means that you will be able to identify your own contribution to the research but will your 
identity w ill still remain anonymous. If you prefer not to pick your own pseudonym, I will 
choose one on your behalf. Place names will also be provided with pseudonyms in order to 
preserve participant confidentiality.
Time commitm ent
The focus group will take approximately lh o u r (excluding breaks). You may also wish to 
discuss potential questions w ith me prior to taking part and/or check through your own 
transcript and take part in a second interview. Therefore I anticipate that the total amount of 
tim e required o f you, will be approximately 1- 3 hours.
Conduct o f the researcher
If you are unhappy w ith my conduct during the interview process you can contact a person 
independent o f the study; Karenza Moore, Department of Applied Social Science, Bowland 
North, Lancaster University, Lancaster LAI 4YW. Email: Karenza.moore@lancaster.ac.uk
Sources of support and information
The Hepatitis C Trust helpline: 0845 223 4424
Staffed solely by people w ith Hepatitis C. This confidential service provides both listening 
support and information on any aspect of Hepatitis C.
Open 10.30am to 4.30pm Monday to Friday (except Bank Holidays)
Calls cost 3.5p per minute (more if you are calling from a mobile)
If you have access to  the internet you can also visit: http://www.hepctrust.org.uk/ for a 
wide range of information relating to Hepatitis C and details o f support.
The HepCnomads w w w .hepcnom ads.co .uk
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Online support forum for people who have experienced or are living w ith Hepatitis C. It can 
only be viewed by registering and all membership is free. It does focus on the social side of 
support. Carers and health professionals are also members and all are welcome.
The British Liver Trust Medical Helpline
For worries or concerns about liver disease. The free medical Helpline number is 0800 652 
7330 and is open Monday to Friday from 9am until 5pm.
You can also email your enquiry at: info@britishlivertrust.org.uk
Samaritans
For general confidential non-judgmental emotional support, 24 hours a day
Tel: 08457 909090
Email: io@samaritans.org
W rite to: Chris, PO Box 9090 Stirling, FK8 2SA
Contact Details
If you would like to ask further questions or would like to take part in the research I can be 
contacted:
Heather Mack, Department of Applied Social Science, Bowland North, Lancaster University, 
Lancaster, LAI 4YW.
Office telephone: 01524 594118,
Email: h.mack2@lancaster.ac.uk
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A p p e n d ix  Four: To p ic  gu ide  fo r in te rv ie w s
Project Title: Exploring personal and professional responses to Hepatitis C 
Researcher: Heather Mack 
Interview Schedule
This document outlines some of the topics I would like to cover in an interview with you.
I am sending it to you now so that you have an opportunity to think about how these 
questions relate to your own experiences. If you do not wish to answer a specific question or 
wish to  avoid specific topics, please let me know and I will remove them from your interview 
guide.
The areas below are to be used as a guide. I am most interested in your own experiences 
and as such would encourage you to expand on your responses and areas of specific interest 
or experience.
Opening Questions:
•  Researcher to  introduce herself, talk about the research and reiterate the purpose of 
the Interview. Go through consent form and information sheet.
• Can you tell me a little bit about yourself? (this can be anything you like)
Introductory Questions:
• Can you tell me about the first time you heard of Hepatitis C?
• When did you first realise you might have it?
• At the time, did you know anyone else with Hep C?
• What did you think when you found out you had it?
•  What was your experience of diagnosis like?
Questions about knowledge
• What kind of information were you given?
• Was this useful or not?
•  Did you need to seek further information?
• Have you always received accurate information?
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•  Where do you get your information from now?
• Do you keep up to date with the latest information?
•  Do you pass this information on to others?
Questions about identity/self-perception
•  How do you see yourself?
•  Does Hepatitis C impact on the way you feel about yourself?
•  Has this changed over time? If so, why?
•  Do you feel Hepatitis C is a part of who you are?
•  Is it an important part?
•  Do you think Hep C affects the way you feel about your body?
•  Have you told anyone about your Hep C?
•  What was this experience like?
• How do you decide who to tell?
•  Is this something you had to think about?
•  Is this something you still think about?
Questions about professional interaction
•  Thinking about the services you have received...Have you had a lot o f input from 
health and social care services?
• Which professionals have you had contact with since you found out you had 
Hepatitis C and why?
• What were they like?
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•  Were there any that were more/less supportive?
•  What did you think about this?
•  Is professional support important to you?
•  If so, what is important in a professional? If not, what kind of support is important?
•  What is important in services for people w ith Hepatitis C?
•  What issues do you think need addressing for people living w ith Hep C?
Summary Questions
•  What might you say to someone who has just found out they have Hep C?
•  Can you tell me about any positive aspects of living w ith Hep C that you don't think 
have been discussed?
•  Can you tell me about any negative aspects that you think need addressing that have 
not been discussed?
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